Total syntheses of eremophilane sesquiterpenoids based on biogenetic hypotheses by Liffert, Raphael
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2018
Total syntheses of eremophilane sesquiterpenoids based on biogenetic
hypotheses
Liffert, Raphael
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-175135
Dissertation
Published Version
Originally published at:
Liffert, Raphael. Total syntheses of eremophilane sesquiterpenoids based on biogenetic hypotheses. 2018,
University of Zurich, Faculty of Science.
   
Total Syntheses of Eremophilane Sesquiterpenoids  
Based on Biogenetic Hypotheses 
 
 
Dissertation 
zur 
Erlangung der naturwissenschaftlichen Doktorwürde 
(Dr. sc. nat.) 
vorgelegt der 
Mathematisch-naturwissenschaftlichen Fakultät 
der 
Universität Zürich 
von 
Raphael Liffert 
von 
Emmen LU 
 
 
Promotionskommission 
Prof. Dr. Karl Gademann 
Prof. Dr. Cristina Nevado 
Prof. Dr. Nathan Luedtke 
 
 
Zürich, 2018  
   
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Für meine Familie 
 
  
  
  i 
  
TABLE OF CONTENT 
Table of Content .................................................................................................................... i 
Summary .............................................................................................................................. v 
Zusammenfassung .............................................................................................................. vii 
1 Eremophilane Sesquiterpenoids ...................................................................................... 1 
1.1 Historical Background ................................................................................................ 1 
1.2 Distribution and Classification of Eremophilane-Type Sesquiterpenoids ..................... 7 
1.3 Biosynthetic Pathway for the Formation of Eremophilane Sesquiterpenoids ................ 9 
1.4 Synthetic Contributions over the last Decades ........................................................... 17 
1.4.1 Robinson Annulation Procedures ................................................................................17 
1.4.1.1 Modification of Cyclohexanone ......................................................................................... 19 
1.4.1.2 Modification of Alkylating Reagent .................................................................................. 20 
1.4.1.3 Chiral Imines as Robinson Annulation Precursors (Pfau-d’Angelo method) .................... 26 
1.4.1.4 Enantioselective 1,3-Diketone Robinson Annulation – Syntheses Starting from 
Wieland-Miescher Ketones .................................................................................................28 
1.4.2 Diels-Alder Procedures ...............................................................................................31 
1.4.2.1 Intramolecular Diels-Alder Approach ................................................................................ 31 
1.4.2.2 Intermolecular Diels-Alder Approach ................................................................................ 32 
1.4.3 Miscellaneous Approaches ..........................................................................................35 
1.5 Aim of this Thesis ..................................................................................................... 37 
2 Total Synthesis of Periconianone A ............................................................................... 39 
2.1 Introduction .............................................................................................................. 39 
2.1.1 Proposed Biosynthesis of Periconianone A ..................................................................40 
2.1.2 Strategic Considerations and Aim of this Project .........................................................41 
2.2 Results and Discussion .............................................................................................. 42 
2.2.1 Construction of the AB-Ring System ..........................................................................42 
2.2.1.1 1st Approach ....................................................................................................................... 42 
2.2.1.2 2nd Approach ...................................................................................................................... 46 
2.2.1.3 3rd Approach....................................................................................................................... 51 
 ii 
2.2.2 Construction of the C-Ring by a Double Aldol Approach ............................................59 
2.2.3 Late Stage C7 Hydroxylation Approach ......................................................................63 
2.2.3.1 Installation of the a,b-Unsaturated Aldehyde Side Chain at C7 ........................................ 63 
2.2.3.2 Aldol Cyclization of a,b-Unsaturated Aldehyde 2.68 ....................................................... 65 
2.2.3.3 Enal Reduction and Aldol Cyclization of a-Methylated Aldehyde 2.76 ........................... 67 
2.2.3.4 Dehydrogenation of the C1–C2 Bond and C7 Hydroxylation Attempts ............................ 68 
2.2.4 [2,3]-Wittig Rearrangement Approach ........................................................................72 
2.2.5 Approach Featuring C7 Hydroxylation on the Bicyclic System ...................................76 
2.2.5.1 Installation of the C7 Carbinol by Early-Stage Hydroxylation .......................................... 76 
2.2.5.2 Endgame: Aldol Cyclization, Dehydrogenation and Deprotection .................................... 80 
2.2.5.3 Optimization of the Methenylation Reaction ..................................................................... 82 
2.2.6 Successful Approach to Periconianone A by a Formal [2,3]-Wittig Rearrangement .....86 
2.2.6.1 Installation of the C7 Carbinol ........................................................................................... 86 
2.2.6.2 Endgame: Oxidative Modifications and Aldol Cyclization ............................................... 93 
2.3 Conclusion .............................................................................................................. 100 
3 Microsphaeropsisin B and C, Periconianone C: Total Syntheses and Biogenetic 
Relation ........................................................................................................................ 103 
3.1 Introduction ............................................................................................................ 103 
3.2 Results and Discussion ............................................................................................ 105 
3.2.1 First Enantioselective Total Synthesis of Microsphaeropsisin B and C ...................... 105 
3.2.2 a-Ketol Rearrangement of Microsphaeropsisin B and C to Periconianone C and 4-
epi-Periconianone C .................................................................................................. 112 
3.3 Conclusion .............................................................................................................. 116 
4 Total Syntheses of Guignarderemophilane C and D .................................................. 117 
4.1 Introduction ............................................................................................................ 117 
4.2 Results and Discussion ............................................................................................ 118 
4.3 Conclusion .............................................................................................................. 131 
5 Conclusion .................................................................................................................... 133 
6 Experimental Part........................................................................................................ 135 
6.1 General Methods and Materials ............................................................................... 135 
  iii 
  
6.2 Abbreviations, Acronyms and Symbols ................................................................... 136 
6.3 Total Synthesis of Periconianone A ......................................................................... 140 
6.4 Microsphaeropsisin B and C, Periconianone C218 .................................................... 199 
6.5 Guignarderemophilane C and D229 .......................................................................... 210 
7 Appendices ................................................................................................................... 227 
7.1 Crystal Structures .................................................................................................... 227 
7.2 1H and 13C NMR Spectra ........................................................................................ 233 
8 Acknowledgements ...................................................................................................... 235 
9 References .................................................................................................................... 237 
10 Curriculum Vitae ......................................................................................................... 247 
  
 iv 
This PhD thesis is based on the following manuscripts and parts have been published similarly 
or identical: 
 
Total Synthesis of the Sesquiterpenoid Periconianone A Based on a Postulated Biogenesis 
R. Liffert, A. Linden, K. Gademann, J. Am. Chem. Soc. 2017, 139, 16096–16099. 
 
Total Synthesis of the Polyoxygenated Sesquiterpenes Guignarderemophilanes C and D 
R. Liffert, A. Ilazi, K. Gademann, Helv. Chim. Acta 2018, doi:10.1002/hlca.201800011. 
 
The Furan Shuffling Hypothesis: A Biogenetic Proposal for Eremophilane Sesquiterpenoids 
R. Liffert, N. Lardon, A. Linden, K. Gademann, manuscript in preparation. 
 
  
  v 
  
SUMMARY 
Nature has established highly effective ways to form structurally complex molecules, and 
the elegance of these biosynthetic routes has inspired preparative organic chemists in the past 
and today. This thesis encompasses synthetic studies on eremophilane sesquiterpenoids based 
on biogenetic hypotheses. The development of a divergent approach led to the successful total 
synthesis of six eremophilane-type natural products, none of which has been synthetically 
prepared before. 
In Chapter 1, a general introduction presents eremophilane sesquiterpenes, their 
biosynthesis and strategies described in literature for the preparation of these natural products 
by organic synthesis. Eremophilanes are secondary metabolites structurally characterized by a 
decalin core unit with two one-carbon substituents at C4 and C5, and an isopropyl or 
isopropenyl group at C7. As their constitution cannot be rationalized by L. Ružička’s Isoprene 
Rule, it is not surprising that the correct structural assignment of eremophilone, the first isolated 
and characterized member of the eremophilane family, was a seven-year process including 
several proposals that later turned out incorrect.  
In Chapter 2, the first total synthesis of the complex tricarbocyclic sesquiterpenoid 
periconianone A based on a postulated biogenetic route is reported. Key elements of the 
enantioselective synthetic strategy include the use of an isopropenyl group as a removable 
directing group, a sequence featuring a Rh-mediated O−H insertion/[3,3]-sigmatropic 
rearrangement and subsequent α-ketol rearrangement, and a late stage aldol addition to furnish 
the complex cage-like framework. 
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Chapter 3 contains an account of the first enantioselective total syntheses of 
microsphaeropsisin B and C based on an intermediate from the total synthesis of periconianone 
A. In total, the synthesis of microsphaeropsisin B and C comprises a linear sequence of 15 steps 
starting from g-hydroxy carvone. Mild reaction conditions for an a-ketol rearrangement did not 
only allow for conversion of microsphaeropsisin B into periconianone C, but also for the 
transition of microsphaeropsisin C into 4-epi-periconianone C. Based on the structural 
similarities of the recently isolated eremophilane-type sesquiterpenoids microsphaeropsisin B 
and C and the iso-eremophilane periconianone C, a revised biogenetic hypothesis for C8–C11-
connected iso-eremophilanes is presented and corroborated by strong experimental evidence.  
 
In Chapter 4, the total syntheses of the neural anti-inflammatory agents 
guignarderemophilane C and D are reported. The presented synthetic route proceeds via a 
diketone intermediate from the total synthesis of periconianone A. Key for the successful 
conversion of this intermediate into both targets was finding a suitable strategy to install the 
1,2,3-trihydroxylated A-ring scaffold. For this purpose, a Mitsunobu inversion, epoxidation, 
and regioselective epoxide opening sequence has been effectively employed, before the bicyclic 
ring system was constructed by an aldol condensation reaction on a sterically demanding 
substrate. 
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ZUSAMMENFASSUNG 
Strukturell komplexe Moleküle können in der Natur über hoch effiziente biosynthetische 
Pfade aufgebaut werden, deren Eleganz präparative organische Chemiker in der Vergangenheit 
und auch heute noch inspiriert. Diese Arbeit umfasst die Entwicklung von Synthesestrategien 
für Eremophilan-Sesquiterpenoide in Anlehnung an die vorgeschlagene biosynthetische Route. 
Einer divergenten Synthesestrategie folgend wurden sechs Naturstoffe aus der Familie der 
Eremophilane hergestellt, die so erstmalig durch Totalsynthese zugänglich wurden. 
Im ersten Kapitel dieser Arbeit wird im Rahmen einer allgemeinen Einleitung die 
Naturstofffamilie der Eremophilan-Sesquiterpene vorgestellt, wobei im Besonderen auf deren 
Biosynthese sowie die bislang in der Literatur beschriebenen präparativen Arbeiten zur 
Laborsynthese dieser Naturstoffe eingegangen wird. Eremophilane sind Sekundärmetaboliten, 
die sich strukturell durch eine zentrale Decalin-Einheit mit zwei C1-Substituenten an C4 und 
C5 sowie eine Isopropyl- oder eine Isopropenyl-Gruppe an Position C7 auszeichnen. Da ihre 
Konstitution sich nicht mithilfe von L. Ružičkas Isoprenregel erklären lässt, überrascht es nicht, 
dass die korrekte Strukturaufklärung von Eremophilon, dem ersten isolierten und charak-
terisierten Vertreter der Eremophilan-Naturstofffamilie, sieben Jahre in Anspruch nahm und in 
der Zwischenzeit mehrere Vorschläge veröffentlicht wurden, die sich nachher als nicht korrekt 
erwiesen. 
In Kapitel 2 wird über die erste Totalsynthese des komplexen tricarbocyclischen 
Sesquiterpenoids Periconianon A basierend auf dem postulierten Biosynthesepfad berichtet. 
Besonders bemerkenswert an dieser enantioselektiven Synthese sind die Verwendung eines 
Isopropenyl-Substituenten als abspaltbare dirigierende Gruppe, eine Sequenz aus Rh-
mediierter O–H-Insertion/[3,3]-sigmatroper Umlagerung und anschliessender a-Ketol-
Umlagerung sowie eine Aldoladdition in der Endphase der Synthese, die das komplexe 
käfigartige Molekülgerüst schliesst.  
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Kapitel 3 beschreibt die erste enantioselektive Totalsynthese von Microsphaeropsisin B 
und C ausgehend von einem Intermediat aus der Totalsynthese von Periconianon A. Insgesamt 
umfasst die Synthese von Microsphaeropsisin B und C eine lineare Sequenz von 15 Schritten 
mit g-Hydroxycarvon als Ausgangsstoff. Eine a-Ketol-Umlagerung unter milden Reaktions-
bedingungen ermöglicht die Überführung von Microsphaeropsisin B in Periconianon C sowie 
von Microsphaeropsisin C in 4-epi-Periconianon C. In Hinblick auf die strukturellen Ähnlich-
keiten zwischen den erst kürzlich isolierten Eremophilan-Sesquiterpenoiden Micro-
sphaeropsisin B und C und dem iso-Eremophilan Periconianon C wird eine Revision der 
aktuellen Hypothese zur Biogenese für C8–C11-verknüpfte Iso-Eremophilane vorgeschlagen 
und durch die Ergebnisse aus unseren synthetischen Arbeiten untermauert. 
 
In Kapitel 4 wird über die Totalsynthesen der anti-neuroinflammatorisch wirksamen 
Naturstoffe Guignarderemophilan C und D berichtet. Die vorgestellte Syntheseroute geht von 
dem Diketon-Intermediat aus der Periconianon A-Synthese aus. Ausschlaggebend für die 
erfolgreiche Synthese der beiden angestrebten Naturstoffe von diesem Intermediat aus war die 
Etablierung einer geeigneten Strategie zum Aufbau des 1,2,3-trihydroxylierten A-Rings. Um 
dieses Ziel zu erreichen, wurde eine Mitsunobu-Inversion sowie eine Epoxidierung mit 
anschliessender regioselektiver Ringöffnung durchgeführt, bevor eine intramolekulare 
Aldolkondensation dieses sterisch anspruchsvollen Substrats schliesslich zum Aufbau des 
bicyclischen Ringsystems führte. 
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EREMOPHILANE SESQUITERPENOIDS 1 
 
1 EREMOPHILANE SESQUITERPENOIDS 
1.1 Historical Background1 
In 1932, A. E. Bradfield, A. R. Penfold and J. L. Simonsen reported on the first isolation 
of an eremophilane sesquiterpene from the wood oil of Eremophila mitchellii, a tall shrub or 
small tree endemic to the drier parts of New South Wales, Queensland and South Australia.2 
The highly viscous reddish-brown oil was obtained by steam distillation of the wood shavings. 
By extensive separation procedures, a crystalline ketone characterized by the molecular formula 
C15H22O was isolated and named eremophilone (1.1). Two additional compounds were named 
2-hydroxyeremophilone (1.2) and 2-hydroxy-1,2-dihydroeremophilone (1.3). 
 
Figure 1.1: Structure for eudesmane skeleton and proposed structures for eremophilone, 
hydroxyeremophilone and dihydrohydroxyeremophilone, as published in 1932. 
In a primary report, it was suggested that eremophilone and its derivatives belong to the 
eudesmane family of sesquiterpenes and based on the following structural elucidation, 
structures 1.1, 1.2 and 1.3 were proposed (Figure 1.1): dihydroeremophilol, obtained by 
reduction of eremophilone with sodium in ethanol, was dehydrogenated upon treatment with 
selenium to eudalene with loss of the angular methyl group, thus providing evidence for a 
bicyclic structure (Scheme 1.2). Dehydrogenation using sulfur3 or selenium4 had been a 
valuable method in studying the constitution of natural products and was introduced as well as 
pioneered to the terpene field by L. Ružička. He had shown that a number of sesquiterpenoids 
form cadalene or eudalene upon dehydrogenation. While cadalene contains fifteen carbon 
atoms, eudalene only comprises fourteen carbon atoms. It was suggested that sesquiterpenoids 
leading to both degradation compounds, cadalene and eudalene, are derived from the same 
                                               
1 For reviews: J. L. Simonsen, D. H. R. Barton, in The Terpenes, Vol. III, Cambridge University Press, 1961, pp. 
212-224; E. L. Ghisalberti, in Stud. Nat. Prod. Chem., Vol. 15 (Ed.: A.-u. Rahman), Elsevier, 1995, pp. 225-287; 
D. H. R. Barton, Proc. Chem. Soc. 1958, 61-66. 
2 A. E. Bradfield, A. R. Penfold, J. L. Simonsen, J. Chem. Soc. 1932, 2744-2759. 
3 L. Ružička, E. A. Rudolph, Helv. Chim. Acta 1927, 10, 915-920; L. Ružička, J. Meyer, M. Mingazzini, Helv. 
Chim. Acta 1922, 5, 345-368; L. Ružička, J. Meyer, Helv. Chim. Acta 1921, 4, 505-510. 
4 L. Ružička, Helv. Chim. Acta 1936, 19, 419-423; L. Ružička, E. Peyer, Helv. Chim. Acta 1935, 18, 676-684. 
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2 
farnesyl precursor, but differ in their constitution by the latter bearing an angular methyl group, 
which is cleaved from the carbon skeleton under the harsh reaction conditions applied (Scheme 
1.1). 
 
Scheme 1.1: Cadalene and eudalene as FPP derived sesquiterpenoid dehydrogenation products. 
Formation of tetrahydroeremophilone upon hydrogenation indicated the presence of two 
double bonds in eremophilone. One of those double bonds was found to be incorporated in an 
isopropenyl side chain, established by ozonolysis of the terminal olefin of dihydroeremophilol 
to form a keto-alcohol and formaldehyde. The corresponding acid was then obtained by 
treatment of methyl ketone with sodium hypobromite. The presence of a CH2 group next to the 
carbonyl was proven by the observation that eremophilone formed the crystalline 
hydroxymethylene derivative upon treatment with base and ethyl formate. On the other hand, 
the a,b-unsaturation next to the carbonyl group was disclosed by formation of an epoxide after 
treatment with hydrogen peroxide under basic conditions. The epoxide was opened by sodium 
acetate in acetic anhydride, and basic hydrolysis formed a diosphenol, which was identified as 
hydroxyeremophilone. To incorporate such an R–CH2–CO–CH=CR2 fragment in an 
eudesmane skeleton without the double bond of the isopropenyl group in conjugation, 
eremophilone was suggested to have the constitution given in Figure 1.1. 
 
Scheme 1.2: Experiments for the structural assignment of eremophilone as reported in 1932. 
EudaleneCadalene
OPP OPP
Eremophilone (1.1)
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O OHNa
EtOH
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O
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O
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O
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Hydroxyeremophilone was shown to contain an isopropylidene side chain, as ozonolysis 
released acetone. Together with the finding that hydroxyeremophilone is accessible from 
eremophilone by oxidation, the structure given in Figure 1.1 was assigned. However, the origin 
of double bond isomerization leading to an isopropylidene side chain could not be explained at 
that time. 
During structural elucidation of the sesquiterpenoid a-cyperone,5 J. L. Simonsen and co-
workers utilized a procedure involving Grignard methylation followed by dehydrogenation to 
locate the position of the carbonyl group. Applying the same procedure for eremophilone, viz. 
reaction of tetrahydroeremophilone with methylmagnesium iodide followed by treatment with 
selenium, formed 1,5-dimethylated – and not the anticipated 1,3-dimethylated – naphthalene 
derivative (Scheme 1.3).6 Thus, the carbonyl group was proven to be at position C9 in 
eremophilone and not at position C2, as previously proposed. All the preliminary structural 
suggestions for 1.1, 1.2 and 1.3 (Figure 1.1) were finally ruled out after reduction and 
dehydrogenation of the hydroxymethylene derivative of tetrahydroeremophilane formed 1,6-
dimethyl-7-isopropylnaphthalene in a similar manner. 
 
Scheme 1.3: Identification of the carbonyl group’s position in eremophilone by Grignard 
methylation and dehydrogenation. 
However, the combination of the earlier established R–CH2–CO–CH=CR2 fragment 
(C1=C10 unsaturation) with the finding that the included carbonyl group is located at position 
C9 in an eudesmane skeleton is invalid when C10 is a quaternary carbon atom. Therefore, J. L. 
Simonsen and co-workers proposed bicylco[4.6.0] systems for eremophilone and derivatives, 
before Sir R. Robinson suggested the position for the angular methyl group at C5 instead of 
C10 in a bicyclo[4.4.0] system. Hence, seven years after their first manuscript had been 
published, A. R. Penfold and J. L. Simonsen reported on revised structures for eremophilone 
and its congeners (Figure 1.2).7 
                                               
5 A. E. Bradfield, B. H. Hegde, B. S. Rao, J. L. Simonsen, A. E. Gillam, J. Chem. Soc. 1936, 667-677. 
6 A. E. Bradfield, N. Hellstrom, A. R. Penfold, J. L. Simonsen, J. Chem. Soc. 1938, 767-774. 
7 A. R. Penfold, J. L. Simonsen, J. Chem. Soc. 1939, 87-89. 
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Figure 1.2: Structural formulae for eremophilone, hydroxyeremophilone and dihydrohydroxy-
eremophilone as reported in 1938. 
Indeed, the proposed structure of eremophilone (Figure 1.2) was later proven to be 
correct,8 but the structures of hydroxyeremophilone as well as for dihydrohydroxyeremophilone 
were only partially correct. Evidence for the 1,2-dimethyl pattern was provided by ozonolysis 
of the benzoate of hydroxyeremophilone and subsequent Clemmensen reduction, which gave 
(1,2-dimethylcyclohexyl)acetic acid (1.4). Dehydrogenation of the methyl ester of 1.4 led to 
formation of o-xylene, which was oxidized to phthalic acid with potassium permanganate 
(Scheme 1.4). 
 
Scheme 1.4: Degradation of benzoylated hydroxyeremophilone for the positioning of the two 
methyl groups in eremophilone and its congeners; and of O-methylated hydroxyeremophilone to 
identify the location of the carbonyl group.  
The proposed carbon skeleton of eremophilone, characterized by a methyl group at C5, 
challenged the isoprene rule, which was pioneered at that time and became of significant 
                                               
8 T. A. Geissman, J. Am. Chem. Soc. 1953, 75, 4008-4011. 
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validity.9 When R. Robinson suggested to J. L. Simonsen the revised structures for 
eremophilone and derivatives, he anticipated this connectivity to have its origin in a methyl 
migration via a carbocation rearrangement in an isoprenoid eudesmane precursor. Although we 
are aware of methyl migrations and carbon skeleton rearrangements in terpene biosynthesis 
today, these suggestions were of surprising novelty at the time and can be considered as a 
milestone for subsequent investigations towards terpene biosynthetic hypotheses. As the first 
characterized structure of a naturally occurring sesquiterpene that violates the isoprene rule, L. 
Ružička stated in 1959 that “eremophilone caused a sensation”.10 
The correct structural elucidation for hydroxyeremophilone (1.2) was achieved after the 
hydrogenation product 1.5 of the methyl ether of hydroxyeremophilone had been observed to 
form the 1,6- and not the 1,4-dimethylated naphthalene derivative upon methylation and Se-
mediated dehydrogenation (Scheme 1.4). Additional evidence for the position of the enone 
moiety was provided by ozonolysis of eremophilone, which resulted in the keto-triacid 1.6, 
which was subsequently oxidized to the tetraacid 1.7 by treatment with sodium hypobromite 
(Scheme 1.5).  
 
Scheme 1.5: Ozonolysis to substantiate the position of the carbonyl moiety in eremophilone. 
The relative and absolute configuration of eremophilone, hydroxyeremophilone and 
dihydrohydroxyeremophilone has been established by optical rotatory dispersion (ORD)11 and 
NMR spectroscopy12 studies as well as single crystal X-ray analysis13 and chemical synthesis.14 
ORD studies by the group of C. Djerassi also revealed the B-ring of eremophilone to be 
in a twist-boat conformation, allowing the isopropenyl group at C7 to be in equatorial 
orientation in order to avoid 1,3-diaxial interaction with the methyl substituent at C5. The single 
                                               
9 L. Ružička, Experientia 1953, 9, 357-367. 
10 L. Ružička, Proc. Chem. Soc. 1959, 341-376. 
11 L. H. Zalkow, F. X. Markley, C. Djerassi, J. Am. Chem. Soc. 1960, 82, 6354-6362; L. H. Zalkow, F. X. Markley, 
C. Djerassi, J. Am. Chem. Soc. 1959, 81, 2914-2915. 
12 L. H. Zalkow, A. M. Shaligram, S.-e. Hu, C. Djerassi, Tetrahedron 1966, 22, 337-350. 
13 D. Grant, Acta Cryst. 1957, 10, 498-504. 
14 C. Djerassi, R. Mauli, L. H. Zalkow, J. Am. Chem. Soc. 1959, 81, 3424-3429. 
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crystal X-ray analysis of dihydrohydroxyeremophilone showed the two rings to be arranged in 
a cis-manner, typical for steroidal compounds, and all substituents except the angular methyl 
group, in equatorial orientation (Figure 1.3). 
 
Figure 1.3: Absolute configuration of (–)-eremophilone, (+)-hydroxyeremophilone and (+)-
dihydrohydroxyeremophilone. 
The first successful total syntheses of (±)-eremophilone and its 7-epi-isomer were 
reported by F. E. Ziegler and P. A. Wender in 1974.15 The main synthetic challenge was the 
installation of the two vicinal methyl groups at C4 and C5 in cis-orientation. Additionally, 
application of existing protocols for eremophilane synthesis based on Robinson annulation 
procedures accounted for the wrong oxidation pattern and were thus futile in this synthetic 
endeavor. The key step of the presented synthesis was Claisen rearrangement of the vinyl ether 
1.8 to form a diastereomeric mixture of aldehydes 7S-1.9 and 7R-1.9 (Scheme 1.6). Subsequent 
aldolization and transposition of the C1 carbonyl group to C9 by Wharton rearrangement 
formed eremophilone and 7-epi-eremophilone. A stereoselective synthesis starting from b-
pinene was presented by the group of J. E. McMurry in 1975.16 
 
Scheme 1.6: First total synthesis of eremophilone by Claisen rearrangement and Wharton 
transposition as key steps. 
                                               
15 F. E. Ziegler, P. A. Wender, Tetrahedron Lett. 1974, 15, 449-452. 
16 J. E. McMurry, J. H. Musser, M. S. Ahmad, L. C. Blaszczak, J. Org. Chem. 1975, 40, 1829-1832. 
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1.2 Distribution and Classification of Eremophilane-Type Sesqui-
terpenoids 
For almost 30 years, eremophilone, hydroxyeremophilone and dihydrohydroxy-
eremophilone had been the only isolated members of the eremophilane family of natural 
prodcuts.17 In the last decades, however, more and more compounds were isolated and 
characterized with around 1500 eremophilanes known today (Reaxys search, 03/2018), 
primarily found in higher plants and fungi. In the plant kingdom, these sesquiterpenes are 
mainly present in the Asteraceae family, more precisely in the genera of Ligularia, Senecio, 
Cacalia, and Petasites, out of which the genus of Ligularia contains the most eremophilane-
type natural products with more than 500 derivatives isolated from around 50 species.18 While 
eremophilane-type compounds produced by plants had been known since the isolation of 
eremophilone in 1932; the first member isolated from a fungus was described four decades later 
by C. Riche et al. and named phomenone.19 Today, there are about 150 eremophilanes isolated 
from fungi, and with a few exceptions compounds present in fungi are usually not found in 
plants or occur with the opposite absolute configuration.20 Comprehensive reviews covering 
the structural diversity of eremophilanes isolated from plants18,21 as well as from fungi20 have 
been published recently. 
 
Figure 1.4: Structural types of bi-, tri- and tetracarbocyclic eremophilanes. 
Structurally, eremophilane sesquiterpenes can be divided into compounds containing bi-, 
tri- or tetracarbocyclic skeletons (Figure 1.4). Bicarbocyclic eremophilanes can be classified 
based on the relative orientation of the alkyl substituents at C4, C5 and C7 and the location of 
the decalin double bond in their biogenetic precursors (Figure 1.5). The largest group of 
eremophilanes is supposed to be derived from eremophilene, which is characterized by a 
                                               
17 A. R. Pinder, A. K. Torrence, J. Chem. Soc. C 1971, 3410-3414. 
18 L. Wu, Z. X. Liao, C. Liu, H. Y. Jia, J. Y. Sun, Chem. Biodiversity 2016, 13, 645-671. 
19 C. Riche, C. Pascard-Billy, M. Devys, A. Gaudemer, M. Barbier, J.-F. Bousquet, Tetrahedron Lett. 1974, 15, 
2765-2766. 
20 K. T. Yuyama, D. Fortkamp, W. R. Abraham, Biol. Chem. 2018, 399, 13-28; R. Ebel, Mar. Drugs 2010, 8, 2340. 
21 C. J. Hou, M. Kulka, J. Z. Zhang, Y. M. Li, F. J. Guo, Mini-Rev. Med. Chem. 2014, 14, 664-677. 
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C1=C10 unsaturation and an all-cis-configuration of the three alkyl groups at C4, C5 and C7, 
which are – with few exceptions – b-orientated as in (–)-eremophilene or (–)-eremophilone. 
The decalin core of natural products derived from eremophilene is most often a saturated cis-
fused ring system with minimal 1,3-diaxial interaction owing to the cis-relationship of the 
substituents at C5 and C7. Hence, eremophilanes with a trans-relation of the C4/C5 methyl 
groups to the C7 isopropyl/isopropenyl group, i.e. natural products derived from valencene or 
aristolochene, have either trans-fused rings or they are characterized by C9=C10 or C1=C10 
unsaturation.  
 
Figure 1.5: Structural precursors and prominent members of eremophilane sesquiterpenoids. 
The growth-inhibiting compound (+)-valencene is widely distributed in the essential oils 
of citrus fruits and serves as a flavoring agent and aroma compound precursor in food industry.22 
Biosynthetically, one of the allylic oxidation products of (+)-valencene is (+)-nootkatone, 
known as the most important flavor of grapefruit and synthetically accessible by oxidation of 
(+)-valencene.23 While the (–)-enantiomer of aristolochene was first isolated from the plant 
Aristolochia indica in 1970,24 the (+)-enantiomer was obtained from fungi Aspergillus terreus25 
and Penicillium roqueforti.26 Prominent eremophilanes derived from (+)-aristolochene are (1) 
                                               
22 J. Frohwitter, S. A. E. Heider, P. Peters-Wendisch, J. Beekwilder, V. F. Wendisch, J. Biotechnol. 2014, 191, 
205-213. 
23 H. Erdtman, Y. Hirose, Acta Chem. Scand. 1962, 16, 1311-1314; M. Furusawa, T. Hashimoto, Y. Noma, Y. 
Asakawa, Chem. Pharm. Bull. 2005, 53, 1513-1514. 
24 T. R. Govindachari, P. A. Mohamed, P. C. Parthasarathy, Tetrahedron 1970, 26, 615-619. 
25 D. E. Cane, B. J. Rawlings, C.-C. Yang, J. Antibiot. 1987, 40, 1331-1334. 
26 T. M. Hohn, R. D. Plattner, Arch. Biochem. Biophys. 1989, 272, 137-143; A. A. Chalmers, A. E. de Jesus, C. P. 
Gorst-Allman, P. S. Steyn, J. Chem. Soc., Perkin Trans. 1 1981, 2899-2903. 
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phomenone,19,27 an oxygenated analog of sporogen AO-1, which was obtained from Aspergillus 
oryzae, an industrially relevant fungus in the production of soy sauce, and shows antifungal and 
phytotoxic activities;28 and (2) PR-toxin, a mycotoxin isolated from Penicillium roqueforti, an 
ascomycete industrially used in the production of blue cheeses, such as Roquefort cheese, 
Gorgonzola or Blue Stilton.29 Eremophilanes derived from 5-epi-aristolochene with a trans-
relation of the methyl groups at C4 and C5 are rare with the most prominent member capsidiol, 
isolated from Capsicum frutescens30 and Nicotiana tabacum.31 Capsidiol is a phytoalexin, 
which is generated in response to fungal or viral infection.32 
The regular bicyclic eremophilane motif often features an additional furan or lactone ring 
to give the corresponding furanoeremophilanes or eremophilenolides, respectively. Tricarbo-
cyclic eremophilanes are, with a few exceptions, of the aristolane-type and characterized by the 
gem-dimethylcyclopropane unit fused across positions C6 and C7. The configuration of their 
three alkyl groups at C4, C5 and C7 is stereochemically related to valencane or its enantiomer 
by a cis-relation of the methyl groups and trans relation to the cyclopropane. Compounds 
bearing the ishwarane skeleton form the tetracarbocyclic class of eremophilanes and are 
characterized by fusion of the isopropenyl carbon atoms C11 and C12 with the decalin core at 
C7, C8 and C10. 
1.3 Biosynthetic Pathway for the Formation of Eremophilane 
Sesquiterpenoids 
Today, the biosynthesis of sesquiterpenes is well described to proceed via farnesyl 
pyrophosphate (FPP) as intermediate, which is formed by head-to-tail condensation of 
dimethylallyl diphosphate (DMAPP) with two equivalents of isopentenyl diphosphate (IPP), 
catalyzed by farnesyl pyrophosphate synthase. The enormous structural diversity within this 
class of terpenes with more than 10’000 known members results from sesquiterpene cyclases, 
which catalyze the formation of around 300 distinct 15-carbon skeletons. Although these 
                                               
27 T. Kitahara, H. Kiyota, H. Kurata, K. Mori, Tetrahedron 1991, 47, 1649-1654. 
28 S. Tanaka, K. Wada, S. Marumo, H. Hattori, Tetrahedron Lett. 1984, 25, 5907-5910; Y. Tirilly, J. Kloosterman, 
G. Sipma, J. J. Kettenes-Van Den Bosch, Phytochemistry 1983, 22, 2082-2083. 
29 R.-D. Wei, P. E. Still, E. B. Smalley, H. K. Schnoes, F. M. Strong, Appl. Microbiol. 1973, 25, 111-114. 
30 M. Gordon, A. Stoessl, J. B. Stothers, Can. J. Chem. 1973, 51, 748-752. 
31 J. A. Bailey, R. S. Burden, G. G. Vincent, Phytochemistry 1975, 14, 597. 
32 D. R. Threlfall, I. M. Whitehead, Phytochemistry 1988, 27, 2567-2580; I. M. Whitehead, D. R. Threlfall, D. F. 
Ewing, Phytochemistry 1989, 28, 775-779; R. Li, C.-S. Tee, Y.-L. Jiang, X.-Y. Jiang, P. N. Venkatesh, R. 
Sarojam, J. Ye, Sci. Rep. 2015, 5, 9682. 
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enzymes share a common mechanism of binding and ionization of FPP, the structural diversity 
is explained by a specific sequence of intramolecular cyclizations and rearrangements of the 
substrate while bound to the active site of the cyclase. As numerous reviews on sesquiterpene 
biosynthesis have been published,33 this subchapter summarizes selected scientific results 
gathered over the last century, leading to the generally accepted biosynthetic pathway of 
eremophilane-type sesquiterpenoids. 
As pointed out earlier, initial observations on the biogenesis of eremophilanes were 
provided by Sir R. Robinson, when he suggested that eremophilone, hydroxyeremophilone and 
dihydrohydroxyeremophilone differ from the structures of eudesmane-type sesquiterpenoids. 
He further proposed that the carbon skeleton of these three isolated natural products might be 
derived from an eudesmane precursor by methyl migration from C10 to C5. After the terpene 
rule had been introduced by O. Wallach34 and found considerable affirmation in terpene 
biochemistry, this suggestion was disconcerting since the resulting skeleton after rearrangement 
cannot be explained by this general rule. Therefore, many research groups started to pursue this 
“hot topic” in order to validate Robinson’s biogenetic hypothesis and to provide insights into 
the biosynthetic pathway of eremophilanes. In the beginning, different eudesmanes that might 
serve as model substrates for the 1,2-methyl shift to form the eremophilane-type skeleton have 
been proposed, but were not thoroughly or only unsuccessfully investigated.11a,35 
In 1971, the group of R. G. Lawton hypothesized the involvement of spiro-intermediates 
in order to explain the origin of the stereochemical pattern in valencene- and aristolochene-
derived eremophilanes (Scheme 1.7).36 However, labeling studies of capsidiol using sodium 
[1,2-13C]acetate as precursor in the biosynthesis and subsequent 13C NMR experiments with the 
isolated compound ruled out a mechanism via spiro-intermediates and substantiated Robinson’s 
proposition of a 1,2-methyl shift.37 
                                               
33 For selected reviews: G. A. Cordell, Chem. Rev. 1976, 76, 425-460; J. S. Dickschat, Nat. Prod. Rep. 2011, 28, 
1917-1936. 
34 O. Wallach, Liebigs Ann. Chem. 1887, 238, 78-89. 
35 J. W. Huffman, J. Org. Chem. 1972, 37, 2736-2739; C. H. Heathcock, Y. Amano, Tetrahedron 1968, 24, 4917-
4921; C. H. Heathcock, T. R. Kelly, Tetrahedron 1968, 24, 3753-3765; G. Büchi, F. Greuter, T. Tokoroyama, 
Tetrahedron Lett. 1962, 3, 827-833; J. B. Hendrickson, Tetrahedron 1959, 7, 82-89. 
36 R. G. Lawton, D. J. Dunham, J. Am. Chem. Soc. 1971, 93, 2075-2077. 
37 F. C. Baker, C. J. W. Brooks, S. A. Hutchinson, J. Chem. Soc., Chem. Commun. 1975, 293b-294; F. C. Baker, 
C. J. W. Brooks, Phytochemistry 1976, 15, 689-694. 
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Scheme 1.7: Biogenetic hypothesis for the formation of valencene- or aristolochene-derived 
eremophilanes from eudesmane via spiro-intermediates proposed by the group of R. G. Lawton. 
The first successful biomimetic transformation of an eudesmane- to an eremophilane-type 
sesquiterpenoid dates back to 1972.38 When a mixture of eudesmanolide epoxide 1.10 and 
formic acid in acetone was heated to reflux, the C5-methylated eremophilanolides 1.11 and 
11S-1.12 were formed in 10 % and 34 % yield, respectively (Scheme 1.8). Besides five other 
minor compounds, side-product 11R-1.12 featuring isomerization of the methyl group at C11 
was isolated in 2 % yield. This isomerization was also initiated by stirring 11S-1.12 with K2CO3 
in toluene. In order to validate the structure of 1.12, the obtained compound was converted to 
the known tetrahydroligularenolide in six steps. 
 
Scheme 1.8: First reported reaction involving a 1,2-methyl shift from C10 to C5 in an eudesmane 
sesquiterpenoid in order to provide evidence for the proposed biogenetic route. 
In 1977, the group of A. R. Pinder reported on the in vitro and in vivo rearrangement of 
eudesmanes to eremophilanes.39 After the C11=C12 double bond of paradisiol had been 
hydrogenated, treatment with either formic acid or hydrogen bromide in acetic acid gave 
valencene (1.13) (Scheme 1.9). The same rearrangement product was formed when 
tetrasubstituted olefin 1.14 was subjected to identical reaction conditions. Moreover, 
eremophilane 1.13 was synthesized from nootkatone in four steps and resulted in the identical 
                                               
38 I. Kitagawa, H. Shibuya, H. Takeno, T. Nishino, I. Yosioka, Chem. Pharm. Bull. 1976, 24, 56-60; I. Kitagawa, 
Y. Yamazoe, H. Shibuya, R. Takeda, H. Takeno, I. Yoshioka, Chem. Pharm. Bull. 1974, 22, 2662-2674; I. 
Kitagawa, H. Shibuya, Y. Yamazoe, H. Takeno, I. Yosioka, Tetrahedron Lett. 1974, 15, 111-114; I. Kitagawa, 
Y. Yamazoe, R. Takeda, I. Yosioka, Tetrahedron Lett. 1972, 13, 4843-4846. 
39 C. A. Miller, A. R. Pinder, J. Chem. Soc., Chem. Commun. 1977, 230-231. 
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mixture of 1.13 and 1.14 when submitted to the conditions initiating the 1,2-shift. Therefore, it 
has been suggested that carbocation intermediates 1.15, 1.16 and 1.17 might be involved in the 
rearrangement process.  
 
 
Scheme 1.9: Experiments hinting at the involvement of carbocation intermediates in the 
biosynthesis of eremophilanes. 
In an in vivo experiment, a suspension of [3-14C]-labeled paradisiol in phosphate buffer 
and Triton X-100 was injected into unripe grapefruit and the fruits were exposed to sunlight for 
eight days. 14C-Labeled valencene was isolated with an incorporation of 0.02 % 14C.  
In 1989, P. Ceccherelli et al. reported on the acid-catalyzed rearrangement of 3-keto-4,5-
epoxy eudesmane.40 Based on the observed co-occurrence of cyperanic acid and costic acid 
(Figure 1.6) in the Mediterranean plant Dittrichia viscosa,41 they proposed a biogenetic 
relationship between these natural products. In order to study this hypothesis, 3-keto-4,5-epoxy 
eudesmanes 4S5S-1.18 and 4R5R-1.18 were synthesized. 
 
Figure 1.6: Structures of cyperanic acid and costic acid. 
Treatment of 4a,5a-epoxy eudesmane 1.18 with BF3·OEt2 induced either a methylene 
shift to form the 5/6-bicyclic cyperane 1.19 by ring contraction in 18 % yield or a 1,2-methyl 
shift to form eremophilane-type compound 1.20 in 60 % yield (Scheme 1.10). Stirring the 
                                               
40 P. Ceccherelli, M. Curini, M. C. Marcotullio, O. Rosati, Tetrahedron 1989, 45, 3809-3818. 
41 P. Ceccherelli, M. Curini, M. C. Marcotullio, A. Menghini, J. Nat. Prod. 1988, 51, 1006-1009. 
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mixture of 4S5S-1.18 and Lewis acid for 20 min instead of only 5 min, led to formation of C4-
dimethylated product 1.21.  
 
Scheme 1.10: Rearrangement of 3-keto-4a,5a-epoxy eudesmane to cyperane- (1.19) and 
eremophilane-type (1.20) structures. 
Diverging results were obtained when 4b,5b-epoxy eudesmane 1.18 was subjected to the 
same reaction conditions. Eremophilane 1.20 was not formed, instead a mixture of cyperane 
1.19 and spirovetivane 1.22 was obtained in 61 % and 18 % yield, respectively (Scheme 1.11). 
These results suggested that cyperanes, eremophilanes and spirovetivanes are derived from an 
oxygenated eudesmane precursor. 
 
Scheme 1.11: Rearrangement of 3-keto-4b,5b-epoxy eudesmane to cyperane- (1.19) and 
spirovetivane-type (1.22) structures. 
While most of the earlier biosynthetic studies on terpenes had been carried out on the 
cellular level by incorporation experiments using isotopically labeled precursors, investigations 
on the cell-free level in the sesquiterpene research field started in the 1990’s and were mainly 
pioneered by the group of D. E. Cane.42 Classical feeding experiments with intact organisms 
mainly suffered from poor uptake of the labeled precursors. In contrast, a cell-free system 
eliminates the natural cellular barriers for uptake and thus helped to create a better 
understanding of biosynthetic pathways. The isolation and characterization of several 
sesquiterpene cyclases and their application in both crude and purified form led to the 
formulation and corroboration of terpene biosynthetic mechanisms.43 
                                               
42 For reviews: D. E. Cane, Chem. Rev. 1990, 90, 1089-1103; G. A. Cordell; J. Degenhardt, T. G. Köllner, J. 
Gershenzon, Phytochemistry 2009, 70, 1621-1637. 
43 For review: D. W. Christianson, Chem. Rev. 2017, 117, 11570-11648. 
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In 1990, the group of D. E. Cane reported experiments performed with purified 
aristolochene synthase, which was isolated from cell-free extracts of the fungi Aspergillus 
terreus26b and Penicillium roqueforti.32a The proposed biosynthetic mechanism of this enzyme 
is shown in Scheme 1.12: ionization by cleavage of the pyrophosphate group from (E,E)-FPP, 
is followed by 1,10-cyclization and deprotonation to form S-(–)-germacrene A. Another 
protonation at C1 induces cyclization to the 10b-trans-eudesmane cation 1.23. Sequential 1,2-
hydride and 1,2-methyl shifts with deprotonation at C9 finally releases (+)-aristolochene. Initial 
experiments to provide evidence for this mechanism consisted in incubation of crude 
aristolochene synthase obtained from Aspergillus terreus with [12,13-14C]-labeled FPP44 as 
well as [11,12-13C]- and [11,13-13C]-FPP. The stereochemical course, however, was examined 
by separate incubation of 1R- and 1S-[1-2H]FPP (HA/HB) with aristolochene synthase, which 
revealed the initial 1,10-cyclization to proceed with inversion of configuration at C1. Additional 
labeling experiments showed that deprotonation after the initial cyclization step takes place at 
the terminal cis-methyl group (C12) to form S-germacrene A and the final deprotonation 
proceeds by abstraction of HSi at C9.45 There is evidence that germacrene A is an intermediate 
in the cyclization process and that none of the intermediates is released from the active site in 
the enzymatic process forming (+)-aristolochene from FPP.46 
 
Scheme 1.12: Proposed biogenetic pathway for the synthesis of (+)-aristolochene. 
                                               
44 D. E. Cane, P. C. Prabhakaran, E. J. Salaski, P. H. M. Harrison, H. Noguchi, B. J. Rawlings, J. Am. Chem. Soc. 
1989, 111, 8914-8916. 
45 D. E. Cane, P. C. Prabhakaran, J. S. Oliver, D. B. McIlwaine, J. Am. Chem. Soc. 1990, 112, 3209-3210.  
46 D. E. Cane, C. Bryant, J. Am. Chem. Soc. 1994, 116, 12063-12064; D. E. Cane, Y. S. Tsantrizos, J. Am. Chem. 
Soc. 1996, 118, 10037-10040. 
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In a similar manner, the biosynthetic pathway of 5-epi-aristolochene was profoundly 
investigated.42a,47 The proposed mechanism catalyzed by epi-aristolochene synthase, shown in 
Scheme 1.13, is similar to the one suggested for aristolochene synthase, but leads to a different 
stereoisomer of the eremophilane-type skeleton. 
 
Scheme 1.13: Proposed biogenetic pathway for the synthesis of 5-epi-aristolochene. 
The identification of biosynthetic gene clusters by sequencing efforts and the recent 
advances in biomolecular techniques enabled heterologous expression and in vitro incubation 
studies using purified enzymes in order to investigate biogenetic pathways.48 Gene clusters in 
different organisms encoding for valencene,49 aristolochene, epi-aristolochene or eremophilene 
synthases have been identified. Further, enzymes responsible for oxidation of the sesquiterpene 
carbon skeleton have been discovered, e.g. several cytochrome P450 mono-oxygenases50 
responsible for the oxidation of (+)-valence to (+)-nootkatone. Due to the importance of (+)-
nootkatone to flavor and fragrance industry and its large-scale production from the more 
abundant (+)-valencene, its biosynthetic pathway has been thoroughly investigated. 
Very recently, the research groups of J. Dickschat and M. Christmann reported on the 
isolation of the sesquiterpene cyclase STC3 from the rice pathogenic fungus Fusarium 
fujikuroi, which was expressed in Escherichia coli and produced (+)-eremophilene upon 
                                               
47 K. A. Rising, C. M. Starks, J. P. Noel, J. Chappell, J. Am. Chem. Soc. 2000, 122, 1861-1866; D. J. Schenk, C. 
M. Starks, K. R. Manna, J. Chappell, J. P. Noel, R. M. Coates, Arch. Biochem. Biophys. 2006, 448, 31-44; J. A. 
Faraldos, Y. Zhao, P. E. O'Maille, J. P. Noel, R. M. Coates, ChemBioChem 2007, 8, 1826-1833. 
48 For recent review: J. S. Dickschat, Eur. J. Org. Chem. 2017, 4872-4882. 
49 J. Lücker, P. Bowen, J. Bohlmann, Phytochemistry 2004, 65, 2649-2659. 
50 R. J. Sowden, S. Yasmin, N. H. Rees, S. G. Bell, L.-L. Wong, Org. Biomol. Chem. 2005, 3, 57-64; A. Seifert, 
S. Vomund, K. Grohmann, S. Kriening, V. B. Urlacher, S. Laschat, J. Pleiss, ChemBioChem 2009, 10, 853-861; 
K. Cankar, A. van Houwelingen, D. Bosch, T. Sonke, H. Bouwmeester, J. Beekwilder, FEBS Lett. 2011, 585, 
178-182. 
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incubation with FPP.51 The proposed mechanism of eremophilene biosynthesis is almost 
identical to those described for aristolochene and epi-aristolochene and is summarized in 
Scheme 1.14. Enzymatic conversion of [2-2H,3-13C]-labeled FPP and 13C-NMR analysis of the 
formed eremophilene showed deuterium incorporated at position C4 of eremophilene (Scheme 
1.15, A). This observation substantiates a 1,2-hydride shift from C5 to C4 (1.24 g 1.25) in the 
proposed mechanism.  
 
Scheme 1.14: Proposed biogenetic pathway for the synthesis of (+)-eremophilene. 
Moreover, when D2O was used as solvent for this reaction, no deuterium uptake was 
observed. Therefore, it was suggested that the same proton is involved in protonation of 
germacrene A and deprotonation to form (+)-eremophilene. When [13-13C]-labeled FPP was 
used in the enzymatic reaction, incorporation of 13C was only observed at C13 and not at C12 
of (+)-eremophilene, explaining the stereochemical behavior of the terminal methyl groups in 
FPP in the process. 
A) 
 
B) 
 
Scheme 1.15: Enzymatic conversion of FPP in the presence of the sesquiterpene cyclase STC3. 
A) [2-2H,3-13C]-labeled FPP was used, B) [13-13C]-labeled FPP was used; black dots represent 
13C-isotopes. 
                                               
51 I. Burkhardt, T. Siemon, M. Henrot, L. Studt, S. Rösler, B. Tudzynski, M. Christmann, J. S. Dickschat, Angew. 
Chem. Int. Ed. 2016, 55, 8748-8751. 
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1.4 Synthetic Contributions over the last Decades 
An overview covering eremophilane syntheses up to 1977 is given in the book chapter 
“The Chemistry of the Eremophilane and Related Sesquiterpenes” in “Progress in the 
Chemistry of Organic Natural Products” by A. R. Pinder.52 Therefore, the following subsections 
mainly deal with eremophilane syntheses reported in the last 40 years and the focus primarily 
lies on the categorization and exemplification of strategies elaborated on the construction of the 
bicyclic 6/6 carbon skeleton. 
1.4.1 Robinson Annulation Procedures 
Bicyclic 6/6 diketones are versatile building blocks and have been used as intermediates 
in the construction of numerous steroids and terpenoids like taxol.53 A widely used synthetic 
method to prepare these decalones is the Robinson annulation, a tandem process of Michael 
addition followed by aldol condensation, which was first introduced by Sir R. Robinson and 
W. S. Rapson in 1935 (Scheme 1.16).54,55 
 
Scheme 1.16: Robinson annulation mechanism for the construction of bicyclic 6/6 octalones. 
Condensation of cyclohexanone with styryl methyl ketone under basic conditions gave 
the phenyl substituted octalone 1.26 in 43 % yield (Scheme 1.17, A). However, in the same 
year, the group of R. Robinson reported limitations of their procedure: octalone 1.27 was 
formed in only 15–20 % yield, when a-methylated cyclohexanone and 4-chloro-2-butanone 
were used in the reaction (Scheme 1.17, B).56 The authors already recognized that the 
combination of a substituted cyclohexanone and methyl vinyl ketone, which was expected to 
                                               
52 A. R. Pinder, in Progress in the Chemistry of Organic Natural Products, Vol. 34 (Eds.: W. Herz, H. Grisebach, 
G. W. Kirby), Springer-Verlag, Wien, 1977, pp. 81-186. 
53 For examples: W. S. Cheung, H. N. C. Wong, Tetrahedron 1999, 55, 11001-11016; S. Danishefsky, P. Cain, J. 
Am. Chem. Soc. 1976, 98, 4975-4983; S. J. Danishefsky, J. J. Masters, W. B. Young, J. T. Link, L. B. Snyder, 
T. V. Magee, D. K. Jung, R. C. A. Isaacs, W. G. Bornmann, C. A. Alaimo, C. A. Coburn, M. J. Di Grandi, J. 
Am. Chem. Soc. 1996, 118, 2843-2859; K.-i. Fuhshuku, N. Funa, T. Akeboshi, H. Ohta, H. Hosomi, S. Ohba, T. 
Sugai, J. Org. Chem. 2000, 65, 129-135; T. Nagamitsu, T. Sunazuka, R. Obata, H. Tomoda, H. Tanaka, Y. 
Harigaya, S. Omura, A. B. Smith, J. Org. Chem. 1995, 60, 8126-8127; A. Pemp, K. Seifert, Tetrahedron Lett. 
1997, 38, 2081-2084; A. B. Smith, J. Kingery-Wood, T. L. Leenay, E. G. Nolen, T. Sunazuka, J. Am. Chem. 
Soc. 1992, 114, 1438-1449. 
54 W. S. Rapson, R. Robinson, J. Chem. Soc. 1935, 1285-1288. 
55 For review: F. Gallier, A. Martel, G. Dujardin, Angew. Chem. Int. Ed. 2017, 56, 12424-12458. 
56 E. C. du Feu, F. J. McQuillin, R. Robinson, J. Chem. Soc. 1937, 53-60. 
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18 
be rapidly formed by elimination of HCl from 4-chloro-2-butanone, was not ideally suited for 
this process. This general problem can be explained by the similar basicities of vinyl carbonyl 
compounds and the enolates obtained by deprotonation of the cyclic monoketones, resulting in 
the competitive polymerization reaction of the former. 
A) 
 
B) 
 
 C) 
 
Scheme 1.17: Different substitution pattern for both substrates in the Robinson annulation 
reaction. 
Therefore, the modification of both the vinyl carbonyl Michael acceptor and the 
cyclohexanone were investigated to extend the scope of the Robinson annulation.56 It was found 
that the reaction with quaternary Mannich base 1.28 gave increased yields of 35–40 % (Scheme 
1.17, C) due to slow release of vinyl ketone under basic conditions by Hofmann elimination, 
thus keeping the Michael acceptor reagent at a low concentration. Using cyclohexanone 
compounds that are activated in the a-position, e.g. 1,3- dicarbonyl compounds or b-keto esters, 
yields were further improved. The growing interest in this reaction, not only in the context of 
eremophilane total synthesis, led to substantial progress in the development of new Robinson 
annulation procedures. While methodological optimization today mainly focusses on 
improvements of the diastereo- or enantioselectivity, initial research was primarily concentrated 
on obtaining the desired reactivity pattern and chemoselectivity with acceptable yields. 
Especially in the case of sterically demanding substrates like 2,3-disubstituted cyclohexanones, 
the original Robinson annulation protocol often gave low yields of the desired products due to 
the lack of regio- and stereoselectivity.17,57 It is therefore not surprising that the Robinson 
annulation procedure was already highly investigated in early eremophilane syntheses for 
establishing the characteristic vicinal cis-methyl functionality (C4/C5).58 
                                               
57 C. Berger, M. Franck-Neumann, G. Ourisson, Tetrahedron Lett. 1968, 9, 3451-3452; E. Piers, R. W. Britton, 
W. Dewaal, Can. J. Chem. 1969, 47, 4307-4312. 
58 J. A. Marshall, T. M. Warne, J. Org. Chem. 1971, 36, 178-183; H. C. Odom, A. R. Pinder, J. Chem. Soc. D 
1969, 26-27; M. Pesaro, G. Bozzato, P. Schudel, Chem. Commun. (London) 1968, 1152-1154; J. A. Marshall, 
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1.4.1.1 Modification of Cyclohexanone 
While addition of Michael acceptors at the less substituted a-position of the carbonyl 
group can be carried out efficiently via enamine catalysis, the reaction at the more substituted 
position often results in polymerization of the vinyl carbonyls. In order to address those higher 
substituted and synthetically challenging octalones, many research groups have investigated 
alternative methods. Generally, the more problematic step of the Robinson annulation is the 
intermolecular 1,4-addition and procedures involving a stepwise annulation by1,4-addition and 
aldol condensation show more promising results. 
A stepwise annulation procedure was applied in the synthesis of flourensic acid.59 In order 
to increase the selectivity of the process, masking of the methylene group in a-position of the 
carbonyl group of the cyclohexanone was performed. The synthetic route toward octalone 1.29 
had already been described before for the total synthesis of racemic fukinone and (+)-
hydroxyeremophilone by the group of A. R. Pinder.17 Initial investigations aiming at the 
preparation of 1.29 started from 2,3-dimethylphenol, which was converted to a mixture of cis- 
and trans-2,3-dimethylcyclohexanone (Scheme 1.18). Robinson annulation with methyl vinyl 
ketone under various conditions formed only around 15 % of the desired bicyclic compound in 
an epimeric mixture that could not be fully separated by fractional distillation. Based on studies 
by Piers and co-workers, who had used the n-butylthiomethylene blocking group60 in the 
synthesis of aristolone,61 a methylanilin-substituted enone was applied in the annulation 
procedure. By thus masking the CH2 at one of the two a-positions of the cyclohexanone 
carbonyl group, selective electrophilic 1,4-addition at C5 of 1.30 to the Michael acceptor 
formed in situ from ethyl 3-bromopropionate was possible and gave the desired keto acid 1.31 
in 67 % yield after hydrolysis. An aldol condensation furnished the desired octalone 1.29, which 
was further reacted to racemic flourensic acid. 
                                               
H. Faubl, T. M. Warne, Chem. Commun. (London) 1967, 753-754.Commun. (London) 1968, 1152-1154; J. A. 
Marshall, H. Faubl, T. M. Warne, Chem. Commun. (London) 1967, 753-754. 
59 J. N. Herron, A. R. Pinder, J. Chem. Soc., Perkin Trans. 1 1983, 161-166. 
60 R. E. Ireland, J. A. Marshall, J. Org. Chem. 1962, 27, 1615-1619. 
61 E. Piers, W. d. Waal, R. W. Britton, Can. J. Chem. 1969, 47, 4299-4306. 
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Scheme 1.18: Application of methylene blocking in the synthesis of racemic flourensic acid. 
Similarly, masking of one of the CH2 groups in a-position of 2,3-dimethyl cyclohexanone 
as the benzylthiomethylene derivative was applied in the first enantioselective synthesis of 
sporogen-AO 1 by K. Mori and H. Tumara (Scheme 1.19).62 Addition of masked 
cyclohexanone 1.32 to the Michael acceptor vinyl ester derived from ethyl-3-bromopropanoate 
gave keto ester 1.33 in 92 % yield. After octalone (±)-1.34 had been obtained, dynamic kinetic 
resolution of the racemic mixture proved difficult with stereo-differentiating reagents as well 
as with enzymatic methods; only camphanic chloride showed promising results. After 
separation of the octalone ester diastereomers derived from (±)-1.34 and hydrolysis of the ester, 
enantiopure (+)-1.34 was obtained. Thus, the total synthesis of sporogen-AO 1 was finally 
achieved in a total of 25 steps starting from 2,3-dimethylhydroquinone. 
 
Scheme 1.19: Enantioselective total synthesis of (+)-sporogen-AO 1 via a chiral octalone ester. 
1.4.1.2 Modification of Alkylating Reagent 
Instead of modification of the cyclohexanone substrate, replacement of the electrophilic 
alkylating agent was investigated as well. The Wichterle modification,63 already introduced in 
1948, uses masked carbonyl groups as alkylating agents (e.g. 1,3-dichloro-cis-2-butene) to 
                                               
62K. Mori, H. Tamura, Liebigs Ann. Chem. 1988, 97-105. 
63 O. Wichterle, J. Prochazka, J. Hoffman, Coll. Czech. Chem. Commun. 1948, 3, 300-315. 
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avoid polymerization of the Michael adducts. However, additional steps after the 1,4-addition 
to unmask and to transform the halides to the corresponding ketones makes this approach 
laborious and less elegant. A more suitable proposal was elaborated by the group of G. Stork, 
who introduced the Stork silylenone,64 a vinyl ketone that is a-substituted by a silyl group for 
stabilization of the adjacent negative charge in order to prevent polymerization. This procedure 
featuring addition of the electrophile to the lithium enolate, generated from the corresponding 
cyclohexanone via silyl enol ether formation, led to significantly increased yields for various 
substrates. 
In eremophilane syntheses, the Stork procedure found application in the preparation of 
the progesterone receptor ligands (–)-PF1092A, B and C (Scheme 1.20).65 These compounds 
are eremophilenolides characterized by four contiguous cis-substituents in the A-ring.66 The 
synthesis starts from commercially available R-(+)-5-hydroxymethyl-2(5H)-furanone and 
features an SnCl4-promoted cyclization to construct the substituted cyclohexanone 1.35 in nine 
steps. Desulfurization of 1.35 with Al(Hg) with concomitant reduction of the double bond set 
the stage for the stepwise Robinson annulation procedure using Stork silylenone. Silylation of 
1.36 gave the corresponding silyl enol ether 1.37, which was reacted with silylated methyl vinyl 
ketone to form the diketone 1.38. Basic conditions then triggered both the aldol condensation 
and cleavage of the TMS moiety to form octalone 1.39. (–)-PF1092C was obtained after four 
steps from octalone 1.39 and selective acetylation procedures gave access to (–)-PF1092A and 
(–)-PF1092B.67 
                                               
64 G. Stork, B. Ganem, J. Am. Chem. Soc. 1973, 95, 6152-6153. 
65 K. Tatsuta, S. Yasuda, K.-i. Kurihara, K. Tanabe, R. Shinei, T. Okonogi, Tetrahedron Lett. 1997, 38, 1439-
1442. 
66 K. Yamakawa, M. Kobayashi, S. Hinata, T. Satoh, Chem. Pharm. Bull. 1980, 28, 3265-3274. 
67 K. Kurihara, K. Tanabe, R. Shinei, T. Okonogi, Y. Ohtsuka, S. Omoto, S. Yasuda, K. Tatsuta, J. Antibiot. 1997, 
50, 360-362. 
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Scheme 1.20: Total synthesis of eremophilenolides (–)-PF1092A, B and C by Stork annulation. 
Major drawbacks of Stork’s method are the need to prepare the functionalized Michael 
adducts as well as the removal of the silyl protecting group by harsh reaction conditions after 
completion of the 1,4-addition. 
In addition to the previously described reagents used under basic conditions, the group of 
P. Duhamel introduced hemiacetal vinylogues as methyl vinyl ketone equivalents, which are 
reacted in a Lewis acid-mediated Robinson annulation (Scheme 1.21).68 When the silyl enol 
ether derived from 2-methylcyclohexanone was subjected to the mildly Lewis acidic reaction 
conditions, diketone 1.40 was obtained in 92 % yield. Basic conditions then triggered aldol 
condensation to the octalone 1.41. In later experiments, it was observed that in situ generation 
of the intermediate carbocation 1.42 from an enone (such as methyl vinyl ketone) and an alcohol 
or acetic acid gave the same results, thus avoiding the preparation of hemiacetal vinylogues.69 
                                               
68 P. Duhamel, J.-M. Poirier, G. Tavel, Tetrahedron Lett. 1984, 25, 43-46; P. Duhamel, L. Hennequin, N. Poirier, 
J.-M. Poirier, Tetrahedron Lett. 1985, 26, 6201-6204; P. Duhamel, L. Hennequin, J. M. Poirier, G. Tavel, C. 
Vottero, Tetrahedron 1986, 42, 4777-4786. 
69 P. Duhamel, G. Dujardin, L. Hennequin, J. M. Poirier, J. Chem. Soc., Perkin Trans. 1 1992, 387-396. 
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Scheme 1.21: Formation of the intermediate carbocation by reaction with a Lewis acid from either 
hemiacetal vinylogues or from methyl vinyl ketone in a protic solvent; and annulation reaction of 
intermediate carbocation with a silyl enol ether. 
This elegant and very efficient approach in terms of yield and stereoselectivity was 
applied in several eremophilane syntheses. Starting from the silyl enol ether derived from 2,3-
dimethylcyclohexanone, P. Duhamel synthesized octalone 1.43 in 61 % yield and with a 
diastereomeric ratio of 92:8 in favor of the product with a cis-orientation of the methyl groups 
at C4 and C5. After introduction of the side chain, (±)-dehydrofukinone was obtained in 44 % 
yield over four steps (Scheme 1.22).69 
 
Scheme 1.22: Concise route to (±)-dehydrofukinone. 
In the same year as the primary synthesis of (+)-sporogen-AO 1 was reported, the group 
of T. Kitahara presented an optimized approach toward the same target molecule featuring an 
early enzymatic resolution and the application of Duhamel’s annulation procedure.70 Reduction 
of b-ketoester 1.44 by baker’s yeast gave the hydroxyester 1.45 with an ee of 98.6 %, which 
was converted to dimethylated cyclohexanone 1.46 in eight steps via cyclopropane 1.47 
(Scheme 1.23). The presence of the cyclopropane ring was found to be essential for triggering 
the formation of the desired isomer in the Mitsunobu inversion reaction. After the 
corresponding silyl enol ether had been prepared, Lewis acid-mediated alkylation gave the 1,5-
diketone 1.48 in 56 % yield over two steps. Aldol condensation was catalyzed by pyrrolidine 
in benzene and the prepared octalone 1.49 was converted to sporogen-AO 1 in six more steps.  
                                               
70 T. Kitahara, H. Kurata, K. Mori, Tetrahedron 1988, 44, 4339-4349. 
O
BF3·Et2O
1.42
+ ROH
RO
RO OH
TMSO
O
O
KOH
EtOH
O
for R = Me 1.40, 92 % 1.41, 95 %
MeNO2
1.43, 61 % over 2 steps
dr 92:8
TBSO i) MVK, BF3·Et2OAcOH, MeNO2
ii) NaOMe, MeOH
O 2 steps O
(±)-Dehydrofukinone
44 % over 4 steps
  EREMOPHILANE SESQUITERPENOIDS 
 
24 
 
Scheme 1.23: Optimized enantioselective total synthesis of (+)-sporogen-AO 1. 
In a similar manner without inversion at C3 of 1.47, trinor-eremophilane dendryphiellin 
C was synthesized from the same cyclopropane intermediate (Scheme 1.24).71 After octalone 
1.50 had been obtained, C1=C2 unsaturation was introduced by radical bromination followed 
by dehydrobromination using LiBr and Li2CO3. Oxygenation using Davis’ N-
sulfuryloxaziridine and protecting group modifications gave a-keto ether 1.51 in moderate 
yield. Installation of the aliphatic side chain finally led to dendryphiellin C. 
 
Scheme 1.24: Total synthesis of dendryphiellin C starting from cyclopropane intermediate 1.47. 
Diastereoselective pathways by annulation of precursors derived from the chiral pool are 
extensively applied in the preparation of enantiopure natural products. R. Robinson and 
coworkers described the annulation of dihydrocarvone for the syntheses of cyperones already 
in 1937.72 In 1980, the group of A. Yoshikoshi presented a stereoselective synthesis of (+)-4-
epi-nootkatone starting from b-pinene (Scheme 1.25).73 
                                               
71 H. Akao, H. Kiyota, T. Nakajima, T. Kitahara, Tetrahedron 1999, 55, 7757-7770. 
72 P. S. Adamson, F. C. McQuillin, R. Robinson, J. L. Simonsen, J. Chem. Soc. 1937, 1576-1581. 
73 T. Yanami, M. Miyashita, A. Yoshikoshi, J. Org. Chem. 1980, 45, 607-612. 
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Scheme 1.25: Synthesis of (+)-4-epi-nootkatone from b-pinene. 
Oxidative cleavage and silyl ether formation yields silyl enol ether 1.52. Lewis acid-
mediated Michael addition to trans-3-penten-2-one gives the diketone 1.53. Unfortunately, the 
desired isomer for the preparation of (+)-nootkatone was the minor one formed in this reaction 
(dr 1:4), and therefore the synthesis of (+)-4-epi-nootkatone was presented. The inseparable 4:1 
diastereomeric mixture of 1.53 was subjected to stereoselective methylation, and annulation as 
well as cleavage of the cyclobutane ring of 1.54 was triggered by treatment with anhydrous 
hydrochloric acid. Dehydration using activated aluminum oxide afforded (+)-4-epi-nootkatone 
in 67 % yield over two steps. 
The group of A. de Groot applied Lewis acid-mediated Michael addition for the 
preparation of (–)-PF1092C and (–)-ligularenolide starting from S-carvone (Scheme 1.26).74 
Conjugate addition for the installation of a carbon substituent at C4 to form 1.55 was followed 
by a two-step Robinson annulation procedure.75 The isopropenyl group of 1.56, which served 
as a removable directing group for stereoselective synthesis, was then removed by a Criegee 
rearrangement,76 and the obtained dienone 1.57 transformed to (–)-ligularenolide in four steps. 
Alternatively, octalone 1.56 was converted to (–)-PF1092C in five steps featuring cleavage of 
the isopropenyl group, isomerization and lactone moiety installation. 
                                               
74 L. H. D. Jenniskens, A. de Groot, Tetrahedron Lett. 1997, 38, 7463-7464; L. H. D. Jenniskens, A. de Groot, 
Tetrahedron 1998, 54, 5617-5622. 
75 A. A. Verstegen-Haaksma, H. J. Swarts, B. J. M. Jansen, A. de Groot, Tetrahedron 1994, 50, 10073-10082. 
76 R. Criegee, Angew. Chem. Int. Ed. 1975, 14, 745-752; R. Criegee, W. Schnorrenberg, Liebigs Ann. Chem. 1948, 
560, 141-148. 
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Scheme 1.26: Total synthesis of (–)-PF1092C and (–)-ligularenolide from S-carvone involving a 
Lewis acid-mediated Robinson annulation. 
1.4.1.3 Chiral Imines as Robinson Annulation Precursors (Pfau-d’Angelo method) 
In 1985, Pfau et al. published the first asymmetric Michael addition under neutral 
conditions using chiral imines.77 Condensation of racemic 2-methylcyclohexanone with readily 
available S- or R-1-pheynlethylamine forms a chiral imine 1.58, which is in equilibrium with 
its enamine tautomer 1.59. Reaction with methyl vinyl ketone gives the diketone 1.60 in high 
yield and enantiomeric excess (Scheme 1.27). This versatile method with a broadly expanded 
scope found considerable attention in the synthetic community, and has already been 
extensively reviewed.78,55 
 
Scheme 1.27: Pfau-d’Angelo method for enantioselective 1,4-addition reaction. 
In 1997, the group of H. J. Bestmann reported the first enantioselective total synthesis of 
(+)-petasin and its isomer (+)-isopetasin using the Pfau-d’Angelo approach.79 However, 
chirality was not introduced by 1,4-addition, but by enzymatic kinetic resolution using lipase 
of Candida cylandrea (Scheme 1.28). Protecting group modification, oxidation and installation 
of the methyl substituents at C4 and C5 of 1.61 set the stage for the annulation reaction. 
                                               
77 M. Pfau, G. Revial, A. Guingant, J. d'Angelo, J. Am. Chem. Soc. 1985, 107, 273-274. 
78 J. d'Angelo, D. Desmaële, F. Dumas, A. Guingant, Tetrahedron: Asymmetry 1992, 3, 459-505. 
79 M. C. Witschel, H. J. Bestmann, Synthesis 1997, 1997, 107-112. 
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Scheme 1.28: Total synthesis of (+)-petasin and (+)-isopetasin using the Pfau-d’Angelo method 
on a chiral cyclohexanone precursor. 
While chiral imines derived from achiral cyclohexanones react with high diastereo-
selectivity in the alkylation reaction, this is not the case with substituted chiral cyclohexanone 
precursors. However, a matched situation was achieved by using R-1-phenylethylamine in the 
reaction of 2,3-dimethylated cyclohexanone 1.46 with methyl acrylate to obtain the keto ester 
1.62 in 77 % yield and a dr of 8:1 after in situ hydrolysis of the imine. A three-step procedure 
formed the octalone 1.49, whose lithium enolate reacted with acetone in an aldol addition, thus 
forming the C7-alkylated octalone 1.63 as a single diastereoisomer. Mesylation and elimination 
of the tertiary alcohol, followed by silyl deprotection and coupling to a mixed anhydride of 
angelic acid yielded (+)-isopetasin. The isomer (+)-petasin was obtained by installation of the 
ester at C7, followed by selective elimination using triflic anhydride and Hünig’s base. 
In a formal synthesis of (+)-valencenol, M. Pfau and coworkers presented the 
enantioselective Michael addition of a chiral imine derived from 4-protected 2-methyl-
cyclohexane-1,4-dione to phenyl crotonate (Scheme 1.29).80 
                                               
80 G. Revial, I. Jabin, M. Redolfi, M. Pfau, Tetrahedron: Asymmetry 2001, 12, 1683-1688. 
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Scheme 1.29: Total synthesis of (+)-valencenol using the Pfau-d’Angelo method to install the 
stereogenic centers at C4 and C5. 
Initial experiments revealed that trans-3-penten-2-one did not react with imines derived 
from 2-methylcyclohexanone at room temperature and polymerized at 60°C. Nevertheless, after 
imine 1.64 had been formed, reaction with phenyl crotonate gave the Michael adduct 1.65, 
which spontaneously cyclized to the lactam 1.66 under the given reaction conditions in 38 % 
overall yield and excellent diastereo- and enantioselectivity. In addition to the usually formed 
quaternary stereogenic center, a tertiary one was created in the 1,4-addition reaction. After C1 
homologation of lactam 1.66 had failed, a Belleau-Fujimoto reaction proved to be successful. 
Reductive cleavage of 1.66 formed lactam 1.67, which gave keto acid 1.68 after hydrolysis and 
octalone 1.69 after subsequent C1 homologation. Upon reduction of the C2-carbonyl group and 
deprotection at C7, Grignard reaction81 of the obtained ketone with isopropylmagnesium 
bromide gave (+)-valencenol. 
1.4.1.4 Enantioselective 1,3-Diketone Robinson Annulation – Syntheses Starting from 
Wieland-Miescher Ketones 
Due to the weak acidity of a-hydrogen atoms of monoketones (pKa ≈ 20–25), the Robinson 
annulation procedure usually requires strong bases. To enable this reaction under milder 
conditions, the use of 1,3-dicarbonyl compounds is highly desirable, thus reducing the amount 
of side product formation, polyalkylation at the a-positions of ketones and/or polymerization 
of the electrophiles. In the early 1970s, Z. G. Hajos and D. R. Parrish at Hoffmann La Roche,82 
                                               
81 M. Tori, N. Tsuyama, K. Nakashima, M. Sono, Y. Asakawa, J. Chem. Res. (S) 1990, 164-165. 
82 Z. G. Hajos, D. R. Parrish, J. Org. Chem. 1974, 39, 1615-1621; Z. G. Hajos, D. R. Parrish, J. Org. Chem. 1974, 
39, 1612-1615. 
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as well as U. Eder, G. Sauer and R. Wiechert at Schering AG83 reported on proline-catalyzed 
enantioselective syntheses of bicyclic diketones (Scheme 1.30). This asymmetric 
intramolecular aldol reaction was mainly pioneered for the construction of steroidal CD-rings 
and is well-known today as the Hajos-Parrish-Eder-Sauer-Wiechert transformation.  
 
Scheme 1.30: Asymmetric aldol reaction for the construction of bicyclic diketones as decribed 
by Z. G. Hajos and D. R. Parrish, as well as U. Eder, G. Sauer and R. Wiechert (1.70, n = 1: 
Hajos-Parrish-Eder-Sauer-Wiechert ketone; 1.71, n = 2: Wieland-Miescher ketone). 
Since its discovery, many optimized protocols have been reported and the method was 
extended to numerous other reactions, including Michael additions,84 Mannich reactions85 and 
a-alkylations86 or a-aminations87 of ketones. With regard to the former, T. Bui and C. F. Barbas 
III reported that proline can catalyze the 1,4-addition as well as the aldol condensation step in 
a one-pot Robinson annulation.88 Though a very efficient reaction for synthesizing bicyclic 
diketones, this method is only rarely applied in eremophilane synthesis. This can be explained 
by the additional steps required for the installation of a carbon residue next to the angular methyl 
group in Wieland-Miescher ketone (WMK) to form the characteristic vicinal dimethyl-motif in 
eremophilanes. 
                                               
83 U. Eder, G. Sauer, R. Wiechert, Angew. Chem. Int. Ed. 1971, 10, 496-497. 
84 B. List, P. Pojarliev, H. J. Martin, Org. Lett. 2001, 3, 2423-2425. 
85 B. List, P. Pojarliev, W. T. Biller, H. J. Martin, J. Am. Chem. Soc. 2002, 124, 827-833. 
86 N. Vignola, B. List, J. Am. Chem. Soc. 2004, 126, 450-451. 
87 A. Bøgevig, K. Juhl, N. Kumaragurubaran, W. Zhuang, K. A. Jørgensen, Angew. Chem. Int. Ed. 2002, 41, 1790-
1793. 
88 T. Bui, C. F. Barbas III, Tetrahedron Lett. 2000, 41, 6951-6954. 
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In 2005, J. Bonjoch and coworkers reported the enantioselective synthesis of (+)-
xylarenal A, the first totally synthetic eremophilane bearing a vinyl aldehyde side chain at C7, 
starting from optically active WMK (Scheme 1.31).89 This bicycle was prepared according to 
the method described by N. Harada et al.:90 a simplified protocol for the 1,4-addition gave 
diketone intermediate 1.72, which was stirred at room temperature in the presence of L-proline 
in degassed DMSO for six days. WMK (1.71) was obtained in 82 % yield with 69 % ee, and 
the desired enantiomer was enriched by several crystallization steps. The chemical 
modifications necessary to install the one-carbon unit at C4 were reported by L. A. Paquette et 
al. in the total synthesis of the diterpene lactone (+)-cleomeolide:91 after dithioketalization of 
the C8-carbonyl group, C1 homologation using in situ prepared (methoxymethylene)triphenyl-
phosphorane and acidic hydrolysis formed the aldehyde 1.73. A three-step protocol then formed 
the octalone 1.43, which was subjected to g-oxygenation at C1, installation of the side chain at 
C7, and esterification to install the aliphatic residue to give (+)-xylanrenal A. 
 
Scheme 1.31: Enantioselective total synthesis of (+)-xylarenal A starting from chiral Wieland-
Miescher ketone. 
In order to determine the absolute stereochemistry and to gain access to derivatives for 
SAR studies, the total synthesis of integric acid starting from aldehyde intermediate 1.73 was 
investigated.92 Integric acid was first isolated from the fermentation broth of Xylaria sp. and 
showed inhibition of HIV-1 integrase, a key enzyme created by the retrovirus to enable 
                                               
89 S. Díaz, A. González, B. Bradshaw, J. Cuesta, J. Bonjoch, J. Org. Chem. 2005, 70, 3749-3752. 
90 N. Harada, T. Sugioka, H. Uda, T. Kuriki, Synthesis 1990, 53-56. 
91 L. A. Paquette, T.-Z. Wang, C. M. G. Philippo, S. Wang, J. Am. Chem. Soc. 1994, 116, 3367-3374. 
92 D. C. J. Waalboer, H. A. van Kalkeren, M. C. Schaapman, F. L. van Delft, F. P. J. T. Rutjes, J. Org. Chem. 
2009, 74, 8878-8881. 
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integration of its genetic material into the DNA of an infected cell.93 A one-step orthogonal 
deprotection/protection step of aldehyde 1.73 formed octalone 1.74 and already set the stage 
for g-oxygenation and installation of the side chains at C7 and C1–OH to form integric acid and 
its C4’-diastereoisomer (Scheme 1.32). This led to the assignment of an S-C4’-configuration 
for natural integric acid. 
 
Scheme 1.32: Enantioselective total synthesis of integric acid inspired by the synthesis of (+)-
xylarenal A. 
1.4.2 Diels-Alder Procedures 
1.4.2.1 Intramolecular Diels-Alder Approach 
An intramolecular Diels-Alder approach for the construction of eudesmane and valencane 
sesquiterpenes was presented by F. Näf et al.94 The acyclic triene precursor 1.75 was prepared 
by a decarboxylative Knoevenagel condensation of the b-keto acid 1.76 and conjugated 
aldehyde 1.77 (Scheme 1.33). Heating of this Diels-Alder precursor in toluene at 250°C formed, 
depending on the purity of 1.75, either a 1:1 mixture of the bicyclic decalins cis-1.78 and trans-
1.78 in 93 %, or only the more stable cis-isomer. Acid-catalyzed isomerization gave a,b-
unsaturated enone 1.79, which was converted to 1.80 by heating the tosylhydrazone derivative 
of 1.79, before mild hydride reduction using catecholborane. Ester 1.80 served as a key 
intermediate for the racemic preparation of eremoligenol, eremophilene, valerianol, valencene 
and eremophilone. 
                                               
93 S. B. Singh, D. Zink, J. Polishook, D. Valentino, A. Shafiee, K. Silverman, P. Felock, A. Teran, D. Vilella, D. 
J. Hazuda, R. B. Lingham, Tetrahedron Lett. 1999, 40, 8775-8779. 
94 F. Näf, R. Decorzant, W. Thommen, Helv. Chim. Acta 1982, 65, 2212-2223; F. Näf, R. Decorzant, W. Thommen, 
Helv. Chim. Acta 1979, 62, 114-118. 
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Scheme 1.33: Intramolecular Diels-Alder reaction for the divergent preparation of eremophilane-
type sesquiterpenes. 
1.4.2.2 Intermolecular Diels-Alder Approach 
In 2004, the group of D. S. Reddy introduced a stereocontrolled intermolecular Diels-
Alder/aldol approach to construct the cis-hydrindane motif in the total synthesis of bakkenolide-
A (Scheme 1.34, A).95 Bakkenolide-A is a member of the bakkane family, which is proposed 
to be biogenetically derived from eremophilane precursors. The same procedure was extended 
to the preparation of cis-decalones and by varying the substituents at the dienophile, several 
new members featuring cis-hydrindane and cis-decalone systems were accessible, out of which 
one derivative was converted to racemic nootkatone (Scheme 1.34, B).96  
                                               
95 D. S. Reddy, Org. Lett. 2004, 6, 3345-3347. 
96 K. L. Handore, B. Seetharamsingh, D. S. Reddy, J. Org. Chem. 2013, 78, 8149-8154. 
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Scheme 1.34: Intermolecular Diels-Alder reaction in the racemic synthesis of bakkenolide-A. 
In the meantime, D. S. Reddy and coworkers also applied their approach for the synthesis 
of several eremophilanes. In their first report, substituted A-rings for racemic syntheses of 
eremophilenolide, eremophiledinone and deoxyeremopetasidione have been presented 
(Scheme 1.35).97  
 
Scheme 1.35: Total synthesis of (±)-eremophiledinone and (±)-eremophilenolide. 
The synthesis commenced with diene 1.81 and tiglic aldehyde 1.82, which formed the 
desired Diels-Alder adduct 1.83 with high diastereoselectivity upon treatment with the Lewis 
acid BF3·OEt2. After protection of the aldehyde, the ester moiety was modified to form Weinreb 
amide 1.84. A Grignard reaction and hydrogenation of the C1=C2 double bond furnished the 
primary alcohol 1.85, from which the B-ring was constructed by an aldol condensation reaction 
                                               
97 P. Srinivas, D. S. Reddy, K. S. Kumar, P. K. Dubey, J. Iqbal, P. Das, Tetrahedron Lett. 2008, 49, 6084-6086. 
 
+ O
O
H
(±)-Bakkenolide-A
i) MeAlCl2
ii) KOH
H
O
R2
R3 +
i) BF3·Et2O, CH2Cl2
ii) aq. KOH/MeOH
R2R
3
H
O
R1
O
O
n
n
R1
40 - 50 %
4 steps
for n = 2
R1 = H
R2 = R3 = Me (±)-Nootkatone
H
O
A)
B) H
O
H
O
EtO2C
H
O
H
EtO2C
+
BF3·Et2O
CH2Cl2
6 M HCl
CH2Cl2, reflux
HHO
O
O
O
3 steps
HO
HO
H
O
O
H
2 steps
(±)-Eremophilenolide
70 % over 2 steps
HO
MeO2C
i) NaBH4, MeOH, rt
ii) DBU, benzene, reflux
1.83 ,75 %
(±)-Eremophiledinone 1.86, 80 %
H
N O
O
O
1.84
O
2 steps
1.85
1.81
1.82H
O
  EREMOPHILANE SESQUITERPENOIDS 
 
34 
to give the 6/6 bicyclic system 1.86. Oxidation and esterification yielded (±)-eremophiledinone, 
which was converted to (±)-eremophilenolide in two steps. 
The group of D. S. Reddy further used Diels-Alder adduct 1.83 in the synthesis of (±)-
deoxyeremopetasidione,97 (±)-fukinone and (±)-petasitolone98 via methyl ketone 1.87 as 
common intermediate (Scheme 1.36). The saturated Weinreb amide 1.88 was synthesized in a 
similar manner as shown in the previous synthesis for 1.84, and Grignard reaction of 1.88 with 
MeMgCl gave the key intermediate 1.87. After carbon chain elongation and treatment with 
acid, intramolecular aldol condensation gave 1.89. From this octalone, the synthesis of (±)-
petasitolone was achieved in three and of (±)-fukinone in four steps. 
 
Scheme 1.36: Total synthesis of (±)-deoxyeremopetasidione, (±)-fukinone and (±)-petasitolone. 
Very recently, another divergent approach towards synthetic (±)-botryosphaeridione, (±)-
pleodendione and (±)-4-epi-periconianone B has been published.99 To this end, the synthesis to 
the common octalone intermediate 1.90 commenced from Diels-Alder adduct 1.83, which was 
submitted to Wittig olefination of the aldehyde, reduction of the ester and Grignard addition of 
vinylmagnesium bromide to form the triene 1.91 (Scheme 1.37). Ring closing metathesis using 
Grubbs 2nd generation catalyst and oxidation by pyridinium chlorochromate gave the desired 
cis-octalone 1.90. Several oxidative modifications led to diosphenol 1.92, which was shown to 
react sluggishly in the subsequent allylic oxidation step to 1.93. Nevertheless, (±)-
botryosphaeridione was finally obtained after isomerization at C4 under basic conditions and 
deprotection of the methyl ether. (±)-Pleodendione and (±)-4-epi-periconianone B were 
accessible via the intermediate dienone 1.94, obtained from octalone 1.90 by a 
                                               
98 S. Pasikanti, D. S. Reddy, J. Iqbal, P. K. Dubey, P. Das, Synthesis 2009, 3833-3837. 
99 K. L. Handore, P. D. Jadhav, B. Hazra, A. Basu, D. S. Reddy, ACS Med. Chem. Lett. 2015, 6, 1117-1121. 
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reduction/oxidation procedure. Epimerization as for addressing (±)-botryosphaeridione did not 
take place at either C4 or C11 of 4-epi-periconianone B and thus the diastereoisomer 
periconianone B was not obtained. However, NMR experiments as well as the single crystal X-
ray structure of a precursor hinted at the wrong assignment of periconianone B with respect to 
the stereogenic center at C11 as reported in literature.100 
 
Scheme 1.37: Total synthesis of (±)-pleodendione, (±)-botryosphaeridione and (±)-4-epi-
periconianone B. 
1.4.3 Miscellaneous Approaches 
As a comprehensive review on the plethora of synthetic approaches towards the more 
than 1500 members of the eremophilane family of natural products would exceed the scope of 
this thesis, we will now shortly summarize some of the other routes apart from Diels-Alder 
strategies and Robinson annulation reactions applied for the construction of eremophilanes. 
Especially noteworthy are two excellent examples: the eight-step synthesis of (+)-nootkatone 
by an anionic oxy-Cope reaction in an overall yield of 33 %101 and the efficient synthesis of 
ishwarane by a C–H insertion approach.102 
In section 1.4.1.2, Yoshikoshi’s synthesis of (+)-4-epi-nootkatone starting from b-pinene 
has been presented. The stereoselective step, Lewis acid-mediated conjugate addition of 
allyltrimethylsilane to the enone, did not provide the desired isomer so that the synthesis finally 
yielded (+)-4-epi-nootkatone instead of the desired (+)-nootkatone. In 2009, the group of R. A. 
                                               
100 D. Zhang, H. Ge, J.-h. Zou, X. Tao, R. Chen, J. Dai, Org. Lett. 2014, 16, 1410-1413. 
101 A. M. Sauer, W. E. Crowe, G. Henderson, R. A. Laine, Org. Lett. 2009, 11, 3530-3533. 
102 R. M. Cory, F. R. McLaren, J. Chem. Soc., Chem. Commun. 1977, 587-588. 
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Laine elaborated a different approach toward (+)-nootkatone starting from b-pinene and based 
on Yoshikoshi’s work. A three-step protocol involving oxidative cleavage by inexpensive 
KMnO4, aldol condensation with acetaldehyde, and stereoselective Grignard addition converted 
b-pinene to allylated compound 1.95. An anionic oxy-Cope reaction accounted for the desired 
configuration at C4, and subsequent stereoselective methylation gave the desired C4/C5 cis-
dimethylated compound 1.96. Oxidative cleavage, cyclobutane cleavage and aldol cyclization 
yielded (+)-nootkatone in a high overall yield of 33 % (Scheme 1.38). 
 
Scheme 1.38: Total synthesis of (+)-nootkatone featuring an anionic oxy-Cope reaction. 
Ishwarane is a tetracyclic eremophilane hydrocarbon, characterized by fusion of the 
isopropenyl carbon atoms C11 and C12 with the decalin core at C7, C8 and C10. In 1977, R. 
M. Cory and F. R. McLaren reported a “carbon atom insertion” tactic to construct the complex 
fused skeleton.102 This very elegant approach was an early demonstration of how easy carbenes 
can insert into unactivated C–H bonds, and is one of the most impressive applications of C–H 
activation in total synthesis.103 Their synthetic protocol started from octalone 1.97, which was 
subjected to 1,4-addition of methyl Gilman cuprate to install the methyl group at C10, methyl 
Grignard addition to the carbonyl group and dehydration of the formed tertiary alcohol (Scheme 
1.39). The obtained olefin 1.98 was treated with in situ generated dibromocarbene (CBr4 and 
MeLi at –78°C) to mediate diastereoselective cyclopropanation to form intermediate 1.99, 
which upon warming to –35°C can undergo a lithium-halogen exchange. Subsequent a-
elimination then forms cyclopropylcarbene 1.100, which inserts into the most accessible C–H 
bond to form ishwarane in 26 % yield. 
                                               
103 W. R. Gutekunst, P. S. Baran, Chem. Soc. Rev. 2011, 40, 1976-1991. 
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Scheme 1.39: C–H insertion approach for the total synthesis of ishwarane. 
 
1.5 Aim of this Thesis 
With these synthetic approaches toward eremophilane natural products in mind, we 
started to investigate a concise, stereoselective and divergent approach for the preparation of 
higher oxidized, functionalized and unusually connected members of the eremophilane 
sesquiterpenes. A major challenge in the constructions of polycyclic scaffolds in terpene natural 
product synthesis is the investigation of chemical reactions that can compete with the efficiency 
of natural cyclase enzymes.104 While the early biosynthetic pathways of carbon skeleton 
rearrangements are well investigated, C–C bond formation at the later stage of oxidized 
members of the synthesis, known as tailoring steps, still remains to be discovered. The 
following chapters deal with the investigation of newly discovered bioactive eremophilanes, 
with the elaboration of total syntheses for six members of the eremophilane family of natural 
products as well as with biogenetic hypotheses proposed on the basis of our synthetic studies. 
  
                                               
104M. Willot, M. Christmann, Nat. Chem. 2010, 2, 519. 
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2 TOTAL SYNTHESIS OF PERICONIANONE A 
2.1 Introduction 
In 2014, J. Dai and co-workers reported on the isolation of the secondary metabolite 
periconianone A (2.1) by bioassay-guided fractionation of the EtOAc extracts from the 
fermentation broth of Periconia sp. F-31, an endophytic fungus obtained from the plant Annona 
muricata.100 Extensive application of analytical methods such as NMR spectroscopy, ECD 
calculations, and single crystal X-ray analysis culminated in the structural elucidation of 
periconianone A, an architecturally complex, rigid, and highly oxidized eremophilane 
sesquiterpenoid that is built up on a unique 6/6/6 tricarbocyclic skeleton (Figure 2.1). All ring 
carbon atoms except for one are either stereogenic or sp2-hybridized; together with five 
contiguous stereocenters including two adjacent quaternary stereogenic carbon atoms, this 
structural peculiarity presents an exciting synthetic challenge.
A) 
 
B) 
 
Figure 2.1: A) Culture of endophytic fungus Periconia sp. F-31; B) Chemical structure and 
single crystal X-ray structure of periconianone A (2.1). 
In addition to its striking structural features, periconianone A displays significant neural 
anti-inflammatory activity, inhibiting the lipopolysaccharide-induced nitric oxide (NO) 
production in mouse microglia BV2 cells. The inflammatory mediator NO, one of the key 
signaling molecules in the human body, is produced by macrophages of the central nervous 
system, which are controlled by lipopolysaccharide (LPS) activators. There is evidence that the 
excessive and continuous over production of NO by activated microglia contributes to 
inflammatory-mediated neurodegeneration and neuronal loss.105 In addition, reactive microglia 
might also be jointly responsible for the poor recovery of damaged axons by NO-induced down-
regulation of neurite outgrowth.106 Therefore, manipulation and in particular inhibition of LPS-
induced microglial NO production might be a promising strategy to identify effective 
                                               
105 M. L. Block, L. Zecca, J.-S. Hong, Nat. Rev. Neurosci. 2007, 8, 57. 
106 H. Scheiblich, G. Bicker, Dev. Neurobiol. 2015, 76, 566-584. 
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candidates for the treatment of central nervous system inflammation and to aid the recovery and 
reconstruction of neuronal networks. 
2.1.1 Proposed Biosynthesis of Periconianone A 
Structural diversity in terpene biosynthesis is usually achieved at the initial cyclase phase 
by both polyene cyclizations and cationic rearrangements.107 In contrast, the unprecedented 
tricarbocyclic cage-like skeleton of periconianone A (2.1) is biosynthetically proposed to be the 
result of an unusual late-stage aldol cyclization of the highly oxidized bicyclic eremophilane 
precursor 2.2 (Scheme 2.1).100 Such a C4–C12 linkage forming the additional C-ring in 
periconianone A is to our knowledge unprecedented in other sesquiterpenoids and its 
construction involves formation of a motif with two contiguous all-carbon quaternary 
stereocenters, a challenging structural feature in organic synthesis.108 
 
Scheme 2.1: Proposed biosynthetic pathway of periconianone A (2.1) and synthetic strategy for 
the construction of the C-ring. 
The pathway for the biosynthesis of periconianone A as proposed by J. Dai and co-
workers100 starts from an eremophilane derived precursor (2.3) and forms the aldehyde 2.4 by 
several oxidation events. This intermediate can either be oxidized to the carboxylic acid at C12 
to form periconianone B (2.5), which was isolated from the same extracts as periconianone A, 
or hydroxylated at C7 to form the intermediate 2.2. Retro-aldol reaction of this intermediate 
leads to the known natural product botryosphaeridione (2.6), which was also isolated from the 
same extracts. Alternatively, an intramolecular aldol addition joins C4 and C12 to form 
periconianone A (2.1). 
                                               
107 D. W. Christianson, Chem. Rev. 2006, 106, 3412-3442. 
108 E. A. Peterson, L. E. Overman, Proc. Natl. Acad. Sci. U. S. A. 2004, 101, 11943-11948. 
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2.1.2 Strategic Considerations and Aim of this Project 
In our retrosynthetic proposal, we elaborated a synthetic route targeting the highly 
oxidized eremophilane bicycle 2.2 or a less oxidized precursor in order to test the feasibility of 
the proposed biogenetic C-ring cyclization by intramolecular aldol addition. Keeping in mind 
the lability of β-hydroxy aldehyde intermediate 2.2, which is prone to undergo elimination and 
retro-aldol reactions, two different routes were designed. The first route involves a double aldol 
reaction starting from tricarbonyl compound 2.7 with 2.2/2.8 as intermediate; the second route 
features a late stage C7 hydroxylation after construction of the tricarbocyclic skeleton by aldol 
addition. A potential precursor of the latter approach might be the a,b-unsaturated aldehyde 
2.9, whose double bond could be stereoselectively reduced after aldol cyclization. For the 
installation of the side chain at C7, we envisioned a stepwise protocol of allylation, oxidative 
cleavage and methenylation starting from the diene dione 2.10 (Scheme 2.2). 
 
Scheme 2.2: Retrosynthetic analysis of periconianone A (2.1) involving either a double aldol 
approach from tricarbonyl compound 2.7 or a stepwise approach by late stage hydroxylation at 
C7, stereoselective installation of the C13 methyl group as well as installation and modification 
of the C7 side chain prior to aldol cyclization. 
With this concise synthetic route to periconianone A (2.1) elaborated, we envisioned that 
we could gain synthetic access to structurally diverse derivatives of the natural product for SAR 
studies with the aim to identify the pharmacophore unit and finally synthesize more potent 
neural anti-inflammatory active agents. 
  
7
O
OHO Me
MeHO
Me
Periconianone A (2.1)
O
OO
Me
MeH
H
late stage 
hydroxylation
aldol additionstereoselectivereduction
side chain installation
and modification
O
O
O
O
O
O
OHO Me
MeHO
Me
H
X
X = O-, NR2
2.2: X = O 
2.8: X = NR2+
2.7Periconianone A (2.1)
O
OX
Me
MeHO
Me
H
double aldol approach
late stage C7 hydroxylation approach
2.102.9
  TOTAL SYNTHESIS OF PERICONIANONE A 
 
42 
2.2 Results and Discussion 
2.2.1 Construction of the AB-Ring System 
2.2.1.1 1st Approach 
In the first approach towards the AB-ring system of periconianone A, we aimed to apply 
the Pfau-d’Angelo method (see section 1.4.1.3) to synthesize the mono-protected octalone 
2.11.77,109 Allylation at C7, methylation at C4 and dehydrogenation of the C1–C2 bond after 
ketal deprotection of the carbonyl group at C3 (Scheme 2.3) would deliver the almost fully 
substituted AB-ring system 2.12. The major advantages of this route are its conciseness with 
only eight synthetic steps necessary to obtain the allylated octalone 2.12, and the use of only 
one protecting group. We were aware that introduction of the methyl group at C4 might be 
challenging due to steric interactions, mainly with the substituents on the neighboring 
quaternary carbon center at C5. 
 
Scheme 2.3: First retrosynthetic analysis of the AB-ring system of periconianone A (2.1). 
The synthesis commenced with a-methylation of mono-protected 1,4-cyclohexadione 
(2.13). Deprotonation with LDA in THF and subsequent addition of methyl iodide to the 
reaction mixture formed the desired methylated product in 71 % yield (Scheme 2.4). Reaction 
of the obtained a-methylated ketone 2.14 with R-1-phenylethylamine under Dean-Stark 
conditions gave the chiral imine 2.15, which was subsequently reacted in an enantioselective 
Michael addition to MVK. The alkylated imine 2.16 was then hydrolyzed by methanolic KOH 
and underwent aldol condensation under the same reaction conditions to form the desired 
octalone 2.11 in an overall yield of 63 %, starting from 2.14.109 
                                               
109 M. Pfau, I. Jabin, G. Revial, J. Chem. Soc., Perkin Trans. 1 1993, 1935-1936. 
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Scheme 2.4: Asymmetric synthesis of octalone 2.11 by Robinson annulation via chiral imine 
2.15. 
Purification of octalone 2.11 proved to be challenging: after column chromatography had 
been performed twice, the compound still contained impurities, noticeable by a yellowish color 
and misfitting integrals in the 1H NMR spectrum. On a small scale (50 mg), we were able to 
get rid of the yellow color by filtration of an ethereal solution of this compound over graphite. 
However, on a larger scale (> 1 g) this procedure was not reproducible and the yellow color 
persisted after filtration over graphite or activated charcoal. After screening different solvent 
systems for recrystallization, the best results were obtained by dissolving the compound in a 
1:1 mixture of hexane and diethyl ether at reflux, followed by slowly cooling to room 
temperature to form colorless needles. The enantiomeric excess of octalone 2.11 was 87 %, as 
determined by chiral gas chromatography. As a reference, racemic 2.11 was synthesized in 
59 % yield by a one-step Robinson annulation procedure using KOH and MVK in diethyl ether 
(Scheme 2.5).110 
 
Scheme 2.5: Racemic synthesis of octalone 2.11. 
With this robust and short route to easily access the bicyclic system, the stage was set to 
investigate the functionalization of the octalone core of 2.11. Since we needed to functionalize 
both C4 and C7 with alkyl substituents, our plan was to install the allyl group at C7 first, before 
the ketal protecting group was removed in order to methylate the C4 position. With minor 
modifications to a published procedure, i.e. using freshly distilled DMPU and applying a higher 
                                               
110 B. M. Trost, H. Hiemstra, Tetrahedron 1986, 42, 3323-3332. 
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number of equivalents of LDA (1.5 equiv. instead of 1.1 equiv.),89 we successfully introduced 
the allyl side chain to form allylated octalone 2.17 in 74 % yield (Scheme 2.6). 
 
Scheme 2.6: Allylation of octalone 2.11 and ketal deprotection. 
The ketal was hydrolyzed in the presence of p-toluenesulfonic acid in catalytic amount to 
give the bicyclic enedione 2.18 in 80 % yield. We envisioned installation of the methyl group 
at C4 by deprotonation at the a-position of the C3 carbonyl moiety. In order to avoid 
deprotonation and undesired functionalization at C2 of 2.18, we aimed to dehydrogenate the 
C1–C2 bond prior to C4 alkylation. The screened conditions are summarized in Table 2.1: we 
first investigated organoselenation at the C2 position, followed by oxidation and selenoxide 
elimination.111 However, deprotonation in order to form the kinetic enolate of 2.18 by LiHMDS 
(entry 1) or LDA (entry 2), followed by addition of PhSeBr only resulted in a complex mixture, 
as monitored by 1H NMR spectroscopy. Therefore, we investigated if the desired enolate might 
be formed by trapping the deprotonated species with TMSCl (entry 3) or TESCl (entry 4). In 
the former reaction, only starting material was isolated, possibly due to hydrolysis upon 
workup. The reaction using TESCl showed only low conversion and we obtained traces of two 
differently silylated compounds after column chromatography, indicating deprotonation not 
exclusively taking place at the C2 position. When 2.18 was treated with the bulkier lithium 
tetramethylpiperidide (LTMP, entry 5) as base, only 10 % conversion (1H NMR of the crude 
mixture) to a silylated compound was observed. Applying a modified Saegusa-Ito protocol 
using Pd(TFA)2 and O2 in DMSO at 80°C only led to a complex mixture (entry 6).112 Therefore, 
we started to investigate hypervalent iodine(V) reagents for the dehydrogenation of ketone 2.18 
to the diene dione 2.19. K. C. Nicolaou and co-workers showed that the combination of 2-
iodobenzoic acid (IBX) and a Lewis base oxidizes a variety of ketones and aldehydes to the 
corresponding a,b-unsaturated compounds at room temperature.113 However, applying the 
reported reaction conditions on our substrate, viz. stirring the reaction mixture with IBX and p-
methoxypyridine N-oxide (MPO) in DMSO at ambient temperature, did not bring about the 
                                               
111 H. J. Reich, J. M. Renga, I. L. Reich, J. Am. Chem. Soc. 1975, 97, 5434-5447. 
112 T. Diao, S. S. Stahl, J. Am. Chem. Soc. 2011, 133, 14566-14569. 
113 K. C. Nicolaou, T. Montagnon, P. S. Baran, Angew. Chem. Int. Ed. 2002, 41, 993-996; K. C. Nicolaou, D. L. 
F. Gray, T. Montagnon, S. T. Harrison, Angew. Chem. Int. Ed. 2002, 41, 996-1000. 
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desired conversion. Neither did heating the reaction mixture to 40°C initiate conversion (entry 
7). 
Table 2.1: Screening conditions for the dehydrogenation of 2.18. 
 
a monitored by 1H NMR spectroscopy; b freshly prepared IBX114 was used; c isolated yield after column chromatography. 
We were thus pleased to find 30 % conversion to the desired diene dione 2.19 without 
significant side product formation at a reaction temperature of 60°C, as monitored by 1H NMR 
spectroscopy (entry 8). Prolonged reaction time or further addition of IBX did not lead to 
increased product formation, but rather to more side products (entry 9). When freshly prepared 
IBX114 was used, conversion at a lower temperature of 45°C was observed (entry 10). Upscaling 
                                               
114 M. Frigerio, M. Santagostino, S. Sputore, J. Org. Chem. 1999, 64, 4537-4538. 
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this reaction led to an isolated yield of 23 % for the desired diene dione 2.19 and 19 % of 
recovered starting material 2.18 (entry 11). In order to further optimize the conversion to the 
desired product and suppress side product formation, we investigated conditions with the aim 
to shorten the reaction time. Using double amounts of both reagents IBX and MPO from the 
beginning did indeed accelerate the reaction and furnish more of the desired product with less 
side products on a small scale (entry 12). 
 
Scheme 2.7: Attempts to introduce the one-carbon moiety at C4 of 2.19. 
With diene dione 2.19 in hand, we started to investigate the functionalization at C4 
(Scheme 2.7). Unfortunately, neither methylation (LiHMDS, MeI, DMPU) nor 
aminomethylation (LiHMDS, Eschenmoser’s salt) of the enolate derived from 2.19 was 
successful and did not form the desired compounds 2.20 or 2.21, respectively. Deuteration 
experiments were performed by adding two equivalents of LiHMDS to a solution of 2.19 in 
THF at –78°C, followed by quenching with CD3OD. Analysis of the crude mixture by 1H NMR 
spectroscopy revealed that deprotonation took place at the C4 as well as the C7 position. 
However, electrophiles did not add to the C4 position. This result in combination with the 
sluggish dehydrogenation reaction (Table 2.1) prompted us to abandon this approach. 
2.2.1.2 2nd Approach 
After the first approach had revealed C4 in 2.19 to be inaccessible towards alkylation, we 
designed a new strategy with the aim to introduce the methyl substituent at C4 prior to B-ring 
formation (Scheme 2.8). As outlined in the introduction part (see section 1.4.1.2), elegant 
syntheses of functionalized octalones are described by the groups of P. Duhamel68 and A. de 
Groot74 starting from the chiral pool-derived and commercially available monoterpene S-
carvone (2S-2.22). The latter group has already developed a five-step procedure for the 
synthesis of dienone 2.23. Conjugate addition for the installation of a carbon substituent at C4 
was followed by a two-step Robinson annulation procedure. The isopropenyl group, which 
served as a removable directing group for stereoselective synthesis, was then removed by a 
Criegee rearrangement.76 After obtaining octalone 2.23, we envisioned to introduce the missing 
oxygen substituent at C3 by allylic oxidation. 
O
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Scheme 2.8: Second retrosynthetic analysis of the AB-ring system of periconianone A (2.1). 
The synthesis started by conjugate addition of methyl cuprate to the enone moiety of S-
carvone, followed by subsequent trapping of the resulting enolate as the TMS enol ether. The 
described procedures for this reaction sequence comprise addition of MeMgBr to a solution of 
S-carvone (2S-2.22) in the presence of a catalytic amount of copper bromide dimethyl sulfide 
complex (CuBr·SMe2), TMSCl and hexamethylphosphoric triamide (HMPA) at –40°C. These 
conditions proved laborious, involved the use of carcinogenic and mutagenic HMPA and only 
moderate yields (51 %; lit. 86 %, de 86 %) were obtained for the desired silyl enol ether. 
Therefore, we tested an alternative protocol described by the group of M. T. Reetz,115 based on 
studies by M. S. Kharasch et al.116 using catalytic amounts of cost-efficient CuI and LiCl. These 
metal salts are mixed in THF to give a homogeneous solution of the active copper ate-complex 
Li2[CuX3]. After cooling to 0°C, S-carvone (2S-2.22) and TMSCl were added, followed by 
MeMgBr. This procedure led to quantitative conversion to the desired silyl enol ether (by 
1H NMR). After silica gel flash column chromatography, we isolated the pure product 2.24 in 
68 % yield (Scheme 2.9) and a diastereomeric ratio of >10.1. The moderate yield after 
purification can be explained by hydrolysis during column chromatography and use of crude 
2.24 for the following reaction step might be considered as an alternative. Complete selectivity 
in favor for the trans-2,4-substituted product was observed, even though this diastereoisomer 
(one axial substituent) is supposed to be higher in energy compared to the cis-product (both 
substituents equatorial). It has already been reported in 1966 that stereoselectivity in the 
conjugate addition to 5-substituted cyclohexanones to yield 3,5-disubstituted derivatives is not 
solely governed by thermodynamic arguments regarding the relative stability of the product 
stereoisomers, but also by the energy levels of the respective transitions states.117 Later, 
transition states for this transformation comprising a trihapto coordination (h3) of the allyl 
ligand to the central copper ion derived from the intermediate cuprate complexes shown in 
                                               
115 M. T. Reetz, A. Kindler, J. Organomet. Chem. 1995, 502, C5-C7. 
116 M. S. Kharasch, P. O. Tawney, J. Am. Chem. Soc. 1941, 63, 2308-2316. 
117 N. L. Allinger, C. K. Riew, Tetrahedron Lett. 1966, 7, 1269-1272. 
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Figure 2.2 was proposed.118 The transition state leading to the cis-2,4-substituted 
cyclohexanone (cis-2.26) is unfavored due to steric repulsion between the isopropenyl group 
on the substrate and the methyl ligand bound to the copper ion. This steric interaction is 
nonexistent in the transition state leading to the trans-2,4-substituted cyclohexanone (trans-
2.26), whose formation is thus favored.  
 
Figure 2.2: h3-Allyl cuprate complexes as intermediates in the conjugate addition of methyl 
cuprate to S-carvone rationalizing the observed trans-selectivity with respect to the alkyl 
substituents at C2 and C4. 
With TMS enol ether in hand, Lewis acid-mediated Michael addition using BF3·OEt2 was 
followed by a basic aldol condensation catalyzed by sodium methoxide to give the desired 
octalone 2.25 in 61 % yield and a diastereomeric ratio of >10:1 over two steps. This exclusive 
cis-selectivity with respect to the methyl groups at C4 and C5 can be explained by the conformer 
structures of the starting material as shown in Scheme 2.10. 
 
Scheme 2.9: Conjugate addition and Robinson annulation sequence for the synthesis of octalone 
derivative 2.25. 
Due to A1,2 strain between the methyl groups at position C4 and C5, the transition state 
derived from conformer 2.24-B of the silyl enol ether starting material is preferred over the one 
derived from 2.24-A.119 Additionally, the isopropenyl group favors an equatorial orientation as 
in 2.24-B, and together with the electrophilic attack taking place from the less shielded Re face 
of the enolate’s a-carbon leads to the desired diketo diastereoisomer. 
                                               
118 E. J. Corey, F. J. Hannon, Tetrahedron Lett. 1990, 31, 1393-1396; R. Imbos, A. J. Minnaard, B. L. Feringa, 
Tetrahedron 2001, 57, 2485-2489; S. R. Krauss, S. G. Smith, J. Am. Chem. Soc. 1981, 103, 141-148. 
119 F. Johnson, Chem. Rev. 1968, 68, 375-413. 
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Scheme 2.10: A1,2 strain to explain the cis-selectivity with respective to the methyl groups at C4 
and C5.  
The isopropenyl group of octalone 2.25 was then cleaved by a Criegee rearrangement 
reaction as shown in Scheme 2.11.76 Mechanistically, ozonolysis of 2.25 in a MeOH/CH2Cl2 
mixture forms the peroxy acetal intermediate 2.28 via a primary ozonide. The peroxide moiety 
is then acetylated using acetic anhydride, Et3N and DMAP. This intermediate of an acetylated 
peroxy acetal (2.29) can rearrange to release acetate and form the ester 2.30 after hydrolysis, 
which can be eliminated under basic conditions. This procedure gave the desired dienone 2.23 
in 51 % yield (Scheme 2.11). 
 
Scheme 2.11: Criegee rearrangement mechanism for the synthesis of dienone 2.23. 
With octalone 2.23 in hand, we started to investigate procedures for the oxidation of the 
allylic C3 position. Unfortunately, protocols involving either radical or ionic pathways were 
not successful for octalone 2.23 (Scheme 2.12). Co(acac)2-catalyzed allylic oxidation (t-
BuOOH, acetone, rt), which had previously been applied for the oxidation of various electron-
poor enones,120 resulted in formation of a complex mixture. Riley oxidation121 led to an 
unknown side product lacking a ketone or enone group, since no signal was detected in the 
appropriate chemical shift region in the 13C NMR spectrum. However, a signal at 184 ppm 
                                               
120 X. Q. Han, Z. Y. Zhou, C. Wan, Y. M. Xiao, Z. H. Qin, Synthesis 2013, 45, 615-620. 
121 H. L. Riley, J. F. Morley, N. A. C. Friend, J. Chem. Soc. 1932, 1875-1883. 
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indicated an ester moiety present in this unidentified compound. It is known that conjugated 
bicyclo[4.4.0]decandienones react sluggishly in allylic oxidation reactions. Recently, an allylic 
oxidation procedure of C7 functionalized octalones using PDC (pyridinium dichromate) and t-
BuOOH in benzene gave only 28 % yield of the desired oxidized diene dione, as described by 
the group of D. S. Reddy (see section 1.4.2.2).99 
 
Scheme 2.12: Attempts at the allylic oxidation of 2.23. Reaction conditions: a) Co(acac)2, t-
BuOOH, acetone, rt; b) SeO2, dioxane, 100°C. 
We therefore decided to brominate the C3 position with the aim of replacing the bromide 
by a hydroxy group in an additional solvolysis step. Bromination using N-bromosuccinimide 
(NBS) and azobisisobutyronitrile (AIBN) in CCl4 at 80°C furnished the desired brominated 
dienone 2.31 as a diastereomeric 1:1 mixture in 51 % yield (Scheme 2.13). The choice of 
reaction time had substantial influence on the product’s diastereomeric ratio and an experiment 
with a shorter reaction time of five hours, instead of 18 hours, gave a dr of 7:3. This indicates 
that the bromination might be stereoselective and epimerization on prolonged heating takes 
place. Additionally, dibromination of the C1=C2 double bond as a side reaction was observed. 
Solvolysis was performed by stirring the synthesized bromide 2.31 with silver(I) salts in a 
mixture of acetone and water in the dark. 
 
Scheme 2.13: Bromination of 2.23 and subsequent solvolysis. Reaction conditions: a) Ag2CO3, 
acetone/H2O (8:1), rt; b) CF3COOAg, acetone/H2O (5:1), rt. 
The desired C3 hydroxylated octalone 2.32 was formed along with the elimination 
product 2.33 as the major side product. Due to the low conversion (observed by 1H NMR 
spectroscopy) of the solvolysis step and based on the unsuitability of the dienone moiety in the 
ensuing steps of this synthetic route observed later on, we did not further investigate this 
strategy. The C1=C2 double bond might be more suitable to be installed later on in the 
synthesis. Additionally, we had in parallel started to investigate a 3rd approach towards the total 
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synthesis of periconianone A featuring installation of the C3 oxygen substituent on the 
monocyclic compound, which gave much more promising results. 
2.2.1.3 3rd Approach 
In parallel to the second approach, we investigated if the C3 oxygen substituent might be 
more readily installed at the beginning of the synthesis. Therefore, we envisioned to modify the 
second approach by installation of a hydroxy group in the g-position of carvone and to probe 
the feasibility of A-ring modification on this hydroxylated substrate. In order to 
stereoselectively elaborate the C2, C3 and C4 positions, we outlined the retrosynthetic pathway 
from the targeted diketo compound 2.34 given in Scheme 2.14, considering the stereoselectivity 
of each transformation for the installation of the appropriate substituents. 
 
Scheme 2.14: Third retrosynthetic analysis of the AB-ring system of periconianone A (2.1) 
starting from R-carvone (2R-2.22). 
After the hydroxy group at C3 will be installed and protected, 1,4-addition comparable to 
the 2nd approach will methylate C4. In the conjugate addition of methyl cuprate to S-carvone 
(see previous section), we argued that steric repulsion between the isopropenyl group and the 
methyl ligands of the cuprate complex disfavors one of the transition states, leading to the 
observed selectivity for a trans-2,4 substitution in 2.24. In the case of protected g-hydroxy 
carvone derivative 2.35, we assume that steric repulsion of the methyl ligands on the cuprate 
with the OTBS group on the substrate might be more pronounced than the steric interaction 
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with the isopropenyl group. Therefore, we propose the transition states featuring trihapto 
coordination of the copper ion shown in Scheme 2.14, and the favored trans-2.37 leading to the 
desired trans-3,4 substitution product 2.36. To this end, we intended to start from the R-
enantiomer of carvone (2R-2.22). Both S- and R-carvone have been widely used as sustainable 
starting materials in preparation of enantiopure natural products122,123 and starting with the more 
cost-efficient R-enantiomer is highly desirable. The selectivity in the Michael reaction of TMS 
enol ether 2.36 to MVK to give the desired diketo compound 2.38 was predicted by an all-
equatorial orientation of the substituents at C2, C3 and C4 to minimize the A1,3 strain between 
the C2 isopropenyl and the C4 methyl groups as shown by conformer 2.36-A. 
The synthetic route started with a literature known two-step protocol (Scheme 2.15):124 
preparation of the thermodynamic TMS enol ether 2.39 was achieved by regioselective g-
deprotonation of R-carvone using the Kharasch reagent.116,125 The reduction of iron(III) 
chloride to a lower-valent iron(II) species using methyl lithium or methyl Grignard reagent 
accompanied by formation of methane (ca. 10 %, by reaction of the concomitantly formed 
methyl radical with the solvent) or ethane (ca. 90 %, by recombination of methyl radicals) had 
already been described earlier.126 However, it was not until recently that the red solid, isolated 
after mixing iron(III) chloride with methyl lithium at –30°C followed by removal of lithium 
chloride and the solvent, could be crystallized and fully characterized by the group of A. 
Fürstner.127 Upon slow cooling of a saturated solution of the formed compound in diethyl ether 
from –40°C to –78°C, yellow-orange plates were obtained, whose single crystal X-ray analysis 
showed a dianionic homoleptic iron(II) complex with four methyl ligands in an almost ideal 
tetrahedral arrangement with [Li(OEt2)]+ as counterion and the molecular formula 
[(Me4Fe)(MeLi)][Li(OEt2)]2. Treatment of dihydrocarvone with either this reagent or with 
FeCl3 and MeMgX (as described in the original procedure)128 gave identical results after 
                                               
122 For reviews: Z. G. Brill, M. L. Condakes, C. P. Ting, T. J. Maimone, Chem. Rev. 2017, 117, 11753-11795; F. 
Z. Macaev, in Stud. Nat. Prod. Chem., Vol. 39 (Ed.: A.-u. Rahman), Elsevier, 2013, pp. 233-267. 
123 For recent examples: P. Finkbeiner, K. Murai, M. Röpke, R. Sarpong, J. Am. Chem. Soc. 2017, 139, 11349-
11352; D. Chen, P. A. Evans, J. Am. Chem. Soc. 2017, 139, 6046-6049; L. J. Nannini, S. J. Nemat, E. M. Carreira, 
Angew. Chem. Int. Ed. 2018, 57, 823-826; A. W. Schuppe, D. Huang, Y. Chen, T. R. Newhouse, J. Am. Chem. 
Soc. 2018, 140, 2062-2066. 
124 G.-Q. Tian, J. Yang, K. Rosa-Perez, Org. Lett. 2010, 12, 5072-5074; J. H. Huang, J. R. Yang, J. Zhang, J. Yang, 
Org. Biomol. Chem. 2013, 11, 3212-3222. 
125 M. E. Krafft, R. A. Holton, J. Am. Chem. Soc. 1984, 106, 7619-7621; F. C. E. Saraber, A. Baranovsky, B. J. 
M. Jansen, M. A. Posthumus, A. de Groot, Tetrahedron 2006, 62, 1726-1742. 
126 H. J. Spiegl, G. Groh, H. J. Berthold, Z. Anorg. Allg. Chem. 1973, 398, 225-230; H. J. Berthold, H. J. Spiegl, 
Z. Anorg. Allg. Chem. 1972, 391, 193-202. 
127 A. Fürstner, H. Krause, C. W. Lehmann, Angew. Chem. Int. Ed. 2006, 45, 440-444. 
128 S. M. Ceccarelli, U. Piarulli, C. Gennari, Tetrahedron 2001, 57, 8531-8542. 
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quenching the reaction with TMSCl and Et3N, which strongly corroborates the “Kharasch 
reagent” to match the described iron “super-ate” complex. 
 
Scheme 2.15: Synthesis of g-hydroxy carvone (2.40) by a two-step literature procedure.124 
TMS enol ether 2.39 was then treated with 2.4 equivalents of nitrosobenzene and acetic 
acid to form g-hydroxy carvone (2.40) in 30 % yield over two steps. The yield of 60 % reported 
in literature could not be reproduced, which is in agreement with a recently published article by 
the group of M. A. Brimble.129 Mechanistically, the first equivalent of the nitrosobenzene is 
attacked by the nucleophile 2.39 in a vinylogous Mukaiyama-type aldol reaction to form the 
corresponding g-aminohydroxylated compound. The second equivalent of nitrosobenzene then 
reduces the formed O-substituted N-phenylhydroxylamine intermediate with dissociation of the 
O–N bond releasing the desired g-hydroxy carvone (2.40) and trans-azoxybenzene.130 
Alternatively, g-hydroxy carvone (2.40) was synthesized in a single-step procedure using a 
mixed copper-aluminum oxide catalyst and potassium tert-butoxide.131 Unfortunately, we 
could only isolate 14 % of 2.40 when applying this literature procedure. The installed secondary 
alcohol was protected using TBSCl, imidazole and DMAP. The moderate yield of 66 % of 2.35 
might be explained by impurities present in the starting material and separated at this stage of 
the total synthesis. When the same reaction conditions as for S-carvone (LiCl, CuI, MeMgBr, 
TMSCl, THF, 0°C) were used in the conjugate addition of methyl cuprate to C3-hydroxylated 
enone 2.35, a diastereomeric mixture of 7:3 in favor of the desired isomer was obtained 
(Scheme 2.16). By carrying out the reaction at a lower temperature of –20°C instead of 0°C, 
we could increase this selectivity to 19:6, and at –40°C to >10:1. However, no conversion of 
the starting materials was observed at lower reaction temperatures (–50°C). The enolate formed 
after the addition of methyl cuprate was directly trapped by TMSCl to form the corresponding 
TMS enol ether 2.36. 
                                               
129 J. G. Hubert, D. P. Furkert, M. A. Brimble, J. Org. Chem. 2015, 80, 2231-2239. 
130 D. B. Ramachary, C. F. Barbas, Org. Lett. 2005, 7, 1577-1580. 
131 A. L. García-Cabeza, R. Marín-Barrios, R. Azarken, F. J. Moreno-Dorado, M. J. Ortega, H. Vidal, J. M. Gatica, 
G. M. Massanet, F. M. Guerra, Eur. J. Org. Chem. 2013, 2013, 8307-8314. 
TMSO
2.39
O
R-(–)-Carvone (2R-2.22)
FeCl3, MeMgBr, Et2O, –20°C
then TMSCl, Et3N, DMPU, rt
PhNO, HOAc
CH2Cl2, –78°C OH
O
2.40, 30 %
over 2 steps
H H H
  TOTAL SYNTHESIS OF PERICONIANONE A 
 
54 
 
Scheme 2.16: A-ring functionalization: TBS protection of the secondary C3 hydroxyl group; 1,4-
addition at C4; Michael-addition on methyl vinyl ketone at C5. 
With TMS enol ether 2.36 in hand, we investigated the Michael-addition step on this 
substrate: initial experiments were very low yielding and delivered mostly desilylated starting 
material 2.41. Experiments that showed higher yields for the desired diketone 2.38 were not 
reproducible, which led us to carefully screen the reaction conditions. Briefly, we increased the 
quality of the reagents by distillation of BF3·OEt2 directly prior to the reaction and by the use 
of dry isopropanol as well as dry nitromethane. Addition of all the reagents was performed at  
–78°C, before warming to –65°C and carefully monitoring the reaction temperature. At lower 
reaction temperatures, no conversion took place and at higher temperatures (–20°C), increased 
desilylation was observed. In the procedure described by A. de Groot et al.,74 the mixture of all 
reagents except for the Lewis acid BF3·OEt2 was stirred at –78°C for 30 minutes, before the 
latter was added. We found that during this time, significant desilylation took place. In 
consequence, we only stirred the other reagents for five minutes before adding BF3·OEt2. 
Furthermore, adding extra BF3·OEt2 (0.1 – 0.5 equiv.) after stirring for three to five hours had 
a positive influence on conversion. Combining these optimizations culminated in a yield of 
66 % and a diastereomeric ratio of >10:1 for diketone 2.38, along with formation of a 
diastereomeric mixture of desilylated starting material 2.41 as the only detectable side product. 
Re-silylation of this compound using TMSCl, HMDS and NaI in acetonitrile at room 
temperature delivered the silyl enol ether 2.36 in 84 % yield after flash column chromatography. 
To prevent hydrolysis during chromatography, only a short plug of silica was used to minimize 
the duration of compound/SiO2 interaction. 
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With the fully substituted A-ring in hand, our next aim lay in constructing the B-ring and 
removing the isopropenyl group by a Criegee rearrangement. Aldol condensation of 2.38 using 
sodium methoxide gave the bicyclic compound 2.42 in 84 % yield, whose structure was 
confirmed by single-crystal X-ray analysis (Scheme 2.17). 
 
Scheme 2.17: B-ring formation by an aldol condensation reaction, and single crystal X-ray 
structure of 2.42. 
However, removal of the isopropenyl moiety turned out to be very low-yielding on the 
bicyclic substrate 2.42 using either conditions triggering a Criegee rearrangement or a Criegee 
fragmentation pathway (Table 2.2). While the former transformation was discussed in section 
2.2.1.2, the latter pathway was first described by the group of S. Schreiber132 and mechanistic 
details are given in Scheme 2.18. Ozonolysis of the isopropenyl group leads to a primary 
ozonide, which is cleaved in a 1,3-dipolar cycloreversion to form formaldehyde and the 
carbonyl oxide. The carbonyl oxide is attacked by methanol to form peroxy acetal 2.43. 
Transfer of an electron from Fe2+ to the peroxide function leads to dissociation of the O–O bond 
and formation of the oxy radical 2.44. This radical is destabilized by an antibonding interaction 
with the neighboring methoxy group and easily forms the carbon-centered radical 2.45. 
Oxidation of the radical at C2 to the corresponding carbocation was mediated by Cu2+ to form 
2.46 and subsequent b-elimination results in the fragmentation product 2.47.
                                               
132 S. L. Schreiber, J. Am. Chem. Soc. 1980, 102, 6163-6165; S. L. Schreiber, B. Hulin, W.-F. Liew, Tetrahedron 
1986, 42, 2945-2950. 
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Scheme 2.18: Criegee fragmentation mechanism for octalone 2.42. 
With the same conditions as applied in the previous approach for octalone 2.25 (Table 
2.2, entry 1), reaction of 2.42 yielded a mixture of the desired dienone 2.47 and methyl ketone 
2.48 in a ratio of 2:7 along with some unidentified side products.  
Table 2.2: Selected conditions for the Criegee rearrangement or fragmentation of 2.42 to 2.47. 
 
entry reagent/catalyst solvent temperature observations 
1 i) O3 
then Ac2O, Et3N, DMAP 
ii) NaOMe 
i) CH2Cl2/MeOH (5:1) 
 
ii) MeOH 
i) –78°C 
then rt 
ii) rt 
ii) 2.47/2.48 (2:7) and side 
productsa 
2 i) O3 
then Ac2O, Et3N, DMAP 
ii) NaOMe 
i) CH2Cl2, MeOH (4 
equiv.) 
ii) MeOH 
i) –78°C 
then 0°C 
ii) rt 
ii) 2.47/2.48 (1:4) and side 
productsa 
3 O3 
then Cu(OAc)2·H2O, 
FeSO4·7H2O 
CH2Cl2/MeOH (4:3) –78°C 
then –20°C to rt 
26 % 2.47, 13 % 2.48b 
a monitored by 1H NMR spectroscopy; b isolated yield after column chromatography. 
During the optimization process of this transformation starting from epoxidized S-
carvone,133 A. R. Daniewski et al. found that adjusting the amount of methanol in the reaction 
mixture was the key for successfully triggering the Criegee rearrangement. To form the peroxy 
acetal and to avoid the formation of the thermally more stable secondary ozonide, methanol is 
crucial for the reaction. Cleanest conversion to the desired peroxy acetal was reported using 
only four equivalents of methanol. Unfortunately, following their protocol we observed an even 
                                               
133 A. R. Daniewski, L. M. Garofalo, S. D. Hutchings, M. M. Kabat, W. Liu, M. Okabe, R. Radinov, G. P. 
Yiannikouros, J. Org. Chem. 2002, 67, 1580-1587. 
OTBS
HO
OO
OTBS
OO
OTBS
OTBSOTBS
O3
MeOH/CH2Cl2
FeII FeIII
CuIICuI
OTBS
O
O
HO-
HO O O
OOO
2.432.42 2.44
2.452.462.47
O
OTBS
O
OTBS
conditions
2.42
O
OTBS
O
2.47 2.48
+
H H
TOTAL SYNTHESIS OF PERICONIANONE A 57 
 
higher 1:4 ratio of 2.47/2.48 in favor for undesired 2.48 (entry 2). By applying the reported 
reaction conditions for the Criegee fragmentation with Cu(OAc)2·H2O and FeSO4·7H2O, the 
desired dienone 2.47 was formed in 26 % isolated yield (entry 3).134 Treatment of the methyl 
ketone 2.48 with m-CPBA to bring about the conversion to the desired acetate via a Baeyer-
Villiger oxidation was not successful either and resulted only in formation of a complex 
mixture. 
Instead of extending our screening efforts, we decided to investigate the removal of the 
isopropenyl group at an earlier stage of the synthetic route, viz. either right before the 
construction of the bicyclic structure or even before the Michael addition to methyl vinyl 
ketone. Drawback of the latter strategy is the necessity of additional silyl enol ether formation 
after removal of the isopropenyl group (2.49 g 2.50). However, we investigated both pathways 
in parallel as summarized in Scheme 2.19, Scheme 2.20 and Scheme 2.21. 
 
Scheme 2.19: Attempted strategy comprising an early-stage Criegee fragmentation for the 
removal of the isopropenyl group. 
Criegee fragmentation of cyclohexanone 2.41 gave the desired enone 2.49 in a moderate 
yield of 56 %. Unfortunately, after forming the silyldienolether 2.50, Michal addition to MVK 
only gave a complex mixture. 
                                               
134 X. L. Qi, J. T. Zhang, J. P. Feng, X. P. Cao, Org. Biomol. Chem. 2011, 9, 3817-3824; J. D. White, U. M. 
Grether, C.-S. Lee, Org. Synth. 2005, 82, 108-114. 
OTBS
O
O
O3, MeOH/CH2Cl2, –78°C
then Cu(OAc)2·H2O, 
FeSO4·7H2O, –20°C to rt
OTBS
O
OTBS
O
LDA, TMSCl
THF, –78°C
2.49, 56 %
2.50, 61 %
OTBS
TMSOMVK, BF3·OEt2
i-PrOH/MeNO2/CH2Cl2 
–65°C - –60°C
2.41
H
  TOTAL SYNTHESIS OF PERICONIANONE A 
 
58 
 
Scheme 2.20: Criegee rearrangement of monocyclic compound 2.38. 
In a more elegant approach, we cleaved the isopropenyl group after Michael addition of 
2.36 to MVK. Upon formation of the peroxy acetal derived from 2.38, Criegee rearrangement 
(Ac2O, Et3N, DMAP) only gave minor amounts of the desired enone 2.34, along with methyl 
ketone 2.51 and ester 2.52 as side products in a ratio of 2:13:3 (Scheme 2.20). Pleasingly, the 
conditions used for the Criegee fragmentation discussed earlier formed the desired enone 2.34 
in 67 % isolated yield (Scheme 2.21). 
 
Scheme 2.21: Criegee fragmentation reaction and aldol cyclization to form the bicyclic dienone 
2.53. 
Cyclization of enone 2.34 under basic conditions using NaOMe in MeOH resulted in a 
mixture of the desired aldol product 2.53 and the undesired Michael addition byproduct 2.54 in 
a mixture of 1:1. The concentration of base was found to have no influence on this ratio. Further 
screening of reaction conditions in order to favor formation of the desired condensation product 
culminated in employing enamine catalysis: stirring a mixture of enone, pyrrolidine and acetic 
acid in dichloromethane at room temperature gave the bicyclic dienone 2.53 in 88 % yield. With 
proline as catalyst, no conversion was observed at room temperature and only slow conversion 
without completion at 40°C, although 1.5 equivalents of the amino acid had been added to the 
reaction mixture. 
2.51: R = (CO)Me
2.52: R = O(CO)Me
OTBS
O
O O3, CH2Cl2/MeOH (25:1), –78°C
then Ac2O, Et3N, DMAP
–25°C to rt
then 0.1 M HCl
R
OTBS
O
O
OTBS
O
O
+
2:13:3
(2.34/2.51/2.52)
2.34
H H
2.38
O
OTBS
OTBS
O
O
OTBS
O
O
+
Me Me
OTBS
O
O
O3, MeOH/CH2Cl2, –78°C
then Cu(OAc)2·H2O
FeSO4·7H2O, –20°C to rt
a) NaOMe
MeOH, rt
or b) pyrrolidine
AcOH, CH2Cl2, rt
2.34, 67 %2.40
2.53
a) 1:1 (2.53/2.54)
b) 88 % (2.53)
2.54
H
TOTAL SYNTHESIS OF PERICONIANONE A 59 
 
2.2.2 Construction of the C-Ring by a Double Aldol Approach 
With the AB-ring system 2.53 in hand, we addressed the construction of the C-ring of 
periconianone A (2.1) in order to complete the tricyclic skeleton. As pointed out in the 
retrosynthetic analysis (see section 2.1.2) and on closer examination of the proposed 
biosynthetic pathway, a double aldol reaction would culminate in the desired connectivity 
(Scheme 2.22). Propanal or an enamine derivative of this aldehyde could first add to a carbonyl 
group at position C7 of the highly oxidized octalone 2.7. A second aldol reaction by enolization 
of the ketone at position C4 and attack to the aldehyde group at C12 could then take place to 
complete the tricyclic skeleton of periconianone A (2.1). 
 
Scheme 2.22: Double aldol approach for the construction of the C-ring of periconianone A (2.1). 
The first step in this strategy was oxidation of octalone 2.53 at positions C7 and C3 with 
the goal to synthesize the diosphenol 4-epi-botryosphaeridione (2.6), a compound isolated from 
the same extracts as periconianone A.100 Autoxidation of dienone 2.53 under basic conditions 
(t-BuOK, 18-crown-6, O2) in toluene at –60°C delivered the a-diketone in 52 % yield (Scheme 
2.23). However, 1H NMR analysis (CDCl3) revealed that this compound with the carbonyl 
group at C7 installed exclusively adopted the enol form to give the diosphenol 2.54. TBS 
deprotection using aqueous HF in acetonitrile gave the free allylic alcohol 2.55 in quantitative 
yield. Unfortunately, attempts to oxidize this hydroxy group were not successful using Dess-
Martin periodinane (DMP) and the starting material decomposed during the reaction. Another 
approach consisted in first modifying the A-ring prior to oxidation at C7: the TBS group of 
octalone 2.53 was removed in 74 % yield using aqueous HF in acetonitrile to form 2.56; 
subsequent oxidation by DMP gave the diene dione 2.57 in 86 % yield but attempts towards the 
oxidation at position C7 using the conditions elaborated for octalone 2.53 failed and the starting 
material was decomposed. 
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Scheme 2.23: Attempts to synthesize 4-epi-botryosphaeridione (2.7) as key intermediate in the 
aldol approach. 
In order to study the electrophilicity of the carbonyl group at C7 in light of its preference 
for the enol form in solution (as observed by 1H NMR spectroscopy), we investigated the 
primary aldol reaction of our proposal on test substrate 2.58 without modification of the A-ring. 
Additionally, we planned to test the double aldol approach for the isopropenylated and C3 
oxidized diosphenol, planning to remove the three-carbon directing group at C2 at a later stage 
of the total synthesis. Therefore, the isopropenyl-bearing octalone 2.42 was oxidized using the 
aforementioned autoxidation conditions to give diosphenol 2.58 in 81 % yield (Scheme 2.24). 
This reaction had to be carried out at –28°C, as only 38 % of the desired product was formed at 
room temperature. Unfortunately, no formation of the aldol addition product was observed 
when reacting diosphenol 2.58 with reagent combinations of propanal and L-proline, or with 
LiHMDS and 1-(prop-1-en-1-yl)piperidine. Modification at the A-ring of 2.58 by deprotection 
of the TBS group furnished the secondary alcohol 2.59, but oxidation by DMP only gave a 
complex mixture. 
 
Scheme 2.24: Formation of diosphenols 2.58 and 2.59 as test substrates in the double aldol 
approach. 
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Aiming at an enhancement of the electrophilic character of C7, we investigated a 
protection strategy for the carbonyl group at C8 as summarized in Scheme 2.25. First the enol 
with the hydroxy group at C7 was protected as the TBS enol ether 2.60, after attempts at the 
formation of the more labile TES enol ether had been hampered by hydrolysis during work-up. 
Unfortunately, and even though a mild procedure under aprotic conditions was chosen 
[(TMSOCH2)2, cat. TMSOTf, 0°C to rt],135 protection of the C8 carbonyl group as the ketal 
failed and triggered deprotection of the TBS enol ether instead. 
 
Scheme 2.25: Protection strategy to enhance the electrophilicity of the C7 carbonyl group. 
Further studies towards this protection strategy were performed on test substrate 2.61, 
after the isopropenyl group of 2.25 had been hydrogenated in the presence of Wilkinson’s 
catalyst.136 Oxidation to the diosphenol 2.62 proceeded with 77 % yield at –55°C, after no 
conversion had been observed at lower reaction temperature (–60°C) and formation of a 
complex mixture at higher temperature (–30°C). However, when 2.62 was heated with ethylene 
glycol in the presence of a catalytic amount of p-TsOH at 110°C in toluene, the desired acetal 
was not obtained. Instead, formation of a new compound characterized by an aromatic system 
was observed. Careful structure elucidation using 2D NMR spectroscopy revealed the 
compound to be catechol 2.63. Heating either 2.62 or TBS-protected diosphenol 2.64 with p-
TsOH in toluene at 100°C gave the same compound 2.63, starting from the latter in 68 % yield. 
Mechanistically, it is proposed that upon protonation of the C8 carbonyl group, a [1,2]-alkyl 
shift from C5 to C10 takes place to form the 5,6-spirocyclic intermediate 2.65, which can 
subsequently undergo a second [1,2]-alkyl shift from C10 to C9 to form catechol 2.63. This 
kind of [1,3]-alkyl migration was first described by A. Andreocci in 1893 in the acid-catalyzed 
transposition of santonin to desmotroposantonin,137 and later pioneered and termed dienone-
phenol rearrangement by A. L. Wilds and C. Djerassi in 1946.138 Due to the increased reactivity 
of the highly oxidized diosphenol, we investigated the reduction of the C8 carbonyl moiety. 
Reduction with NaBH4 in MeOH gave no conversion, but with the Luche protocol (NaBH4, 
                                               
135 T. Tsunoda, M. Suzuki, R. Noyori, Tetrahedron Lett. 1980, 21, 1357-1358. 
136 J. A. Osborn, F. H. Jardine, J. F. Young, G. Wilkinson, J. Chem. Soc. A 1966, 1711-1732. 
137 A. Andreocci, Gazz. Chim. Ital. 1893, 23, 468-476. 
138 A. L. Wilds, C. Djerassi, J. Am. Chem. Soc. 1946, 68, 1715-1719. 
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CeCl3·7H2O, MeOH, rt) followed by acidic work-up, phenol 2.66 and deprotected diosphenol 
2.62 were formed in a 4:3 ratio, as monitored by 1H NMR spectroscopy of the crude reaction 
mixture. This kind of reduction and rearrangement cascade has been described by H. 
Dannenberg et al. on oxidized testosterone derivatives:139 reduction of the carbonyl moiety 
forms the intermediate 2.67, which dehydrates upon protonation of the hydroxy group and 
rearranges to the phenol 2.66 in a dienol-phenol rearrangement. Unfortunately, this experiment 
was not reproducible and no reduction took place when protected diosphenol 2.64 was 
subjected to the same reaction conditions. 
 
Scheme 2.26: Investigations for protection or reduction of the C8 carbonyl group using the test 
substrate 2.61. 
Starting from octalone 2.25, we also tested a sequence featuring C7-hydroxylation, 
protection of the C8 carbonyl group and oxidation of the newly installed C7 hydroxy substituent 
to the ketone. Oxidation in a-position of the carbonyl group in octalone 2.25 was either 
performed by Rubottom oxidation or treatment with Pb(OAc)4 to afford the C7–O-acetylated 
compound. However, protection of the C8 carbonyl group did neither take place for the C7–
OH nor the C7–OAc octalones. Due to the increased reactivity of the highly oxidized 
diosphenols, their potential role as intermediates in this synthesis was not investigated any 
further. 
                                               
139 H. Dannenberg, D. Dannenberg-von Dresler, T. Köhler, Chem. Ber. 1960, 93, 1989-1998. 
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2.2.3 Late Stage C7 Hydroxylation Approach 
In the presented approach summarized in Scheme 2.27, we envisioned the construction 
of the tricyclic skeleton in a stepwise procedure by installation of a side chain at C7 as a first 
step in order to obtain the tricarbonyl intermedate 2.68. Aldol cyclization would then form the 
6/6/6 tricarbocyclic skeleton 2.69, whose terminal olefin at C11=C13 could be reduced in a 
stereoselective substrate-controlled hydrogenation from the convex side of the molecule by 
coordination of the catalyst’s transition metal ion to the hydroxy group at C12. 
Dehydrogenation of the C1–C2 bond of 2.70 as well as oxidation at C7 would form 
periconianone A (2.1). 
 
Scheme 2.27: Tricarbonyl compound 2.68 as an intermediate for the synthesis of periconianone 
A (2.1) by aldol cyclization, substrate-controlled hydrogenation of the terminal methylene group 
and late-stage dehydrogenation (C1–C2) and hydroxylation (C7). 
2.2.3.1 Installation of the a,b-Unsaturated Aldehyde Side Chain at C7 
After bicyclic dienone 2.53 had been shown to be too reactive in the ensuing steps of the 
synthesis and mainly decomposed in the C7 alkylation process, we decided to remove the 
unsaturation in the monocyclic enone 2.34. Hydrogenation using Pd/C as catalyst in ethyl 
acetate (Scheme 2.28) gave the diketone intermediate. On the other hand, with methanol as 
solvent a mixture of desired ketone and the corresponding dimethyl acetal was formed. Similar 
observations for the reduction of a bicyclic enone in the presence of methanol are described by 
P. Hudson and P. J. Parson.140 Subsequently, the B-ring was formed by an aldol condensation 
reaction using NaOMe in methanol at room temperature to furnish the desired octalone 2.71 in 
88 % yield over two steps. Allylation of octalone 2.71 at position C7 was low-yielding (LDA, 
allyl bromide, DMPU, THF, –78°C to rt, o.n.): the reaction stopped at around 50 % conversion 
with only 30 % isolated yield. Increasing the number of equivalents of base or of allyl bromide 
did not have any influence on the conversion; instead double allylation at position C7 was 
observed. Therefore, we introduced the less reactive prenyl group, not only to avoid 
dialkylation, but also for its higher reactivity in the subsequent ozonolysis step, as the prenyl 
group's double bond is more electron-rich compared to the one of the allyl group. Treatment of 
                                               
140 P. Hudson, P. J. Parsons, Synlett 1992, 867-868. 
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octalone 2.71 with LiHMDS in THF/DMPU at –78°C was followed by addition of TBAI and 
prenyl bromide. The mixture was slowly warmed up to room temperature and stirred overnight. 
The desired prenylated octalone 2.72 was isolated with 83 % yield in a diastereomeric ratio of 
>10:1 in favor of the desired 7R-configured stereoisomer. The stereochemical outcome of this 
diastereoface-differentiating addition on the enolate is explained by the transition state shown 
in Scheme 2.28: all substituents in the A-ring are in an equatorial orientation except for the 
angular methyl group at C5, which shields the Si face and thus favors electrophilic attack on 
the a carbon atom from the Re face. 
 
Scheme 2.28: Formation of octalone 2.71 and installation of the C7 side chain. 
Ozonolysis was performed in a mixture of CH2Cl2 and MeOH using pyridine as a co-
solvent. Pyridine is known to increase the yield for various substrates in the ozonolysis 
reaction141 and allows for better regioselectivity.142 More recently, the function of pyridine was 
examined more closely and the mechanism of this transformation has been studied by the group 
of P. H. Dussault (Scheme 2.29).143 They propose pyridine to be an organocatalyst in the 
reaction, viz. after the primary ozonide is broken up, addition of pyridine to the carbonyl oxide 
                                               
141 K. Griesbaum, Chem. Commun. (London) 1966, 920-921; G. Slomp, J. L. Johnson, J. Am. Chem. Soc. 1958, 
80, 915-921. 
142 E. J. Corey, K. Achiwa, J. A. Katzenellenbogen, J. Am. Chem. Soc. 1969, 91, 4318-4320; B. M. Trost, M. R. 
Machacek, H. C. Tsui, J. Am. Chem. Soc. 2005, 127, 7014-7024. 
143 R. Willand-Charnley, T. J. Fisher, B. M. Johnson, P. H. Dussault, Org. Lett. 2012, 14, 2242-2245. 
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can take place to generate a zwitterion that might react with another carbonyl oxide. The formed 
bisperoxyacetal then undergoes fragmentation to form molecular oxygen, two carbonyl groups, 
and release pyridine. Using the conditions given in Scheme 2.28, we isolated 85 % of aldehyde 
2.73. When the reaction was performed in the absence of pyridine, a complex mixture was 
formed containing traces of the desired compound. The methylene group was installed under 
basic conditions using Eschenmoser’s salt (dimethylmethylideneammonium iodide) and the 
desired enal 2.74 was formed in 85 % yield. After removal of the TBS group by treatment with 
aqueous HF in acetonitrile and oxidation by DMP, tricarbonyl 2.68 was isolated in 85 % yield 
over two steps. 
 
Scheme 2.29: Mechanism for ozonolysis in the presence of pyridine as proposed by the group of 
P. H. Dussault. 
2.2.3.2 Aldol Cyclization of a,b-Unsaturated Aldehyde 2.68 
With tricarbonyl compound 2.68 in hand, the stage was set to investigate the key aldol 
transformation of the presented synthetic route. This reaction was found to work best with 
NaOMe in a 10:1 MeOH/THF mixture at 0°C. The desired tricyclic compound 2.69 was 
isolated in 41 % and methyl ether 2.75 in 9 % yield. The latter compound is presumably formed 
upon Michael addition of methoxide to the enal, which can then undergo the aldol addition 
process. With K2CO3 as a base in the same solvent mixture, only 25 % yield of the desired aldol 
addition product 2.69 was achieved. Using DBU in toluene at room temperature resulted in 
formation of a complex mixture, whereas no conversion was observed with titanium 
tetrachloride in toluene. 
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Scheme 2.30: Aldol cyclization of a,b-unsaturated aldehyde 2.68 and hydrogenation attempt. 
For the ensuing steps of the synthesis, we planned to first hydrogenate the terminal double 
bond, followed by two oxidation steps to deliver periconianone A (2.1). The hydrogenation was 
supposed to proceed diastereoface-selectively from the convex Re face of 2.69. However, the 
reaction with Wilkinson’s catalyst (benzene, rt, 1 atm of H2) almost exclusively proceeded by 
Si face attack on the double bond, thus forming the undesired 11R-stereoisomer 2.70 in 80 % 
yield with a diastereomeric ratio of 20:1. The structure of the product stereoisomer was 
confirmed by single-crystal X-ray analysis. The first step in the hydrogenation with Wilkinson’s 
complex is oxidative cis-addition of H2 on the pre-catalyst [RhCl(PPh3)3] to give the fully 
saturated Rh(III) complex [RhCl(H)2(PPh3)3]. Ligand substitution of the chloride by the 
alkoxide on C12 and of one phosphine ligand by p-coordination of the terminal alkene of 2.69 
gives the intermediate complex shown in Scheme 2.31 (L = PPh3). Migratory insertion is the 
rate-determining step leading to an intermediate featuring a 5,6-cis fused ring system, where S 
is a solvent molecule (benzene) coordinating to the central Rh(III) ion (Scheme 2.31). The 
stereoselectivity of this hydrogenation is determined by the face, from which the hydrogen atom 
is transferred, i.e. either from the Si or from the Re face of the terminal double bond. We propose 
that the observed formation of the 11R-stereoisomer is favored due to steric hindrance by the 
methyl group at C4, thus blocking the Re face of the terminal double bond for coordination of 
Wilkinson’s catalyst. 
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Scheme 2.31: Proposed mechanism in the Rh-catalyzed hydrogenation leading to the 11R-isomer 
of tricycle 2.70 (S = solvent molecule). 
2.2.3.3 Enal Reduction and Aldol Cyclization of a-Methylated Aldehyde 2.76 
Aiming to prepare tricycle 2.70 with 11S-configuration, we investigated an alternative 
route by installing the methyl group at C11 earlier in the synthesis. After attempts at the
methylation of C11 on aldehyde 2.73 or its dimethyl hydrazone derivative had turned out 
unsuccessful, we elaborated a protocol for the reduction of enal 2.74. We were aware of the 
formation of a diastereomeric mixture with R- and S-configuration at C11; however, we 
presumed that the aldol addition under basic conditions would be fully reversible and 
epimerization of the stereogenic center at the a-position to the aldehyde group would finally 
lead to the thermodynamically more favorable diastereoisomer with the methyl group in the 
equatorial position (see structure 2.70, Scheme 2.32). Although using high catalyst loadings 
and 1 to 10 atm of H2 pressure, hydrogenation experiments in the presence of Pd/C or 
Wilkinson’s catalyst were very low-yielding. Additionally, Wilkinsons’s catalyst triggered 
decarbonylation of the aldehyde.144 Therefore, we screened different protocols for 1,4-
hydrosilylation and subsequent hydrolysis of the intermediary silyl enol ether. Best results in 
terms of yield and chemoselectivity were obtained with palladium nanoparticles.145  
 
Scheme 2.32: Enal reduction approach and aldol cyclization of a-methylated aldehyde 2.76. 
A heterogeneous mixture of substrate 2.74, HSiEt3, PdCl2 and tricyclohexylphosphine 
(PCy3) in THF/water (1:1) was stirred at room temperature and formed the desired methylated 
                                               
144 J. Tsuji, K. Ohno, Tetrahedron Lett. 1965, 6, 3969-3971; K. Ohno, J. Tsuji, J. Am. Chem. Soc. 1968, 90, 99-
107. 
145 M. Benohoud, S. Tuokko, P. M. Pihko, Chem. Eur. J. 2011, 17, 8404-8413. 
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aldehyde 2.76 in 80 % yield and a diastereomeric ratio of 2:1. When the reaction was performed 
in the absence of water, formation of a mixture of desired aldehyde 2.76 and its silyl enol ether 
was observed. For analytical purposes, the diastereoisomers were separated. By aldol 
cyclization of diastereopure 11R- and 11S-2.77 to 2.70 under conditions that prevent 
isomerization of the stereogenic center at C11 (diphenyl phosphate, toluene, 65°C; see section 
2.2.6.2) and analysis of the corresponding crude 1H NMR spectra, we revealed that the 11R-
configured diastereoisomer was preferably formed in the enal reduction. 
Modification of the A-ring by deprotection of the TBS group and oxidation of the 
secondary alcohol to the ketone set the stage for the aldol reaction. Applying the conditions 
used for the transformation of enal 2.68 to 2.69 (NaOMe in MeOH/THF at 0°C) gave only 
traces of the desired product after stirring for three hours, and a complex mixture when stirred 
overnight. However, performing the reaction at a temperature between 15 and 25°C formed 
tricycles 11R-2.70 and 11S-2.70 in 33 % yield and a diastereomeric ratio of 4:1. When the 11R-
isomer of aldehyde 2.77 was used as starting material for this reaction, the 1H NMR spectrum 
of the crude product indicated epimerization at C11: both the 11S-isomer of the starting material 
2.77 as well as the desired S-configured tricycle 2.70 were detected. Screening for improved 
reaction conditions, we found even more side product formation using the inorganic base 
K2CO3 in MeOH at room temperature. An improved yield of 50 % of tricycle 2.70 in a 
diastereomeric ratio of 9:1 (11S/11R) was obtained using the amidine base DBU in CH2Cl2 at 
room temperature.146 After crystallization, the structure of tricycle 11S-2.70 was confirmed by 
single-crystal X-ray analysis. 
2.2.3.4 Dehydrogenation of the C1–C2 Bond and C7 Hydroxylation Attempts 
With tricycle 11S-2.70 in hand and in order to complete the total synthesis of 
periconianone A (2.1), we envisioned to first dehydrogenate the C1–C2 carbon bond in the A-
ring, followed by installation of the C7 hydroxy group. Deprotonation at C2 by LiHMDS and 
trapping of the formed enolate as TMS enol ether was performed quantitatively. However, 
Saegusa oxidation (Pd(OAc)2, MeCN, rt)112,147 of the TMS enol ether was very low-yielding 
and only traces of the desired product were detected in the 1H NMR spectrum of the crude 
mixture. With the one-step protocol using the reagent combination of IBX and MPO in DMSO, 
no conversion was observed, not even at 80°C.113 Unfortunately, the same result was obtained 
                                               
146 C. Li, X. Yu, X. Lei, Org. Lett. 2010, 12, 4284-4287; I. Cota, R. Chimentao, J. Sueiras, F. Medina, Catal. 
Commun. 2008, 9, 2090-2094. 
147 S. B. Herzon, A. G. Myers, J. Am. Chem. Soc. 2005, 127, 5342-5344. 
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by using iodic acid in a DMSO/cyclohexane mixture (5:1).148 The desired diene dione 2.78 was 
finally produced in 42 % yield by selenoxide elimination: a-selenylation using LiHMDS and 
phenylselenyl chloride in THF at –78°C was followed by oxidation with hydrogen peroxide at 
0°C (Scheme 2.33).111  
 
Scheme 2.33: Dehydrogenation and attempted C7 hydroxylation. 
Numerous studies have been reported for the a-hydroxylation of carbonyl compounds, 
typically involving oxidation of the corresponding enolates or silyl enol ethers by hypervalent 
iodine compounds149 or oxygen transfer reagents, such as metal oxidants150 [i.e. 
MoO5·pyridine·HMPA, Pb(OAc)4, Tl(OAc)3, OsO4], N-sulfonyl oxaziridines,151 dioxiranes152 
and perbenzoic acids153 (Rubottom oxidation). Sir D. H. R. Barton and co-workers reported 
autoxidation of pregnan-20-one using sodium or potassium alkoxides and molecular oxygen.154 
The formed a-hydroxyperoxy ketone intermediates can then be reduced in the presence of zinc 
and acetic acid. Later, the group of J. N. Gardner found superior yields for this process by using 
the reductant triethyl phosphite for quenching the intermediary hydroperoxy radicals in situ, 
thus avoiding side reactions like oxidative a-carbon cleavage due to the presence of reactive 
radical species.155 Unfortunately, applying the described conditions to tricycle 2.78 using t-
BuOK and P(OMe)3 in a THF/t-BuOH mixture (4:1) under an O2 atmosphere at –40°C only 
gave a complex mixture. No conversion was observed when replacing the alkoxide with 
Cs2CO3 as base and the solvent mixture with DMSO, as described in a recently reported 
                                               
148 K. C. Nicolaou, T. Montagnon, P. S. Baran, Angew. Chem. Int. Ed. 2002, 41, 1386-1389. 
149 A. Duschek, S. F. Kirsch, Chem. Eur. J. 2009, 15, 10713-10717; R. M. Moriarty, S. C. Gupta, H. Hu, D. R. 
Berenschot, K. B. White, J. Am. Chem. Soc. 1981, 103, 686-688. 
150 G. M. Rubottom, R. Marrero, J. M. Gruber, Tetrahedron 1983, 39, 861-865; J. P. McCormick, W. Tomasik, 
M. W. Johnson, Tetrahedron Lett. 1981, 22, 607-610; A. McKillop, J. D. Hunt, E. C. Taylor, J. Org. Chem. 
1972, 37, 3381-3382; E. Vedejs, D. A. Engler, J. E. Telschow, J. Org. Chem. 1978, 43, 188-196. 
151 F. A. Davis, B. C. Chen, Chem. Rev. 1992, 92, 919-934. 
152 W. Adam, L. Hadjiarapoglou, X. Wang, Tetrahedron Lett. 1989, 30, 6497-6500. 
153 G. M. Rubottom, R. Marrero, J. Org. Chem. 1975, 40, 3783-3784; G. M. Rubottom, R. Marrero, Synth. 
Commun. 1981, 11, 505-511. 
154 E. J. Bailey, D. H. R. Barton, J. Elks, J. F. Templeton, J. Chem. Soc. 1962, 1578-1591. 
155 J. N. Gardner, T. L. Popper, F. E. Carlon, O. Gnoj, H. L. Herzog, J. Org. Chem. 1968, 33, 3695-3699; J. N. 
Gardner, F. E. Carlon, O. Gnoj, J. Org. Chem. 1968, 33, 3294-3297. 
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protocol for the formation of various tertiary a-hydroxy ketones.156 Before screening of reaction 
conditions was continued, we tested the accessibility of C7–H towards deprotonation. 
Deuteration experiments by quenching a reaction mixture of 2.78 and base 
(LDA/LiHMDS/KHMDS/NaHMDS/t-BuOK) at different temperatures from –78°C to 0°C 
with CD3OD revealed this bridgehead position not to be accessible for deprotonation. The 
qualitative generalization describing the structural limitation of reactivity in bridged ring 
compounds is known as Bredt’s rule:157 except for larger ring systems, compounds with a C=C 
or C=N double bond at a branching position of a carbon bridge ("bridgehead") cannot exist due 
to the lack of π overlap as a result of the steric constraints that impede the required alignment 
of the pz orbitals. However, limits for the validity of Bred’s rule have been described by V. 
Prelog et al.158 and many other research groups.159 A more quantitative definition for the limits 
of Bredt’s rule was later defined by F. S. Fawcett, who introduced the S value as the sum of the 
number of atoms in the bridges of a polycyclic system.160 Bicyclic compounds with an S value 
of ³ 9 were categorized as isolable with a bridgehead double bond and those with a S value of 
³ 7 as observable. However, the synthesis of isolable bicylco[3.3.1]non-1-ene by J. R. 
Wiseman161 and J. A. Marshall162 and subsequent studies on highly strained bicyclic alkenes 
called for a revision of this rule. Tricyclic rings have been discussed as well, but due to their 
complexity, one of the three carbocycles is usually neglected and the system analyzed as if it 
were a bicycle.160 Thus, in the case of tricyclic 2.78, the BC-ring system might be specified as 
a bicyclo[3.3.1] core (Scheme 2.34).  
 
Scheme 2.34: Deprotonation attempts on tricyclic compound 2.78.  
                                               
156 Y.-F. Liang, N. Jiao, Angew. Chem. Int. Ed. 2014, 53, 548-552. 
157 J. Bredt, Liebigs Ann. Chem. 1924, 437, 1-13. 
158 V. Prelog, P. Barman, M. Zimmermann, Helv. Chim. Acta 1949, 32, 1284-1296; V. Prelog, J. Chem. Soc. 1950, 
420-428. 
159 K. J. Shea, Tetrahedron 1980, 36, 1683-1715. 
160 F. S. Fawcett, Chem. Rev. 1950, 47, 219-274. 
161 J. R. Wiseman, J. Am. Chem. Soc. 1967, 89, 5966-5968. 
162 J. A. Marshall, H. Faubl, J. Am. Chem. Soc. 1967, 89, 5965-5966. 
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More recent studies on bridgehead lithiation – substitution studies on bicyclic [3.3.1] 
ketones have shown the feasibility of bridgehead enolization in those systems.163 However, we 
suppose that the additional fused A-ring of 2.78 as well as the conjugated diene dione moiety 
strongly influence the geometry and contribute to higher ring strain in the BC-ring system. 
Extensive research in the field of C–H activation led to protocols addressing chemo-, regio- and 
stereoselective oxidation.164 However, neither the structural features of the catalyst nor the 
presence of directing groups in the starting material have any systematic influence on the 
selectivity and outcome of the reactions. A general trend for oxidizability is observed with 
regard to the electronic and steric properties of the C–H bonds: most of the known reagents for 
C–H activation are electrophilic and prefer oxidation of electron-rich as well as sterically less 
hindered bonds. For ring systems, another general observation has been reported, viz. faster 
activation of equatorial C–H bonds compared to axial ones regardless of the choice of reagent 
system. K. Chen, A. Eschenmoser and P. Baran explain this phenomenon to be mainly based 
on strain release during the transition to the activated complex, which is larger for equatorial 
C–H bonds than for axial ones.165 However, in the case of 2.78, electronic considerations are 
conflictive with those based on strain release arguments: comparing the chemical shifts of the 
13C NMR signals of tricycle 2.78 as an indicator of the corresponding C–H bond’s electron 
density, the signals for C6 (37.1 ppm) and C11 (33.2 ppm) are more upfield compared to C7 
(48.9 ppm), thus hinting at the tendency of positions C6 and C11 to be oxidized prior to position 
C7 based on electronic reasoning, whereas position C7 is expected to be oxidized more readily 
based on strain release arguments. In face of these opposing arguments, we tested the reactivity 
of tricycle 2.78 towards the White-Chen catalyst (Fe(PDP), AcOH, H2O2, MeCN, rt).164c 
Unfortunately, the 1H NMR spectrum of the crude reaction mixture showed decomposition of 
the starting material and formation of a complex mixture. The same results were obtained by 
applying stable radical cation salts derived from triarylamines [tris(4-
bromophenyl)ammoniumyl hexachloroantimonate, K2CO3, MeCN/H2O, rt], which are known 
to oxidize ketones to the corresponding a-hydroxy ketones or a-diketo compounds.166 In order 
to test additional conditions, one might consider protection of the C12–OH group, which is 
                                               
163 C. J. Hayes, N. S. Simpkins, D. T. Kirk, L. Mitchell, J. Baudoux, A. J. Blake, C. Wilson, J. Am. Chem. Soc. 
2009, 131, 8196-8210. 
164 M. Canta, M. Rodríguez, M. Costas, in Site-Selective Catalysis (Ed.: T. Kawabata), Springer International 
Publishing, Cham, 2015, pp. 27-54; T. Newhouse, P. S. Baran, Angew. Chem. Int. Ed. 2011, 50, 3362-3374; M. 
S. Chen, M. C. White, Science 2007, 318, 783-787; G. J. Chuang, W. Wang, E. Lee, T. Ritter, J. Am. Chem. Soc. 
2011, 133, 1760-1762; L. V. Desai, K. L. Hull, M. S. Sanford, J. Am. Chem. Soc. 2004, 126, 9542-9543. 
165 K. Chen, A. Eschenmoser, P. S. Baran, Angew. Chem. Int. Ed. 2009, 48, 9705-9708. 
166 M. Schulz, R. Kluge, L. Sivilai, B. Kamm, Tetrahedron 1990, 46, 2371-2380. 
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prone to oxidize to the ketone under the given reaction conditions. However, taking into account 
the highly reactive nature of the diene dione system, we finally had to abandon this approach 
and install the tertiary carbinol at an earlier stage of the synthesis. 
2.2.4  [2,3]-Wittig Rearrangement Approach 
This approach was designed in order to facilitate an early installation of the tertiary 
carbinol at the stage of the bicyclic AB-ring system. It was envisioned to first synthesize the 
C7 crotyl ether 2.79, which would undergo a [2,3]-sigmatropic rearrangement upon 
deprotonation of the C7–H to form the desired C7 carbinol 2.80 (Scheme 2.35). As one of the 
best investigated variants of a [2,3]-shift, this kind of transformation involving a-oxy 
carbanions is better known as the [2,3]-Wittig rearrangement. This [2,3]-shift works best when 
the intermediary carbanion is stabilized by an electron-withdrawing group, as in intermediate 
2.81. However, although various “p-acceptor” functional groups are reported for their 
beneficial effect on Wittig [2,3]-shifts, examples with carbanions/enolates derived from a-
allyloxy carbonyl compounds are rare, as they can undergo either the [2,3]-shift or the 
competing [3,3]-sigmatropic rearrangement, depending on the reaction conditions.167 
 
Scheme 2.35: [2,3]-Wittig rearrangement approach for the stereoselective installation of the C7 
carbinol. 
For the synthesis of crotylated a-hydroxyenone 2.79, we intended to synthesize a-
diazoketone 2.82, which would undergo an O–H insertion using crotyl alcohol in the presence 
of a Rh(II)-catalyst. Direct diazoketone formation under basic conditions was unsuccessful and 
resulted in formation of a complex mixture. Therefore, we used a two-step protocol: the enolate 
of octalone 2.71 was quantitatively converted to the trifluoroacylated compound using 
trifluoroethyl trifluoroacetate at –78°C. Treatment of this compound with mesyl azide and 
triethylamine gave the desired diazoketone 2.82 in 61 % yield over two steps (Scheme 2.36).168 
The yield of our initial experiments was around 22 to 28 %, and we found that slow addition of 
the mesyl azide by syringe pump and prolonged reaction time significantly increased formation 
                                               
167 J. Kallermerten, in Houben-Weyl, Methods of Organic Chemistry, Vol. E 21d (Eds.: G. Helmchen, R. W. 
Hoffmann, J. Mulzer, E. Schaumann), Thieme Verlag, Stuttgart, 1995, pp. 3757-3809. 
168 R. L. Danheiser, R. F. Miller, R. G. Brisbois, S. Z. Park, J. Org. Chem. 1990, 55, 1959-1964. 
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of the desired diazoketone 2.82. Unfortunately, the reaction of 2.82 with trans-crotyl alcohol in 
the presence of Rh(II) did not form the anticipated ether 2.79 as the primary insertion product. 
Slow addition of a solution of diazoketone 2.82 in CH2Cl2 to a solution of four equivalents of 
trans-crotyl alcohol and 1 mol% Rh2(OAc)4 in CH2Cl2 mainly yielded diosphenol 2.83. 
Increasing the number of equivalents for trans-crotyl alcohol (20 equiv.) led to formation of 
a-allylated a-hydroxyketone 2.84 and diosphenol 2.83 in a 4:1 mixture, of which 2.84 was 
isolated in 62 % yield as a diastereomeric mixture (2:1) after column chromatography. More 
details and mechanistic discussion for this transformation will be given in section 2.2.6. Using 
Rh2(TFA)4 as catalyst, a complex mixture was formed containing a-allylated a-hydroxyketone 
2.84, diosphenol 2.83 and a third compound (2.85) in a ratio of 4:3:5. The unknown compound 
was identified as the ring contraction product 2.85 upon isolation and structural elucidation by 
2D NMR spectroscopy. 
 
Scheme 2.36: Synthesis of a-diazoketone 2.82 and attempted OH-insertion reaction. 
Aiming to prepare a-keto ether 2.79, we started to investigate an alternative route 
involving a-hydroxylation of octalone 2.71 followed by O-crotylation. Installation of the 
hydroxy group was achieved using the Rubottom protocol:169 the silyl enol ether was formed 
by treatment of octalone 2.71 with LiHMDS and TMSCl at –78°. Treatment with m-CPBA and 
work-up was followed by stirring the crude mixture containing the desired a-hydroxy ketone 
and the partially silylated a-hydroxy ketone with citric acid in MeOH to give a-hydroxy ketone 
2.86 in 69 % yield and a diastereomeric ratio of 3:2 (7S/7R). For analytical purposes, the 
diastereoisomers were separated and their absolute configuration was established using 
                                               
169 A. Hassner, R. H. Reuss, H. W. Pinnick, J. Org. Chem. 1975, 40, 3427-3429; G. M. Rubottom, M. A. Vazquez, 
D. R. Pelegrina, Tetrahedron Lett. 1974, 15, 4319-4322. 
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NOESY NMR spectroscopy. The diastereomeric mixture of 2.86 was submitted to crotylation 
using Ag2O, TBAI and crotyl bromide to give crotylated a-hydroxy enone 2.79 in 68 % yield 
and retained diastereomeric ratio of 3:2 (7S/7R, Scheme 2.37). In the absence of TBAI, the 
reaction was slower and had to be heated to 45°C to observe conversion. This modification 
resulted in lower yields due to increased side product formation. Using sodium hydride as base 
in THF at 0°C to room temperature as well as n-BuLi at –78°C only led to formation of a 
complex mixture. 
 
Scheme 2.37: Rubottom oxidation of octalone 2.71 followed by O-crotylation. 
With crotylated a-hydroxy enone 2.79 in hand, we started to investigate the feasibility of 
the [2,3]-Wittig rearrangement and screened reaction conditions, as summarized in Table 2.3. 
At low temperature (–70°C), lithium enolates derived from ketones or esters generated in 
HMPA-THF are reported to selectively undergo the [2,3]-shift, and not the [3,3]-Claisen 
rearrangement.170 Unfortunately, neither at –78°C (entry 1) nor by gradually warming up the 
reaction mixture (entry 2) could we detect formation of the desired rearranged product. Lewis 
base catalysts have been reported to induce [2,3]-Wittig rearrangements of silyl enol ethers 
generated from the corresponding a-allyloxy carbonyl compounds.171 The corresponding TMS 
enol ether of 2.79 was formed quantitatively by treatment with TMSOTf and Et3N in CH2Cl2. 
Unfortunately, treatment of crude TMS enol ether with LiHMDS did not induce the desired 
[2,3]-shift (entry 3). S. E. Denmark and co-workers have recently reported a quaternary 
ammonium phase-transfer catalyzed [2,3]-Wittig rearrangement for a very limited substrate 
scope.172 Applying their reaction conditions (entry 4), we were not able to observe any 
conversion and a diastereoisomer of the starting material with epimerization at stereogenic 
center C7 was recovered. Using tetrabutylammonium hydroxide173 as phase-transfer catalyst 
only led to formation of a complex mixture (entry 5). Neither did pyrrolidine as 
                                               
170 M. Koreeda, J. I. Luengo, J. Am. Chem. Soc. 1985, 107, 5572-5573; T. Osamu, S. Takahiro, M. Koichi, N. 
Takeshi, Chem. Lett. 1986, 15, 1599-1602. 
171 Y. Sato, H. Fujisawa, T. Mukaiyama, Bull. Chem. Soc. Jpn. 2006, 79, 1275-1287. 
172 S. E. Denmark, L. R. Cullen, J. Org. Chem. 2015, 80, 11818-11848. 
173 M. J. Jansma, T. R. Hoye, Org. Lett. 2012, 14, 4738-4741. 
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organocatalyst174 bring about the conversion to the desired [2,3]-Wittig rearranged product and 
formation of a complex mixture was observed by 1H NMR spectroscopy (entry 6).  
Table 2.3: Selected conditions for the attempted [2,3]-Wittig rearrangement of a-keto ether 2.79. 
 
entry reagent solvent temperature observationsa 
1 LDA HMPA/THF –78°C low conversion to dealkylated side-product 
2 LDA HMPA/THF –78°C to –60°C to  –20°C to 0°C to rt complex and inseparable mixture 
3 i) Et3N, TMSOTf ii) LiHMDS 
i) CH2Cl2 
ii) DMF 
i) 0°C to rt 
ii) rt 
i) full conversion 
ii) desilylated side-product 
4 KOH, TBAB toluene/H2O rt to 40°C no conversion 
5 TBAOH MeOH/i-PrOH rt to 50°C complex mixture 
6 pyrrolidine MeOH 0°C to rt complex mixture 
a monitored by 1H NMR spectroscopy. 
In order to prevent a-allyloxy ketones from undergoing the competing [3,3]-Claisen 
rearrangement, the groups of M. Koreeda and D. Enders investigated carbanions derived from 
a-allyloxy hydrazones as protected substrates in the [2,3]-Wittig rearrangement process.175 To 
test if the hydrazone derivative of substrate 2.79 would undergo a [2,3]-sigmatropic 
rearrangement, we synthesized a-crotyloxy N,N-dimethylhydrazone 2.87: a-hydroxy ketone 
2.86 was treated with 1,1-dimethylhydrazine to form the a-hydroxy hydrazone, which was O-
crotylated using sodium hydride and crotyl bromide. Unfortunately, when 2.87 was subjected 
to the described reaction conditions (KH, t-BuOH/THF, 0°C or t-BuLi, THF, –100°C to 0°C), 
we did not observe formation of any [2,3]-rearranged product (Scheme 2.38). 
 
                                               
174 A. McNally, B. Evans, M. J. Gaunt, Angew. Chem. Int. Ed. 2006, 45, 2116-2119. 
175 J. I. Luengo, M. Koreeda, J. Org. Chem. 1989, 54, 5415-5417; D. Enders, M. Bartsch, D. Backhaus, J. Runsink, 
G. Raabe, Synthesis 1996, 1438-1442. 
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Scheme 2.38: Synthesis of a-crotyloxy N,N-dimethylhydrazone 2.87 and attempted [2,3]-Wittig 
rearrangement. Reaction conditions: a) KH, t-BuOH/THF, 0°C, complex mixture; b) t-BuLi, 
THF, –100°C to 0°C, complex mixture. 
2.2.5 Approach Featuring C7 Hydroxylation on the Bicyclic System 
In the following approach, we elaborated an alternative route for the installation of the 
C7 carbinol. A multi-step sequence comparable to the late-stage C7 hydroxylation approach 
(section 2.2.3) was designed. Starting from octalone 2.71, two possible pathways can be 
considered as summarized in Scheme 2.39: either a-hydroxylation of prenylated octalone 2.72 
in order to install the C7 carbinol as a second step, or introduction of an allyl or prenyl group 
by a-alkylation at position C7 in octalone 2.86 formed by hydroxylation of C7. Hydroxylation 
of the prenylated octalone 2.72 was considered problematic due to stereoselectivity issues, 
keeping in mind that hydroxylation of octalone 2.71 had resulted in a diastereomeric mixture 
of 3:2, as described in the previous section (2.2.4). In contrast, prenylation of octalone 2.71 
furnished the desired isomer with a diastereomeric ratio of >10:1. Therefore, we decided to start 
our investigations on the latter approach. 
 
Scheme 2.39: Stereoselective elaboration of the C7 carbinol by hydroxylation and alkylation. 
2.2.5.1 Installation of the C7 Carbinol by Early-Stage Hydroxylation 
Before we started to investigate the C7 alkylation of the a-hydroxy ketone 2.86, we first 
had to identify an appropriate protecting group for the secondary alcohol under the premise that 
the reaction conditions for its cleavage should be orthogonal to those needed for removal of the 
TBS protecting group. Additionally, the protecting group for the secondary alcohol should not 
be too sterically demanding, since a bulky group at this position would perturb the alkylation 
process. We first opted for the methoxymethyl (MOM) group, and MOM ether 2.88 was 
synthesized in 91 % yield by treating a-hydroxy ketone 2.86 with MOMBr and DIPEA in 
CH2Cl2 at 40°C (Scheme 2.40). 
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Scheme 2.40: Protection of a-hydroxy ketone 2.86. Reaction conditions: a) MOMBr, DIPEA, 
CH2Cl2, 40°C; b) BnBr, Ag2O, CH2Cl2, rt.  
Selected screening conditions for the alkylation of MOM-protected a-hydroxy ketone 
2.88 are summarized in Table 2.4 (entries 1–4). No prenylated product was formed using 
LiHMDS or LDA in the presence of DMPU in THF at –78°C, followed by addition of prenyl 
bromide and TBAI and warming to room temperature (entries 1 and 2). Using a large excess of 
NaH, prenyl bromide and TBAI in DMF (entry 4) resulted in formation of traces of the desired 
alkylated product 2.89. However, we were not able to reproduce this result or improve the 
conversion by adjusting the reaction conditions. Using less equivalents of reagents resulted in 
no conversion, and higher reaction temperatures (0°C or room temperature) led to 
decomposition of the starting material. Therefore, we investigated the accessibility of the proton 
at C7 of 2.88 towards deprotonation. Different bases (LDA, LiHMDS, NaHMDS, KHMDS) 
were tested at different temperatures (–78°C to –20°C). After treating the compounds in THF 
at –78°C with the appropriate base, quenching with MeOD-d4 or D2O was performed. The 
experiments revealed that the cleanest conversion took place at –78°C, though with a maximum 
conversion of only 50 %. At higher temperatures (–40°C or –20°C), significant side product 
formation was observed. We assume that the enolate derived from MOM-protected a-hydroxy 
ketone 2.88 upon deprotonation at C7 might be stabilized by interaction of the alkali metal 
cation with the additional oxygen atom of the protecting group, i.e. formation of a seven-
membered chelate ring (scheme in Table 2.4). Thus, this intermediate might not be reactive 
enough for alkylation. Therefore, we investigated the alkylation of a benzyl-protected substrate: 
benzyl ether 2.90 was synthesized in a yield of 91 % by treating a diastereomeric mixture of a-
hydroxy ketone 2.86 with BnBr and Ag2O in CH2Cl2 at room temperature overnight. Initial 
alkylation attempts showed around 20 % conversion using the reagent allyl iodide (Table 2.4, 
entry 6). Increasing the concentration of reagents (entry 7) as well as addition of LiCl (entry 8) 
did not influence the reaction outcome. Experiments for the benzyl-protected substrate were 
run at –78°C and slowly warmed up to 15°C or room temperature overnight. By gradually 
warming up the reaction mixture, we found that careful control of the reaction temperature was 
key for this transformation: at temperatures lower than –40°C, no reaction took place; 
temperatures above –35°C led to formation of significant amounts of side products (entries 9–
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10). Best results were obtained when stirring a mixture of 2.90 with 2.4 equivalents of LiHMDS 
for one hour at –78°C, before four equivalents of DMPU were added. After stirring had been 
continued for 30 minutes, eight equivalents of allyl iodide (freshly filtered over K2CO3) were 
added and the mixture was stirred at a temperature between –39.5 and –35.5°C for six hours. 
Strictly following this optimized protocol, the desired product 2.91 was isolated in 75 % yield 
(entry 11). 
Table 2.4: Selected screening conditions for the alkylation of protected secondary alcohol 2.88 
and 2.90. 
 
entry R1 conditions observations 
1 MOM LiHMDS (1.5 equiv.), DMPU (4 equiv.), THF, –78°C 
then prenyl bromide (4 equiv.), TBAI (4 equiv.), –78°C to rt 
epimerization at C7,  
no alkylated producta 
2 MOM LDA, DMPU, THF, –78°C 
then prenyl bromide, TBAI, –78°C to rt 
no conversiona,b 
3 MOM NaH (3 equiv.), DMF, –40°C 
then prenyl bromide (4 equiv.), TBAI (4 equiv.), –40°C to rt 
no alkylated producta,b 
4 MOM NaH (100 equiv.), DMF, –40°C 
then prenyl bromide (50 equiv.), TBAI (10 equiv.), –40°C to rt 
low conversion to alkylated 
producta 
not reproducible 
5 Bn LiHMDS (2 equiv.), DMPU (12 equiv.), THF, –78°C 
then prenyl bromide (4 equiv.), NaI (4 equiv.), –78°C to rt, o.n. 
20 % conversiona 
6 Bn LiHMDS (2 equiv.), DMPU (4 equiv.), THF, –78°C 
then allyl iodide (4 equiv.), –78°C to 15°C, o.n. 
20 % conversiona 
7 Bn LiHMDS (4 equiv.), DMPU (10 equiv.), THF, –78°C 
then allyl iodide (10 equiv.), –78°C to 15°C, o.n. 
20 % conversiona 
8 Bn LiHMDS (2 equiv.), DMPU (4 equiv.), LiCl (4 equiv.), THF, –78°C 
then allyl iodide (8 equiv.), –78°C to rt, o.n. 
low conversionb 
9 Bn LiHMDS (2 equiv.), DMPU (4 equiv.), LiCl (4 equiv.), THF, –78°C 
then allyl iodide (4 equiv.), –40°C - –35°C, 3 h 
2:3 (2.91/2.90)a 
22 %c (52 % brsm) 
10 Bn  LiHMDS (2 equiv.), DMPU (4 equiv.), LiCl (4 equiv.), THF, –78°C 
then allyl iodide (8 equiv.), –40°C - –35°C, 3 h 
1:1 ratio of 2.91/2.90a 
11 Bn LiHMDS (2.4 equiv.), THF, –78°C, 1 h 
then DMPU (4 equiv.), –78°C, 30 min 
then allyl iodide (8 equiv.), –39.5°C - –35.5°C, 6 h 
75 %c 
a monitored by 1H NMR spectroscopy; b monitored by thin layer chromatography of aliquot samples drawn from the reaction 
mixture; c isolated yield after column chromatography.  
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The terminal double bond of the benzyl-protected carbinol 2.91 was cleaved by 
ozonolysis to give the aldehyde 2.92 in 87 % yield, before the methylene group was installed 
by Eschenmoser methenylation (Scheme 2.41). Although a small-scale approach delivered 
78 % of the desired product 2.93 using Eschenmoser’s salt and Et3N in CH2Cl2, this reaction 
was not reproducible on larger scale and elimination of the tertiary OBn group was observed to 
form dienone 2.94 as main product. Using freshly recrystallized Eschenmoser’s salt (sulfolane, 
140°C) did not alter the reaction outcome. Under the given reaction conditions (5 equiv. 
Eschenmoser’s salt, 10 equiv. base), the (dimethylamino)methyl intermediate 2.95, formed by 
Mannich-type reaction of the enolized carbonyl with the iminium ion of Eschenmoser's salt, 
was not observed due to elimination to 2.93 or double elimination to 2.94. With lower 
concentrations of base (4 equiv.) and reagent (2 equiv.) formation of a 1:1 mixture of 
methenylated product and intermediate 2.95 was observed by 1H NMR spectroscopy. When the 
crude product of a reaction on the 20 mg scale was dissolved in CH2Cl2 and stirred in the 
presence of SiO2 for 90 minutes at room temperature, a mixture of the desired product 2.93 and 
dienone 2.94 in a 2:1 ratio was formed. Unfortunately, we were not able to reproduce this 
reaction outcome on a 100 mg scale and only isolated 18 % of the target compound 2.93. Best 
results for a small-scale approach were obtained by using three equivalents of Eschenmoser’s 
salt and six equivalents of base. However, when five 20 mg scale reactions were performed in 
parallel under identical conditions, a different ratio of products was observed in each of these 
batches. Since the reaction mainly showed problems on a larger scale, screening of reaction 
conditions was cumbersome, and we could not identify a set of reaction conditions reproducibly 
favoring the desired product, viz. triggering elimination only for the tertiary amine and not the 
OBn group. 
 
Scheme 2.41: Side chain modification of benzyl ether 2.91 by ozonolysis and methenylation. 
To further optimize this reaction, one might consider using only one equivalent of base 
and reagent with the aim to obtain intermediate 2.95, which could be converted to the alkene 
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by N-methylation and Hofmann elimination or by oxidation to the corresponding N-oxide to 
induce a Cope elimination, and thus avoid basic or acidic conditions triggering the side reaction. 
This approach was investigated by treating aldehyde 2.92 with LiHMDS (1.2 equiv.) at –78°C, 
before Eschenmoser’s salt (2.5 equiv.) was added and the mixture was allowed to warm to room 
temperature. Unfortunately, formation of a complex mixture was observed. Using 
paraformaldehyde and freshly prepared diisopropylammonium trifluoroacetate (1.0 equiv.) in 
THF gave dienone 2.94 along with unidentified byproducts.176 Stirring a mixture of aldehyde 
2.92 and formaldehyde in aqueous isopropanol in the presence of a catalytic amount of 
pyrrolidine and propionic acid led to formation of a 5:2 mixture of dienone 2.94 and desired 
product 2.93, along with other side products.177 a-Methylation of the aldehyde 2.92 by 
formation of the enolate (LiHMDS, THF, –78°C) and subsequent alkylation with MeI gave no 
conversion at lower temperatures (–78°C, –30°C) and decomposition of the starting material 
when warmed up to room temperature. The same results were obtained when the corresponding 
dimethylhydrazone derivative of aldehyde 2.92 (dimethylhydrazine, THF, 0°C to room 
temperature) was subjected to the identical a-methylation conditions. 
Although we could not elaborate an optimized procedure for the installation of C13, we 
proceeded with the ensuing steps of the synthetic route, including reduction of the enal and A-
ring modifications. Conditions used for the substrate 2.74 lacking the OBn group (see chapter 
2.2.3) have been successfully applied for substrate 2.93 and we obtained the tricarbonyl 
compound 2.96 in 55 % yield over three steps (Scheme 2.42). 
 
Scheme 2.42: Side chain and A-ring modifications for benzyl ether substrate 2.93. 
2.2.5.2 Endgame: Aldol Cyclization, Dehydrogenation and Deprotection 
With tricarbonyl compound 2.96 in hand, we tested the same conditions for the aldol 
cyclization step as in the late-stage C7 hydroxylation approach (see chapter 2.2.3) by treating 
2.96 with DBU at room temperature for three hours. Unfortunately, the starting material 
decomposed and no desired aldol product was detected after work-up and analysis of the crude 
                                               
176 A. Bugarin, K. D. Jones, B. T. Connell, Chem. Commun. 2010, 46, 1715-1717. 
177 A. Erkkilä, P. M. Pihko, J. Org. Chem. 2006, 71, 2538-2541. 
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product's 1H NMR spectrum. Therefore, we performed the reaction at 0°C and isolated a new 
compound after the mixture had been stirred for three hours, worked up and separated by 
preparative TLC. However, this new compound was not identified as the expected aldol product 
and additional to the proton at C7, other olefinic protons were visible in the 1H NMR spectrum. 
After structure elucidation based on 2D NMR, the new compound was identified as the diene 
dione 2.97. Under the given reaction conditions, autoxidation of the C1–C2 bond took place to 
form the desired conjugated diene dione moiety. Subsequent experiments (see section 2.2.6.2) 
showed that this oxidation process only takes place on the bicyclic system and was not observed 
for the isolated tricyclic aldol product 2.98 when treated with DBU. As the observed 
autoxidation is an irreversible process, this might be explained by a late transition state for this 
transformation together with better stabilization by p-orbital overlap of the adjacent double 
bonds in the diene system of the bicyclic oxidation product, compared to the diene in the 
tricyclic system 2.97, due to higher geometric strain in the latter. Since the crude mixture mainly 
comprised unidentified decomposition products and only traces of the tricycle 2.97, we 
performed the reaction at –4°C. Conversion of the starting material to both product and side 
products was significantly slower and the reaction had to be stirred for two days until aldehyde 
2.96 was fully consumed. Purification of the crude mixture gave tricycle 2.97 in 20 % yield and 
a diastereomeric ratio of >10:1. When the initial experiment at room temperature was repeated 
with three equivalents of DBU under an oxygen atmosphere, 2.97 was isolated in 25 % yield. 
Experiments using K2CO3 in a MeOH/THF mixture at 0°C or room temperature formed only 
complex mixtures. 
 
Scheme 2.43: Endgame by aldol cyclization and deprotection of the benzyl group. 
The last step of this synthetic route consisted in deprotection of the tertiary alcohol at C7. 
Being aware of the sensitive diene dione moiety and the secondary alcohol at C12, we tested 
conditions that showed most promising results on the AB-ring system 2.91, which will be 
discussed in the following section 2.2.5.3. However, stirring a mixture of 2.97 and BCl3 in 
CH2Cl2 at –50°C did not initiate debenzylation and the mixture was gradually warmed in steps 
of 10°C, until monitoring by TLC showed conversion at –20°C. After quenching and usual 
work-up procedure, 40 % conversion to periconianone A (2.1) was indicated by 1H NMR 
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spectroscopy (Scheme 2.43). No conversion was monitored when adding the cation scavenger 
pentamethylbenzene to the reaction mixture.178 
2.2.5.3 Optimization of the Methenylation Reaction 
Due to the elimination of the OBn group encountered during the methenylation of 
aldehyde 2.92, we tested if the unprotected carbinol at C7 might be a more suitable substrate in 
this reaction. Several protocols for removal of the benzyl group were unsuccessful using 
aldehyde 2.92 as substrate. Although hydrogenolysis (H2, Pd/C, EtOAc, rt) removed the benzyl 
group, decomposition of the aldehyde was observed. Catalytic transfer hydrogenation 
(ammonium formate, Pd/C, MeOH, reflux)179 showed low conversion to different side products. 
Although benzyl ethers are usually not sensitive to cleavage by DDQ, a few protocols for 
deprotection of tertiary benzyl ethers using this reagent have been described.180 Unfortunately, 
only a complex mixture was formed using DDQ in a 20:1 mixture of CH2Cl2 and water. The 
radical anion of di-tert-butylbiphenyl (prepared by adding Li to a solution of di-tert-
butylbiphenyl at 0°C)181 in THF at –78°C gave a mixture of different compounds and traces of 
the known aldehyde 2.73 lacking the C7 hydroxy group. This indicates that reductive cleavage 
of the C7–O bond instead of the ArCH2–O bond took place. 
 
Scheme 2.44: Benzyl deprotection attempts on aldehyde 2.92. 
Applying the Lewis acid BCl3 at different temperatures (–78°C, –60°C, –40°C, –20°C, 
0°C, rt) was unsuccessful, too. However, applying the latter conditions (BCl3, CH2Cl2, –78°C 
to rt) for allylated compound 2.91 led to significant formation of 2.99. Besides deprotection of 
the benzyl group, partial removal of the TBS group was observed. Key for the optimization of 
reaction conditions was adding the reagent at –78°C, before the mixture was warmed up to  
                                               
178 X.-D. Ren, N. Zhao, S. Xu, H.-N. Lü, S.-G. Ma, Y.-B. Liu, Y. Li, J. Qu, S.-S. Yu, Tetrahedron 2015, 71, 4821-
4829; K. Okano, K. I. Okuyama, T. Fukuyama, H. Tokuyama, Synlett 2008, 1977-1980. 
179 T. Bieg, W. Szeja, Synthesis 1985, 76-77. 
180 E. Vedejs, R. A. Buchanan, Y. Watanabe, J. Am. Chem. Soc. 1989, 111, 8430-8438; A. F. Sviridov, M. S. 
Ermolenko, D. V. Yashunsky, V. S. Borodkin, N. K. Kochetkov, Tetrahedron Lett. 1987, 28, 3839-3842; T. 
Tanaka, Y. Oikawa, N. Nakajima, T. Hamada, O. Yonemitsu, Chem. Pharm. Bull. 1987, 35, 2203-2208; N. 
Ikemoto, S. L. Schreiber, J. Am. Chem. Soc. 1992, 114, 2524-2536; Y. Oikawa, K. Horita, O. Yonemitsu, 
Tetrahedron Lett. 1985, 26, 1541-1544. 
181 P. K. Freeman, L. L. Hutchinson, J. Org. Chem. 1980, 45, 1924-1930; S. J. Shimshock, R. E. Waltermire, P. 
DeShong, J. Am. Chem. Soc. 1991, 113, 8791-8796. 
BnO
O
O
OTBS
2.92H
HO
O
O
OTBS
H
deprotection
TOTAL SYNTHESIS OF PERICONIANONE A 83 
 
–50°C and stirred at this temperature for one hour. Typical protocols recommend to quench the 
reaction mixture with MeOH.178 However, carefully quenching the solution at –50°C by 
aqueous 1 M NaOH solution before warming up to room temperature significantly improved 
the outcome of the reaction with 75 % yield for carbinol 2.99. For larger scale experiments, 
addition of the cation scavenger pentamethylbenzene was found to improve the yield.178b 
 
Scheme 2.45: Benzyl deprotection of allylated substrate 2.91 and side chain modification by 
ozonolysis and methenylation reaction in the presence of the unprotected tertiary carbinol at C7. 
Ozonolysis of the deprotected substrate 2.99 gave b-hydroxy aldehyde 2.100 in 88 % 
yield. However, ratios between 3:1 and 3:2 for diosphenol 2.83 and enal 2.101 (Scheme 2.45) 
were observed after subjecting the aldehyde to methenylation conditions (3.0 equiv. of 
Eschenmoser’s salt, 6.0 equiv. of Et3N). Changing the base to LiHMDS (1.5 equiv.) at –78°C 
showed clean conversion to diosphenol 2.83. Similar results of an eremophilane forming its 
corresponding trinor-eremophilane under basic conditions (NaOMe) have been reported for the 
brassinolide-inhibitor KM-01 by S. Kim et al. (Scheme 2.46).182 Studies on the phytoalexin 7-
hydroxycostal, an eudesmane-type sesquiterpene, revealed the hydroxy-enal moiety to be 
implicated in its antifungal activity.183 Incubation experiments in sweet potato culture medium 
showed degradation of 7-hydroxycostal to ketone 2.102. Therefore, a mechanistic pathway of 
conjugate addition of a nucleophile to the enal followed by a fragmentation to release acrolein, 
formally a retro-Baylis-Hillman-type reaction, was proposed. Based on this report and the 
known phytotoxicity of acrolein, the group of J. Clardy suggested a similar mechanism for the 
                                               
182 S.-k. Kim, M. Hatori, M. Ojika, Y. Sakagami, S. Marumo, Bioorg. Med. Chem. 1998, 6, 1975-1982. 
183 J. A. Schneider, K. Nakanishi, J. Chem. Soc., Chem. Commun. 1983, 353-355. 
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host-selective phytotoxin bipolaroxin.184 Experiments to chemically prove this proposed 
biosynthetic transformation have already been attempted on monocyclic test-substrates without 
success.185 Therefore, it would not only be interesting to investigate the observed reaction for 
bipolaroxin, but also to clarify whether diosphenol 2.83 is formed by retro-aldol reaction of 
aldehyde 2.100 in the presence of base, or whether it first reacts to the (dimethylamino)methyl 
intermediate, which can undergo the retro-Baylis-Hillman process. 
 
Scheme 2.46: Formation of trinor-eremophilanes by a proposed retro-Baylis-Hillman-type 
reaction. 
To avoid formation of dienone 2.94, observed during the methenylation procedure of 
benzyl-protected aldehyde 2.92, as well as diosphenol 2.83, observed for free carbinol 2.100, 
we envisioned to test different silyl protecting groups at C7–OH in this transformation. 
Protection of the secondary alcohol with TESCl and imidazole in CH2Cl2 formed the desired 
silyl ether 2.103 in 68 % yield. Unfortunately, alkylation attempts to form the tertiary silyl-
protected carbinol 2.104 were not successful and no conversion was observed, not even at room 
temperature. Nevertheless, we were able to protect tertiary carbinol 2.99 by using TESOTf and 
2,6-lutidine in CH2Cl2 at 0°C in 84 % yield, after the milder conditions used previously for 
protection of the secondary alcohol 2.103 (TESCl, imidazole, CH2Cl2, rt) showed no 
conversion. SEM-protected carbinol was synthesized using both pathways: protection using 
SEMCl and DIPEA in CH2Cl2 at room temperature gave the protected isomers 7S- and 7R-
2.105 in a combined yield of 84 %. Modifying the alkylation conditions optimized for the 
benzylated compound 2.90 by applying higher temperatures (–36°C to –32°C) gave the desired 
SEM carbinol 2.106 in 64 % yield. Alternatively, 2.106 was synthesized by protection of free 
carbinol 2.99 using SEMCl and DIPEA in CH2Cl2 at room temperature. 
                                               
184 F. Sugawara, G. Strobel, L. E. Fisher, G. D. Van Duyne, J. Clardy, Proc. Natl. Acad. Sci. U. S. A. 1985, 82, 
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Scheme 2.47: TES and SEM protection, ozonolysis and methenylation attempts for the protected 
substrates 2.104 and 2.106. Reaction conditions: a) TESCl, imidazole, CH2Cl2, rt; b) SEMCl, 
DIPEA, CH2Cl2, rt; c) TESOTf, 2,6-lutidine, CH2Cl2, 0°C; d) SEMCl, DIPEA, CH2Cl2, rt; e) 
LiHMDS, THF, –78°C, 1 h, then DMPU, –78°C, 30 min, then allyl iodide, –38°C, 3 h, –20°C, 
15 h, 0°C, 3 h, rt, 3 h; f) LiHMDS, THF, –78°C, 1 h, then DMPU, –78°C, 30 min, then allyl 
iodide, –36°C - –32°C, 21 h. 
Cleavage of the terminal double bond in 2.104 and 2.106 by ozonolysis (O3, pyridine, 
CH2Cl2/MeOH, –78°C; then PPh3, rt) was performed in high yield and set the stage for the 
methenylation. Methenylation (5 equiv. Eschenmoser’s salt, 10 equiv. Et3N, CH2Cl2, rt, 3 h) of 
TES-protected carbinol 2.107 gave a 7:1 mixture of the corresponding (dimethylamino)methyl 
intermediate (dr 4:3 at C11) and starting material. Stirring this mixture and SiO2 in CH2Cl2 for 
2.5 hours resulted in a 4:3:1 mixture of dienone 2.94, desired enal 2.108 and starting material, 
respectively. Using a lower amount of the reagents (3 equiv. Eschenmoser’s salt, 6 equiv. Et3N) 
only gave 30 % conversion to the (dimethylamino)methyl intermediate. Eschenmoser 
methenylation of SEM-protected carbinol 2.109 did not give the (dimethylamino)methyl 
intermediate, but a mixture of desired product 2.110 and dienone 2.94. Similar to the reactions 
with the benzyl and TES-protected carbinols, these experiments were not reproducible. 
Although screening different bases (Et3N, DIPEA, DBU) and concentrations of both reagents 
(base and Eschenmoser’s salt), optimization of the reaction conditions to trigger product 
formation failed. Most promising results with a 5:2 ratio of desired product 2.110 and dienone 
2.94 were obtained using three equivalents of Eschenmoser’s salt and six equivalents of DIPEA 
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in CH2Cl2 at room temperature with stirring for three hours. Applying these reaction conditions 
on a larger scale gave a 1:2 ratio of 2.110 and 2.94 (crude product 1H NMR spectrum) and an 
isolated yield of only 13 % for the desired product 2.110 after column chromatography. 
2.2.6 Successful Approach to Periconianone A by a Formal [2,3]-Wittig 
Rearrangement 
2.2.6.1 Installation of the C7 Carbinol 
Based on the findings that in the presence of Rh2(OAc)4, diazoketone 2.82 reacted with 
trans-crotyl alcohol in a tandem O–H insertion/Claisen-rearrangement to furnish a-allylated 
a-hydroxyketone 2.84 (see chapter 2.2.4), we investigated the feasibility of a [1,2]-shift of the 
four carbon fragment from C8 to C7 in 2.84, aiming to obtain the formal [2,3]-rearranged 
product 2.80 (Scheme 2.48). [1,2]-Alkyl or -aryl migrations in a-hydroxy ketones or aldehydes 
are termed a-ketol or acyloin rearrangement. The synthetic value of this transformation has 
been considerably increased since its discovery in the D-ring homoannulation of steroids.186 
Nevertheless, it is rarely used in total synthesis187 and most of the reported reactions involving 
this type of rearrangement are unanticipated.188 Mediated by Brønsted bases or acids, Lewis 
acids or heat, the a-ketol rearrangement is known to be a reversible process with the equilibrium 
usually lying on the side of the thermodynamically more stable a-hydroxy carbonyl isomer. 
Typical substrates that undergo this [1,2]-shift are β-hydroxy a-diketones forming the more 
stable β-dicarbonyl compound189 or compounds where ring strain is released by this 
transformation.186 By comparing 2.80 and 2.84, we hypothesize that formation of a conjugated 
enone moiety might be the thermodynamic driving force to trigger the desired formation of 
2.80. An a-ketol rearrangement with formation of a conjugated system as thermodynamic 
driving force has not been reported in literature to date. 
                                               
186 N. L. Wendler, D. Taub, R. Firestone, Experientia 1959, 15, 237-239; L. A. Paquette, J. E. Hofferberth, in 
Organic Reactions, Vol. 62 (Ed.: L. E. Overman), John Wiley & Sons, Inc., 2004, pp. 477-567. 
187 Z.-L. Song, C.-A. Fan, Y.-Q. Tu, Chem. Rev. 2011, 111, 7523-7556. 
188 T. E. Adams, M. El Sous, B. C. Hawkins, S. Hirner, G. Holloway, M. L. Khoo, D. J. Owen, G. P. Savage, P. J. 
Scammells, M. A. Rizzacasa, J. Am. Chem. Soc. 2009, 131, 1607-1616; S. Dong, J. Zhu, J. A. Porco, J. Am. 
Chem. Soc. 2008, 130, 2738-2739; B. Gerard, G. Jones, J. A. Porco, J. Am. Chem. Soc. 2004, 126, 13620-13621; 
K. C. Nicolaou, P. K. Sasmal, H. Xu, J. Am. Chem. Soc. 2004, 126, 5493-5501; S. Hanessian, R. Roy, Can. J. 
Chem. 1985, 63, 163-172; J. L. Wood, A. A. Holubec, B. M. Stoltz, M. M. Weiss, J. A. Dixon, B. D. Doan, M. 
F. Shamji, J. M. Chen, T. P. Heffron, J. Am. Chem. Soc. 1999, 121, 6326-6327. 
189 J.-H. Chen, S. R. Levine, J. F. Buergler, T. C. McMahon, M. R. Medeiros, J. L. Wood, Org. Lett. 2012, 14, 
4531-4533; J. L. Wood, B. M. Stoltz, H.-J. Dietrich, D. A. Pflum, D. T. Petsch, J. Am. Chem. Soc. 1997, 119, 
9641-9651. 
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Scheme 2.48: Formal [2,3]-Wittig rearrangement by O–H insertion of trans-crotyl alcohol into 
the carbenoid derived from diazoketone 2.82 and subsequent Claisen rearrangement followed by 
a proposed [1,2]-shift. 
After initial experiments using the Lewis acid BF3·OEt2189,190 had only triggered 
elimination of the tertiary alcohol to form a conjugated dienone, we were very pleased that 
treatment of a-allylated a-hydroxyketone 2.84 with Al(Ot-Bu)3 or Al(Oi-Pr)3 induced the [1,2]-
shift.191 The desired a-allylated hydroxyenone 2.80 was isolated in 52 % yield and retained 
(C7/C8/C11) diastereomeric ratio (dr 2:1 for C11) after treatment of 2.84 with Al(Ot-Bu)3 for 
50 minutes at 70°C. The 1H NMR spectrum of the crude reaction mixture showed almost no 
side product formation, which was confirmed by the isolation of 32 % of the starting material, 
giving a yield of 84 % based on recovered starting material. The diastereoisomers were 
separated using column chromatography, and the structure of the main isomer of 2.80 was 
confirmed by single-crystal X-ray analysis. Unfortunately, an S-configuration at C11 showed 
that the undesired isomer was formed preferentially in the Claisen rearrangement, assuming the 
a-ketol rearrangement to be a stereospecific transformation. 
 
Scheme 2.49: a-Ketol rearrangement induced by Al(Ot-Bu)3 to form the desired C7 carbinol 2.80 
(dr 2:1) and single crystal X-ray structure of 11S-2.80. 
Initially, the ensuing steps of the synthesis were carried out with the obtained 
diastereomeric 2:1 mixture of 2.80, since we intended to use basic conditions for the aldol 
addition step to construct the tricyclic skeleton, allowing for isomerization of the stereogenic 
center at C11 after cleaving the terminal double bond. However, while screening conditions for 
                                               
190 I. Drutu, E. S. Krygowski, J. L. Wood, J. Org. Chem. 2001, 66, 7025-7029; J. L. Wood, G. A. Moniz, Org. 
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191 L. A. Paquette, J. E. Hofferberth, J. Org. Chem. 2003, 68, 2266-2275. 
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88 
this cyclization reaction, which will be discussed later in this section, we found basic conditions 
to be unsuitable for our substrate. As the optimized reaction conditions did not induce 
isomerization at C11, we investigated how to trigger selective formation of the 11R-isomer of 
2.84 in the tandem O–H insertion/[3,3]-sigmatropic rearrangement process. 
The reaction of a-diazoketones with allylic alcohols in the presence of rhodium(II) to 
form the corresponding a-alkylated a-hydroxyketones via O–H insertion and spontaneous 
Claisen rearrangement has been reported by J. L. Wood and co-workers.189,190,192 
Mechanistically, formation of the rhodium carbene complex derived from the corresponding 
diazo compound by release of N2 is followed by O–H insertion of the allylic alcohol. J. L. Wood 
and co-workers suggest formation of a (Z)-enol intermediate upon intramolecular proton 
transfer after the insertion step. The (Z)-enol intermediate can then either undergo ketonization 
to the a-keto ether (formal insertion product) or a subsequent [3,3]-sigmatropic rearrangement 
to the a-alkylated a-hydroxyketone (Scheme 2.50). 
 
Scheme 2.50: O–H insertion of allylic alcohols into the rhodium carbene complexes derived from 
a-diazoketones, and [3,3]-sigmatropic rearrangement via a (Z)-enol intermediate and six-
membered cyclic transition state. 
Additionally, kinetic studies have been performed by J. L Wood and coworkers in order 
to rule out the involvement of Rh or acid in the rearrangement process.190b These reported 
observations are in accordance with our findings, as the a-keto ether byproduct 2.79 formed by 
keto-enol tautomerism of the central intermediate 2.111 (Scheme 2.52) did not undergo the 
[3,3]-sigmatropic rearrangement, even upon prolonged reaction time. Neither did isolated 
                                               
192 J. L. Wood, G. A. Moniz, D. A. Pflum, B. M. Stoltz, A. A. Holubec, H.-J. Dietrich, J. Am. Chem. Soc. 1999, 
121, 1748-1749. 
R1
O
N2
R2
R5
R4
R3
HO
Rh(II)
O
R3
R2
R1
R5
HOR4
R3
R4
R5 O
R2
R1OH
[3,3]
ketonization
R1
O
R2
O
R3
R5
R4R1
O
[Rh]
R2 R1
OH
O
R2 R3
R4
R5
insertion
TOTAL SYNTHESIS OF PERICONIANONE A 89 
 
a-keto ether 2.79 undergo Claisen rearrangement by heating in the absence or presence of base 
(Et3N) and/or in the presence of Rh2(OAc)4 under microwave irradiation (Scheme 2.51). 
 
Scheme 2.51: Attempts to initiate the Claisen-rearrangement for isolated a-keto ether 2.79. 
Mechanistically, we assumed that the formed enol 2.111 would undergo a concerted 
sigmatropic rearrangement process. Although trans-crotyl alcohol containing only 5 % of the 
cis-isomer was used in this reaction, we were surprised by the moderate stereochemical 
outcome of 2:1 (S/R) at C11 for a-alkylated a-hydroxyketone 2.84. Stereoselectivity in the 
Claisen rearrangement is dictated by the geometric requirements for a cyclic transition state, 
and the energetic preference for chair-like transition states is well described.193 However, for 
the ester enolate Claisen rearrangement the existence of both chair- and boat-like transitions 
states has been reported by R. E. Ireland and co-workers.194 While acyclic substrates favor 
rearrangements via chair transition states, cyclohexenyl silyl ketene acetals can react via either 
chair or boat transitions states. Therefore, we assume that both the chair (TS 1) and the twist 
boat (TS 2) transition state might be accessible in this [3,3]-sigmatropic rearrangement to form 
both C11-diastereoisomers of a-alkylated a-hydroxyketone 2.84 (Scheme 2.52). 
Aiming for the diastereoselective preparation of the 11R-isomer of 2.84, we investigated 
the influence of choosing either cis- or trans-crotyl alcohol as starting material for the tandem 
O–H insertion/Claisen rearrangement process. Indeed, when cis-crotyl alcohol was used in this 
reaction sequence, we observed formation of a-alkylated a-hydroxyketone 2.84 in a 
diastereomeric ratio of 3:1 in favor for the 11R-isomer (Scheme 2.52). However, this 
transformation did not take place at room temperature and the reaction mixture had to be heated 
to 65°C. The higher activation barrier for the cis-substrate might be explained by the methyl 
group at C11 in axial position in the cyclic transition states TS-3 and TS-4 resulting in stronger 
1,3-diaxial interactions as in TS-1 and TS-2 with this methyl group in equatorial position. Thus, 
TS-1 and TS-2 are proposed to be lower in energy than TS-3 and TS-4 (Scheme 2.52). The 
                                               
193 R. L. Vance, N. G. Rondan, K. N. Houk, F. Jensen, W. T. Borden, A. Komornicki, E. Wimmer, J. Am. Chem. 
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best conditions were found by slowly adding a solution of diazoketone 2.82 in toluene or 1,2-
dichloroethane to a pre-heated (65°C) mixture of crotyl alcohol (20 equiv.) and Rh2(OAc)4 
(3.5 mol%) in the same solvent, which gave the desired product in 60 % yield. Higher 
(100 equiv.) or lower (2 equiv.) amounts of cis-crotyl alcohol resulted in lower yields and 
formation of more side products. Instead of adding diazoketone 2.82 to a solution of Rh2(OAc)4 
and crotyl alcohol, J. L. Wood and co-workers used a protocol by adding the catalyst to a 
solution of the reactants.190b By adding Rh2(OAc)4 (1 mol%) to a solution of diazoketone 2.82 
and crotyl alcohol (2.5 equiv.), followed by heating to 65°C, formed 50 % of the desired 
compound 2.84 in a small scale approach (20 mg). 
 
Scheme 2.52: Tandem O–H insertion and Claisen-rearrangement using either the trans- or cis-
isomer of crotyl alcohol, and proposed transition states to explain the stereochemical outcome 
with respect to the configuration at C11. 
Unfortunately, conditions used afore (Table 2.5, entry 1) for the a-ketol rearrangement 
of the mixture containing more of the 11S-isomer (2:1 11S/11R) were lower yielding when a 
mixture containing more of the 11R-isomer (3:1 11R/11S) was used as starting material 
(entry 2). Therefore, reaction conditions for the [1,2]-shift were screened. Since the 
diastereoisomers could not be separated using column chromatography after the tandem O–H 
insertion/Claisen rearrangement reaction, we subjected mixtures containing both 11S-2.84 and 
11R-2.84 to several sets of reaction conditions. Increasing the concentration of Al(Ot-Bu)3 was 
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found to give a lower yield owing to more side product formation (entry 3). Using cyclohexane 
or diglyme instead of toluene as solvent did not influence the reaction outcome significantly 
(entries 4 and 5). An increased reaction temperature (100°C) led to more side product 
formation. With increased reaction time, more side products were also formed at lower 
temperatures (60°C or rt). Basic conditions using K2CO3 (entry 6), Cs2CO3 (entries 7 and 8)195 
or aqueous NaOH (entry 9)196 gave low conversion. Similar results compared to the initial 
conditions (entry 2) were obtained using KOt-Bu in toluene (entry 10).197 Unfortunately, this 
reaction turned out to proceed sluggishly and more side product formation was indicated by 
1H NMR spectroscopy of the crude reaction mixture. In a recently published report by the group 
of J. Zhu,198 enantioselective a-ketol rearrangements of α-hydroxy acetals using catalytic 
amounts of chiral phosphoramide BINOL derivatives have been presented. In order to apply 
their protocol in the reaction with our substrate, we synthesized the known phosphoramide 
2.112.199 With the reported reaction conditions, desired a-allylated hydroxyenone 2.80 was 
isolated in 50 % yield and 80 % based on recovered starting material (entry 11). However, while 
repeating the protocol for the preparation of phosphoramide 2.112, more attention was paid to 
the separation by column chromatography and a minor unknown compound, initially not 
separated from the main product, was separated from phosphoramide 2.112. When used as a 
reagent for the a-ketol rearrangement, fractions containing pure phosphoramide 2.112 showed 
no conversion (entry 12). However, applying the isolated phosphoramide byproduct as reagent 
gave 72 % yield for the desired [1,2]-rearranged product 2.80 as indicated by 1H NMR 
spectroscopy of the crude reaction mixture (entry 13). The group of M. Rueping discovered that 
upon purification by column chromatography, phosphoramides can form their corresponding 
calcium salts due to ionic impurities in the silica gel.200 In order to prove that the so far unknown 
compound triggering the desired acyloin rearrangement is the corresponding calcium salt of 
phosphoramide 2.112, we stirred a mixture of purified 2.112 and Ca(OMe)2 in MeOH.201 Indeed 
did the 1H as well as 31P NMR spectra indicate the synthesized calcium salt 2.113 to be identical 
to the unknown compound isolated before, and it also triggered the desired ketol rearrangement. 
                                               
195 M. Kawamura, S. Kamo, S. Azuma, K. Kubo, T. Sasamori, N. Tokitoh, K. Kuramochi, K. Tsubaki, Org. Lett. 
2017, 19, 301-303. 
196 L. Leng, X. Zhou, Q. Liao, F. Wang, H. Song, D. Zhang, X.-Y. Liu, Y. Qin, Angew. Chem. Int. Ed. 2017, 56, 
3703-3707. 
197 E. Mosettig, U. Beglinger, F. Dolder, H. Lichti, P. Quitt, J. A. Waters, J. Am. Chem. Soc. 1963, 85, 2305-2309. 
198 H. Wu, Q. Wang, J. Zhu, Angew. Chem. Int. Ed. 2017, 56, 5858-5861. 
199 K. Tomooka, M. Suzuki, M. Shimada, R. Ni, K. Uehara, Org. Lett. 2011, 13, 4926-4929. 
200 M. Rueping, B. J. Nachtsheim, R. M. Koenigs, W. Ieawsuwan, Chem. Eur. J. 2010, 16, 13116-13126. 
201 M. Rueping, T. Bootwicha, S. Kambutong, E. Sugiono, Chem. Asian. J. 2012, 7, 1195-1198. 
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Using a catalytic amount (10 mol%) instead of two equivalents of 2.113 slowed down the 
reaction and caused more side product formation, resulting in lower yields (entry 14). 
Table 2.5: Selected conditions for the a-ketol rearrangement. 
 
entry reagent solvent temperature time scale 
yield  
(1H NMR) 
isolated yieldc 
1a Al(OtBu)3 (2.0 equiv.) toluene 70°C 50 min 240 mg  
52 %  
(84 %) 
2b Al(OtBu)3 (2.0 equiv.) toluene 70°C 50 min 61 mg  
39 %  
(69 %) 
3b Al(OtBu)3 (3.0 equiv.) toluene 70°C 50 min 250 mg  
33 % 
(56 %) 
4b Al(OtBu)3 (2.0 equiv.) cyclohexane 70°C 50 min 3 mg 33 %  
5b Al(OtBu)3 (2.0 equiv.) diglyme 70°C 50 min 2 mg 35 %  
6b K2CO3 (4.0 equiv.) toluene 80°C 12 h 2 mg 8 %  
7b Cs2CO3 (1.0 equiv.) DMF 60°C 80 min 2 mg 9 %  
8b Cs2CO3 (1.0 equiv.) DMF 80°C 80 min 2 mg 14 %  
9b NaOH (1 M) H2O/dioxane (1:1) 90°C 2 h 2 mg 24 %  
10b KOtBu (1.5 equiv.) toluene rt 10 min 2 mg 39 %  
11b 
2.112/2.113 
(unknown ratio), 
4Å MS 
cyclohexane 70°C 11 h 325 mg  
50 % 
(80 %) 
12a/b 2.112 (2.0 equiv.), 4Å MS cyclohexane 70°C 9 h 2 mg 0 %  
13a 2.113 (2.0 equiv.), 4Å MS cyclohexane 70°C 9 h 2 mg 72 %  
14a 2.113 (10 mol%) cyclohexane 70°C 48 h 2 mg 58 %  
15a Ca(OMe)2 (2.0 equiv.) MeOH rt 44 h 324 mg  
71 %  
(80 %) 
16b Ca(OMe)2 (2.0 equiv.) MeOH rt 44 h 73 mg  70 % 
17a NaOMe (2.0 equiv.) MeOH rt 24 h 2 mg 0 %  
a 2:1 mixture of 11S/11R-2.84 was used; b 3:1 mixture of 11R/11S-2.84 was used; c yields based on recovered starting material 
are given in parentheses. 
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Knowing about the involvement of Ca(II) in this process, we tested if the phosphoramide 
could be replaced by a simpler anion. Fortunately, treatment of 2.84 with Ca(OMe)2 in MeOH 
at room temperature induced the [1,2] shift as well, and an increased yield of 71 % (for a 2:1 
mixture of 11S/11R, entry 15) or 70 % (for a 3:1 mixture of 11R/11S, entry 16) for 2.80 was 
obtained after purification of the reaction mixture. A test experiment replacing Ca(OMe)2 with 
NaOMe showed no conversion (entry 17) and further substantiated Ca(II) to be essential in the 
presented transformation. In order to evidence the Ca(II)-mediated a-ketol rearrangement to be 
a reversible process, the purified products have been submitted to the same reaction conditions 
(Ca(OMe)2, MeOH, rt, 45 hours). Analysis of the crude reaction mixture by 1H NMR 
spectroscopy showed a ratio of 1:5 for a-alkylated a-hydroxyketone 2.84 and a-alkylated 
a-hydroxyenone 2.80. These findings further indicate the desired product 2.80 to be 
thermodynamically favored under the given reaction conditions. Separation of the 3:1 mixture 
of 2.80 (11R/11S) resulted in almost diastereopure 11R-a-alkylated a-hydroxyenone 2.80 (dr 
14:1), and the structure was confirmed by single-crystal X-ray analysis (Scheme 2.53). 
 
Scheme 2.53: Optimized reaction conditions for the a-ketol rearrangement of a diastereomeric 
3:1 (11R/11S) mixture of 2.84 and single crystal X-ray structure of 11R-2.80. 
2.2.6.2 Endgame: Oxidative Modifications and Aldol Cyclization 
As already mentioned (section 2.2.6.1), we anticipated that the stereogenic center at C11 
would epimerize after ozonolysis of the terminal double under the basic reaction conditions 
used for the aldol reaction. Therefore, we initially performed the ensuing steps using a 
diastereomeric 2:1 (11S/11R) mixture of 2.80. However, for analytical purposes all the reactions 
were also performed using diastereopure 11S- and 11R-2.80, respectively. Modification of the 
A-ring involved cleavage of the TBS group of 2.80 and oxidation of the resulting secondary 
hydroxy group by DMP to afford the carbonyl group at C3. Ozonolysis of the terminal double 
bond of 2.114 formed 2.115 and set the stage for the aldol reaction. Unfortunately, both acidic 
(2 M HCl, acetone, 60°C) and basic (DBU, CH2Cl2, 0°C or KOt-Bu, THF, –78°C or K2CO3, 
18-crown-6, MeOH, rt) conditions did not give the desired tricyclic product 2.98 and led to 
retro-aldol reaction by cleavage of the C7–C11 bond to form diosphenol 2.116. 
Ca(OMe)2
MeOH, rt
11R/11S-2.84, dr 3:1
(major diastereomer drawn)
O OTBS
OH
*
X-ray structure of 11R-2.80
O
OTBS
HO
*
11R/11S-2.80, 70 %, dr 3:1
(dr 14:1 after separation)
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Scheme 2.54: A-ring modifications and ozonolysis to form b-hydroxy aldehyde 2.115. Retro-
aldol reaction of 2.115 under basic or acidic conditions to form diosphenol 2.116. 
Table 2.6: Selected conditions for the protection of the tertiary carbinol for the dicarbonyl 
compound 2.114. 
 
entry R conditions observationsa 
1 TES TESOTf (2 equiv.), 2,6-lutidine (3 equiv.), CH2Cl2, 0°C202 complex mixture 
2 TMS TMS-imidazole, CH2Cl2, rt, 5 h; then reflux, o.n.203 no conversion 
3 TMS TMSI (2.5 equiv.), HMDS (4 equiv.), CH2Cl2, 0°C, 30 min204 compound 2.119 was formed, but 
decomposed; not reproducible 
4 THP DHP (4 equiv.), PPTS (10 mol%), CH2Cl2, rt, 2 h205 no conversion 
5 THP DHP (4 equiv.), PPTS (10 mol%), CH2Cl2, 45°C, 2 d 
additional DHP (4 equiv.) after 5 h and 8 h 
compound 2.118 was formed as 
diastereoisomers, but in a mixture 
with side products 
6 THF DHF (20 equiv.), PPTS (10 mol%), CH2Cl2, rt, o.n. complex mixture, formation of 
2.117 with side products 
a monitored by 1H NMR spectroscopy. 
                                               
202 A. Nishida, I. Miyoshi, Y. Ogasawara, S. Nagumo, N. Kawahara, M. Nishida, H. Takayanagi, Tetrahedron 
2000, 56, 9241-9257. 
203 L. D. Rowe, R. C. Beier, M. H. Elissalde, L. H. Stanker, R. D. Stipanovic, Synth. Commun. 1993, 23, 2191-
2197. 
204 G. Y. C. Leung, H. Li, Q.-Y. Toh, A. M. Y. Ng, R. J. Sum, J. E. Bandow, D. Y. K. Chen, Eur. J. Org. Chem. 
2011, 2011, 183-196. 
205 J. D. White, G. L. Bolton, A. P. Dantanarayana, C. M. J. Fox, R. N. Hiner, R. W. Jackson, K. Sakuma, U. S. 
Warrier, J. Am. Chem. Soc. 1995, 117, 1908-1939. 
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Therefore, we investigated protection of the tertiary hydroxy group at C7. Initially, we 
attempted to protect the carbinol of the dicarbonyl compound 2.114 with a labile TES (Table 
2.6, entry 1) or TMS (entries 2 and 3) protecting group, which would allow for removal after 
ozonolysis and aldol cyclization using mild reaction conditions. Unfortunately, all silyl 
protection attempts on this substrate proceeded sluggishly and only the experiment using TMSI 
(2.5 equiv.) and HMDS (4 equiv.) in CH2Cl2 at 0°C formed the silyl ether, but also autoxidized 
the C1–C2 bond to the diene dione. This highly conjugated compound turned out to be an 
unsuitable substrate in the subsequent aldol cyclization due to its instability and high reactivity. 
Attempted installation of a THP or THF ether did either fail (entry 4) or show only low 
conversion to the desired compounds (entries 5 and 6). 
Table 2.7: Selected conditions for the protection of the tertiary carbinol on the a-allylated  
a-hydroxyenone 2.80. 
 
entry R conditionsa observations 
1 Bn BnBr, NaH, TBAI, THF, rt complex mixtureb 
2 Bn BnBr, KHMDS, THF, –78°C to rt complex mixtureb 
3 Bn Bn-OPT, MgO, trifluorotoluene, 84°C, o.n. dehydrated side 
product 2.123b 
4 Bn CCl3C(=NH)OBn (4 equiv.), Sc(OTf)3 (5 mol%), toluene, rt, 2 d no conversion 
5 Bn CCl3C(=NH)OBn (4 equiv.), TfOH (5 mol%), CH2Cl2/CH (1:2), to rt no conversion 
6 PMB CCl3C(=NH)OPMB (4 equiv.), Sc(OTf)3 (5 mol%), CH2Cl2/CH (1:2), rt, o.n. low conversionb 
7 PMB CCl3C(=NH)OPMB (4 equiv.), Sc(OTf)3 (5 mol%), 
CH2Cl2/CH (1:2), 4 Å MS, rt, 1 h 30 min 
60 % conversionb 
8 PMB CCl3C(=NH)OPMB (4 equiv.), Yb(OTf)3 (5 mol%),  
CH2Cl2/CH (1:2), 4 Å MS, rt, 1 h 45 min 
65 % 2.122c 
a Bn-OPT = 2-benzyloxy-1-methylpyridinium triflate; CH = cyclohexane; b monitored by 1H NMR spectroscopy; c isolated 
yield after column chromatography. 
In section 2.2.5, we presented a synthetic route leading to periconianone A using a benzyl 
protecting group for the tertiary carbinol. Therefore, we aimed at the installation of a benzyl 
(Bn) or para-methoxybenzyl (PMB) group for carbinol 2.80. Selected conditions are 
summarized in Table 2.7. Basic conditions using BnBr, NaH and TBAI in THF resulted in a 
O
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*
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complex mixture (entry 1).206 Replacing NaH by KHMDS (entry 2), already successfully 
applied in the protection of tertiary hydroxyl groups,207 did also not lead to the desired protected 
product 2.121. Neutral conditions by using the Dudley reagent 2-benzyloxy-1-
methylpyridinium triflate (Bn-OPT) at elevated temperature (84°C) triggered elimination of the 
tertiary hydroxyl group to form the dienone 2.123 (entry 3).208 Under Lewis acidic conditions 
using Sc(OTf)3 (entry 4) or in the presence of TfOH as Brønsted acid (entry 5) and the 
corresponding trichloroacetimidate,209 benzylation did not take place; however, low conversion 
to the PMB-protected carbinol 2.122 was observed (entry 6). Applying the same conditions 
with addition of 4 Å molecular sieves as proton scavenger210 and slow addition of the 
trichloroacetimidate improved the conversion to 60 %, as monitored by 1H NMR spectroscopy 
(entry 7). With Yb(OTf)3 as Lewis acid similar results with an isolated yield of 65 % for PMB-
protected 2.122 (entry 8) were obtained. 
A-ring modification by deprotection of the TBS group and oxidation of the secondary 
alcohol followed by ozonolysis gave the PMB-protected tricarbonyl compound 2.124 in 66 % 
yield over three steps. We were thus able to attempt the key aldol reaction to construct the C-
ring. Applying the conditions used previously for the benzyl-protected tricarbonyl compound 
(DBU, CH2Cl2, O2, rt) led to formation of a complex mixture (Table 2.8, entry 1). Using 
20 mol% of the guanidine base TBD instead of DBU showed fast consumption of the aldehyde 
(30 min) at room temperature and formed a mixture of the dehydrogenated tricycle 2.125 and 
C1–C2 saturated tricycles 2.126 and 2.127 in a mixture of 1:1.4:2.3 (entry 2). When the same 
experiment was performed at –20°C, only low conversion was observed after stirring overnight 
(entry 3). However, when the amount of TBD was increased to two equivalents, 2.125, 2.126 
and 2.127 were formed in a ratio of 1:0.8:2.2 (entry 4). Using NaOMe in MeOH, conditions for 
the successful cyclization of methenylated tricarbonyl compound 2.68, resulted in a complex 
mixture (entry 5). Under acidic conditions (HCl, acetone, rt), formation of a complex mixture 
was observed as well (entry 6). Organocatalytic aldol reactions using Hayashi-Jørgensen 
catalyst211 showed no conversion at room temperature or at 40°C (entry 7). A major 
                                               
206 M. J. Di Grandi, C. A. Coburn, R. C. A. Isaacs, S. J. Danishefsky, J. Org. Chem. 1993, 58, 7728-7731. 
207 C. L. Hugelshofer, T. Magauer, J. Am. Chem. Soc. 2016, 138, 6420-6423. 
208 K. W. C. Poon, S. E. House, G. B. Dudley, Synlett 2005, 3142-3144. 
209 P. Eckenberg, U. Groth, T. Huhn, N. Richter, C. Schmeck, Tetrahedron 1993, 49, 1619-1624; T. Iversen, D. R. 
Bundle, J. Chem. Soc., Chem. Commun. 1981, 1240-1241. 
210 M. Adinolfi, G. Barone, A. Iadonisi, M. Schiattarella, Tetrahedron Lett. 2002, 43, 5573-5577. 
211 J. Franzén, M. Marigo, D. Fielenbach, T. C. Wabnitz, A. Kjærsgaard, K. A. Jørgensen, J. Am. Chem. Soc. 2005, 
127, 18296-18304; Y. Hayashi, H. Gotoh, T. Hayashi, M. Shoji, Angew. Chem. Int. Ed. 2005, 44, 4212-4215. 
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breakthrough for the cyclization reaction was found by treating tricarbonyl 2.124 with 
organophosphates as Brønsted acid catalysts:212 although reactions using aqueous phosphoric 
acid (entry 8) showed no conversion, the chiral BINOL phosphate R-(−)-1,1′-binaphthyl-2,2′-
diyl hydrogenphosphate (entry 9) or the achiral diphenyl phosphate (entry 10) both induced 
clean conversion to tricylces 2.126 and 2.127, as monitored by 1H NMR spectroscopy. Under 
the given reaction conditions, we found that the stereogenic center at C11 was not isomerized, 
as the 1H NMR spectrum of the crude product showed formation of 2.126 and 2.127 in a ratio 
of 1:2; the same ratio as in the starting material. 
Table 2.8: Synthesis of PMB-protected tricarbonyl compound 2.124 and aldol cyclization 
attempts. 
 
entry conditions 2.125/2.126/2.127a observationsa 
1 DBU (3 equiv.), CH2Cl2, O2, rt, 3.5 h  complex mixture 
2 TBD (20 mol%), THF, O2, rt, 30 min 1:1.4:2.3 and other side products 
3 TBD (20 mol%), THF, O2, –20°C, o.n.  low conversion 
4 TBD (2 equiv.), THF, O2, –20°C, 2.5 h 1:0.8:2.2 and other side products 
5 NaOMe (2 equiv.), MeOH, rt, 30 min  complex mixture 
6 HCl (2 equiv.), acetone, rt, 30 min  complex mixture 
7 Hayashi cat. (20 mol%), AcOH, CH2Cl2, rt, 2 h 
then 40°C, o.n. 
 no conversion 
8 H3PO4 (20 % in H2O), THF, 65°C, o.n.  no conversion 
9 R-(−)-1,1′-binaphthyl-2,2′-diyl hydrogenphosphate 
(10 mol%), toluene, 65°C, o.n. 
0:1:2 clean conversion to 
2.126/2.127 
10 diphenyl phosphate, toluene, 65°C, 17 h 0:1:2 clean conversion to 
2.126/2.127 
a ratio monitored by 1H NMR spectroscopy. 
                                               
212 G. Pousse, F. L. Cavelier, L. Humphreys, J. Rouden, J. Blanchet, Org. Lett. 2010, 12, 3582-3585. 
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We were very pleased that under the same reaction conditions, the unprotected tricarbonyl 
compound 2.115 (dr 1:2) highly efficiently cyclizes to give the same 1:2 mixture (11R/11S) of 
aldol addition product 2.98. Aiming at the preparation of pure 11R-2.98, diastereopure terminal 
olefin 11R-2.80 was converted to the tricarbonyl compound 11S-2.115 in 76 % yield over three 
steps. Aldol cyclization using the optimized reaction conditions (diphenyl phosphate, toluene, 
65°C) gave the tricycle 11R-2.98 in 71 % yield and with a diastereomeric ratio of >10:1, 
respective to C11 and C12.  
 
Scheme 2.55: Synthesis of diastereopure tricarbonyl 11S-2.115 and endgame in the synthesis of 
periconianone A (2.1) involving aldol cyclization to tricycle 11R-2.98 using diphenyl phosphate 
and dehydrogenation of the C1–C2 bond. 
With tricycle 11R-2.98 in hand, we addressed the last transformation towards 
periconianone A (2.1) by introducing unsaturation at the C1–C2 bond. As already discussed in 
section 2.2.5.2, autoxidation by treating tricycle 2.98 with DBU or TBD did not bring about the 
desired oxidation. In section 2.2.3.4, dehydrogenation conditions have been screened for 
tricycle 2.70 lacking the C7 hydroxy group. Although not effective for the introduction of the 
C1=C2 unsaturation with substrate 2.70, experiments using the Saegusa protocol [Pd(TFA)2, 
O2, DMSO, EtOAc, rt],112 or hypervalent iodine reagents (iodic acid, cyclohexane, DMSO, 
45°C)148 have been tested on tricycle 2.98. Unfortunately, both protocols led to decomposition 
of the starting material. Using DDQ (dioxane, 100°C), an effective reagent for installing 
a,b-unsaturation in steroidal ketones,213 also led to decomposition. We were very pleased that 
a-selenylation followed by selenoxide elimination,111 already successful for the 
                                               
213 D. Walker, J. D. Hiebert, Chem. Rev. 1967, 67, 153-195. 
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dehydrogenation of 2.70 (see section 2.2.3.4), facilitated conversion to periconianone A (2.1). 
After screening the reagent concentrations (LiHMDS and PhSeCl) and different oxidation 
reagents (H2O2, H2O2/pyridine, m-CPBA, O3, NaIO4), we found the best conditions by using 
LiHMDS (4 equiv.) and phenylselenyl chloride (2 equiv.) in THF at –78°C, before the reaction 
was quenched by addition of aqueous NaIO4 and warming to room temperature. Work-up after 
the selenylation step prior to oxidation did not improve the yield of this reaction. Using 
Mukaiyama’s reagent (N-tert-butylbenzenesulfinimidoyl chloride)214 for the dehydrogenation 
in a one-pot manner with the aim to avoid the oxidation step did only form traces of the natural 
product 2.1. 
After purification by column chromatography, both the 1H and 13C NMR spectra of 
synthetic periconianone A (2.1) were in agreement with the reported spectra for the isolated 
material (Table 2.9 and Figure 2.3).100
 
 
Figure 2.3: 1H NMR (in DMSO-d6) overlay of natural (top) and synthetic (bottom) periconianone 
A (2.1). 
 
                                               
214 T. Mukaiyama, J. Matsuo, H. Kitagawa, Chem. Lett. 2000, 1250-1251. 
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Table 2.9: 1H and 13C NMR comparison for natural 2.1 and synthetic 2.1. 
 
position 
natural 2.1 
dH lit.a, b 
(600 MHz, DMSO-d6) 
synthetic 2.1 
dH this workb 
(500 MHz, DMSO-d6) 
natural 2.1 
dC lit.a 
(150 MHz, DMSO-d6) 
synthetic 2.1 
dC this work 
(126 MHz, DMSO-d6) 
1 7.45 (dd, 10.2, 1.2) 7.45 d (10.2) 142.3 142.3 
2 5.94 (d, 10.2) 5.94 (d, 10.1) 128.8 128.8 
3   199.9 199.9 
4   56.0 56.0 
5   44.8 44.9 
6 1.95 (d, 13.8, Hb) 1.96 (d, 13.8) 40.2 40.2 
 1.73 (d, 13.8, Ha) 1.73 (d, 13.8)   
7   75.7 75.7 
8   198.7 198.7 
9 6.12 (s) 6.12 (s) 123.4 123.4 
10   161.4 161.4 
11 1.59 (m) 1.60 (dq, 10.1, 6.7) 44.8 44.9 
12 3.32 (dd, 10.2, 7.2) 3.38 – 3.31 (m) 72.8 72.8 
13 0.75 (d, 6.6) 0.76 (d, 6.7) 12.1 12.2 
14 1.07 (s) 1.08 (s) 8.0 8.0 
15 1.05 (s) 1.06 (s) 23.3 23.3 
7-OH 5.14 (s) 5.07 (s)   
12-OH 4.87 (d, 7.2) 4.83 (d, 7.2)   
a See reference 100 for published NMR spectroscopic data of natural 2.1. b coupling constants JH-H are given in 
parentheses (Hz). 
2.3 Conclusion 
In conclusion, the first enantioselective total synthesis of periconianone A was 
accomplished in 15 steps starting from known g-hydroxy carvone (Scheme 2.56). The AB-ring 
system was efficiently constructed in six steps including a Criegee fragmentation to remove the 
isopropenyl moiety, a directing group used for the stereoselective installation of the substituents 
at C3, C4 and C5. Besides the key aldol transformation, the main challenge of the synthesis was 
the stereoselective elaboration of the C7 carbinol unit. Although present in diverse bioactive 
eremophilane-type natural products, there has so far been no synthetic strategy addressing the 
construction of this structural motif. After several synthetic proposals had been elaborated and 
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shown to be unsuccessful, we tackled this challenge by an early and stereoselective installation 
of this functional group before constructing the C-ring of periconianone A. The a-diazoketone 
derivative of the corresponding octalone was synthesized in two steps, and its transition metal 
carbene complex formed by reaction with a Rh(II) precursor reacted with (Z)-crotyl alcohol in 
an efficient tandem process of crotyl-O-insertion and spontaneous Claisen rearrangement. 
Treatment of the formed a-hydroxy ketone bearing the C8 carbinol unit with a simple and cost-
efficient calcium salt then triggered the a-ketol rearrangement to shift the carbinol unit to the 
desired C7 position in a formal [2,3]-Wittig rearrangement. 
 
Scheme 2.56: Key steps in the total synthesis of periconianone A. 
After the A-ring as well as the allylic side chain had been modified by functional group 
interconversions, a postulated biogenetic aldol reaction furnished the complex cage-like 
tricyclic skeleton with high diastereoselectivity. Careful screening of reaction conditions 
enabled mimicking this late-stage aldol transformation without any protecting group for the 
sensitive b-hydroxy aldehyde, a motif that is prone to elimination or retro-aldol reactions. 
Additionally, aldol reactions catalyzed by organic phosphonic acids are rare and underexplored, 
and there are only few examples reported in literature. Our strategy sets the stage for the concise 
synthesis of other eremophilane-type natural products bearing a carbinol motif at C7 as well as 
the preparation of structurally diverse derivatives of periconianone A in order to find more 
potent neural anti-inflammatory active agents. SAR studies by preparation of periconianone A 
derivatives and biological testing of their ability to inhibit the LPS-induced NO production in 
mouse microglia BV2 cells are underway. 
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3 MICROSPHAEROPSISIN B AND C, PERICONIANONE C: 
TOTAL SYNTHESES AND BIOGENETIC RELATION 
3.1 Introduction 
Recently, the group of J. Dai reported an unusual furan-type iso-eremophilane, isolated 
from the endophytic fungus Periconia sp. F-31 and named periconianone C (3.1).215 Extensive 
structure elucidation using 2D NMR spectroscopy indicated a linkage of the three-carbon 
moiety (usually bound at C7) to the C8 of the decalin core, a connectivity previously not 
reported for members of the furanoeremophilane-type sesquiterpene family (Figure 3.1). 
 
Figure 3.1: Chemical structures of microsphaeropsisins B (3.2) and C (3.3), and periconianone 
C (3.1). 
Additionally, the proposed structure was confirmed by single-crystal X-ray analysis and 
a biosynthetic pathway has been suggested (Scheme 3.1). It is assumed that after precursor 3.4, 
bearing the usual C7–C11 linkage is formed by cyclization of FPP catalyzed by sesquiterpene 
synthases and subsequent oxidation events, a pinacol rearrangement might take place to shift 
the isopropenyl moiety from C7 to C8. Additional oxidation events would then form 
periconianone C (3.1) after ketalization. This biogenetic proposal is supported by the isolation 
of the putative precursor 3.4 from the same extracts of the fungus Periconia sp. F-31 as 
periconianone C (3.1). 
 
Scheme 3.1: Proposed biosynthetic pathway to periconianone C (3.1) by J. Dai and co-workers. 
                                               
215 J. Liu, D. Zhang, M. Zhang, J. Zhao, R. Chen, N. Wang, D. Zhang, J. Dai, J. Nat. Prod. 2016, 79, 2229-2235. 
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A different biosynthetic proposal features an early rearrangement of the eudesmane-type 
precursor 3.5: instead of methyl group migration to form the eremophilane skeleton, the C1–
C10 bond might undergo a 1,2-alkyl shift to form the spiro intermediate 3.6, whose C4–C5 
bond can undergo another 1,2-shift to form the C8 isopropenylated decalin 3.7 (Scheme 3.2). 
This iso-eremophilane was isolated in small amounts from the roots of the South African 
Helichrysum davyi S. Moore by the group of F. Bohlmann.216 Subsequent oxidation events on 
3.7 might then lead to the formation of periconianone C. However, a pathway featuring spiro 
intermediates was ruled out for the biogenesis of C7 isopropenylated eremophilanes (see 
section 1.3) and as no other oxidized derivatives of C8–C11-connected eremophilanes have 
been described to date, this pathway appears less probable. 
 
Scheme 3.2: Alternative hypothetical biosynthetic pathway to periconianone C (3.1) by an early 
rearrangement. 
Only recently, two structurally very similar furan-type eremophilanes were isolated from 
co-cultivation of the endophytic fungus Trichoderma sp. 307 with the aquatic pathogenic 
bacterium Acinetobacter johnsonii B2, and named microsphaeropsisin B (3.2) and C (3.3) 
(Figure 3.1).217 Except for the linkage of the furan moiety, the structure of microsphaeropsisin 
B is identical to the one of periconianone C. In the course of the total synthesis of periconianone 
A (see section 2), we discovered that bicyclic a-allylated a-hydroxyketones can undergo 1,2-
shifts at positions C7 and C8. Based on these findings as well as the structural similarities of 
3.1 and 3.2, we suggested an alternative biogenesis for C8–C11-connected 
furanoeremophilanes by an equilibrium between the open forms of microsphaeropsisin B (3.2’) 
and periconianone C (3.1’) via an a-ketol rearrangement (Scheme 3.3). 
                                               
216 I. Jakupovic, T. Teetz, F. Bohlmann, Phytochemistry 1987, 26, 1841-1842. 
217 L. Zhang, S. Niaz, D. Khan, Z. Wang, Y. Zhu, H. Zhou, Y. Lin, J. Li, L. Liu, Mar. Drugs 2017, 15, 35. 
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Scheme 3.3: Our proposed biosynthetic pathway including microsphaeropsisin B (3.2) as a 
biogenetic precursor of periconianone C (3.1). 
In order to investigate our proposed biogenetic proposal, we developed an efficient 
synthetic route to microsphaeropsisin B (3.2). Starting from 11S-a-alkylated a-hydroxyenone 
2.80, whose synthesis was elaborated in the course of the total synthesis of periconianone A 
(see section 2), we envisioned to modify the A-ring as well as the three-carbon side chain by a 
stepwise oxidation protocol to give access to microsphaeropsisin B (3.2). Having 3.2 at hand, 
we investigated the aforementioned transition of microsphaeropsisin B to periconianone C by 
an a-ketol rearrangement. 
3.2 Results and Discussion 
3.2.1 First Enantioselective Total Synthesis of Microsphaeropsisin B and C 
For investigations on the transition of the 11S-isomer of a-alkylated a-hydroxyenone 
2.80 to microsphaeropsisin B (3.2), different routes were elaborated.218 The main challenge 
consisted in finding a suitable sequence for achieving the desired oxidation states on the  
functionalized positions, i.e. to optimize the order in which these reactions were to be carried 
out on the A-ring and on the side chain. Oxidative cleavage of the terminal double bond, 
followed by reduction of the formed aldehyde gave access to the furan-bearing compound 3.8 
(Scheme 3.4). Although different fluoride sources were screened, deprotection of the TBS 
group was still low-yielding under optimized conditions using Et3N·3HF in THF. Another 
approach consisted in fully oxidizing the A-ring prior to modification of the side chain: 
deprotection of the TBS group of 11S-2.80 using HF in a MeCN/THF mixture was followed by 
DMP-mediated oxidation of the secondary alcohol to install the carbonyl moiety at C3 and gave 
11S-2.114 in 89 % yield over two steps. Unfortunately, dehydrogenation using DBU and O2 in 
                                               
218 N. Lardon, Master Thesis 2017, Zurich. 
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CH2Cl2 was low-yielding and the formed diene dione 3.9 was found to be very unstable and 
unsuitable for the ensuing steps of the synthesis.  
 
Scheme 3.4: A-ring and side chain modification attempts. 
We therefore decided to use the approach outlined in Scheme 3.5: after installation of the 
carbonyl moiety at C3, a subsequent oxidative cleavage of the terminal double bond furnished 
aldehyde 11R-2.115 in 76 % yield. Having this tricarbonyl-bearing substrate in hand, we 
addressed the selective reduction of the aldehyde at C12 without reducing the keto groups at 
C3 or C8. This transformation was identified as a key challenge and extensive screening was 
necessary to optimize the yield for the desired mono-reduced product 3.10. Reactions with 
NaBH4 were very low-yielding and also led to reduction of the carbonyl moiety at C3. The 
milder reducing agent NBu4B(OAc)3H (prepared in situ form NBu4BH4 and AcOH)219 gave 
only 18 % yield of the desired product 3.10. Comparable results were obtained using 
NMe4B(OAc)3H:220 at –20°C, a complex mixture was formed; at room temperature, traces of 
primary alcohol 3.10 could be detected. 
 
Scheme 3.5: Oxidative cleavage of 11S-2.114 and reduction of the side chain in 11R-2.115. 
                                               
219 C. F. Nutaitis, G. W. Gribble, Tetrahedron Lett. 1983, 24, 4287-4290. 
220 S. A. Ramachandran, R. K. Kharul, S. Marque, P. Soucy, F. Jacques, R. Chênevert, P. Deslongchamps, J. Org. 
Chem. 2006, 71, 6149-6156. 
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After screening different reaction temperatures and various concentrations of the reducing 
agent DIBAL-H, we found superior conditions at –88°C to –78°C by using 1.5 equivalents of 
DIBAL-H to yield a mixture of 28 % of the desired product, 12 % of doubly reduced (C12 and 
C3) compound and 11 % of starting material. Testing other reducing agents for this 
transformation, we obtained the best result by adding three equivalents of NaB(OAc)3H to a 
solution of the aldehyde 11R-2.115 in CH2Cl2 to give 63 % of the desired mono-reduced 
compound 3.10.221 
With intermediate 3.10 in hand, we started to investigate the final dehydrogenation step 
to microsphaeropsisin B (3.2). When the aldol reaction for construction of the C-ring in the 
total synthesis of periconianone A (2.1) had been carried out in the presence of DBU or TBD, 
this reaction had been accompanied by oxidation of the C1–C2 bond of the Bn- (2.96) or PMB-
protected (2.124) tricarbonyl compounds to give the desired diene dione function prior to 
cyclization (see section 2.2.5.2). We applied the same reaction conditions to substrate 3.10 with 
the aim not only to dehydrogenate the C1–C2 bond, but also to epimerize the stereogenic center 
in a-position to the carbonyl moiety at C4 to form both microsphaeropsisin B (3.2) and C (3.3). 
Initial attempts by using DBU in CH2Cl2 only led to trace amounts of the desired compounds. 
However, a significant increase in yield for both natural products was achieved by applying 
TBD. 
 
Scheme 3.6. Dehydrogenation and C4 epimerization to complete the total synthesis of 
microsphaeropsisin B (3.2) and C (3.3). 
After work-up, analysis of the 1H NMR spectra of the crude reaction mixture still 
indicated the presence of unidentified side products. Therefore, we monitored this 
transformation by means of 1H NMR spectroscopy, aiming to gain insights into the mechanism 
of this reaction. Briefly, after 15 minutes, the formation of an unknown intermediate was 
                                               
221 A. Orue, U. Uria, E. Reyes, L. Carrillo, J. L. Vicario, Angew. Chem. Int. Ed. 2015, 54, 3043-3046. 
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observed, which disappeared with prolonged reaction time. Only traces of this intermediate 
could be detected after four hours, which prompted us to extend the reaction time from 
30 minutes to five hours. This modification did not only give better yields, it also proved to be 
the key for the successful isolation of pure microsphaeropsisin B (3.2), after attempts to separate 
this intermediate from 3.2 had been unsuccessful using column chromatography or RP-HPLC.  
 
 
Figure 3.2: 1H NMR spectra (in MeOD-d4) of natural (top)217 and synthetic (bottom) 
microsphaeropsisin B (3.2). 
Mechanistically, we suggest the intermediacy of a peroxide species in this transformation, 
which forms 3.2 and 3.3 after elimination of H2O2. This assumption is based on literature 
precedents that describe transformations of steroidal ketones into their corresponding 
hydroperoxy ketones in the presence of oxygen under basic conditions, and the isolation and 
characterization of such intermediates.154 In order to examine if the dehydrogenation of 3.10 to 
3.2 and 3.3 might proceed via a similar pathway, we measured the reaction mixture’s peroxide 
concentration: indeed, the presence of H2O2 was indicated both after 15 minutes and 2.5 hours, 
and increased with prolonged reaction time. In order to rule out the oxidation of THF in this 
reaction mixture,222 we performed a test reaction in the absence of substrate 3.10: both after 
15 minutes and 2.5 hours no peroxide formation was monitored in pure THF, confirming the 
                                               
222 H. L. Jackson, W. B. McCormack, C. S. Rondestvedt, K. C. Smeltz, I. E. Viele, J. Chem. Educ. 1970, 47, A175. 
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starting material to be involved in this process. After separation by preparative HPLC, we 
obtained microsphaeropsisin C (3.3) in 35 %, and microsphaeropsisin B (3.2) in 10 % yield. 
The 1H and 13C NMR spectra of the synthesized compounds were in agreement with those 
reported in literature for the isolated natural products (Table 3.1 and Table 3.2).217 However, 
we identified additional minor signals in the 1H (Figure 3.2 and Figure 3.3) as well as 13C NMR 
spectra. These signals are hardly visible in the 1H NMR spectra of the isolated compounds and 
no structural assignment had been performed by L. Zhang et al.217 After extensive structural 
elucidation using 2D NMR, we could assign those minor signals to the open forms of the 
corresponding natural products (not shown in Table 3.1 and Table 3.2, see experimental section 
6.4), which are in equilibrium with their furan-type isomers (Scheme 3.6). 
Table 3.1: 1H and 13C NMR data of natural and synthetic microsphaeropsisin B (3.2). 
 
position 
natural 3.2 
dH lit.a, b 
(400 MHz, MeOD-d4) 
synthetic 3.2 
dH this workb 
(500 MHz, MeOD-d4) 
natural 3.2 
dC lit.a 
(100 MHz, MeOD-d4) 
synthetic 3.2 
dC this work 
(126 MHz, MeOD-d4) 
1 7.04 (d, 9.8) 7.05 (d, 9.8) 146.6 146.6 
2 5.84 (d, 9.8) 5.85 (d, 9.8) 126.3 126.3 
3   206.8 206.8 
4 2.24 (q, 7.3) 2.25 (q, 7.2) 55.0 55.0 
5   39.9 39.9 
6 1.79 (d, 14.1) 1.80 (d, 14.0) 34.6 34.6 
 1.44 (d, 14.1) 1.44 (d, 14.1)   
7   77.8 77.8 
8   100.5 100.5 
9 6.10 (s) 6.11 (s) 135.3 135.3 
10   139.4 139.4 
11 2.58 (ddq, 8.3, 7.2, 6.4) 2.60 – 2.55 (m) 43.9 43.8 
12 4.07 (dd, 8.8, 8.3) 4.08 (t, 8.5) 71.8 71.8 
 3.34 (dd, 8.8, 6.4) 3.35 (dd, 10.5, 8.5)   
13 1.01 (d, 7.2) 1.02 (d, 7.0) 9.2 9.2 
14 0.95 (d, 7.3) 0.97 (d, 7.1) 14.8 14.8 
15 1.35 (s) 1.37 (s) 28.0 28.0 
a See reference 217 for published NMR spectroscopic data of natural 3.2. b coupling constants JH-H are given in parentheses 
(Hz). 
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Figure 3.3: 1H NMR spectra (in MeOD-d4) of natural (top)217 and synthetic (bottom) 
microsphaeropsisin C (3.3). 
Optical rotation values of both synthesized natural products were measured and compared 
to the ones reported in literature for the isolated material in order to confirm their absolute 
configuration to be identical: the measured value of [α]$%& = –20.2° (c = 0.60, MeOH) for 
microsphaeropsisin B (3.2) was in agreement with the one reported in literature ([α]$%'  = –16.0° 
(c = 0.10, MeOH)); however, a significant discrepancy was observed for microsphaeropsisin C 
(3.3) with an optical rotation value of [α]$%(= +67.0° (c = 0.48, MeOH) for the synthesized and 
a reported value of [α]$%'= –124.0° (c = 0.025, MeOH) for the isolated material. In order to 
prove the isolated natural and synthetic 3.3 to be identical, we measured a CD spectrum of 
synthesized microsphaeropsisin C, which was in agreement with the one reported in literature 
(Figure 3.4).217  
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Table 3.2: 1H and 13C NMR data of natural and synthetic microsphaeropsisin C (3.3). 
 
position
natural 3.3 
dH lit.a, b 
(400 MHz, MeOD-d4) 
synthetic 3.3 
dH this workb 
(500 MHz, MeOD-d4) 
natural 3.3 
dC lit.a 
(100 MHz, MeOD-d4) 
synthetic 3.3 
dC this work 
(126 MHz, MeOD-d4) 
1 7.01 (d, 9.8) 7.05 (d, 9.8) 146.1 146.1 
2 5.93 (d, 9.8) 5.96 (d, 9.4) 128.4 128.4 
3   203.4 203.4 
4 2.40 (q, 6.9) 2.44 (q, 6.8) 54.4 54.4 
5   40.4 40.4 
6 1.87 (d, 14.0) 1.91 (d, 13.9) 38.9 38.9 
 1.51 (d, 14.0) 1.51 (d, 14.0)   
7   77.6 77.6 
8   100.3 100.3 
9 5.94 (s) 5.97 (s) 132.2 132.2 
10   142.4 142.4 
11 2.54 (ddq, 7.8, 6.9, 6.4) 2.61 – 2.53 (m) 43.9 43.9 
12 4.04 (dd, 8.3, 7.8) 4.07 (t, 8.5) 71.6 71.6 
 3.31 (dd, 8.3, 6.4) 3.34 (dd, 10.6, 8.5)   
13 1.01 (d, 6.9) 1.03 (d, 7.0) 9.2 9.2 
14 1.08 (d, 6.9) 1.10 (d, 6.8) 7.5 7.5 
15 1.16 (s) 1.19 (s) 20.9 20.9 
a See reference 217 for published NMR spectroscopic data of natural 3.3. b coupling constants JH-H are given in parentheses 
(Hz). 
  
Figure 3.4: CD spectrum of synthetic microsphaeropsisin C (3.3) in MeOH (left), reported CD 
spectrum of isolated 3.3 in MeOH (right).217 
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3.2.2 a-Ketol Rearrangement of Microsphaeropsisin B and C to 
Periconianone C and 4-epi-Periconianone C 
With microsphaeropsisin B (3.2) and C (3.3) in hand, the stage was set to investigate the 
hypothesis of a biomimetic α-ketol rearrangement for the transition of both natural products 
into their respective rearranged C8–C11-connected regioisomers. Our studies commenced with 
the transposition of 3.3. Unfortunately, the best conditions for triggering the reaction of 2.84 to 
2.80 (Ca(OMe)2, MeOH, rt) did not bring about the desired conversion of 3.3 to 3.11, as 
monitored by 1H NMR spectroscopy of the crude reaction mixture. Therefore, the reaction 
mixture was heated to 60°C and we were very pleased to observe that a new compound was 
formed and identified as the 4-epi-isomer of periconianone C after isolation and careful 
structural elucidation by 2D NMR spectroscopy. Additionally, the structure of 3.11 was 
confirmed by single-crystal X-ray analysis (Scheme 3.7). Analysis of the crude reaction mixture 
by 1H NMR spectroscopy mainly showed the product 3.11 and starting material 3.3 with hardly 
any side products. After purification by flash column chromatography, 4-epi-periconianone C 
and microsphaeropsisin C were isolated in a combined yield of 75 % in almost equivalent 
amount. 
 
Scheme 3.7: Transposition of microsphaeropsisin C (3.3) to 4-epi-periconianone C (3.11) via an 
a-ketol rearrangement. 
The same reaction conditions (Ca(OMe)2, MeOH, 60°C) were applied to 
microsphaeropsisin B (3.2) with the aim to trigger the a-ketol rearrangement to periconianone 
C (3.1). Fortunately, the desired natural product 3.1 was observed along with remaining starting 
material 3.2 by 1H NMR analysis of the crude mixture (Scheme 3.8). Additionally, during the 
course of the reaction, the basic conditions triggered partial epimerization at C4 to form 
microsphaeropsisin C (3.3) as well as 4-epi-periconianone C (3.11). After no epimerization had 
been observed for the reaction using microsphaeropsisin C as starting material, we assume a 
higher stability for the compounds with cis-configuration (3.3 and 3.11) of the methyl groups 
at C4 and C5, compared to those with trans-configuration (3.1 and 3.2). This hypothesis is 
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further supported by the fact that higher concentrations of 3.3, compared to 3.2, were found in 
the fungal extracts. 
 
Scheme 3.8: Transposition of microsphaeropsisin B (3.2) to periconianone C (3.1) via an a-ketol 
rearrangement. 
Separation of the crude reaction mixture containing the four known isomers was found to 
be challenging: by column chromatography we were only able to separate the more apolar 4-
epi-periconianone C (3.11) from the other three compounds 3.1, 3.2 and 3.3. Therefore, 
conditions for separation by reversed-phase HPLC have been screened and a reasonable 
separation for microsphaeropsisin B (43 %) and C (8 %), as well as for periconianone C (22 %) 
and 4-epi-periconianone C (7 %) was achieved using an isocratic solvent system of 20 % MeCN 
in water (Figure 3.5). 
 
Figure 3.5: Semi-preparative RP-HPLC chromatogram of 3.2, 3.3, 3.1 and 3.11 (solvent: 20 % 
MeCN in water, isocratic). 
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The 1H and 13C NMR spectra of synthesized periconianone C (3.1) were in agreement 
with the spectra reported in literature for the isolated material (Table 3.3),215 and both the 
opened and closed structures of 3.1 were observed in the 1H NMR spectrum (Figure 3.6). The 
optical rotation values for synthesized ([α]$%% = –53.8° (c = 0.19, MeOH)) and natural material 
([α]$%% = –45.5° (c = 0.11, MeOH)) do not significantly differ.215 
Table 3.3: 1H and 13C NMR data of natural and synthetic periconianone C (3.1). 
 
position 
natural 3.1 
dH lit.a, b 
(600 MHz, DMSO-d6) 
synthetic 3.1 
dH this workb 
(500 MHz, DMSO-d6) 
natural 3.1 
dC lit.a 
(150 MHz, DMSO-d6) 
synthetic 3.1 
dC this work 
(126 MHz, DMSO-d6) 
1 7.06 (d, 9.6) 7.06 (d, 9.7) 144.6 144.6 
2 5.77 (d, 9.6) 5.77 (d, 9.7) 124.2 124.2 
3   203.0 203.0 
4 2.07 (q, 6.6) 2.07 (q, 7.2) 52.4 52.5 
5   40.0 39.7 
6 1.95 (d, 13.8) 1.95 (d, 13.9) 41.7 41.7 
 1.65 (d, 13.8) 1.65 (d, 13.8)   
7   103.0 103.0 
8   76.1 76.1 
9 6.14 (s) 6.13 (s) 136.8 136.8 
10   136.7 136.7 
11 2.16 (m) 2.22 – 2.12 (m) 44.6 44.6 
12 3.73 (dd, 7.8, 7.8) 3.73 (t, 7.4) 70.0 70.0 
 3.53 (dd, 7.8, 11.4) 3.53 (dd, 11.1, 7.4)   
13 0.95 (d, 6.6) 0.95 (d, 6.6) 9.1 9.1 
14 0.87 (d, 6.6) 0.87 (d, 7.1) 14.2 14.2 
15 1.19 (s) 1.18 (s) 26.1 26.1 
7-OH  5.61   
8-OH  5.23   
a See reference 215 for published NMR spectroscopic data of natural 3.1. b coupling constants JH-H are given in 
parentheses (Hz). 
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Figure 3.6: 1H NMR spectra (in DMSO-d6) of natural (top) and synthetic (bottom) periconianone 
C (3.1).215 
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3.3 Conclusion 
In conclusion, the first enantioselective total syntheses of microsphaeropsisin B and C in 
15 steps from known g-hydroxy carvone are presented. The tandem OH-insertion/[3,3] 
rearrangement as well as the a-ketol rearrangement, both key reactions developed in the course 
of the total synthesis of periconianone A, have been successfully incorporated into our synthetic 
route for the synthesis of the desired 11S-isomer of a-allylated a-hydroxy enone 2.80. For the 
last five synthetic transformations, selective reduction of the aldehyde in the presence of two 
other carbonyl moieties was identified as an exigent challenge. After careful screening of 
reaction conditions, we achieved the desired mono-reduction with high chemoselectivity and 
without overreduction of the substrate. Unusual autoxidation conditions using a guanidine base 
and molecular oxygen did not only lead to dehydrogenation of the C1–C2 bond to form the 
desired diene dione, but also to epimerization of the C4 position forming both C7–C11-
connected natural product stereoisomers. After minor modification of our protocol for the α-
ketol rearrangement, we were successful to bring about the rearrangement of both natural 
products microsphaeropsisin B and C into their regioisomers periconianone C and 4-epi-
periconianone C by heating the substrates with calcium methoxide in MeOH. These findings 
strongly support our biogenetic hypothesis of microsphaeropsisin B being a biosynthetic 
precursor of periconianone C, and hint at the occurrence of other eremophilane-type terpenoids 
bearing a C8–C11 linkage. 
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4 TOTAL SYNTHESES OF GUIGNARDEREMOPHILANE C 
AND D 
4.1 Introduction 
Except for C5, all carbons in eremophilanes are known to be accessible for oxidation, 
with hydroxylation often taking place at C1, C3, C7 and/or C12. However, C1,C2,C3-
trihydroxylated eremophilanes are rare: besides the two target compounds, only four such 
natural products have been described to date, viz. ligumacrophyllatin,223 sporogen AO-2,224 
1b,8b-dihydroxy-2b,3a-diangeloyloxyeremophil-7(11)-en-8a(12)-olide,225 and guignard-
eremophilane F226 (Figure 4.1). The former is characterized by an all a-configuration of the 
three hydroxy groups (1a,2a,3a); the second by a 1a,2b,3a-configuration; the third by a 
1b,2b,3a-configuration; and the latter as a stereoisomer of guignarderemophilane C by a 
1b,2a,3a-configuration. 
 
Figure 4.1: Eremophilane sesquiterpenes containing a 1,2,3-trihydroxylated A-ring. 
Neither of these compounds have been synthesized yet and there is no reported 
preparative strategy addressing this unusual trihydroxylated A-ring motif. Recently, two natural 
products with a 1a,2b,3b-trihydroxylated scaffold have been isolated for the first time from the 
fungus Guignardia mangiferae, and named guignarderemophilanes C (4.1) and D (4.2).227 The 
fungus Guignardia mangiferae is an endosymbiont of plants such as Gelsemium elegans, whose 
extracts are used in traditional Chinese medicine as nervous relaxant and for the treatment of 
pain.228 Both eremophilanes showed neural anti-inflammatory activity by inhibiting the LPS-
induced NO production in BV2 cells with IC50 values of 6.4 and 4.2 µM, respectively.227 
                                               
223 B. Fu, Q. X. Zhu, X. P. Yang, Z. J. Jia, Pharmazie 2002, 57, 275-278. 
224 Y.-B. Zeng, S.-S. Li, W.-L. Mei, W.-H. Dong, K.-M. Li, H.-F. Dai, J. Asian Nat. Prod. Res. 2015, 17, 280-284. 
225 E. W. Li, J. Pan, K. Gao, Z. J. Jia, Planta Med. 2005, 71, 1140-1144. 
226 Y. Zhou, Y.-H. Li, H.-B. Yu, X.-Y. Liu, X.-L. Lu, B.-H. Jiao, J. Asian Nat. Prod. Res. 2017, 1-8. 
227 Y. Liu, Y. Li, J. Qu, S. Ma, C. Zang, Y. Zhang, S. Yu, J. Nat. Prod. 2015, 78, 2149-2154. 
228 V. Dutt, S. Thakur, V. J. Dhar, A. Sharma, Pharmacogn. Rev. 2010, 4, 185-194. 
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Besides periconianone A (see section 2.1), guignarderemophilanes C and D and their 
derivatives may be potential lead candidates for developing treatment options for neuro-
degenerative diseases, too. 
 
Figure 4.2. Retrosynthetic analysis of guignarderemophilanes C (4.1) and D (4.2), starting from 
the known enone 2.34. 
Besides the unusual 1,2,3-trihydroxylated scaffold, another striking structural feature of 
both eremophilane sesquiterpenoids is the presence of five contiguous stereogenic centers in 
the six-membered A-ring, one of which is quaternary. Guignarderemophilane C contains an 
additional stereogenic center (C7) connected to an isopropenyl moiety with unsaturation in b,g 
position of the carbonyl group, which is prone to isomerize to the a,b-unsaturated ketone, as in 
guignarderemophilane D. From a retrosynthetic perspective, we envisioned to use cyclo-
hexanone derivative 2.34, whose synthesis has been elaborated in the course of the total 
synthesis of periconianone A (see section 2.2.1.3). As a first challenge, we addressed the stereo-
selective installation of the aforementioned three hydroxy groups. To this end, we envisioned 
inversion of the stereocenter at C3 by Mitsunobu reaction of cyclohexanone derivative 2.34, as 
well as a diastereoselective epoxidation and regioselective epoxide opening sequence to install 
the C1 and C2 hydroxy groups. Functionalization at C7 to install the three-carbon unit for 
completion of the 15-carbon skeleton was envisioned by an aldol addition of acetone, followed 
by regioselective dehydration. 
4.2 Results and Discussion 
We had at first envisioned the synthesis to commence by epoxidation of the C1=C2 
double bond of enone 2.34, followed by an aldol condensation to form the octalone core 4.3 
OTBS
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O
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(Scheme 4.1).229 While screening conditions for the epoxidation, we found diverging diastereo-
selectivities for different peroxide sources: with hydrogen peroxide,230 epoxidation on the same 
face as the OTBS group in the A-ring was observed and we isolated epoxy ketones 1S,2R- and 
1R,2S-4.4 with a dr of 3:1. Using tert-butyl hydrogen peroxide, the epoxidation exclusively 
took place (dr > 10:1) on the opposite face with respect to the OTBS group. Observations for 
similar substrates with comparable stereochemical outcome have already been described in 
literature.231 Although the obtained selectivities cannot be fully explained based on steric or 
stereoelectronic effects or both, it might be reasonable to argue that attack of the sterically more 
demanding tert-butyl hydrogen peroxide preferably takes place from the less shielded face of 
the six-membered ring at C2 of 2.34 with the OTBS group in a pseudoequatorial position. 
However, applying the described conditions for the latter reaction, instead of the epoxy ketone, 
we observed spontaneous closure of the B-ring to form the octalone 1S,2S-4.3 (Scheme 4.1).  
 
Scheme 4.1: Epoxidation of enone 2.34 and tandem epoxidation/aldol condensation approach.  
To the best of our knowledge, this is the first reported example of a tandem epoxidation–
aldol condensation sequence. After work-up of the reaction mixture, the 1H NMR spectrum of 
the crude product indicated formation of octalone 1S,2S-4.3 and an unknown compound in a 
ratio of 4:1. When the reaction time was decreased from five hours to one hour, the ratio of the 
two products increased to 2:3 in favor of the unknown compound. This byproduct was identified 
to be the bicyclic g,d-epoxy b-hydroxy ketone 4.5 by isolation and structure elucidation based 
on 2D NMR spectra. Therefore, we hypothesize the epoxidation to take place prior to the aldol 
                                               
229 A. Ilazi, Master Thesis 2016, Basel. 
230 T. Kamikubo, K. Ogasawara, Chem. Commun. 1996, 1679-1680; C. K. Jana, J. Hoecker, T. M. Woods, H. J. 
Jessen, M. Neuburger, K. Gademann, Angew. Chem. Int. Ed. 2011, 50, 8407-8411. 
231 G. Toribio, G. Marjanet, R. Alibes, P. de March, J. Font, P. Bayon, M. Figueredo, Eur. J. Org. Chem. 2011, 
1534-1543; M. Á. Fresneda, R. Alibés, P. Bayón, M. Figueredo, Eur. J. Org. Chem. 2016, 2016, 3568-3574. 
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addition forming the isolated intermediate, which can subsequently undergo dehydration to give 
octalone 1S,2S-4.3. An aldol addition, epoxidation and dehydration pathway is less likely, since 
the electron rich C1=C2 double bond of the hypothetically formed bicyclic aldol addition 
product would not undergo epoxidation under the given reaction conditions. Additionally, the 
intermediacy of g,d-epoxy b-hydroxy ketone 4.5 rules out a pathway in which nucleophilic 
epoxidation takes place after aldol condensation in a 1,6-fashion to the dienone system. 
Cyclization of epoxy ketone 1S,2R-4.4 (major diastereoisomer) provided access to the other 
octalone diastereoisomer 1R,2R-4.3.232 The absolute configuration of both isomers of epoxy 
ketone 4.4 as well as octalone 4.3 could not be established by NOESY NMR spectroscopy. 
Therefore, we performed reductive cleavage of epoxy ketone 1S,2R-4.4 to give b-hydroxy 
ketone 4.6 using the reactive species Na[PhSeB(OEt)3] prepared in situ from (SePh)2, NaBH4 
and AcOH in a 1:1 mixture of CH2Cl2 and EtOH.233 NOESY NMR spectroscopy showed 
correlations of H1ax to H2, H3 and H15; of H2 to both H1ax and H1eq; of H3 to H1ax, H2, H14 
and H15 (Scheme 4.2). Coupling constants for the proton signals at positions C1, C2, C3 and 
C4 (3JH1ax-H2eq = 3.5 Hz; 3JH1eq-H2eq = 3.7 Hz; 3JH2eq-H3ax = 2.7 Hz; 3JH3ax-H4ax = 10.0 Hz) further 
corroborated the assignment of the absolute configuration at stereogenic center C2 of 4.6, and 
hence provided substantial evidence for the configurational assignment of intermediates 4.3 and 
4.4 obtained after epoxidation. 
 
Scheme 4.2: Reductive cleavage of epoxy ketone 4.4 to b-hydroxy ketone 4.6 and key NOESY 
correlations for the configurational assignment of the C2 hydroxy group. 
However, epoxy alcohol 4.7 was found completely unreactive towards Mitsunobu 
reaction conditions (up to 150°C under microwave irradiation)234 and did not form the ester 4.8 
after the TBS-protecting group in 1S,2R-4.4 had been removed (Scheme 4.3).  
                                               
232 J. Christoffers, H. Scharl, Eur. J. Org. Chem. 2002, 1505-1508. 
233 M. Miyashita, T. Suzuki, A. Yoshikoshi, Tetrahedron Lett. 1987, 28, 4293-4296; M. Miyashita, T. Suzuki, M. 
Hoshino, A. Yoshikoshi, Tetrahedron 1997, 53, 12469-12486. 
234 O. Mitsunobu, Synthesis 1981, 1-28; K. Kim, J. K. Cha, Angew. Chem. Int. Ed. 2009, 48, 5334-5336. 
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Scheme 4.3: Investigation of the Mitsunobu reaction of epoxy alcohol 4.7. 
Therefore, we decided to use a route which addresses the inversion of the configuration 
at C3 first. TBS deprotection of enone 2.34 with aqueous HF in MeCN already set the stage for 
the Mitsunobu reaction. No conversion was monitored applying standard Mitsunobu protocols 
using PPh3, DIAD and acetic acid as nucleophile.234 It is well documented in literature that 
acetic acid can react sluggishly in the Mitsunobu reaction.235 Therefore, we decided to 
investigate the reaction using the more suitable nucleophile para-nitrobenzoic acid. Key for the 
successful transformation was to use Volante’s method,236 a modified Mitsunobu procedure, 
which involves mixing of PPh3 and DIAD first before adding the alcohol 4.9 and the acid to the 
reaction mixture at 0°C. After the mixture was warmed up to room temperature and stirred for 
35 minutes, heating in the microwave at 60°C for one hour led to formation of the ester 4.10 
with full inversion at C3 and 92 % yield over two steps (Scheme 4.4). Conditions used earlier 
for the tandem epoxidation and aldol reaction of enone 2.34 did not result in the transformation 
of enone 4.10 to its desired epoxy octalone. Fortunately, aldol cyclization of the ester 4.10 via 
an intermediate enamine upon reaction with pyrrolidine in the presence of AcOH furnished the 
doubly unsaturated octalone 4.11 in 61 % yield. There are only few literature reports on the 
epoxidation of g,d-unsaturated octalones, and unfortunately, the C1=C2 double bond could not 
be epoxidized by m-CPBA.237 However, we succeeded to form the epoxide of monocyclic 4.10. 
Epoxidation of electron-poor double bonds is usually conducted under basic conditions using a 
nucleophilic peroxide reagent. With the base-sensitive ester moiety at C3, a functional group 
necessary in the envisioned regioselective epoxide opening (4.12 g 4.13), we tried to find 
conditions avoiding hydrolysis of this ester. We were able to optimize the yield of the 
epoxidation reaction up to 82 % in favor of epoxy ketone 4.8 with an intact ester group on a 
small scale using Na2CO3 and H2O2 in an acetone/H2O mixture.238 However, we observed 
longer reaction times and decreased yields on a larger scale. After extensive screening, best 
                                               
235 D. L. Hughes, R. A. Reamer, J. Org. Chem. 1996, 61, 2967-2971. 
236 R. P. Volante, Tetrahedron Lett. 1981, 22, 3119-3122. 
237 B. W. Katona, C. L. Cummins, A. D. Ferguson, T. Li, D. R. Schmidt, D. J. Mangelsdorf, D. F. Covey, J. Med. 
Chem. 2007, 50, 6048-6058. 
238 S. Claessens, P. Habonimana, N. De Kimpe, Org. Biomol. Chem. 2010, 8, 3790-3795; N. R. Modugu, G. Mehta, 
Tetrahedron Lett. 2015, 56, 6030-6033. 
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results in terms of conversion to both epoxy ketones 4.8 and 4.14 were obtained by a reagent 
combination of triton B and H2O2 in THF at 0°C, which led to formation of the two compounds 
in a combined yield of 78 % (4.14/4.8 5:2). The secondary hydroxy group of hydrolyzed epoxy 
ketone 4.14 was acetylated using standard reaction conditions (Ac2O, Et3N, DMAP) to give the 
acetoxy epoxide 4.15 in 88 % yield. With the aim to minimize the use of protecting groups, we 
continued by cyclizing the B-ring of epoxy ketone 4.15 and envisioned epoxide opening at a 
later stage. Unfortunately, neighboring group-assisted hydrolysis231,239 on the octalone 
intermediate 4.12 resulted in formation of a complex mixture. 
 
Scheme 4.4. Inversion of the hydroxy group at C3 in 4.9 by a Mitsunobu reaction, construction 
of the B-ring and attempted hydrolysis of the epoxide in 4.12. 
Therefore, we designed an approach with the aim to first complete the substitution pattern 
on the A-ring using protecting groups for the hydroxy functions at C1 and C2. Regioselective 
epoxide opening was triggered by treatment of 4.15 with the Lewis acid BF3·OEt2 to form the 
desired triol 4.16 in 93 % yield (Scheme 4.5). Scaling up this reaction from 10 mg to >100 mg 
turned out to be problematic: the required reaction time was much longer (seven hours instead 
of two hours) and the yield dropped to 43 %.  
                                               
239 J. Aucktor, C. Anselmi, R. Brückner, M. Keller, Synlett 2014, 25, 1312-1318. 
OR
O
O
PPh3, DIAD, THF, 0°C
then mw, 60°C
COOHO2N
O
OR
O
O
4.10, R = p-NBz
92 % over 2 steps
Triton B, H2O2
THF, 0°C
O O
OR
O
OR
pyrrolidine, AcOH
CH2Cl2, rt
4.11, R = p-NBz
61 %
4.14, R = H, 56 %
4.8, R = p-NBz
      22 %
4.15, R = Ac, 88 %
Ac2O, DMAP
Et3N
CH2Cl2, rt
pyrrolidine, AcOH
CH2Cl2, rt
4.12, R = Ac
79 %
m-CPBA
CH2Cl2
0°C to rt
O OH
OH
OAc
4.13
O
F3B O
O
O
BF3·OEt2
toluene, 0°C
OR
O
O
2.34, R = TBS
4.9, R = H
HF (aq.)
MeCN, rt
TOTAL SYNTHESES OF GUIGNARDEREMOPHILANE C AND D 123 
 
 
Scheme 4.5: Regioselective hydrolysis of the epoxide in 4.15. 
With 4.16 in hand, the next challenge was to find appropriate protecting groups for the 
anti-diol at C1 and C2. Ideally, these protecting groups would be cleavable under identical 
reaction conditions with respect to the conditions needed for cleavage of the acetyl group. 
Another aspect was to strive for very mild deprotection conditions as to avoid isomerization of 
the isopropenyl group to be installed in subsequent steps of the synthesis. Being aware that the 
C2 hydroxy function in b-position to the carbonyl group was prone to elimination, we initially 
investigated the introduction of acetyl and benzoyl protecting groups on the anti-diol at C1/C2. 
However, elimination of acetic acid or benzoic acid was observed in both the protection and 
the following aldol cyclization steps.  
 
Scheme 4.6. Attempted strategies with acetyl and benzoyl protecting groups on the C1/C2 diol. 
Acetylation of 4.16 using Ac2O, Et3N and DMAP furnished a mixture of the desired fully 
acetylated triol 4.17 (44 %) and elimination product 4.18 (5:1). Benzoylation of 4.16 by BzCl, 
Et3N and DMAP gave only 22 % yield of the desired dibenzoylated product 4.19. For both 4.17 
and 4.19, cyclization using pyrrolidine and AcOH resulted in partial elimination of the C2 acetyl 
(3:1 mixture of 4.20 and 4.21) or C2 benzoyl (2:1 mixture of 4.22 and 4.23) groups, respectively 
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(Scheme 4.6). Unsatisfactory results were also obtained for the cyclization attempts using the 
unprotected diol 4.16, resulting in decomposition without formation of octalone 4.13. 
Only mono-protection at either the C1 or the C2 hydroxy group was observed in the 
reaction with TBSCl to form silyl ethers 4.24 and 4.25 (3:1) in a combined yield of 91 % 
(Scheme 4.7). Attempted removal of the acetyl group at C3 with the goal to install silicon-based 
protecting groups for all three hydroxy substituents only gave a complex mixture instead of 
unprotected triol 4.26. 
 
Scheme 4.7: TBS protection of C1/C2 diol and deprotection attempt for the C3–OAc group. 
The reagent TIPDSCl2, widely applied in carbohydrate chemistry for the protection of 
1,2- and 1,3-diols,240 was found suitable for our substrate, and the fully protected triol 4.27 was 
isolated in 69 % yield (Scheme 4.8). The following aldol condensation reaction with substrate 
4.27 via an enamine intermediate generated by reaction with pyrrolidine in the presence of 
AcOH was successful (see Scheme 4.4), and both conversion and yield were further improved 
by changing the solvent from CH2Cl2 to the more apolar toluene to form octalone 4.28 in 68 % 
yield. Despite the steric demand of the TIPDS group and the imparted increase in rigidity of the 
A-ring due to its fusion to an additional seven-membered silyloxy ring, intramolecular aldol 
addition to the ketone at C10 still took place. Studying the structure of the aldol addition 
intermediate 4.29 (Scheme 4.8), it is discernible that the bottom face of the A-ring is not overly 
shielded from the TIPDS group in pseudo-equatorial orientation. Upon elimination of water, 
we now had octalone 4.28 in hand and addressed the installation of the isopropenyl group for 
targeting the sesquiterpene skeleton. Similar procedures on octalones using a two-step 
procedure have already been described in literature:241 first, aldol addition to acetone gives the 
                                               
240 M. Lalonde, T. H. Chan, Synthesis 1985, 817-845; A. G. Myers, P. M. Harrington, E. Y. Kuo, J. Am. Chem. 
Soc. 1991, 113, 694-695. 
241 S. Torii, T. Inokuchi, K. Kawai, Bull. Chem. Soc. Jpn. 1979, 52, 861-866; T. Kitahara, H. Kurata, K. Mori; M. 
C. Witschel, H. J. Bestmann, Tetrahedron Lett. 1995, 36, 3325-3328; R. Riclea, J. S. Dickschat, Angew. Chem. 
Int. Ed. 2015, 54, 12167-12170. 
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tertiary alcohol, which is then dehydrated regioselectively using Burgess reagent.242 For the 
aldol step, we had to slightly modify the literature procedure and add the acetone to the enolate 
at –40°C, as previous experiments had shown no conversion and full recovery of starting 
material when the electrophile was added at –78°C. In case of our substrate, the seven-
membered ring of the TIPDS group influences the conformation of the A- and B-ring and might 
thus lower the reactivity of the enolate formed by deprotonation of 4.28. Upon modification of 
the known procedure, we isolated the desired tertiary alcohol 4.30 in an acceptable yield of 
67 % with full diastereoselectivity. 
 
Scheme 4.8. Construction of the B-ring and endgame in the synthesis of guignarderemophilanes 
C (4.1) and D (4.2). 
To complete the installation of the three-carbon side chain, regioselective elimination of 
water from 4.30 was achieved by treatment with Burgess reagent to give the isopropenylated 
octalone 4.31 as the desired elimination product in a modest yield of 54 %. Using triflic 
                                               
242 G. M. Atkins, E. M. Burgess, J. Am. Chem. Soc. 1968, 90, 4744-4745; P. Crabbe, C. Leon, J. Org. Chem. 1970, 
35, 2594-2596; D. B. Ushakov, V. Navickas, M. Ströbele, C. Maichle-Mössmer, F. Sasse, M. E. Maier, Org. 
Lett. 2011, 13, 2090-2093. 
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anhydride and DIPEA241c instead of the milder Burgess reagent resulted in the formation of a 
complex mixture. Having all substituents installed, the endgame of the synthesis was addressed 
by deprotection of both the TIPDS and acetyl groups. With a combination of CsF and ammonia 
in methanol at 50°C,243 all protecting groups were cleaved. However, formation of 
guignarderemophilane C (4.1) was not observed, as the alkaline reaction conditions turned out 
to effect isomerization of the C=C double bond of the isopropenyl group to provide 
guignarderemophilane D (4.2) instead. Therefore, in order to avoid isomerization and to give 
access to 4.1, a milder two-step procedure was developed. Compound 4.31 was treated with 
TBAF as fluoride anion source to cleave the TIPDS group and after work-up, the acetyl group 
was removed by reaction with ammonia in methanol at room temperature.  
 
Figure 4.3: Analytical (top, column: Synergi Hydro-RP 4 µm 80 Å, 150 mm x 4.6 mm; solvent 
A: H2O; solvent B: MeCN; flow = 1.0 mL/min; T = rt; UV detection at l = 222 nm; solvent 
system: isocratic, [B] = 18 %) and preparative RP-HPLC chromatograms of 
guignarderemophilanes C and D (bottom, column: Synergi Hydro-RP 10 µm 80 Å, 150 mm x 
10.0 mm; solvent A: H2O; solvent B: MeCN; flow = 4.6 mL/min; T = rt; UV detection at l = 222 
nm; solvent system: isocratic, [B] = 18 %.). 
                                               
243 J. R. McCarthy, D. P. Matthews, D. M. Stemerick, E. W. Huber, P. Bey, B. J. Lippert, R. D. Snyder, P. S. 
Sunkara, J. Am. Chem. Soc. 1991, 113, 7439-7440. 
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Both natural products were obtained after evaporation of the solvent and the ratio of the 
two natural product isomers slightly increased to 4.6:1 (4.1/4.2) in favor of 4.2 upon purification 
by flash column chromatography. A reasonable separation of the isomers was accomplished by 
reversed-phase HPLC resulting in pure guignarderemophilane C (4.1) and 
guignarderemophilane D (4.2, Figure 4.3). Optimized separation conditions on the analytical 
HPLC column Synergi Hydro-RP 4 µm 80 Å (150 mm x 4.6 mm) by an isocratic eluent of 18 % 
MeCN in water (flow = 1.0 mL/min, Rt = 18.6 min for 4.1 and 19.9 min for 4.2) were 
successfully reproduced on the semi-preparative column Synergi Hydro-RP 10 µm 80 Å 
(150 mm x 10.0 mm, flow = 4.5 mL/min, Rt = 18.0 min for 4.1 and 19.2 min for 4.2). 
Alternatively, guignarderemophilane D (4.2) was obtained from its isomer 4.1 by treatment 
with NaOMe in MeOH at 0°C in 70 % yield. 
 
 
Figure 4.4: 1H NMR spectra (in MeOD-d4) of natural (top) and synthetic (bottom) 
guignarderemophilane C (4.1).227 
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The NMR spectra (1H and 13C) of both the synthetic compounds were in agreement with 
those reported for the isolated natural products (Table 4.1 and Table 4.2),[9] but for the optical 
rotation values we observed substantial differences and opposite signs for both compounds: our 
measured optical rotation value for guignarderemophilane C was [𝛼𝛼]*%+ = +35° (c = 0.88, 
MeOH) and the reported value [𝛼𝛼]*%'= –175° (c = 0.01, MeOH). The values for guignard-
eremophilane D were [𝛼𝛼]*%+ = +38° (c = 0.70, MeOH) for the synthetic and [𝛼𝛼]*%' = –121° 
(c = 0.12, MeOH) for the isolated material, as reported in literature. In order to provide evidence 
for the identity of the isolated natural products and the synthetic material, we measured a CD 
spectrum of synthesized 4.1, which was in agreement with the one reported in literature (Figure 
4.5). 
Table 4.1: 1H and 13C NMR data of natural and synthetic guignarderemophilane C (4.1). 
 
position natural 4.1 
dH lit.a, b 
(600 MHz, MeOD-d4) 
synthetic 4.1 
dH this workb 
(500 MHz, MeOD-d4) 
natural 4.1 
dC lit.a 
(150 MHz, MeOD-d4) 
synthetic 4.1 
dC this work 
(126 MHz, MeOD-d4) 
1 4.47 (dd, 10.2, 1.8) 4.48 (dd, 10.4, 2.0) 70.1 70.1 
2 3.39 (dd, 10.2, 3.0) 3.38 (dd, 10.4, 3.3) 77.4 77.4 
3 3.85 (t, 3.0) 3.86 (t, 3.0) 75.6 75.6 
4 1.50 (m) 1.51 (qd, 7.1, 2.8) 45.8 45.8 
5   40.8 40.8 
6 1.99 (dd, 12.0, 4.8) 1.99 (dd, 13.0, 4.6) 44.3 44.4 
 1.88 (dd, 12.0, 9.0) 1.88 (t, 13.7)   
7 3.23 (dd, 15.0, 4.8) 3.24 (dd, 14.4, 4.6) 51.3 51.3 
8   201.8 201.7 
9 6.19 (d, 1.8) 6.20 (d, 2.0) 122.0 122.0 
10   172.6 172.6 
11   144.9 144.9 
12 4.93 (t, 1.8) 4.93 (t, 1.7) 114.7 114.7 
 4.81 (brs) 4.80–4.82 (m)   
13 1.69 (s) 1.70 (t, 1.0) 20.2 20.2 
14 1.13 (d, 6.6) 1.14 (d, 7.1) 11.8 11.8 
15 1.41 (s) 1.41 (s) 19.7 19.7 
a See reference 227 for published NMR spectroscopic data of natural 4.1. b coupling constants JH-H are given in 
parentheses (Hz). 
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Figure 4.5: Reported CD spectrum of isolated guignarderemophilane C (4.1) in MeOH (left)227 
and CD spectrum of synthetic 4.1 in MeOH (c = 0.2 mM, right). 
 
 
Figure 4.6: 1H NMR spectra (in MeOD-d4) of natural (top) and synthetic (bottom) 
guignarderemophilane D (4.2).227 
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Table 4.2: 1H and 13C NMR data of natural and synthesized guignarderemophilane D (4.2). 
 
position natural 4.2 
dH lit.a, b 
(600 MHz, MeOD-d4) 
synthetic 4.2 
dH this workb 
(500 MHz, MeOD-d4) 
natural 4.2 
dC lit.a 
(150 MHz, MeOD-
d4) 
synthetic 4.2 
dC this work 
(126 MHz, MeOD-d4) 
1 4.43 (dd, 10.3, 1.8) 4.43 (dd, 10.4, 2.2) 70.1 70.1 
2 3.39 (dd, 10.2, 3.6) 3.38 (dd, 10.3, 3.3) 77.6 77.6 
3 3.85 (t, 3.0) 3.86 (t, 2.9) 75.6 75.6 
4 1.56 (m) 1.55 (qd, 7.1, 2.7) 44.7 44.8 
5   43.0 43.1 
6 2.97 (d, 13.8) 2.98 (d, 13.6) 43.6 43.7 
 2.11 (d, 13.8) 2.12 (d, 14.3)   
7   145.6 145.5 
8   194.2 194.2 
9 6.19 (s) 6.19 (d, 2.2) 124.2 124.2 
10   171.2 171.3 
11   128.6 128.7 
12 2.07 (s) 2.08 (d, 2.1) 22.8 22.8 
13 1.88 (s) 1.89 (d, 1.4) 22.4 22.4 
14 1.16 (d, 6.0) 1.18 (d, 1.4) 12.1 12.1 
15 1.18 (s) 1.17 (s) 20.1 20.1 
a See reference 227 for published NMR spectroscopic data of natural 4.2. b coupling constants JH-H are given in 
parentheses (Hz). 
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4.3 Conclusion 
In conclusion, we present the first total syntheses of the polyoxygenated eremophilane-
type sesquiterpenes guignarderemophilane C (4.1) and D (4.2) by applying a concise route with 
the intermediacy of enone 2.34. Starting from g-hydroxy carvone (2.40), both syntheses have 
been achieved in 15 and 14 steps, respectively. Installation of the three hydroxy groups in the 
A-ring was identified as a key challenge, which was successfully tackled by applying a 
Mitsunobu inversion, epoxidation and regioselective hydrolysis of the epoxide with 
neighboring-group participation. The synthesis was successfully accomplished by establishing 
all stereogenic centers in the A-ring before the B-ring was constructed by aldol cyclization. 
Additionally, in the course of our synthetic endeavor, we observed a spontaneous aldol 
condensation under specific epoxidation reaction conditions. In order to find more potent neural 
anti-inflammatory active agents, derivatization of both the natural products and synthetic 
intermediates is envisioned. 
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5 CONCLUSION 
The present PhD thesis encompasses synthetic and biogenetic studies on eremophilane 
sesquiterpenoids, which culminated in the successful total syntheses of periconianone A and C, 
microsphaeropsisin B and C as well as guignarderemophilane C and D by a divergent approach.  
Synthetic investigations on periconianone A are presented in Chapter 2. Starting from 
known g-hydroxy carvone, the total synthesis of this complex tricarbocyclic sesquiterpenoid 
was achieved in 15 linear steps. Key transformations on the way to periconianone A are a 
Criegee fragmentation, a Rh-mediated O–H insertion followed by spontaneous Claisen reaction 
and a-ketol rearrangement, and a biomimetic late-stage aldol cyclization to construct the 
tricarbocyclic framework. 
 
The discovery that bicyclic a-allylated a-hydroxyketones in the eremophilane skeleton 
can undergo 1,2-shifts led to the biogenetic hypothesis presented in Chapter 3. Based on the 
structural similarities of microsphaeropsisin B and periconianone C, both isolated from 
endophytic fungi, a novel proposal on the biosynthesis of C8–C11-connected 
furanoeremophilanes was elaborated. To provide evidence by organic synthesis, an 
enantioselective synthesis of microsphaeropsisin B and C starting from the a-allylated a-
hydroxyketone intermediate in the periconianone A synthesis was investigated first. Having 
successfully synthesized microsphaeropsisin B and C, suitable reaction conditions for the 
rearrangement of these two natural products into their regioisomers periconianone C and 4-epi-
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periconianone C were devised. The obtained findings provide strong experimental evidence for 
the biogenetic hypothesis of microsphaeropsisin B being a biosynthetic precursor of 
periconianone C, and hint at the occurrence of other eremophilane-type terpenoids bearing a 
C8–C11 linkage. 
Finally, in Chapter 4 the total syntheses of the polyoxygenated eremophilane-type 
sesquiterpenes guignarderemophilane C and D starting from a diketone intermediate of the 
periconianone A synthesis are presented. The main challenge in this synthetic endeavor was the 
installation of the three contiguous hydroxy groups in the A-ring, which was finally met by a 
route comprising a Mitsunobu inversion, epoxidation and regioselective epoxide opening. With 
specific epoxidation conditions, we observed spontaneous aldol condensation, which directly 
led to formation of the octalone core. Altogether, key to the successful synthesis of 
guignarderemophilane C and D was the installation of all stereogenic centers on the A-ring 
before the B-ring was closed by an intramolecular aldol addition.  
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6 EXPERIMENTAL PART  
6.1 General Methods and Materials 
All chemicals have been purchased from Acros, Alfa Aesar, Fluorochem or Sigma-Aldrich and 
were used without further purification (except for Et3N, which was freshly distilled before use). 
All reactions have been carried out in flame-dried glassware (unless aqueous reagents were 
used) and reactions involving air sensitive compounds have been performed under an argon or 
nitrogen atmosphere. Solvents applied for chemical transformations were either anhydrous 
quality or HPLC grade solvents, which have been dried by filtration through activated 
aluminum oxide under nitrogen (H2O content <10 ppm, Karl-Fischer titration). For work-up 
and purification, solvents have been distilled from technical grade. All synthetic 
transformations have been monitored by either thin layer chromatography (TLC) or 1H NMR 
spectroscopy. Yields refer to purified, dried and spectroscopically pure compounds. TLC was 
performed on Merck silica gel 60 F254 plates (0.25 mm thickness) pre-coated with a fluorescent 
indicator. Concentration under reduced pressure was performed by rotary evaporation at 40°C 
or by lyophilization. Flash chromatography was performed using silica gel 60 (230-400 mesh) 
from SiliCycle or Sigma-Aldrich with a forced flow eluent at 0.1–0.3 bar pressure. HPLC was 
performed by using an Agilent 1100 series instrument equipped with reversed-phase columns 
for analytical separation or semi-preparative separation; or by using a modular Shimadzu HPLC 
instrument (CBM-20A system controller, SPD-20A UV/Vis detector, LC-20A solvent delivery 
unit, SIL-20A auto-sampler, CTO-20A column oven, and DGU-20A online degassing unit) 
equipped with reversed-phase columns for analytical separation, semi-preparative separation or 
preparative separation. All 1H and 13C NMR spectra were recorded using a Bruker 250 MHz, 
400 MHz or 500 MHz (1H) & 63 MHz, 101 MHz or 126 MHz (13C) spectrometer at room 
temperature (unless otherwise stated). Chemical shifts (δ-values) are reported in ppm, spectra 
were calibrated relative to the residual proton chemical shifts (CHCl3, δ = 7.26; DMSO-d5, δ = 
2.50; MeOD-d3, δ = 3.31) and carbon chemical shifts (CDCl3, δ = 77.16; DMSO-d6, δ = 39.52; 
MeOD-d4, δ = 49.00) of the solvents; multiplicity is reported as follows: s = singlet, d = doublet, 
t = triplet, q = quartet, m = multiplet or unresolved and coupling constant J is given in Hz. IR 
spectra were recorded on a Varian 800 FT-IR ATR Spectrophotometer or a Perkin Elmer 
SpectrumTwo ATR-FTIR. The absorptions are reported in cm−1. All HRMS-ESI mass spectra 
were recorded by the Mass Spectrometric Service of the University of Basel on a QTOF-ESI 
spectrometer (Bruker maXis 4G) or the Mass Spectrometric Service of the University of Zurich 
on a QExactive instrument (Thermo Fisher Scientific, Bremen, Germany) equipped with a 
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heated electrospray (ESI) ionization source and connected to a Dionex Ultimate 3000 UHPLC 
system. HRMS-EI mass spectra were measured by the Mass Spectrometric Service of the 
University of Zurich on a Thermo DFS (ThermoFisher Scientific, Bremen, Germany) double-
focusing magnetic sector mass spectrometer (geometry BE): mass spectra were measured in 
electron impact (EI) mode at 70 eV, with solid probe inlet, source temperature of 200°C, 
acceleration voltage of 5 kV, and resolution of 2’500. Melting points (M.p.) were determined 
using a Büchi B-545 apparatus in open capillaries and are uncorrected. Optical rotations °[𝛼𝛼]*-  
were measured at the sodium D line using a 1 mL cell with 1 dm path length, or a 0.2 mL cell 
with 0.1 dm path length on a Jasco P-2000 digital polarimeter and the concentration c is given 
in g/100 mL CHCl3 or MeOH. CD spectra were acquired on a JASCO J-810 spectrometer. X-
ray analyses performed at the University of Basel: Data collections for both crystal structures 
were performed at low temperature (123 K) using Mo Ka radiation on a Bruker KappaAPEX 
diffractometer. Integration of the frames and data reduction was carried out using APEX2.244 
The structures were solved by direct methods using SIR92.245 All non-hydrogen atoms were 
refined using anisotropically by full-matrix least squares on F using CRYSTALS.246 Hydrogen 
atoms were placed in calculated positions by means of the “riding” model. X-ray analyses 
performed at the University of Zurich: The single crystal X-ray measurements at the University 
of Zurich were made on a Rigaku Oxford Diffraction SuperNova area-detector diffractometer 
using Cu Ka radiation (λ = 1.54184 Å) from a micro-focus X-ray source and an Oxford 
Instruments Cryojet XL cooler. 
6.2 Abbreviations, Acronyms and Symbols  
°C ................................................................................................................. degree centigrade 
Å ............................................................................................................................... ångström 
Ac ...................................................................................................................................acetyl 
AIBN ..................................................................................................... azobisisobutyronitrile 
aq. ............................................................................................................................... aqueous 
atm ......................................................................................................................... atmosphere 
BINOL ........................................................................................................ 1,1’-bi-2-naphthol 
Bn ................................................................................................................................. benzyl 
Bu .................................................................................................................................... butyl 
                                               
244 Bruker Analytical X-ray Systems Inc., 2006, Apex2, Version 2 User Manual, M86-E01078,Madison, WI. 
245 A. Altomare, G. Cascarano, C. Giacovazzo, A. Guagliardi, M. C. Burla, G. Polidori, M. Camalli, J. Appl. Cryst. 
1994, 27, 435-436. 
246 P. W. Betteridge, J. R. Carruthers, R. I. Cooper, K. Prout, D. J. Watkin, J. Appl. Cryst. 2003, 36, 1487. 
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Bz ................................................................................................................................benzoyl 
cat. ............................................................................................................................... catalyst 
cm ........................................................................................................................... centimeter 
CD ............................................................................................................... circular dichroism 
CPBA ............................................................................................... chloroperoxybenzoic acid 
Cy ........................................................................................................................... cyclohexyl 
δ ............................................................................................................... NMR chemical shift 
d ................................................................................................................................... doublet 
d ........................................................................................................................................ deci 
DBU.................................................................................. 1,8-diazabicyclo(5.4.0)undec-7-ene 
DDQ .................................................................... 2,3-dichloro-5,6-dicyano-1,4-benzoquinone 
DHF ..................................................................................................................... dihydrofuran 
DHP .................................................................................................................... dihydropyran 
DIAD .......................................................................................... diisopropyl azodicarboxylate 
DIBAL ..................................................................................................... diisobutylaluminium 
DIPEA ......................................................................................... N,N’-diisopropylethylamine 
DMAP .............................................................................................. 4-dimethylaminopyridine 
DMAPP ........................................................................................... dimethylallyl diphosphate 
DMF ......................................................................................................... dimethylformamide 
DMP ................................................................................................. Dess-Martin periodinane 
DMPU ......................................................................................... N,N’-dimethylpropyleneurea 
DMSO ......................................................................................................... dimethyl sulfoxide 
dr .............................................................................................................. diastereomeric ratio 
ECD ............................................................................................ electronic circular dichroism 
ee .............................................................................................................. enantiomeric excess 
EI ................................................................................................................ electron ionization 
ESI ........................................................................................................electrospray ionization 
Et ..................................................................................................................................... ethyl 
equiv. ....................................................................................................................... equivalent 
FPP ...................................................................................................... farnesyl pyrophosphate 
FT ................................................................................................................ Fourier transform 
g ....................................................................................................................................... gram 
h ........................................................................................................................................ hour 
HMDS ...................................................................................................... hexamethyldisilazan 
HMPA ............................................................................................ hexamethylphosphoramide 
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HPLC ....................................................................... high-performance liquid chromatography 
HRMS .................................................................................high-resolution mass spectrometry 
Hz .................................................................................................................................... hertz 
IBX ........................................................................................................ 2-iodoxybenzoic acid 
IPP ..................................................................................................... isopentenyl diphosphate 
IR .................................................................................................................................infrared 
J .......................................................................................................... NMR coupling constant 
L .................................................................................................................................... ligand 
L ....................................................................................................................................... liter 
LDA .................................................................................................. lithium diisopropylamide 
LTMP .........................................................................................lithium tetramethylpiperidide 
µ ..................................................................................................................................... micro 
m ................................................................................................................................ multiplet 
m ...................................................................................................................................... milli 
m ..................................................................................................................................... meter 
M ....................................................................................................................... molar, mol L-1 
M .................................................................................................................................... mega 
M.p. .................................................................................................................... melting point 
Me................................................................................................................................. methyl 
min ................................................................................................................................ minute 
MOM ...............................................................................................................methoxymethyl 
MPO ............................................................................................. p-methoxypyridine N-oxide 
Ms ...................................................................................................................................mesyl 
MS .............................................................................................................. mass spectrometry 
MS .................................................................................................................. molecular sieve 
MVK ......................................................................................................... methyl vinyl ketone 
mw .......................................................................................................................... microwave 
n ....................................................................................................................................... nano 
NBS ........................................................................................................ N-bromosuccinimide 
NMR ........................................................................ nuclear magnetic resonance spectroscopy 
NOESY ....................................................................... nuclear Overhauser effect spectroscopy 
o.n. ............................................................................................................................ overnight 
ORD................................................................................................ optical rotatory dispersion 
QTOF ................................................................................................quadrupole time-of-flight 
PCC ...............................................................................................pyridinium chlorochromate 
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PDC ..................................................................................................... pyridinium dichromate 
Ph .................................................................................................................................. phenyl 
PMB.............................................................................................................. p-methoxybenzyl 
ppm ................................................................................................................ parts per million 
PPTS ......................................................................................... pyridinium p-toluenesulfonate 
Pr ................................................................................................................................... propyl 
q .................................................................................................................................... quartet 
Rf ...................................................................................................................... retention factor 
RP ..................................................................................................................... reversed phase 
Rt ........................................................................................................................ retention time 
rt .................................................................................................................. room temperature 
s .................................................................................................................................... singlet 
S.................................................................................................................................... solvent 
SAR ........................................................................................... structure–activity relationship 
sat. ............................................................................................................................. saturated 
SEM ......................................................................................... 2-(trimethylsilyl)ethoxymethyl 
SM .................................................................................................................. starting material 
t .......................................................................................................................................triplet 
TBA ........................................................................................................ tetrabutylammonium 
TBD .................................................................................. 1,5,7-triazabicyclo[4.4.0]dec-5-ene 
TBHP ................................................................................................. tert-butyl hydroperoxide 
TBS ....................................................................................................... tert-butyldimethylsilyl 
TES ........................................................................................................................ triethylsilyl 
Tf .................................................................................................................................... triflic 
TFA ............................................................................................................trifluoroacetic acid 
THF ................................................................................................................. tetrahydrofuran 
THP ................................................................................................................ tetrahydropyran 
TIPDS .................................................................................................tetraisopropyldisiloxane 
TLC ................................................................................................ thin layer chromatography 
TMS .................................................................................................................... trimethylsilyl 
Ts ..................................................................................................................................... tosyl 
UHPLC ............................................................ ultra high-performance liquid chromatography 
UV ........................................................................................................................... ultraviolet 
ν/ ........................................................................................................................... wavenumber 
WMK ............................................................................................... Wieland-Miescher ketone 
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6.3 Total Synthesis of Periconianone A 
 
(7R,8aR)-7-Allyl-8a-methyl-1,3,4,7,8,8a-hexahydro-6H-spiro[naphthalene-2,2'-[1,3]di-
oxolan]-6-one (2.17): To a cooled (–78°C) solution of diisopropylamine (102 µL, 0.720 mmol, 
1.6 equiv.) in THF (3.0 mL) was added n-BuLi (1.6 M in THF, 422 µL, 0.675 mmol, 1.5 equiv.) 
dropwise via syringe. The resulting solution was stirred for 40 min at this temperature, before 
a solution of 5R-2.11 (100 mg, 0.450 mmol, 1.0 equiv.) in THF (0.5 mL) was added. The 
mixture was stirred at –78°C for 30 min and then DMPU (61 µL, 0.495 mmol, 1.1 equiv.) and 
allyl bromide (0.16 mL, 1.80 mmol, 4.0 equiv.) were added dropwise. After stirring at –78°C 
was continued for 20 min, the mixture was allowed to warm up to rt o.n. The mixture was 
quenched by addition of sat. aq. NH4Cl solution and diluted with H2O and Et2O. The layers 
were separated and the aqueous layer was extracted with Et2O (2 x). The combined organic 
layers were washed with brine, dried over Na2SO4, filtered and concentrated. The residue was 
purified by flash column chromatography (pentane/Et2O 3:1) to give 2.17 (87 mg, 0.332 mmol, 
74 %) as a white slurry. 
TLC: Rf = 0.6 (SiO2, pentane/Et2O 1:1). FTIR (neat): ν/ = 2920, 2360, 1709, 1666, 1434, 1362, 
1291, 1238, 1187, 1106, 1066, 1030, 1008, 916, 878 cm−1. 1H NMR (400 MHz, CDCl3) δ = 
5.83 – 5.71 (m, 1H), 5.76 (d, J = 1.2, 1H), 5.05 (d, J = 10.7, 1H), 5.05 – 4.98 (m, 1H), 4.06 – 
3.97 (m, 2H), 3.96 – 3.87 (m, 2H), 2.76 – 2.69 (m, 1H), 2.66 (ddd, J = 14.7, 5.0, 1.8, 1H), 2.48 
(ddt, J = 13.0, 8.5, 4.3, 1H), 2.30 (ddd, J = 14.8, 4.6, 2.6, 1H), 2.07 (dt, J = 15.4, 8.0, 1H), 1.91 
(ddt, J = 13.1, 5.3, 2.8, 1H), 1.84 (dd, J = 12.8, 4.2, 1H), 1.80 (dd, J = 12.7, 2.1, 1H), 1.70 – 
1.61 (m, 1H), 1.61 – 1.51 (m, 2H), 1.38 (s, 3H). 13C NMR (101 MHz, CDCl3) δ = 200.3, 167.3, 
136.4, 124.5, 116.8, 108.1, 64.9, 63.9, 48.2, 44.4, 41.4, 37.3, 35.2, 33.6, 30.3, 23.6. HRMS 
(ESI) Exact mass calculated for C16H23O3+ [M+H]+: 263.1642, found: 263.1639; for 
C16H22NaO3+ [M+Na]+: 285.1461, found: 285.1458. 
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(7R,8aR)-7-Allyl-8a-methyl-1,3,4,7,8,8a-hexahydronaphthalene-2,6-dione (2.18): To a 
solution of 2.17 (250 mg, 0.953 mmol, 1.0 equiv.) in acetone (10.0 mL) was added p-TsOH 
(181 mg, 0.953 mmol, 1.0 equiv.) and the solution was stirred at rt for 4 h. The mixture was 
diluted with H2O and Et2O, and the layers were separated. The aqueous layer was extracted 
with Et2O (2 x) and the combined organic layers were dried over Na2SO4, filtered and 
concentrated. The residue was purified by flash column chromatography (pentane/Et2O 3:2) to 
give 2.18 (174 mg, 0.797 mmol, 84 %) as a colorless solid. 
TLC: Rf = 0.50 (SiO2, pentane/Et2O 1:2); 0.32 (SiO2, pentane/Et2O 1:1). FTIR (neat): ν/ = 2966, 
2917, 2865, 1707, 1664, 1434, 1360, 1290, 1253, 1188, 1081, 1029, 1006, 953, 915, 880, 771 
cm−1. 1H NMR (400 MHz, CDCl3) δ = 5.91 (s, 1H), 5.82 – 5.70 (m, 1H), 5.10 – 5.05 (m, 1H), 
5.05 – 5.02 (m, 1H), 2.86 – 2.75 (m, 1H), 2.75 – 2.67 (m, 2H), 2.56 – 2.50 (m, 2H), 2.50 – 2.43 
(m, 1H), 2.38 (s, 2H), 2.12 (dtd, J = 14.4, 8.0, 1.2, 1H), 1.91 (dd, J = 13.4, 4.7, 1H), 1.72 (t, J 
= 13.7, 1H), 1.26 (s, 3H). 13C NMR (101 MHz, CDCl3) δ = 208.3, 199.5, 163.3, 135.9, 125.6, 
117.3, 54.6, 43.3, 41.6, 40.1, 40.0, 33.5, 31.4, 24.0. HRMS (ESI) Exact mass calculated for 
C14H19O2+ [M+H]+: 219.1380, found: 219.1378; for C14H18NaO2+ [M+Na]+: 241.1199, found: 
241.1196. 
 
 
(7R,8aR)-7-Allyl-8a-methyl-1,7,8,8a-tetrahydronaphthalene-2,6-dione (2.19): IBX 
(405 mg, 1.37 mmol, 3.0 equiv.) and MPO·H2O (172 mg, 1.37 mmol, 3.0 equiv.) were 
dissolved in DMSO (2.5 mL) under stirring for 30 min at 45°C. The mixture was then charged 
with 2.18 (100 mg, 0.458 mmol, 1.0 equiv.) and stirring was continued for 2 d at 45°C. The 
turbid reaction mixture was quenched by addition of sat. aq. NaHCO3 solution and diluted with 
H2O. The obtained solution was extracted with Et2O (3 x) and the combined organic layers were 
washed with sat. aq. NaHCO3 solution and H2O, dried over Na2SO4, filtered and evaporated to 
give a 1:1 mixture of desired product 2.19 and SM 2.18 (1H NMR, total 65 mg crude). The 
residue was subjected to flash column chromatography (pentane/Et2O 2:1) to give 2.19 
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(22.6 mg, 0.104 mmol, 23 %) as a yellow oil and recovered SM 2.18 (18.6 mg, 85 µmol, 19 %) 
as colorless needles. 
TLC: Rf = 0.65 (SiO2, pentane/Et2O 1:2). 1H NMR (400 MHz, CDCl3) δ = 7.04 (d, J = 9.9, 
1H), 6.18 (d, J = 9.8, 1H), 6.05 (s, 1H), 5.81 – 5.68 (m, 1H), 5.11 – 5.06 (m, 1H), 5.06 – 5.03 
(m, 1H), 2.77 – 2.69 (m, 1H), 2.57 (ddt, J = 13.0, 8.6, 4.4, 1H), 2.47 (s, 2H), 2.18 (dtt, J = 14.3, 
7.9, 1.1, 1H), 1.95 (dd, J = 13.3, 4.8, 1H), 1.78 (t, J = 13.6, 1H), 1.32 (s, 3H). 13C NMR 
(101 MHz, CDCl3) δ = 199.8, 197.9, 157.1, 143.2, 135.6, 132.0, 129.1, 117.5, 51.7, 42.1, 41.8, 
37.1, 33.7, 24.6. HRMS (ESI) Exact mass calculated for C14H16NaO2+ [M+Na]+: 239.1043, 
found: 239.1039. 
 
 
(((3S,5S)-2,3-Dimethyl-5-(prop-1-en-2-yl)cyclohex-1-en-1-yl)oxy)trimethylsilane (2.24): 
LiCl (28 mg, 0.67 mmol, 0.2 equiv.) was flame-dried in vacuo. CuI (63 mg, 0.33 mmol, 
0.1 equiv.) and dry THF (10 mL) were added. The mixture was stirred until a clear green 
solution was formed and then cooled to 0°C. S-Carvone (500 mg, 3.33 mmol, 1.0 equiv.) and 
TMSCl (0.47 mL, 3.66 mmol, 1.1 equiv.) were added sequentially to form a yellow solution. 
After 10 min, a solution of MeMgBr (3 M in Et2O, 1.33 mL, 4.00 mmol, 1.2 equiv.) was added 
dropwise and the formed suspension was stirred for 30 min at 0°C. The reaction mixture was 
quenched by addition of sat. aq. NH4Cl solution and extracted with Et2O (3 x). The combined 
organic layers were dried over Na2SO4, filtered and concentrated. The residue was purified by 
flash column chromatography (pentane, 1 % Et3N) to give 2.24 (537 mg, 2.25 mmol, 68 %, dr 
>10:1) as a colorless oil. Analytical data of 2.24 is in accordance to reference 75. 
 
 
(4aR,5R,6R)-6-Bromo-4a,5-dimethyl-4,4a,5,6-tetrahydronaphthalen-2(3H)-one (3R-2.31) 
and (4aR,5R,6S)-6-bromo-4a,5-dimethyl-4,4a,5,6-tetrahydronaphthalen-2(3H)-one (3S-
2.31): A solution of diene dione 2.23 (50 mg, 0.284 mmol, 1.0 equiv.), NBS (76 mg, 
O TMSOLiCl, CuI, MeMgBr, TMSCl
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0.426 mmol, 1.5 equiv.) and AIBN (4.7 mg, 0.028 mmol, 0.1 equiv.) in CCl4 (3.0 mL) was 
heated at 80°C for 18 h. The mixture was allowed to cool to rt, before pentane was added to 
precipitate the succinimide. The obtained suspension was filtered through a short pad of Celite 
and the filtrate was concentrated. The residue was subjected to flash column chromatography 
(pentane/Et2O 2:1) to give brominated octalone 2.31 (36.8 mg, 0.284 mmol, 51 %, dr 1:1) as a 
yellow oil. 
TLC: Rf = 0.59 and 0.63 (SiO2, pentane/Et2O 1:2). 1H NMR (400 MHz, CDCl3, signals are 
marked with a or b corresponding to their diastereoisomers) δ = 6.36a (dd, J = 9.6, 5.0, 1H), 6.35 
– 6.31b (m, 1H), 6.24a (dd, J = 9.7, 0.8, 1H), 6.12b (dd, J = 9.8, 2.0, 1H), 5.79b (s, 1H), 5.78a 
(s, 1H), 4.88a (t, J = 4.9, 1H), 4.62b (dt, J = 10.1, 2.2, 1H), 2.65b (dd, J = 14.4, 5.5, 1H), 2.60a 
(dd, J = 14.4, 5.5, 1H), 2.55 – 2.42a+b (m, 2H), 2.14 – 1.98a+b (m, 2H), 1.91 – 1.64a+b (m, 4H), 
1.29a (s, 3H), 1.22b (d, J = 6.8, 3H), 1.22a (d, J = 6.8, 3H), 1.10b (s, 3H). 
 
 
(4S,5R)-4-((tert-Butyldimethylsilyl)oxy)-2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one 
(2.35): To a solution of 4S,5R-4-hydroxy carvone (2.40, 5.54 g, 33.3 mmol, 1.0 equiv.), 
imidazole (6.80 g, 99.9 mmol, 3.0 equiv.) and DMAP (1.02 g, 8.33 mmol, 0.25 equiv.) in dry 
CH2Cl2 (140 mL) was added TBSCl (10.0 g, 66.6 mmol, 2.0 equiv.), and the reaction mixture 
was stirred for 3 h at rt. The reaction was quenched with sat. aq. NH4Cl solution and the layers 
were separated. The aqueous layer was extracted with CH2Cl2 (3 x) and the combined organic 
layers were washed with H2O, dried over Na2SO4, filtered and concentrated. The residue was 
purified by flash column chromatography (pentane/Et2O 10:1) to give 2.35 (6.12 g, 21.9 mmol, 
66 %) as a yellowish oil.  
TLC: Rf = 0.60 (SiO2, pentane/Et2O 6:1). Optical rotation: [𝛼𝛼]*%( = +148.6° (c = 0.56, CHCl3). 
FTIR (neat): ν/ = 2955, 2930, 2893, 2858, 2362, 2340, 1682, 1470, 1362, 1254, 1083, 865, 837, 
776 cm−1. 1H NMR (400 MHz, CDCl3) δ = 6.53 (dq, J = 2.8, 1.5 Hz, 1H), 4.89 (p, J = 1.6 
Hz,1H), 4.87 – 4.83 (m, 1H), 4.40 (dp, J = 9.1, 2.0 Hz, 1H), 2.72 (ddd, J = 13.2, 9.1, 4.5 Hz, 
1H), 2.48 (dd, J = 16.2, 4.5 Hz, 1H), 2.40 (dd, J = 16.2, 12.8 Hz, 1H), 1.78 (dd, J = 1.7 Hz, 
3H), 1.73 (dd, J = 1.5, 0.8 Hz, 3H), 0.90 (s, 9H), 0.11 (s, 3H), 0.06 (s, 3H). 13C NMR 
(101 MHz, CDCl3) δ = 199.2, 148.9, 143.8, 134.8, 114.0, 70.5, 52.5, 41.4, 25.9 (3C), 20.5, 18.2, 
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15.6, -4.2, -4.6. HRMS (ESI) Exact mass calculated for C16H28NaO2Si+ [M+Na]+: 303.1745, 
found: 303.1751. 
 
 
tert-Butyl(((1S,2R,6R)-2,3-dimethyl-6-(prop-1-en-2-yl)-4-((trimethylsilyl)oxy)cyclohex-3-
en-1-yl)oxy)dimethylsilane (2.36): LiCl (185 mg, 4.36 mmol, 0.2 equiv.) was flame-dried in 
vacuo. CuI (415 mg, 2.18 mmol, 0.1 equiv.) and dry THF (135 mL) were added. The mixture 
was stirred until a clear green solution was formed and then cooled to –40°C. 2.35 (6.12 g, 
21.8 mmol, 1.0 equiv.) in dry THF (30 mL) and TMSCl (3.04 mL, 24.0 mmol, 1.1 equiv.) were 
added sequentially to form a yellow solution. After 10 min, a solution of MeMgBr (3 M in Et2O, 
8.72 mL, 26.2 mmol, 1.2 equiv.) was added dropwise and the formed suspension was stirred 
for 30 min at –40°C. The reaction mixture was then quenched by addition of sat. aq. NH4Cl 
solution and extracted with Et2O (3 x). The combined organic layers were dried over Na2SO4, 
filtered and concentrated to give 2.36 (8.0 g, 21.7 mmol, quant., dr >10:1) as a yellow oil. 
TLC: Rf = 0.99 (SiO2, pentane/Et2O 6:1), 0.80 (Al2O3, pentane). 1H NMR (400 MHz, CDCl3) 
δ = 4.82 – 4.78 (m, 2H), 3.46 (dd, J = 9.5, 6.6 Hz, 1H), 2.40 (td, J = 9.8, 5.4 Hz, 1H), 2.20 – 
2.11 (m, 1H), 2.11 – 1.98 (m, 2H), 1.72 (t, J = 1.1 Hz, 3H), 1.53 – 1.51 (m, 3H), 1.07 (d, J = 
6.9 Hz, 3H), 0.86 (s, 9H), 0.16 (s, 9H), 0.07 (s, 3H), 0.04 (s, 3H). 13C NMR (101 MHz, CDCl3) 
δ = 146.4, 141.6, 113.9, 112.6, 77.6, 49.2, 43.5, 34.6, 26.2 (3C), 21.2, 18.6, 18.2, 14.0, 0.8 
(3C), -3.2, -3.6. 
 
 
(2R,3R,4S,5R)-4-((tert-Butyldimethylsilyl)oxy)-2,3-dimethyl-2-(3-oxobutyl)-5-(prop-1-en-
2-yl)cyclohexan-1-one (2.38): A solution of 2.36 (16.6 g, 45.0 mmol, 1.0 equiv.) in dry CH2Cl2 
(210 mL) was cooled to –78°C. MeNO2 (7.3 mL, 3.0 equiv.), i-PrOH (10.3 mL, 3.0 equiv.) and 
MVK (7.3 mL, 90.0 mmol, 2.0 equiv.) were added sequentially. After stirring the reaction 
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mixture for 5 min, BF3·Et2O (6.84 mL, 54.0 mmol, 1.2 equiv.) was added dropwise and the 
mixture was allowed to warm to –65°C. After 3.5 h at this temperature, additional BF3·Et2O 
(0.57 mL, 0.1 equiv.) was added, stirred o.n. and the reaction mixture was then quenched by 
addition of sat. aq. NaHCO3 solution. The mixture was extracted with CH2Cl2 (3 x) and the 
combined organic layers were washed with brine, dried over Na2SO4, filtered and concentrated. 
The residue was purified by flash column chromatography (pentane/Et2O 3:1) to give 2.38 
(10.9 g, 29.8 mmol, 66 %, dr >10:1) as a colorless solid. Desilylated starting material 2.41 
(4.26 g, 14.35 mmol, 32 %) was obtained as a yellow oil. 
M.p. = 77.7 – 79.8°C. TLC: Rf = 0.38 (SiO2, pentane/Et2O 3:1). Optical rotation: [𝛼𝛼]*%( = 
+22.8° (c = 0.63, CHCl3). FTIR (neat): ν/ = 2957, 2932, 2893, 2857, 2362, 2340, 1712, 1649, 
1463, 1435, 1363, 1255, 1164, 1075, 886, 836, 775, 680 cm−1. 1H NMR (500 MHz, CDCl3) δ 
= 4.85 – 4.82 (m, 2H), 3.75 (t, J = 9.2 Hz, 1H), 2.59 (dd, J = 14.3, 12.8 Hz, 1H), 2.49 – 2.39 
(m, 2H), 2.34 – 2.25 (m, 2H), 2.14 (s, 3H), 1.95 (ddd, J = 14.3, 11.2, 4.6 Hz, 1H), 1.76 – 1.69 
(m, 1H), 1.71 (dd, J = 1.5, 0.9 Hz, 3H), 1.65 – 1.58 (m, 1H), 1.05 (s, 3H), 0.98 (d, J = 6.9 Hz, 
3H), 0.88 (s, 9H), 0.06 (s, 3H), 0.02 (s, 3H). 13C NMR (101 MHz, CDCl3) δ = 213.8, 208.9, 
144.6, 114.3, 73.9, 52.8, 50.3, 44.5, 41.6, 38.8, 30.1, 29.4, 26.3 (3C), 20.5, 20.3, 18.5, 
12.7, -3.0, -3.4. HRMS (ESI) Exact mass calculated for C21H38NaO3Si+ [M+Na]+: 389.2482, 
found: 389.2483. 
 
 
tert-Butyl(((1S,2R,6R)-2,3-dimethyl-6-(prop-1-en-2-yl)-4-((trimethylsilyl)oxy)cyclohex-3-
en-1-yl)oxy)dimethylsilane (2.36): Ketone 2.41 (9.04 g, 30.5 mmol, 1.0 equiv.) in MeCN 
(200 mL) was added to a solution of NaI (18.3 g, 122 mmol, 4.0 equiv.), TMSCl (11.7 mL, 
91.5 mmol, 3.0 equiv.) and HMDS (25.9 mL, 122 mmol, 4.0 equiv.) in MeCN (20 mL) at rt. 
The mixture was stirred for 2 h before it was quenched by addition of sat. aq. NH4Cl solution 
(pH < 7) and extracted with Et2O (3 x). The combined organic layers were dried over Na2SO4, 
filtered and evaporated. The residue was filtered through a short plug of silica (pentane/Et2O 
20:1) to give 2.36 (9.43 g, 25.6 mmol, 84 %) as a colorless oil. 
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(4aR,5R,6S,7R)-6-((tert-Butyldimethylsilyl)oxy)-4a,5-dimethyl-7-(prop-1-en-2-yl)-
4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one (2.42): To a solution of 2.38 (300 mg, 
0.818 mmol, 1.0 equiv.) in MeOH (3.0 mL) was added a solution of NaOMe (0.5 M in MeOH, 
1.96 mL, 0.982 mmol, 1.2 equiv.) and the mixture was stirred for 20 h at rt to form an orange 
solution. H2O was added and the mixture was extracted with Et2O (3 x). The combined organic 
layers were washed with H2O, dried over Na2SO4, filtered and concentrated. The residue was 
purified by flash column chromatography (pentane/Et2O 4:1) to give 2.42 (238 mg, 
0.683 mmol, 84 %) as a yellowish oil. 
M.p. = 79.9 – 80.8°C. TLC: Rf = 0.50 (SiO2, pentane/Et2O 2:1). Optical rotation: [𝛼𝛼]*%& = 
+49.0° (c = 0.90, CHCl3). FTIR (neat): ν/ = 2930, 2896, 2855, 1671, 1469, 1429, 1360, 1251, 
1188, 1120, 1075, 1020, 953, 888, 834, 774, 707, 672 cm−1. 1H NMR (500 MHz, CDCl3) δ = 
5.75 (d, J = 1.5 Hz, 1H), 4.85 (q, J = 1.2 Hz, 2H), 3.56 (t, J = 9.7 Hz, 1H), 2.52 – 2.44 (m, 1H), 
2.40 (ddd, J = 16.9, 13.8, 4.9 Hz, 1H), 2.34 (dddd, J = 16.9, 5.3, 3.4 Hz, 0.9 Hz, 1H), 2.25 – 
2.16 (m, 2H), 2.04 (ddd, J = 13.5, 5.0, 3.4 Hz, 1H), 1.73 (t, J = 1.1 Hz, 3H), 1.76 – 1.69 (m, 
1H), 1.45 – 1.37 (m, 1H), 1.14 (s, 3H), 1.01 (d, J = 6.8 Hz, 3H), 0.87 (s, 9H), 0.05 (s, 3H), 0.01 
(s, 3H). 13C NMR (101 MHz, CDCl3) δ = 199.5, 169.1, 145.5, 124.1, 114.0, 74.4, 54.1, 50.3, 
39.4, 37.4, 36.1, 33.6, 26.4 (3C), 20.8, 18.6, 17.6, 12.0, -2.8, -3.3. HRMS (ESI) Exact mass 
calculated for C21H36NaO2Si+ [M+Na]+: 371.2377, found: 371.2381. 
 
 
(4R,5R,6R)-4-((tert-Butyldimethylsilyl)oxy)-5,6-dimethyl-6-(3-oxobutyl)cyclohex-2-en-1-
one (2.34): A solution of 2.38 (250 mg, 0.686 mmol, 1.0 equiv.) and Sudan III (spatula tip) in 
CH2Cl2/MeOH (6.0 mL, 1:2) was cooled to –78°C and O3 was bubbled through the solution 
until the red color disappeared. The solution was purged with N2 for 5 min and the mixture was 
warmed to –20°C. Cu(OAc)2·H2O (272 mg, 1.36 mmol, 2.0 equiv.) was added, followed by 
FeSO4·7H2O (228 mg, 0.818 mmol, 1.2 equiv.) after 30 min. The mixture was stirred for 1 h 
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and then allowed to slowly warm to rt o.n. Aq. HCl solution (0.1 M) was added and the mixture 
was stirred for 30 min before the layers were separated. The aqueous layer was extracted with 
CH2Cl2 (3 x) and the combined organic layers were dried over Na2SO4, filtered and 
concentrated. The residue was purified by flash column chromatography (pentane/Et2O 3:1) to 
give 2.34 (148 mg, 0.456 mmol, 67 %) as a colorless solid.  
M.p. = 79.9 – 83.8°C. TLC: Rf = 0.62 (SiO2, pentane/Et2O 1:1). Optical rotation: [𝛼𝛼]*%( =  
–102.7° (c = 0.51, CHCl3). FTIR (neat): ν/ = 2933, 2897, 2857, 1716, 1668, 1463, 1413, 1367, 
1293, 1250, 1200, 1168, 1070, 1006, 940, 873, 841, 778, 719, 691, 659 cm−1. 1H NMR (400 
MHz, CDCl3) δ = 6.70 (dd, J = 10.3, 1.9 Hz, 1H), 5.86 (dd, J = 10.3, 2.1 Hz, 1H), 4.18 (dt, J 
= 9.1, 2.0 Hz, 1H), 2.37 – 2.20 (m, 2H), 2.21 – 2.07 (m, 1H), 2.12 (s, 3H), 2.04 – 1.93 (m, 1H), 
1.65 – 1.56 (m, 1H), 1.01 (s, 3H), 1.00 (d, J = 6.8 Hz, 3H), 0.93 (s, 9H), 0.14 (s, 3H), 0.12 (s, 
3H). 13C NMR (101 MHz, CDCl3) δ = 208.6, 203.3, 151.5, 127.4, 71.2, 48.5, 42.9, 38.5, 30.0, 
28.7, 25.9 (3C), 19.4, 18.2, 11.3, -4.1, -4.6. HRMS (ESI) Exact mass calculated for C18H33O3Si+ 
[M+H]+: 325.2193, found: 325.2193; for C18H32NaO3Si+ [M+Na]+: 347.2013, found: 347.2014. 
 
 
(4aR,5R,6R)-6-((tert-Butyldimethylsilyl)oxy)-4a,5-dimethyl-4,4a,5,6-tetrahydronaphthal-
en-2(3H)-one (2.53): A mixture of 2.34 (20.0 mg, 62 µmol, 1.0 equiv.), pyrrolidine (6.1 µL, 
74 µmol, 1.2 equiv.) and AcOH (4.2 µL, 74 µmol, 1.2 equiv.) in CH2Cl2 (1.0 mL) was stirred 
for 22 h at rt. After 22 h aq. HCl (1.0 M) and Et2O were added and the layers were separated. 
The aqueous layer was extracted with Et2O (2 x) and the combined organic layers were dried 
over Na2SO4, filtered and concentrated. The residue was subjected to flash column 
chromatography (pentane/Et2O 3:1) to give 2.53 (16.6 mg, 54 µmol, 88 %) as colorless crystals. 
or 
 
A solution of 2.42 (50 mg, 0.143 mmol, 1.0 equiv.) and Sudan III (spatula tip) in 
CH2Cl2/MeOH (3.0 mL, 5:1) was cooled to –78°C and O3 was bubbled through the solution 
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until the red color disappeared. The mixture was purged with O2 and Ar and allowed to warm 
up to –20°C. Cu(OAc)2·H2O (57.1 mg, 0.286 mmol, 2.0 equiv.) was added, followed by 
FeSO4·7H2O (47.7 mg, 0.172 mmol, 1.2 equiv.) after 20 min. The suspension was stirred at –
20°C for 3 h, then slowly warmed up to rt and stirred o.n. H2O was added and the layers were 
separated. The aqueous layer was extracted with CH2Cl2 (3 x) and the combined organic layers 
were washed with sat. aq. NaHCO3 solution, brine and H2O, dried over Na2SO4, filtered and 
concentrated. The residue was subjected to flash column chromatography (pentane/Et2O 3:1) 
to give 2.53 (15.8 mg, 0.052 mmol, 36 %) as colorless solid. 
M.p. = 46.5 – 47.4°C. TLC: Rf = 0.50 (SiO2, pentane/Et2O 2:1). Optical rotation: [𝛼𝛼]*%( = 
+35.5° (c = 0.39, CHCl3). FTIR (neat): ν/ = 2953, 2857, 2361, 1668, 1464, 1353, 1257, 1131, 
1080, 1022, 943, 878, 836, 776, 668 cm−1. 1H NMR (400 MHz, CDCl3) δ = 6.10 (dd, J = 10.0, 
1.6 Hz, 1H), 6.06 (dd, J = 10.0, 1.5 Hz, 1H), 5.73 (s, 1H), 4.08 (d, J = 9.4 Hz, 1H), 2.54 (ddd, 
J = 17.9, 14.5, 5.3 Hz, 1H), 2.41 (dddd, J = 17.9, 5.2, 2.2, 1.0 Hz, 1H), 2.03 (ddd, J = 13.2, 
5.4, 2.3 Hz, 1H), 1.75 (td, J = 13.9, 5.2 Hz, 1H), 1.61 (dq, J = 9.4, 6.8 Hz, 1H), 1.09 (s, 3H), 
1.03 (d, J = 6.8 Hz, 3H), 0.92 (s, 9H), 0.13 (s, 3H), 0.12 (s, 3H). 13C NMR (101 MHz, CDCl3) 
δ = 199.5, 162.4, 141.2, 127.8, 124.5, 71.8, 47.3, 37.4, 34.0, 33.4, 26.0 (3C), 18.2, 16.4, 
10.7, -3.9, -4.5. HRMS (ESI) Exact mass calculated for C18H31O2Si+ [M+H]+: 307.2088, found: 
307.2083; for C18H30NaO2Si+ [M+Na]+: 329.1907, found: 329.1902. 
 
 
(4aS,5R,6R)-6-((tert-Butyldimethylsilyl)oxy)-3-hydroxy-4a,5-dimethyl-5,6-dihydro-
naphthalen-2(4aH)-one (2.54): To a solution of 2.53 (16.6 mg, 54 µmol, 1.0 equiv.) and 18-
crown-6 (21.5 mg, 81 µmol, 1.5 equiv.) in toluene (1.0 mL) at –60°C (dry-ice/acetone bath) 
was added t-BuOK (15.2 mg, 0.135 mmol, 2.5 equiv.). O2 was bubbled through the reaction 
mixture for 2 min and the orange solution was allowed to stir under an O2 atmosphere (1 atm) 
for further 30 min. After TLC showed full consumption of the starting materials, the mixture 
was quenched by addition of aq. HCl solution (0.1 M, pH = 5) and extracted with Et2O (3 x). 
The combined organic layers were dried over Na2SO4, filtered and concentrated. The residue 
was purified by flash column chromatography (pentane/Et2O 3:1) to give diosphenol 2.54 
(9.0 mg, 28 µmol, 52 %) as a colorless solid. 
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M.p. = 91.2 – 95.4°C. TLC: Rf = 0.66 (SiO2, pentane/Et2O 1:1). Optical rotation: [𝛼𝛼]*%( = –
88.2° (c = 0.45, CHCl3). FTIR (neat): ν/ =3383, 2955, 2931, 2857, 1642, 1258, 1228, 1197, 
1062, 892, 867, 837, 776 cm−1. 1H NMR (400 MHz, CDCl3) δ = 6.40 (s, 1H), 6.33 (dd, J = 
10.0, 1.8, 1H), 6.33 (s, 1H), 6.22 (d, J = 0.7, 1H), 6.08 (dd, J = 10.0, 2.3, 1H), 4.07 – 3.99 (m, 
1H), 1.65 (dq, J = 9.1, 6.7, 1H), 1.22 (d, J = 6.8, 3H), 1.11 (s, 3H), 0.91 (s, 9H), 0.13 (s, 3H), 
0.13 (s, 3H). 13C NMR (101 MHz, CDCl3) δ = 181.2, 164.6, 146.9, 139.6, 127.4, 121.9, 121.6, 
71.8, 46.1, 43.3, 25.9 (3C), 21.6, 18.1, 12.0, -3.8, -4.4. HRMS (ESI) Exact mass calculated for 
C18H28NaO3Si+ [M+Na]+: 343.1700, found: 343.1701. 
 
 
(4aS,5R,6R)-3,6-Dihydroxy-4a,5-dimethyl-5,6-dihydronaphthalen-2(4aH)-one (2.55): To 
a solution of 2.54 (7.0 mg, 22 µmol, 1.0 equiv.) in MeCN (0.5 mL) was added a solution of HF 
(48 % in H2O, 9 µL, 0.218 mmol, 10.0 equiv.). The mixture was stirred for 3 h and then 
quenched by addition of sat. aq. NaHCO3 solution. The mixture was extracted with Et2O (3 x) 
and the combined organic layers were washed with H2O, dried over Na2SO4, filtered and 
concentrated. The residue was subjected to flash column chromatography (pentane/Et2O 1:2) 
to give 2.55 (4.5 mg, 22 µmol, quant.) as a yellowish solid. 
M.p. = 114.5 – 115.9°C. TLC: Rf = 0.57 (SiO2, Et2O). Optical rotation: [𝛼𝛼]*%( = –13.6° (c = 
0.37, CHCl3). FTIR (neat): ν/ = 3366, 2976, 1619, 1426, 1304, 1218, 1029, 892 cm−1. 1H NMR 
(400 MHz, CDCl3) δ = 6.41 (s, 1H), 6.39 (dd, J = 10.0, 2.2, 1H), 6.33 (s, 1H), 6.24 (d, J = 0.7, 
1H), 6.20 (dd, J = 9.9, 2.3, 1H), 4.03 (d, J = 9.3, 1H), 1.61 (brs, 1H), 1.57 – 1.53 (m, 1H), 1.31 
(d, J = 6.7, 3H), 1.12 (s, 3H). 13C NMR (101 MHz, CDCl3) δ = 181.2, 164.2, 147.0, 138.6, 
128.2, 122.0, 121.7, 71.3, 46.5, 43.2, 21.5, 11.8. HRMS (ESI) Exact mass calculated for 
C12H14NaO3+ [M+Na]+: 229.0835, found: 229.0836. 
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(4aR,5R,6R)-6-Hydroxy-4a,5-dimethyl-4,4a,5,6-tetrahydronaphthalen-2(3H)-one (2.56): 
To a solution of 2.53 (78.1 mg, 0.255 mmol, 1.0 equiv.) in MeCN (3.0 mL) was added a 
solution of HF (48 % in H2O, 54 µL, 1.28 mmol, 5.0 equiv.) at rt. The mixture was stirred for 
5 h and then quenched by addition of sat. aq. NaHCO3 solution. The mixture was extracted with 
Et2O (3 x) and the combined organic layers were washed with H2O, dried over Na2SO4, filtered 
and concentrated. The residue was subjected to flash column chromatography (pentane/Et2O 
1:1 to 100 % Et2O) to give 2.56 (36.2 mg, 0.188 mmol, 74 %) as a colorless oil. 
TLC: Rf = 0.46 (SiO2, Et2O). Optical rotation: [𝛼𝛼]*%( = +181.2° (c = 0.52, CHCl3). FTIR 
(neat): ν/ = 3400, 2971, 2881, 1648, 1622, 1585, 1445, 1416, 1356, 1318, 1272, 1233, 1203, 
1130, 1034, 1001, 948, 883, 756, 640, 577, 530 cm−1. 1H NMR (500 MHz, CDCl3) δ = 6.18 
(dd, J = 10.0, 1.5, 1H), 6.15 (dd, J = 9.9, 1.5, 1H), 5.76 (s, 1H), 4.08 (d, J = 9.8, 1H), 2.54 
(ddd, J = 17.9, 14.6, 5.4, 1H), 2.43 (dddd, J = 18.0, 5.2, 2.3, 1.0, 1H), 2.05 (ddd, J = 13.3, 5.4, 
2.3, 1H), 1.77 (td, J = 13.9, 5.1, 1H), 1.54 (dq, J = 9.6, 6.8, 1H), 1.12 (d, J = 6.8, 3H), 1.10 (s, 
3H). 13C NMR (126 MHz, CDCl3) δ = 199.5, 162.0, 140.1, 128.5, 124.9, 71.4, 47.7, 37.5, 33.9, 
33.3, 16.3, 10.4. HRMS (ESI) Exact mass calculated for C12H17O2+ [M+H]+: 193.12231, found: 
193.12258. 
 
 
(1R,8aR)-1,8a-Dimethyl-1,7,8,8a-tetrahydronaphthalene-2,6-dione (2.57): NaHCO3 
(546 mg, 6.50 mmol, 5.0 equiv.) and DMP (827 mg, 1.95 mmol, 1.5 equiv.) were added 
sequentially to a solution of 2.56 (250 mg, 1.30 mmol, 1.0 equiv.) in CH2Cl2 (30 mL) at 0°C. 
The mixture was stirred at this temperature for 1 h, before sat. aq. Na2S2O3 solution was added 
and the layers were separated. The aqueous layer was extracted with CH2Cl2 (3 x) and the 
combined organic layers were washed with sat. aq. NaHCO3 solution, H2O, dried over Na2SO4, 
filtered and concentrated. The residue was purified by flash column chromatography (pentane/ 
Et2O 1:1) to give 2.57 (212 mg, 1.11 mmol, 86 %) as a yellowish solid. 
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M.p. = 105.7 – 107.3°C. TLC: Rf = 0.19 (SiO2, pentane/Et2O 1:1). Optical rotation: [𝛼𝛼]*%& = 
+256.1° (c = 0.45, CHCl3). FTIR (neat): ν/ = 2971. 2947, 2874, 1656, 1570, 1451, 1417, 1355, 
1328, 1267, 1231, 1206, 1139, 1103, 1065, 1025, 947, 885, 833, 784, 757, 724, 654 cm−1. 
1H NMR (500 MHz, CDCl3) δ = 7.00 (d, J = 9.8, 1H), 6.23 (d, J = 9.9, 1H), 6.05 (d, J = 0.9, 
1H), 2.58 (q, J = 6.8, 1H), 2.56 – 2.51 (m, 2H), 2.16 – 2.09 (m, 1H), 2.00 (td, J = 12.8, 7.3, 
1H), 1.16 (s, 3H), 1.15 (d, J = 6.8, 3H). 13C NMR (126 MHz, CDCl3) δ = 200.0, 198.8, 159.5, 
142.4, 132.3, 129.2, 52.2, 40.0, 34.5, 33.5, 18.3, 7.1. HRMS (ESI) Exact mass calculated for 
C12H15O2+ [M+H]+: 191.10666, found: 191.10685. 
 
 
(4aS,5R,6S,7R)-6-((tert-Butyldimethylsilyl)oxy)-3-hydroxy-4a,5-dimethyl-7-(prop-1-en-2-
yl)-5,6,7,8-tetrahydronaphthalen-2(4aH)-one (2.58): To a solution of 2.42 (49.8 mg, 
0.143 mmol, 1.0 equiv.) and 18-crown-6 (56.7 mg, 0.214 mmol, 1.5 equiv.) in toluene (5.0 mL) 
at –28°C (dry-ice/acetone bath) was added t-BuOK (64.2 mg, 0.572 mmol, 4.0 equiv.). The 
solution turned orange and O2 was bubbled through the reaction mixture for 15 min. The yellow 
solution was then allowed to stir under an O2 atmosphere (1 atm) for further 15 min. After TLC 
showed full consumption of the starting materials, the mixture was quenched by addition of aq. 
HCl solution (0.1 M, pH = 5) and extracted with Et2O (3 x). The combined organic layers were 
washed with sat. aq. NaHCO3 solution, H2O, dried over Na2SO4, filtered and concentrated. The 
residue was purified by flash column chromatography (pentane/Et2O 3:1) to give 2.58 (42.0 mg, 
0.116 mmol, 81 %) as a yellowish oil. 
TLC: Rf = 0.72 (SiO2, pentane/Et2O 1:1). Optical rotation: [𝛼𝛼]*%& = –55.0° (c = 1.34, CHCl3). 
FTIR (neat): ν/ = 3379, 2953, 2631, 1645, 1431, 1384, 1229, 1073, 886, 835, 774, 679 cm−1. 
1H NMR (400 MHz, CDCl3) δ = 6.31 (s, 1H), 6.27 (s, 1H), 6.18 (d, J = 1.4 Hz, 1H), 4.88 (s, 
2H), 3.62 (t, J = 9.7 Hz, 1H), 2.59 (td, J = 13.6, 1.5 Hz, 1H), 2.32 (dd, J = 13.5, 4.3 Hz, 1H), 
2.21 (ddd, J = 13.9, 9.9, 4.3 Hz, 1H), 1.75 (s, 3H), 1.45 (dq, J = 9.5, 6.8 Hz, 1H), 1.19 (s, 3H), 
1.18 (d, J = 6.7 Hz, 3H), 0.84 (s, 9H), 0.05 (s, 3H), 0.00 (s, 3H). 13C NMR (101 MHz, CDCl3) 
δ = 181.6, 170.5, 146.3, 145.2, 123.5, 121.4, 114.3, 74.1, 55.5, 48.6, 44.2, 37.2, 26.3 (3C), 20.5, 
20.0, 18.6, 13.6, -2.7, -3.4. HRMS (ESI) Exact mass calculated for C21H34NaO3Si+ [M+Na]+: 
385.2169, found: 385.2170. 
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(4aS,5R,6S,7R)-3,6-Dihydroxy-4a,5-dimethyl-7-(prop-1-en-2-yl)-5,6,7,8-tetrahydro-
naphthalen-2(4aH)-one (2.59): To a solution of 2.58 (8.7 mg, 24 µmol, 1.0 equiv.) in MeCN 
(0.5 mL) was added a solution of HF (48 % in H2O, 10 µL, 0.24 mmol, 10 equiv.). The mixture 
was stirred for 4 h at rt and then quenched by addition of sat. aq. NaHCO3 solution. The mixture 
was extracted with Et2O (3 x) and the combined organic layers were washed with H2O, dried 
over Na2SO4, filtered and concentrated. The residue was subjected to flash column 
chromatography (pentane/Et2O 1:1) to give 2.59 (5.0 mg, 20 µmol, 84 %) as a colorless oil. 
TLC: Rf = 0.27 (SiO2, pentane/Et2O 1:1). 1H NMR (400 MHz, CDCl3) δ = 6.31 (s, 1H), 6.30 
(s, 1H), 6.22 (d, J = 1.3, 1H), 5.01 (p, J = 1.7, 1H), 4.94 (dd, J = 1.7, 0.9, 1H), 3.51 (td, J = 
10.0, 2.3, 1H), 2.60 (td, J = 13.4, 1.5, 1H), 2.39 (dd, J = 13.4, 4.2, 1H), 2.16 (ddd, J = 13.9, 
10.2, 4.2, 1H), 1.79 (s, 3H), 1.76 (d, J = 2.7, 1H), 1.51 – 1.39 (m, 1H), 1.27 (d, J = 6.7, 3H), 
1.21 (s, 3H). 13C NMR (101 MHz, CDCl3) δ = 181.6, 169.7, 146.3, 144.6, 123.4, 122.2, 115.0, 
70.9, 55.6, 47.1, 44.1, 36.0, 20.0, 18.8, 12.4. HRMS (ESI) Exact mass calculated for 
C15H20NaO3+ [M+Na]+: 271.1305, found: 271.1305. 
 
 
(4aS,5R,6R)-3,6-bis((tert-Butyldimethylsilyl)oxy)-4a,5-dimethyl-5,6-dihydronaphthalen-
2(4aH)-one (2.60): To a solution of 2.54 (10.0 mg, 31 µmol, 1.0 equiv.) in CH2Cl2 (0.6 mL) 
was added imidazole (8.5 mg, 0.125 mmol, 4.0 equiv.) and TBSCl (9.4 mg, 62 µmol, 
2.0 equiv.) and the mixture was stirred for 2 h at rt, before it was poured into H2O and diluted 
with CH2Cl2. The layers were separated and the aqueous layer was extracted with CH2Cl2 (3 x). 
The combined organic layers were dried over Na2SO4, filtered and concentrated. The crude 
1H NMR spectra showed clean conversion and the residue was subjected to flash column 
chromatography (pentane/Et2O 10:1) to give 2.60 (6.1 mg, 14 µmol, 45 %) as a colorless oil. 
1H NMR (400 MHz, CDCl3) δ = 6.30 (s, 1H), 6.28 (d, J = 8.7, 1H), 6.09 (s, 1H), 6.01 (d, J = 
10.0, 1H), 4.02 (dd, J = 9.1, 2.5, 1H), 1.70 – 1.61 (m, 1H), 1.19 (d, J = 6.7, 3H), 1.10 (s, 3H), 
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0.96 (s, 9H), 0.91 (s, 9H), 0.20 (s, 3H), 0.16 (s, 3H), 0.13 (s, 3H), 0.13 (s, 3H). 13C NMR (101 
MHz, CDCl3) δ = 182.5, 160.8, 148.1, 138.4, 131.5, 127.3, 124.2, 71.9, 45.7, 43.3, 25.9 (3C), 
25.9 (3C), 21.4, 18.7, 18.2, 11.9, -3.8, -4.3, -4.4, -4.5. 
 
 
(4aR,5S,7S)-7-Isopropyl-4a,5-dimethyl-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one 
(2.61): Wilkinsons's catalyst (10.6 mg, 11.5 µmol, 2.5 mol%) was added to a solution of the 
octalone 2.25 (100 mg, 0.458 mmol, 1.0 equiv.) in benzene (2.0 ml) under an H2 atmosphere 
(1 atm) and the mixture was stirred at rt o.n. Reaction control by TLC showed remaining 
starting material and additional Wilkinson’s catalyst (10.6 mg, 11.5 µmol, 2.5 mol%) was 
added. After stirring was continued for 4 h, the mixture was concentrated. The obtained residue 
was purified by flash column chromatography (pentane/Et2O 3:1) to give the isopropylated 
compound 2.61 (93.7 mg, 0.425 mmol, 93 %) as pale orange crystals. 
M.p. = 69 – 72°C. TLC: Rf = 0.57 (SiO2, pentane/Et2O 1:1). Optical rotation: [𝛼𝛼]*%( = +122.5° 
(c = 0.56, CHCl3). FTIR (neat): ν/ = 2960, 2874, 2362, 1674, 1616, 1460, 1232, 952, 857. 
1H NMR (400 MHz, CDCl3) δ = 5.74 (s, 1H), 2.49 – 2.30 (m, 4H), 2.04 (ddd, J = 13.4, 5.1, 
3.0, 1H), 1.77 – 1.46 (m, 5H), 1.45 – 1.37 (m, 1H), 1.12 (s, 3H), 0.90 – 0.84 (m, 9H). 13C NMR 
(101 MHz, CDCl3) δ = 199.6, 170.6, 125.7, 41.8, 39.0, 37.4, 36.4, 35.9, 34.2, 33.0, 27.3, 21.2, 
20.8, 16.5, 15.5. HRMS (ESI) Exact mass calculated for C15H25O+ [M+H]+: 221.1900, found: 
221.1900. 
 
 
(4aS,5S,7S)-3-Hydroxy-7-isopropyl-4a,5-dimethyl-5,6,7,8-tetrahydronaphthalen-2(4aH)-
one (2.62): To a solution of the isopropylated enone 2.61 (200 mg, 0.908 mmol, 1.0 equiv.) and 
18-crown-6 (360 mg, 1.36 mmol, 1.5 equiv.) in toluene (10 mL) at –60°C (dry-ice/acetone 
bath) was added t-BuOK (204 mg, 1.82 mmol, 2.0 equiv.) to form a yellow solution. O2 was 
O O(PPh3)3RhCl, H2
benzene, rt
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bubbled through this solution for 3 min, before it was allowed to stir under an O2 atmosphere 
(1 atm) at –55°C for 1.5 h. The mixture was acidified to pH = 1 by addition of aqueous HCl 
(0.1 M), stirred for further 30 min and extracted with Et2O (3 x). The combined organic layers 
were washed with H2O, dried over Na2SO4, filtered and concentrated. The residue was 
subjected to flash column chromatography (pentane/Et2O 3:1) to give the diosphenol 2.62 
(163 mg, 0.696 mmol, 77 %) as a brownish solid. 
M.p. = 68 – 70°C. TLC: Rf = 0.70 (SiO2, pentane/Et2O 1:1). Optical rotation: [𝛼𝛼]*%( = –75.9° 
(c = 0.10, CHCl3). FTIR (neat): ν/ = 3380, 2963, 2965, 2871, 2362, 1632, 1459, 1417, 1373, 
1302, 1203, 909, 875, 618 cm−1. 1H NMR (400 MHz, CDCl3) δ = 6.33 (s, 1H), 6.32 (s, 1H), 
6.18 (s, 1H), 2.54 – 2.50 (m, 2H), 1.70 – 1.64 (m, 1H), 1.64 – 1.48 (m, 3H), 1.44 – 1.34 (m, 
1H), 1.14 (s, 3H), 1.02 (d, J = 6.3, 3H), 0.89 (d, J = 6.5, 3H), 0.81 (d, J = 6.6, 3H). 13C NMR 
(101 MHz, CDCl3) δ = 181.6, 171.3, 146.4, 124.5, 123.0, 44.5, 43.8, 37.2, 35.7, 32.3, 26.4, 
21.2, 20.8, 18.7, 16.5. HRMS (ESI) Exact mass calculated for C15H23O2+ [M+H]+: 235.1691, 
found: 235.1693. 
 
 
(4aS,5S,7S)-3-((tert-Butyldimethylsilyl)oxy)-7-isopropyl-4a,5-dimethyl-5,6,7,8-tetra-
hydronaphthalen-2(4aH)-one (2.64): To a solution of diosphenol 2.62 (105 mg, 0.448 mmol, 
1.0 equiv.) and imidazole (122 mg, 1.79 mmol, 4.0 equiv.) in CH2Cl2 (5.0 ml) was added 
TBSCl (135 mg, 0.896 mmol, 2.0 equiv.) and the mixture was stirred for 2.5 h at rt. The 
reaction mixture was poured into H2O and the layers were separated. The aqueous layer was 
extracted with CH2Cl2 and the combined organic layers were washed with brine, dried over 
Na2SO4, filtered and concentrated. The residue was purified by flash column chromatography 
(pentane/Et2O 10:1) to give the TBS protected diosphenol 2.64 (128 mg, 0.368 mmol, 82 %) as 
a colorless solid. 
M.p. = 50 – 53°C. TLC: Rf = 0.81 (SiO2, pentane/Et2O 5:1). Optical rotation: [𝛼𝛼]*%( = –46.4° 
(c = 0.57, CHCl3). FTIR (neat): ν/ = 2956, 2930, 2894, 2858, 2362, 1664, 1612, 1461, 1250, 
1195, 871, 838, 783 cm−1. 1H NMR (400 MHz, CDCl3) δ = 6.29 (s, 1H), 6.04 (t, J = 1.0, 1H), 
2.49 – 2.45 (m, 2H), 1.70 – 1.47 (m, 4H), 1.42 (dtd, J = 12.8, 6.4, 4.1, 1H), 1.13 (s, 3H), 1.00 
(d, J = 6.3, 3H), 0.96 (s, 9H), 0.89 (d, J = 6.4, 3H), 0.82 (d, J = 6.5, 3H), 0.19 (s, 3H), 0.18 (s, 
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3H). 13C NMR (101 MHz, CDCl3) δ = 182.8, 166.7, 147.5, 133.9, 125.6, 44.5, 43.5, 36.9, 35.0, 
32.4, 26.3, 25.9 (3C), 21.3, 20.8, 18.7, 18.6, 16.4, -4.3, -4.4. HRMS (ESI) Exact mass 
calculated for C21H37O2Si+ [M+H]+: 349.2559, found: 349.2557. 
 
 
(6S,8S)-6-Isopropyl-4,8-dimethyl-5,6,7,8-tetrahydronaphthalene-1,2-diol (2.63): To a 
solution of 2.64 (20 mg, 57 µmol, 1.0 equiv.) in toluene (2.0 ml) was added p-TsOH·H2O 
(2.2 mg, 12 µmol, 0.2 equiv.) and the mixture was stirred at 80°C for 3 h. Almost no conversion 
was monitored by TLC (pentane/Et2O 5:1) and the mixture was heated to 100°C o.n. Additional 
p-TsOH·H2O (8.7 mg, 46 µmol, 0.8 equiv.) was added and the mixture was diluted with Et2O 
and quenched by addition of sat. aq. NaHCO3 solution after 2.5 h at 100°C. The layers were 
separated and the aqueous layer was extracted with Et2O (2 x). The combined organic layers 
were washed with H2O, dried over Na2SO4, filtered and concentrated. The residue was 
subjected to flash column chromatography (pentane/Et2O 4:1) to give 2.63 (9.1 mg, 39 µmol, 
68 %) as a colorless oil. 
TLC: Rf = 0.17 (SiO2, pentane/Et2O 5:1). Optical rotation: [𝛼𝛼]*%0 = –22.7° (c = 0.46, CHCl3). 
FTIR (neat): ν/ = 3437, 2957, 2930, 2872, 1816, 1468, 1385, 1289, 1176, 919 cm−1. 1H NMR 
(500 MHz, CDCl3) δ = 6.57 (s, 1H), 4.98 (s, 1H), 4.78 (s, 1H), 3.20 (p, J = 6.6, 6.0, 1H), 2.64 
(ddd, J = 16.8, 5.2, 2.0, 1H), 2.12 (s, 3H), 2.15 – 2.06 (m, 1H), 1.76 – 1.70 (m, 1H), 1.70 – 1.63 
(m, 1H), 1.63 – 1.56 (m, 1H), 1.44 (td, J = 12.5, 5.3, 1H), 1.26 (d, J = 7.0, 3H), 1.02 – 0.95 (m, 
6H). 13C NMR (126 MHz, CDCl3) δ = 140.2, 139.4, 129.4, 128.3, 128.2, 114.6, 34.5, 33.0, 
32.8, 30.8, 28.3, 20.9, 19.9, 19.8, 19.3. MS (EI) Mass calculated for C15H22O2 [M]+: 234.16, 
found: 234.22. 
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(6S,8S)-6-Isopropyl-4,8-dimethyl-5,6,7,8-tetrahydronaphthalen-2-ol (2.66): To a stirred 
solution of 2.64 (10 mg, 29 µmol, 1.0 equiv.) and CeCl3·7H2O (10.7 mg, 29 µmol, 1.0 equiv.) 
in MeOH (1.0 mL) at 0 °C was added NaBH4 (2.2 mg, 57 µmol, 2.0 equiv.). The mixture was 
allowed to warm up to rt and stirred for 2 h. Aqueous HCl (1 M) was added and the mixture was 
extracted with Et2O (3 x). The combined organic layers were washed with brine, dried over 
NaSO4, filtered and concentrated. The residue was subjected to flash column chromatography 
(pentane/Et2O 4:1) to give 2.66 (2.4 mg, 11 µmol, 38 %) as a colorless solid. 
TLC: Rf = 0.47 (SiO2, pentane/Et2O 3:1). 1H NMR (500 MHz, CDCl3) δ = 6.50 (d, J = 2.8, 
1H), 6.48 (d, J = 2.7, 1H), 4.39 (s, 1H), 2.95 (dddd, J = 13.0, 7.2, 4.8, 2.3, 1H), 2.62 (ddd, J = 
16.5, 5.0, 1.8, 1H), 2.18 (s, 3H), 2.12 (dd, J = 16.5, 10.6, 1H), 1.67 – 1.62 (m, 2H), 1.62 – 1.57 
(m, 1H), 1.55 – 1.48 (m, 1H), 1.24 (d, J = 7.2, 3H), 0.97 (t, J = 6.4, 6H). 13C NMR (126 MHZ, 
CDCl3, DEPT 135/HMBC) δ = 152.8, 143.7, 138.0, 127.5, 114.5, 112.6, 35.2, 33.2, 33.0, 32.4, 
30.6, 24.0, 19.8 (2C), 19.8. MS (EI) Mass calculated for C15H22O [M]+: 218.17, found: 218.22. 
 
 
(2R,3R,4R)-4-((tert-Butyldimethylsilyl)oxy)-2,3-dimethyl-2-(3-oxobutyl)cyclohexan-1-one 
(6.1): A mixture of 2.34 (200 mg, 0.616 mmol, 1.0 equiv.) and 5 % Pd/C (32.8 mg, 2.5 mol%) 
in EtOAc (10 mL) was stirred under an H2 atmosphere (1 atm) for 2 h. The mixture was then 
filtered through a short pad of Celite (rinsed with Et2O) and the solvent was removed under 
reduced pressure to give 6.1 (202 mg, 0.616 mmol, quant.) as a colorless oil. 
TLC: Rf = 0.74 (SiO2, pentane/Et2O 1:1). Optical rotation: [𝛼𝛼]*%( = –4.9° (c = 0.40, CHCl3). 
FTIR (neat): ν/ = 2932, 2888, 2858, 1708, 1463, 1430, 1361, 1292, 1254, 1099, 1070, 988, 954, 
884, 835, 775, 661, 629 cm−1. 1H NMR (400 MHz, CDCl3) δ = 3.79 (ddd, J = 9.0, 4.2 Hz, 1H), 
2.55 – 2.35 (m, 3H), 2.32 – 2.22 (m, 1H), 2.13 (s, 3H), 2.12 – 2.06 (m, 1H), 2.01 – 1.92 (m, 
1H), 1.78 – 1.61 (m, 3H), 1.02 (s, 3H), 0.94 (d, J = 6.8 Hz, 3H), 0.90 (s, 9H), 0.09 (s, 3H), 0.09 
H
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H
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(s, 3H). 13C NMR (101 MHz, CDCl3) δ = 214.3, 208.9, 71.7, 50.6, 44.7, 38.9, 35.9, 33.8, 30.1, 
29.6, 26.0 (3C), 20.5, 18.2, 12.6, -4.1, -4.6. HRMS (ESI) Exact mass calculated for C18H35O3Si+ 
[M+H]+: 327.2350, found: 327.2348; for C18H34NaO3Si+ [M+Na]+: 349.2169, found: 349.2169. 
 
 
(4aR,5R,6R)-6-((tert-Butyldimethylsilyl)oxy)-4a,5-dimethyl-4,4a,5,6,7,8-hexahydro-
naphthalen-2(3H)-one (2.71): To a solution of 6.1 (3.53 g, 10.8 mmol, 1.0 equiv.) in MeOH 
(56.0 mL) was added a solution of NaOMe (0.5 M in MeOH, 28.1 mL, 14.0 mmol, 1.3 equiv.) 
and the mixture was stirred for 4 h at rt. H2O was added and the resulting turbid mixture was 
extracted with Et2O (3 x). The combined organic layers were washed with brine, dried over 
Na2SO4, filtered and concentrated. The slurry was again partitioned between H2O and Et2O and 
separated. After extraction of the aqueous layer with Et2O (2 x), the combined organic layers 
were dried over Na2SO4, filtered and concentrated. The residue was purified by flash column 
chromatography (pentane/Et2O 3:1) to give 2.71 (2.92 g, 9.46 mmol, 88 %) as a colorless solid.  
M.p. = 37.1 – 39.9°C. TLC: Rf = 0.67 (SiO2, pentane/Et2O 1:1). Optical rotation: [𝛼𝛼]*%( = 
+78.7° (c = 0.57, CHCl3). FTIR (neat): ν/ = 2951, 2858, 1678, 1621, 1463, 1386, 1359, 1253, 
1185, 1073, 1019, 948, 889, 867, 834, 775, 683 cm−1. 1H NMR (400 MHz, CDCl3) δ = 5.74 (s, 
1H), 3.57 (ddd, J = 10.5, 4.4 Hz, 1H), 2.46 – 2.33 (m, 3H), 2.28 (ddd, J = 14.9, 4.7, 2.8 Hz, 1 
H), 2.08 – 1.98 (m, 2H), 1.73 (ddd, J = 13.7, 5.4 Hz, 1H), 1.45 (dddd, J = 14.6, 12.0, 10.7, 4.4 
Hz, 1H), 1.36 (dq, J = 10.0, 6.6 Hz, 1H), 1.11 (s, 3H), 0.98 (d, J = 6.7 Hz, 3H), 0.89 (s, 9H), 
0.08 (s, 3H), 0.07 (s, 3H). 13C NMR (101 MHz, CDCl3) δ = 199.6, 169.4, 124.3, 72.0, 50.1, 
39.3, 36.0, 35.9, 33.6, 31.5, 26.0 (3C), 18.2, 17.4, 11.2, -3.9, -4.5. HRMS (ESI) Exact mass 
calculated for C18H33O2Si+ [M+H]+: 309.2244, found: 309.2246; for C18H32NaO2Si+ [M+Na]+: 
331.2064, found: 331.2065. 
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(3R,4aR,5R,6R)-6-((tert-Butyldimethylsilyl)oxy)-4a,5-dimethyl-3-(3-methylbut-2-en-1-
yl)-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one (2.72): To a cooled (–78°C) solution of 
2.71 (2.00 g, 6.48 mmol, 1.0 equiv.) in THF (100 mL) were added sequentially a solution of 
LiHMDS (1.0 M in THF, 9.72 mL, 9.72 mmol, 1.5 equiv.) and DMPU (3.13 mL, 25.9 mmol, 
4.0 equiv.) dropwise via syringe. The resulting solution was stirred for 2 h at –78°C, before 
prenyl bromide (2.99 mL, 25.9 mmol, 4.0 equiv.) and TBAI (9.57 g, 25.9 mmol, 4.0 equiv.) 
were added. The mixture was allowed to slowly warm up to rt and stirred o.n., before it was 
quenched by addition of sat. aq. NH4Cl solution and diluted with H2O and Et2O. The layers 
were separated and the aqueous layer was extracted with Et2O (3 x). The combined organics 
were washed with brine, dried over Na2SO4, filtered and concentrated. The residue was purified 
by flash column chromatography (pentane/ Et2O 6:1) to give 2.72 (2.25 g, 5.38 mmol, 83 %, 
90 % purity according to 1H NMR spectrum) as a colorless oil. 
TLC: Rf = 0.76 (SiO2, pentane/Et2O 3:1). Optical rotation: [𝛼𝛼]*%& = +56.0° (c = 0.51, CHCl3). 
FTIR (neat): ν/ = 3676, 2956, 2930, 2859, 1675, 1627, 1461, 1381, 1253, 1072, 889, 835, 
775 cm−1. 1H NMR (400 MHz, CDCl3) δ = 5.71 (d, J = 1.7 Hz, 1H), 5.09 (dddd, J = 9.1, 6.7, 
2.7, 1.3 Hz, 1H), 3.55 (td, J = 10.5, 4.4 Hz, 1H), 2.63 – 2.52 (m, 1H), 2.43 – 2.23 (m, 3H), 2.08 
– 1.96 (m, 3H), 1.70 (s, 3H), 1.61 (s, 3H), 1.49 – 1.27 (m, 3H), 1.11 (s, 3H), 0.97 (d, J = 6.7 
Hz, 3H), 0.88 (s, 9H), 0.07 (s, 3H), 0.06 (s, 3H). 13C NMR (101 MHz, CDCl3) δ = 200.9, 168.1, 
133.5, 124.2, 121.9, 71.9, 50.6, 42.0, 42.0, 39.9, 35.8, 31.1, 27.6, 26.0, 26.0 (3C), 18.2, 18.0, 
17.6, 11.1, -3.9, -4.5. HRMS (ESI) Exact mass calculated for C23H41O2Si+ [M+H]+: 377.2870, 
found: 377.2873; for C23H40NaO2Si+ [M+Na]+: 399.2690, found: 399.2689. 
 
 
2-((2S,7R,8R,8aR)-7-((tert-Butyldimethylsilyl)oxy)-8,8a-dimethyl-3-oxo-1,2,3,5,6,7,8,8a-
octahydronaphthalen-2-yl)acetaldehyde (2.73): A solution of 2.72 (1.0 g, 2.65 mmol, 
1.0 equiv.), pyridine (0.85 mL, 10.6 mmol, 4.0 equiv.) and Sudan III (spatula tip) in 
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CH2Cl2/MeOH (100 mL, 1:1) was cooled to –78°C and O3 was bubbled through the solution 
until the red color disappeared. The reaction was purged with O2 and Ar, before PPh3 (1.39 g, 
5.30 mmol, 2.0 equiv.) was added and the mixture was allowed to warm up to rt. After stirring 
for 2 h at rt, the solvent was removed by evaporation and the residue was subjected to flash 
column chromatography (pentane/Et2O 3:1) to give 2.73 (788 mg, 2.25 mmol, 85 %) as a 
colorless solid. 
M.p. = 58.2 – 60.3°C. TLC: Rf = 0.53 (SiO2, pentane/Et2O 1:1). Optical rotation: [𝛼𝛼]*%& = 
+40.4° (c = 0.33, CHCl3). FTIR (neat): ν/ = 2931, 2886, 2857, 1724, 1673, 1625, 1463, 1386, 
1253, 1186, 1076, 1007, 888, 834, 774, 691 cm−1. 1H NMR (400 MHz, CDCl3) δ = 9.86 (t, J = 
1.2 Hz, 1H), 5.76 (d, J = 1.7 Hz, 1H), 3.56 (ddd, J = 10.5, 4.4 Hz, 1H), 3.08 – 2.96 (m, 2H), 
2.41 (tdd, J = 14.5, 5.1, 1.9 Hz, 1H), 2.36 – 2.26 (m, 2H), 2.08 – 1.96 (m, 2H), 1.56 – 1.27 (m, 
3H), 1.19 (s, 3H), 0.96 (d, J = 6.8 Hz, 3H), 0.89 (s, 9H), 0.08 (s, 3H), 0.07 (s, 3H). 13C NMR 
(101 MHz, CDCl3) δ = 201.0, 199.1, 169.1, 123.3, 71.8, 50.5, 43.8, 42.9, 40.2, 37.5, 35.8, 31.3, 
26.0 (3C), 18.2, 17.5, 11.0, -3.9, -4.5. HRMS (ESI) Exact mass calculated for C20H35O3Si+ 
[M+H]+: 351.2350, found: 351.2353; for C20H34NaO3Si+ [M+Na]+: 373.2169, found: 373.2174. 
 
 
2-((2S,7R,8R,8aR)-7-((tert-Butyldimethylsilyl)oxy)-8,8a-dimethyl-3-oxo-1,2,3,5,6,7,8,8a-
octahydronaphthalen-2-yl)acrylaldehyde (2.74): Eschenmoser's salt (408 mg, 2.16 mmol, 
2.5 equiv.) was added to a solution of 2.73 (303 mg, 0.864 mmol, 1.0 equiv.) and Et3N 
(2.43 mL, 17.3 mmol, 20 equiv.) in CH2Cl2 (150 mL) at rt. The mixture was stirred for 3.5 h 
and then quenched by addition of H2O and acidified with aq. HCl solution (1.0 M, pH = 1). 
After stirring was continued for 30 min, the layers were separated and the aqueous layer was 
extracted with CH2Cl2 (2 x). The combined organic layers were dried over Na2SO4, filtered and 
concentrated. The residue was dissolved in CH2Cl2 and SiO2 was added. After stirring for 1 h, 
the mixture was concentrated and purified by flash column chromatography (pentane/Et2O 1:1) 
to give 2.74 (227 mg, 0.625 mmol, 72 %) as a colorless oil. 
TLC: Rf = 0.43 (SiO2, pentane/Et2O 1:1). Optical rotation: [𝛼𝛼]*%( = +12.0° (c = 0.27, CHCl3). 
FTIR (neat): ν/ = 2932, 2885, 2857, 2361, 1745, 1677, 1626, 1463, 1363, 1326, 1252, 1186, 
NEt3, CH2Cl2, rt
then SiO2, CH2Cl2
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1131, 1078, 956, 888, 835, 775 cm−1. 1H NMR (400 MHz, CDCl3) δ = 9.57 (s, 1H), 6.33 (s, 
1H), 6.23 (s, 1H), 5.79 (d, J = 1.7 Hz, 1H), 3.63 (dd, J = 14.2, 4.8 Hz, 1H), 3.57 (dd, J = 10.5, 
4.3 Hz, 1H), 2.43 (tdd, J = 14.4, 5.0, 1.9 Hz, 1H), 2.32 (ddd, J = 14.9, 4.6, 2.7 Hz, 1H), 2.04 
(ddt, J = 9.4, 7.4, 3.8 Hz, 1H), 1.99 (dd, J = 13.0, 4.8 Hz, 1H), 1.90 (t, J = 13.6 Hz, 1H), 1.47 
(dddd, J = 14.2, 12.5, 10.8, 4.5 Hz, 1H), 1.38 (dq, J = 10.0, 6.8 Hz, 1H), 1.20 (s, 3H), 0.96 (d, 
J = 6.8 Hz, 3H), 0.89 (s, 9H), 0.08 (s, 6H). 13C NMR (101 MHz, CDCl3) δ = 197.1, 193.5, 
168.6, 148.5, 136.1, 123.9, 71.8, 50.4, 42.1, 41.9, 40.1, 35.7, 31.2, 26.0 (3C), 18.2, 17.4, 
11.1, -3.8, -4.5. HRMS (ESI) Exact mass calculated for C21H35O3Si+ [M+H]+: 363.2350, found: 
363.2353; for C21H34NaO3Si+ [M+Na]+: 385.2169, found: 385.2174. 
 
 
2-((2S,7R,8R,8aR)-7-Hydroxy-8,8a-dimethyl-3-oxo-1,2,3,5,6,7,8,8a-octahydronaphthal-
en-2-yl)acrylaldehyde (6.2): To a solution of 2.74 (23.5 mg, 65 µmol, 1.0 equiv.) in MeCN 
(2.5 mL) was added a solution of HF (48 % in H2O, 27.3 µL, 0.648 mmol, 10 equiv.). The 
mixture was stirred for 2 h, before it was quenched with sat. aq. NaHCO3 solution. The mixture 
was extracted with Et2O (3 x) and the combined organic layers were washed with H2O, dried 
over Na2SO4, filtered and concentrated. The residue was purified by filtration through a short 
plug of SiO2 (eluted with Et2O) to give 6.2 (15.0 mg, 60 µmol, 93 %) as a colorless oil. 
 
TLC: Rf = 0.24 (SiO2, Et2O). Optical rotation: [𝛼𝛼]*%& = +51.2° (c = 0.76, CHCl3). FTIR (neat): 
ν/ = 3434, 2972, 2941, 2880, 2363, 1668, 1624, 1445, 1326, 1242, 1196, 1034, 956 cm−1. 
1H NMR (400 MHz, CDCl3) δ = 9.57 (s, 1H), 6.35 (d, J = 0.7 Hz, 1H), 6.24 (s, 1H), 5.82 (d, J 
= 1.7 Hz, 1H), 3.68 – 3.57 (m, 2H), 2.47 (dddd, J = 15.0, 14.1, 5.1, 1.9 Hz, 1H), 2.37 (ddd, J 
= 15.0, 4.7, 2.6 Hz, 1H), 2.17 (dtd, J = 12.2, 4.8, 2.7 Hz, 1H), 2.01 (dd, J = 13.0, 4.9 Hz, 1H), 
1.93 (t, J = 13.5 Hz, 1H), 1.53 – 1.40 (m, 2H), 1.35 (dq, J = 10.3, 6.8 Hz, 1H), 1.21 (s, 3H), 
1.05 (d, J = 6.8 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ = 196.9, 193.5, 167.9, 148.4, 136.3, 
124.3, 71.2, 50.2, 42.1, 41.9, 40.1, 35.3, 31.2, 17.4, 10.5. HRMS (ESI) Exact mass calculated 
for C15H21O3+ [M+H]+: 249.1485, found: 249.1482; for C15H20NaO3+ [M+Na]+: 271.1305, 
found: 281.1307. 
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2-((2S,8R,8aR)-8,8a-Dimethyl-3,7-dioxo-1,2,3,5,6,7,8,8a-octahydronaphthalen-2-yl)acryl-
aldehyde (2.68): NaHCO3 (40.1 mg, 0.48 mmol, 8.0 equiv.) and DMP (50.6 mg, 0.12 mmol, 
2.0 equiv.) were added sequentially to a solution of 6.2 (14.8 mg, 60 µmol, 1.0 equiv.) in 
CH2Cl2 (1.5 mL) at 0°C. The mixture was warmed up to rt and stirred for 30 min, before sat. 
aq. Na2S2O3 was added. The layers were separated and the aqueous layer was extracted with 
CH2Cl2 (2 x). The combined organic layers were washed with H2O, dried over Na2SO4, filtered 
and concentrated. The residue was purified by flash column chromatography (Et2O) to give 
2.68 (13.4 mg, 54 µmol, 91 %) as a colorless solid. 
M.p. = 84.2°C (decomposed). TLC: Rf = 0.45 (SiO2, Et2O). Optical rotation: [𝛼𝛼]*%( = +26.7° 
(c = 0.66, CHCl3). FTIR (neat): ν/ = 2973, 2361, 1715, 1676, 1625, 1445, 1324, 1181, 960, 920, 
867 cm−1. 1H NMR (400 MHz, CDCl3) δ = 9.56 (s, 1H), 6.37 (s, 1H), 6.26 (s, 1H), 5.97 (s, 1H), 
3.57 (dd, J = 14.3, 4.5 Hz, 1H), 2.86 – 2.73 (m, 2H), 2.65 – 2.49 (m, 3H), 2.21 (dd, J = 14.2, 
13.1 Hz, 1H), 1.97 (dd, J = 13.0, 4.6 Hz, 1H), 1.16 (s, 3H), 1.02 (d, J = 6.7 Hz, 3H). 13C NMR 
(101 MHz, CDCl3) δ = 209.5, 196.3, 193.3, 164.5, 148.0, 136.6, 125.1, 53.8, 43.2, 42.9, 41.4, 
39.8, 32.1, 18.1, 7.2. HRMS (ESI) Exact mass calculated for C15H19O3+ [M+H]+: 247.1329, 
found: 247.1325; for C15H18NaO3+ [M+Na]+: 269.1148, found: 269.1149. 
 
 
To a solution of 2.68 (131 mg, 0.53 mmol, 1.0 equiv.) in MeOH/THF (29 mL, 10:1) at 0°C was 
added dropwise NaOMe (0.5 M in MeOH, 1.28 mL, 0.64 mmol, 1.2 equiv.) and the mixture 
was stirred for 2 h at this temperature. H2O and EtOAc were added and the layers were 
separated. The aqueous layer was extracted with EtOAc (3 x) and the combined organic layers 
were dried over Na2SO4, filtered and concentrated. The residue was purified by flash column 
chromatography (Et2O) to give 2.69 (54.1 mg, 0.22 mmol, 41 %) as a colorless solid and 2.75 
(12.7 mg, 0.05 mmol, 9 %) as a beige solid. 
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(1R,7S,8aS,10R)-10-Hydroxy-1,8a-dimethyl-9-methylene-1,3,4,7,8,8a-hexahydro-1,7-
ethanonaphthalene-2,6-dione (2.69): 
M.p. = 169.2 – 175.3°C. TLC: Rf = 0.39 (SiO2, Et2O). Optical rotation: [𝛼𝛼]*%( = +79.8° (c = 
0.65, CHCl3). FTIR (neat): ν/ = 3418, 2953, 1705, 1673, 1619, 1464, 1446, 1386, 1329, 1285, 
1237, 1167, 1106, 1069, 1049, 1011, 995, 918, 892, 862, 772, 731, 565, 537 cm−1. 1H NMR 
(500 MHz, CDCl3) δ = 6.17 (s, 1H), 5.22 (s, 1H), 5.19 (s, 1H), 4.78 (dt, J = 7.2, 2.3, 1H), 3.32 
(t, J = 2.5, 1H), 2.96 (tdd, J = 12.1, 7.4, 1.5, 1H), 2.82 (ddd, J = 16.0, 12.1, 8.0, 1H), 2.70 (ddd, 
J = 16.0, 7.4, 1.3, 1H), 2.62 (dd, J = 12.1, 8.0, 1H), 2.01 (dd, J = 13.5, 2.7, 1H), 1.96 (dd, J = 
13.6, 3.4, 1H), 1.90 (d, J = 7.2, 1H), 1.11 (s, 3H), 1.03 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 
= 209.5, 197.4, 165.9, 140.9, 126.4, 112.9, 72.0, 59.8, 54.0, 42.1, 38.6, 35.6, 30.7, 22.8, 7.9. 
HRMS (ESI) Exact mass calculated for C15H19O3+ [M+H]+: 247.1329, found: 247.1328; for 
C15H18NaO3+ [M+Na]+: 269.1148, found: 269.1148. 
(1R,7S,8aS,9R,10R)-10-Hydroxy-9-(methoxymethyl)-1,8a-dimethyl-1,3,4,7,8,8a-hexa-
hydro-1,7-ethanonaphthalene-2,6-dione (2.75): 
M.p. = 100.7 – 103.8°C. TLC: Rf = 0.43 (SiO2, Et2O). Optical rotation: [𝛼𝛼]*%( = –83.1° (c = 
0.49, CHCl3). FTIR (neat): ν/ = 3455, 2923, 1704, 1668, 1448, 1387, 1332, 1283, 1169, 1109, 
1040, 963, 887, 749, 559 cm−1. 1H NMR (500 MHz, CDCl3) δ = 6.13 (s, 1H), 4.25 (dd, J = 
10.3, 1.5, 1H), 3.68 (dd, J = 9.6, 3.9, 1H), 3.59 (d, J = 1.5, 1H), 3.35 (dd, J = 9.3, 7.6, 1H), 
3.33 (s, 3H), 2.95 – 2.80 (m, 2H), 2.71 – 2.62 (m, 1H), 2.60 – 2.53 (m, 2H), 2.04 – 1.91 (m, 
3H), 1.18 (s, 3H), 1.09 (s, 3H). 13C NMR (126 MHz, CDCl3) δ = 209.9, 198.9, 166.1, 127.3, 
76.2, 74.2, 59.3, 58.3, 45.7, 41.5, 38.6, 38.4, 34.3, 30.8, 23.1, 8.5. HRMS (ESI) Exact mass 
calculated for C16H23O4+ [M+H]+: 279.15909, found: 279.15926. 
 
 
(1R,7S,8aS,9R,10R)-10-Hydroxy-1,8a,9-trimethyl-1,3,4,7,8,8a-hexahydro-1,7-ethano-
naphthalene-2,6-dione (11R-2.70): A solution of 2.69 (30.0 mg, 0.122 mmol, 1.0 equiv.) and 
Wilkinson's catalyst (4.21 mg, 6.1 µmol, 5 mol%) in benzene (2.0 mL) was stirred under an H2 
atmosphere (1 atm) for 2 h. The solvent was evaporated and the residue was subjected to flash 
O
OHO Me
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column chromatography (Et2O) to give 11R-2.70 (24.3 mg, 98 µmol, 80 %, dr 20:1) as a 
colorless solid. 
M.p. = 133.1 – 138.3°C. TLC: Rf = 0.26 (SiO2, Et2O). Optical rotation: [𝛼𝛼]*%( = –83.4° (c = 
1.10, CHCl3). FTIR (neat): ν/ = 3420, 2922, 1701, 1657, 1460, 1387, 1297, 1166, 1109, 1085, 
1037, 1009, 990, 889, 743, 568, 498 cm−1. 1H NMR (500 MHz, CDCl3) δ = 6.19 (s, 1H), 4.17 
(d, J = 6.4, 1H), 2.93 (dddd, J = 12.6, 11.6, 8.0, 1.4, 1H), 2.79 – 2.72 (m, 1H), 2.69 (ddd, J = 
16.8, 8.1, 2.1, 1H), 2.55 (ddd, J = 12.3, 7.6, 2.0, 1H), 2.50 (q, J = 2.8, 1H), 2.20 (dq, J = 7.4, 
2.0, 1H), 2.06 (dd, J = 14.1, 3.0, 1H), 1.82 (dd, J = 14.1, 3.0, 1H), 1.18 (s, 3H), 1.14 (s, 3H), 
1.12 (d, J = 7.4, 3H). 13C NMR (126 MHz, CDCl3) δ = 211.6, 200.9, 165.5, 127.6, 69.4, 58.2, 
49.1, 41.1, 39.0, 34.6, 30.3, 29.4, 23.7, 14.0, 11.0. HRMS (ESI) Exact mass calculated for 
C15H21O3+ [M+H]+: 249.1485, found: 249.1485; for C15H20NaO3+ [M+Na]+: 271.1305, found: 
281.1306. 
 
 
A solution of 2.74 (280 mg, 0.772 mmol, 1.0 equiv.) and HSiEt3 (149 µL, 0.926 mmol, 
1.2 equiv.) in THF (3.0 mL) was added to a suspension of PdCl2 (6.84 mg, 38.6 µmol, 5 mol%) 
and PCy3 (21.6 mg, 77.2 µmol 10 mol%) in THF/H2O (9.0 mL, 1:2). The mixture was stirred 
at rt for 90 min, before it was filtered through a short plug of Al2O3 (eluted with EtOAc). The 
solvent was evaporated and the residue subjected to flash column chromatography 
(pentane/Et2O 1:1) to give 2.76 (224 mg, 0.614 mmol, 80 %, dr 2:1 11R/11S) as a yellowish 
oil. For analytical purposes, 2.76 was purified by additional flash column chromatography 
(pentane/Et2O 5:2) to give 11R-2.76 as a colorless solid and 11S-2.76 as a colorless oil. 
(R)-2-((2S,7R,8R,8aR)-7-((tert-Butyldimethylsilyl)oxy)-8,8a-dimethyl-3-oxo-
1,2,3,5,6,7,8,8a-octahydronaphthalen-2-yl)propanal (11R-2.76): 
M.p. = 85.0 – 89.1°C. TLC: Rf = 0.50 (SiO2, pentane/Et2O 1:1). Optical rotation: [𝛼𝛼]*%( = 
+64.3° (c = 0.52, CHCl3). FTIR (neat): ν/ = 2930, 2857, 1724, 1670, 1625, 1462, 1361, 1252, 
1223, 1131, 1098, 1070, 1007, 955, 889, 868, 834, 774, 685 cm−1. 1H NMR (500 MHz, CDCl3) 
δ = 9.76 (s, 1H), 5.75 (d, J = 1.8, 1H), 3.57 (td, J = 10.5, 4.3, 1H), 3.02 (ddd, J = 14.6, 4.7, 3.5, 
1H), 2.57 (qd, J = 7.2, 3.5, 1H), 2.41 (tdd, J = 14.5, 5.1, 2.0, 1H), 2.31 (ddd, J = 15.0, 4.5, 2.8, 
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1H), 2.03 (dtd, J = 12.3, 4.8, 2.7, 1H), 1.96 (dd, J = 13.0, 4.7, 1H), 1.70 (t, J = 13.9 Hz, 1H), 
1.46 (dddd, J = 14.4, 12.5, 10.9, 4.5, 1H), 1.37 (dq, J = 10.0, 6.8, 1H), 1.17 (s, 3H), 1.15 (d, J 
= 7.2, 3H), 0.99 (d, J = 6.7, 3H), 0.89 (s, 9H), 0.08 (s, 3H), 0.07 (s, 3H). 13C NMR (126 MHz, 
CDCl3) δ = 204.3, 198.2, 169.3, 124.0, 71.8, 50.6, 45.6, 44.4, 40.2, 39.6, 35.7, 31.3, 26.0 (3C), 
18.2, 17.5, 11.2, 9.7, -3.8, -4.5. HRMS (ESI) Exact mass calculated for C21H36NaO3Si+ 
[M+Na]+: 387.2326, found: 387.2328. 
(S)-2-((2S,7R,8R,8aR)-7-((tert-Butyldimethylsilyl)oxy)-8,8a-dimethyl-3-oxo-
1,2,3,5,6,7,8,8a-octahydronaphthalen-2-yl)propanal (11S-2.76): 
TLC: Rf = 0.61 (SiO2, pentane/Et2O 1:1). Optical rotation: [𝛼𝛼]*%0 = +35.8° (c = 0.71, CHCl3). 
FTIR (neat): ν/ = 2930, 2857, 1724, 1672, 1626, 1462, 1361, 1252, 1132, 1098, 1070, 1006, 
889, 834, 774, 690, 581 cm−1. 1H NMR (500 MHz, CDCl3) δ = 9.76 (s, 1H), 5.76 (d, J = 1.7, 
1H), 3.56 (td, J = 10.5, 4.3, 1H), 3.07 (qd, J = 7.1, 4.5, 1H), 2.96 (dt, J = 14.5, 4.5, 1H), 2.40 
(tdd, J = 14.6, 5.1, 1.9, 1H), 2.30 (ddd, J = 14.9, 4.6, 2.7, 1H), 2.03 (dtd, J = 12.4, 4.8, 2.7, 
1H), 1.87 (dd, J = 13.0, 4.5, 1H), 1.54 – 1.40 (m, 2H), 1.33 (dq, J = 10.0, 6.7, 1H), 1.17 (s, 
3H), 1.07 (d, J = 7.3, 3H), 0.96 (d, J = 6.8, 3H), 0.89 (s, 9H), 0.07 (s, 3H), 0.07 (s, 3H). 
13C NMR (126 MHz, CDCl3) δ = 204.3, 198.6, 169.0, 123.8, 71.8, 50.7, 44.9, 42.0, 40.0, 38.4, 
35.7, 31.2, 26.0 (3C), 18.2, 17.4, 11.1, 10.1, -3.8, -4.5. HRMS (ESI) Exact mass calculated for 
C21H37O3Si+ [M+Na]+: 365.25065, found: 365.25057. 
 
 
(R)-2-((2S,7R,8R,8aR)-7-Hydroxy-8,8a-dimethyl-3-oxo-1,2,3,5,6,7,8,8a-octahydro-
naphthalen-2-yl)propanal (11R-6.3): To a solution of 11R-2.76 (54.0 mg, 0.148 mmol, 
1.0 equiv.) in MeCN (2.5 mL) was added a solution of HF (48 % in H2O, 62 µL, 1.48 mmol, 
10 equiv.). The mixture was stirred for 2.5 h, before it was quenched by addition of sat. aq. 
NaHCO3 solution. The mixture was extracted with Et2O (3 x) and the combined organic layers 
were washed with H2O, dried over Na2SO4, filtered and concentrated. The residue was purified 
by flash column chromatography (Et2O) to give 11R-6.3 (28.4 mg, 0.114 mmol, 77 %) as a 
colorless oil. 
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TLC: Rf = 0.25 (SiO2, Et2O). Optical rotation: [𝛼𝛼]*%& = +91.8° (c = 0.64, CHCl3). FTIR (neat): 
ν/ = 1972, 2939, 2879, 1718, 1660, 1621, 1445, 1370, 1345, 1254, 1223, 1032, 961, 953, 924, 
897, 871, 731, 686, 580 cm−1. 1H NMR (500 MHz, CDCl3) δ = 9.73 (s, 1H), 5.74 (d, J = 1.7, 
1H), 3.59 (td, J = 10.7, 4.3, 1H), 3.00 (dt, J = 14.7, 4.2, 1H), 2.58 (qd, J = 7.2, 3.6, 1H), 2.43 
(tdd, J = 14.5, 5.1, 1.9, 1H), 2.33 (ddd, J = 15.1, 4.7, 2.7, 1H), 2.14 (dtd, J = 12.3, 4.8, 2.7, 
1H), 1.96 (dd, J = 13.0, 4.7, 1H), 1.69 (t, J = 13.8, 1H), 1.42 (dtd, J = 14.2, 11.8, 4.8, 1H), 1.31 
(dq, J = 10.2, 6.7, 1H), 1.16 (s, 3H), 1.14 (d, J = 7.1, 3H), 1.06 (d, J = 6.7, 3H). 13C NMR (126 
MHz, CDCl3) δ = 204.2, 198.2, 168.9, 124.1, 71.0, 50.3, 45.5, 44.2, 40.1, 39.3, 35.1, 31.1, 17.4, 
10.6, 9.7. HRMS (ESI) Exact mass calculated for C15H23O3+ [M+H]+: 251.16417, found: 
251.16432. 
 
 
(S)-2-((2S,7R,8R,8aR)-7-Hydroxy-8,8a-dimethyl-3-oxo-1,2,3,5,6,7,8,8a-octahydro-
naphthalen-2-yl)propanal (11S-6.3): To a solution of 11S-2.76 (72.6 mg, 0.199 mmol, 
1.0 equiv.) in MeCN (3.3 mL) was added a solution of HF (48 % in H2O, 84 µL, 1.99 mmol, 
10 equiv.). The mixture was stirred for 2.5 h, before it was quenched by addition of sat. aq. 
NaHCO3 solution. The mixture was extracted with Et2O (3 x) and the combined organic layers 
were washed with H2O, dried over Na2SO4, filtered and concentrated. The residue was purified 
by flash column chromatography (Et2O) to give 11S-6.3 (33.4 mg, 0.133 mmol, 67 %) as a 
colorless oil. 
TLC: Rf = 0.28 (SiO2, Et2O). Optical rotation: [𝛼𝛼]*%( = +50.8° (c = 0.48, CHCl3). FTIR (neat): 
ν/ = 3425, 2971, 2938, 2878, 1720, 1663, 1623, 1445, 1373, 1256, 1221, 1032, 954, 923, 871, 
731, 698, 582 cm−1. 1H NMR (400 MHz, CDCl3) δ = 9.75 (s, 1H), 5.78 (d, J = 1.8, 1H), 3.61 
(td, J = 10.7, 4.4, 1H), 3.05 (qd, J = 7.2, 4.5, 1H), 2.97 (dt, J = 14.4, 4.6, 1H), 2.45 (tdd, J = 
14.2, 5.1, 1.9, 1H), 2.34 (ddd, J = 15.0, 4.8, 2.6, 1H), 2.15 (dtd, J = 12.2, 4.8, 2.7, 1H), 1.89 
(dd, J = 13.0, 4.5, 1H), 1.56 – 1.47 (m, 1H), 1.47 – 1.39 (m, 1H), 1.32 – 1.24 (m, 1H), 1.18 (s, 
3H), 1.08 (d, J = 7.3, 3H), 1.05 (d, J = 6.8, 3H). 13C NMR (101 MHz, CDCl3) δ = 204.2, 198.6, 
168.5, 124.0, 71.1, 50.4, 44.9, 42.0, 40.0, 38.3, 35.2, 31.1, 17.3, 10.5, 10.2. HRMS (ESI) Exact 
mass calculated for C15H22NaO3+ [M+Na]+: 273.14612, found: 273.14558. 
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(R)-2-((2S,8R,8aR)-8,8a-Dimethyl-3,7-dioxo-1,2,3,5,6,7,8,8a-octahydronaphthalen-2-
yl)propanal (11R-2.77): NaHCO3 (230 mg, 2.74 mmol, 8.0 equiv.) and DMP (290 mg, 
0.684 mmol, 2.0 equiv.) were sequentially added to a solution of 11R-6.3 (85.6 mg, 
0.342 mmol, 1.0 equiv.) in CH2Cl2 (4.3 mL) at 0°C and the mixture was stirred for 2 h. Sat. aq. 
Na2S2O3 and sat. aq. NaHCO3 solutions were added and the layers were separated. The aqueous 
layer was extracted with CH2Cl2 (3 x) and the combined organic layers were washed with H2O, 
dried over Na2SO4, filtered and concentrated. The residue was purified by flash column 
chromatography (pentane/Et2O 2:1 to Et2O) to give 11R-2.77 (53.2 mg, 0.342 mmol, 63 %) as 
a yellowish oil. 
TLC: Rf = 0.34 (SiO2, Et2O). Optical rotation: [𝛼𝛼]*%( = +69.0° (c = 0.72, CHCl3). FTIR (neat): 
ν/ = 2974, 2943, 2724, 1712, 1666, 1624, 1445, 1366, 1345, 1254, 1222, 1181, 1074, 1008, 958, 
922, 893, 865, 827, 797, 770, 727, 678, 623, 570 cm−1. 1H NMR (500 MHz, CDCl3) δ = 9.74 
(s, 1H), 5.92 (s, 1H), 2.98 (ddd, J = 11.5, 7.9, 3.7, 1H), 2.81 – 2.74 (m, 2H), 2.69 (qd, J = 7.3, 
3.6, 1H), 2.62 – 2.48 (m, 3H), 1.98 – 1.92 (m, 2H), 1.19 (d, J = 7.3, 3H), 1.13 (s, 3H), 1.05 (d, 
J = 6.7, 3H). 13C NMR (126 MHz, CDCl3) δ = 209.7, 204.0, 197.8, 165.3, 125.4, 54.1, 45.6, 
44.7, 43.6, 40.0, 39.1, 32.3, 18.4, 10.1, 7.5. HRMS (ESI) Exact mass calculated for C15H21O3+ 
[M+H]+: 249.14852, found: 249.14863. 
 
 
(S)-2-((2S,8R,8aR)-8,8a-Dimethyl-3,7-dioxo-1,2,3,5,6,7,8,8a-octahydronaphthalen-2-
yl)propanal (11S-2.77): NaHCO3 (89.4 mg, 1.06 mmol, 8.0 equiv.) and DMP (113 mg, 
0.266 mmol, 2.0 equiv.) were added sequentially to a solution of 11S-6.3 (33.3 mg, 
0.133 mmol, 1.0 equiv.) in CH2Cl2 (1.7 mL) at 0°C and the mixture was stirred for 1 h. Sat. aq. 
Na2S2O3 and sat. aq. NaHCO3 solutions were added and the layers were separated. The aqueous 
layer was extracted with CH2Cl2 (3 x) and the combined organic layers were washed with H2O, 
dried over Na2SO4, filtered and concentrated. The residue was purified by flash column 
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chromatography (pentane/Et2O 2:1 to Et2O) to give 11S-2.77 (10.0 mg, 40 µmol, 30 %) as a 
colorless oil. 
TLC: Rf = 0.33 (SiO2, Et2O). Optical rotation: [𝛼𝛼]*%( = +24.0° (c = 0.50, CHCl3). FTIR (neat): 
ν/ = 2971, 2920, 2851, 1713, 1669, 1625, 1446, 1375, 1345, 1254, 1221, 1180, 1074, 1051, 
1014, 974, 921, 865, 798, 578 cm−1. 1H NMR (400 MHz, CDCl3) δ = 9.76 (s, 1H), 5.93 (s, 1H), 
3.07 (dt, J = 11.8, 7.2, 1H), 2.98 (dt, J = 14.4, 4.5, 1H), 2.77 (dt, J = 10.5, 6.3, 2H), 2.60 – 2.52 
(m, 2H), 2.48 (q, J = 6.8, 1H), 1.89 (dd, J = 13.0, 4.6, 1H), 1.75 (t, J = 13.7, 1H), 1.15 (s, 3H), 
1.11 (d, J = 7.4, 3H), 1.03 (d, J = 6.8, 3H).13C NMR (101 MHz, CDCl3) δ = 209.4, 203.8, 
198.0, 164.8, 125.0, 54.0, 44.8, 43.3, 42.4, 39.9, 38.2, 32.1, 18.0, 10.3, 7.2. HRMS (ESI) Exact 
mass calculated for C15H21O3+ [M+H]+: 249.14852, found: 249.14856. 
 
 
(1R,7S,8aS,9S,10R)-10-Hydroxy-1,8a,9-trimethyl-1,3,4,7,8,8a-hexahydro-1,7-ethano-
naphthalene-2,6-dione (11S-2.70): To a solution of a mixture of 11R- and 11S-2.77 (10.0 mg, 
40.3 µmol, 1.0 equiv.) in CH2Cl2 (2.5 mL) was added DBU (18 µL, 0.121 mmol, 3.0 equiv.) 
and the mixture was stirred at rt for 18 h. The mixture was quenched by addition of aq. HCl 
(0.1 M) and diluted with Et2O. The layers were separated and the aqueous layer was extracted 
with Et2O (2 x). The combined organic layers were washed with sat. aq. NaHCO3 solution, 
H2O, dried over Na2SO4, filtered and concentrated. The residue was subjected to flash column 
chromatography (Et2O) to give 11S-2.70 (5.0 mg, 20.1 µmol, 50 %, dr >10:1) as a colorless 
solid. 
or 
 
To a solution of 11S-2.77 (10.0 mg, 40.3 µmol, 1.0 equiv.) in toluene (1.5 mL) was added 
diphenyl phosphate (5.04 mg, 20.2 µmol, 0.5 equiv.) and the mixture was heated at 65°C for 
4.5 h. The yellow mixture was partitioned between sat. aq NaHCO3 solution and EtOAc. The 
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layers were separated and the aqueous layer was extracted with EtOAc. The combined organic 
layers were dried over Na2SO4, filtered and concentrated. The residue was subjected to flash 
column chromatography (Et2O) to give 11S-2.70 (5.1 mg, 21 µmol, 51 %, dr >10:1) as a 
colorless solid. 
M.p. = 150.2 – 151.6°C. TLC: Rf = 0.26 (SiO2, Et2O). Optical rotation: [𝛼𝛼]*%% = –89.2° (c = 
0.78, CHCl3). FTIR (neat): ν/ = 3436, 2961, 2920, 2874, 1703, 1666, 1463, 1386, 1332, 1274, 
1243, 1208, 1174, 1151, 1098, 1040, 888, 750 cm−1. 1H NMR (400 MHz, CDCl3) δ = 6.13 (s, 
1H), 3.82 (dd, J = 10.5, 5.1 Hz, 1H), 3.00 – 2.62 (m, 3H), 2.59 – 2.49 (m, 2H), 1.96 (dd, J = 
3.1, 1.2 Hz, 2H), 1.87 – 1.70 (m, 1H), 1.44 (d, J = 5.7 Hz, 1H), 1.17 (s, 3H), 1.12 (s, 3H), 1.04 
(d, J = 6.8 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ = 211.0, 199.2, 165.1, 127.5, 74.9, 58.9, 
49.2, 41.6, 38.7, 34.7, 34.5, 30.3, 23.5, 16.1, 8.3. HRMS (ESI) Exact mass calculated for 
C15H20NaO3+ [M+Na]+: 271.1305, found: 271.1299. 
 
 
(1R,7S,8aS,9S,10R)-10-Hydroxy-1,8a,9-trimethyl-1,7,8,8a-tetrahydro-1,7-ethano-
naphthalene-2,6-dione (2.78): To a stirred solution of 11S-2.70 (10.0 mg, 40.3 µmol, 
1.0 equiv.) in THF (1.0 mL) at –78°C was added dropwise a solution of LiHMDS (1.0 M in 
THF, 101 µL, 101 µmol, 2.5 equiv.). After 30 min at –78°C, a solution of PhSeCl (15.4 mg, 
80.6 µmol, 2.0 equiv.) in THF (0.3 mL) was added dropwise. The solution was stirred for 2 h 
at –78°C, before it was quenched by addition of sat. aq. NH4Cl solution and extracted with Et2O 
(3 x). The combined organic layers were washed with H2O, dried over Na2SO4, filtered and 
concentrated. The residue was dissolved in THF (1.5 mL) and a solution of H2O2 (30 % in H2O, 
30 µL, 0.322 mmol, 8.0 equiv.) was added at 0°C. After stirring for 90 min the mixture was 
warmed up to rt and stirred for another 90 min. Sat. aq. Na2S2O3 solution and Et2O were added 
and the layers were separated. The aqueous layer was extracted with Et2O (2 x) and the 
combined organic layers were washed with H2O, dried over Na2SO4, filtered and concentrated. 
The residue was subjected to flash column chromatography (pentane/Et2O 1:2) to give 2.78 
(4.2 mg, 17.1 µmol, 42 %) as a colorless solid. 
M.p. = 140.5 – 146.4°C. TLC: Rf = 0.40 (SiO2, Et2O). Optical rotation: [𝛼𝛼]*%% = +258.8° (c = 
0.21, CHCl3). FTIR (neat): ν/ = 3451, 2958, 2922, 2361, 1666, 1462, 1380, 1274, 1242, 1150, 
i) LiHMDS, PhSeCl
THF, –78°C
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1103, 1035, 903 cm−1. 1H NMR (400 MHz, CDCl3) δ = 7.29 (dd, J = 10.1, 1.1 Hz, 1H), 6.10 
(s, 1H), 6.04 (d, J = 10.1 Hz, 1H), 3.51 (d, J = 10.4 Hz, 1H), 2.52 (dt, J = 5.7, 3.2 Hz, 1H), 
2.12 (dd, J = 14.3, 3.3 Hz, 1H), 1.97 – 1.89 (m, 1H), 1.90 (dd, J = 14.3, 2.8 Hz, 1H), 1.70 (s, 
1H), 1.25 (s, 3H), 1.22 (s, 3H), 1.02 (d, J = 6.8 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ = 
201.1, 198.5, 160.4, 143.5, 129.5, 126.1, 72.9, 55.8, 48.9, 42.9, 37.1, 33.2, 24.6, 16.6, 8.0. 
HRMS (ESI) Exact mass calculated for C15H18NaO3+ [M+Na]+: 269.1148, found: 269.1148. 
 
 
(4aR,5R,6R)-6-((tert-Butyldimethylsilyl)oxy)-3-diazo-4a,5-dimethyl-4,4a,5,6,7,8-
hexahydronaphthalen-2(3H)-one (2.82): To a cooled (–78°C) solution of 2.71 (500 mg, 
1.62 mmol, 1.0 equiv.) in THF (20 mL) was added a solution of LiHMDS (1.0 M in THF, 
2.11 mL, 2.11 mmol, 1.3 equiv.) dropwise via syringe. The resulting yellow solution was stirred 
for 30 min at –78°C, before 2,2,2-trifluoroethyl trifluoroacetate (308 µL, 2.27 mmol, 
1.4 equiv.) was added dropwise. The mixture was stirred for 90 min at –78°C and then 
quenched by addition of sat. aq. NH4Cl solution and diluted with Et2O. The layers were 
separated and the aqueous layer extracted with Et2O (2 x). The combined organic layers were 
washed with H2O, dried over Na2SO4, filtered and concentrated to give crude 6.4 (651 mg, 
1.62 mmol, quant.) as a colorless oil. 
Crude 6.4 (611 mg, 1.51 mmol, 1.0 equiv.) was dissolved in MeCN (4.5 mL). Et3N (637 µL, 
4.53 mmol, 3.0 equiv.) was added, followed by dropwise addition of a solution of 
MsN3 (238 mg, 1.96 mmol, 1.3 equiv.) in MeCN (4.5 mL) over a period of 90 min. The yellow 
mixture was stirred for 3.5 h at rt, before it was diluted with Et2O and washed with 1.0 M aq. 
NaOH solution. After separation, the aqueous layer was extracted with Et2O (2 x) and the 
combined organics were washed with H2O, dried over Na2SO4, filtered and concentrated. The 
residue was purified by flash column chromatography (pentane/Et2O/Et3N 300:100:4) to give 
2.82 (344 mg, 0.925 mmol, 61 %) as a yellow oil.  
TLC: Rf = 0.41 (SiO2, pentane/Et2O 2:1). Optical rotation: [𝛼𝛼]*%( = +94.2° (c = 0.75, CHCl3). 
FTIR (neat): ν/ = 2931, 2884, 2857, 2077, 1640, 1602, 1440, 1356, 1300, 1253, 1220, 1188, 
1068, 1007, 872, 834, 775, 676 cm−1. 1H NMR (400 MHz, CDCl3) δ = 5.75 (d, J = 1.9 Hz, 
O
OTBSHO
CF3
O
OTBS N2
O
OTBSLiHMDS, THF, –78°C
2.82, 61 % over 2 steps
O
O
2.71
MsN3, NEt3
 
MeCN, rt
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1H), 3.52 (td, J = 10.5, 4.2 Hz, 1H), 2.80 (d, J = 14.0 Hz, 1H), 2.65 (d, J = 14.1 Hz, 1H), 2.47 
– 2.30 (m, 2H), 2.02 – 1.93 (m, 1H), 1.52 – 1.39 (m, 2H), 1.13 (s, 3H), 1.01 (d, J = 6.8 Hz, 3H), 
0.89 (s, 9H), 0.07 (s, 3H), 0.07 (s, 3H). 13C NMR (101 MHz, CDCl3) δ = 183.9, 163.4, 124.3, 
72.0, 58.6, 49.6, 40.3, 35.1, 35.0, 31.0, 26.0 (3C), 19.0, 18.2, 11.6, -3.9, -4.6. HRMS (ESI) 
Exact mass calculated for C18H31O2N2Si+ [M+H]+: 335.21493, found: 335.21471; for 
C18H30NaO2N2Si+ [M+Na]+: 357.19688, found: 357.19671. 
 
 
To a cooled (–78°C) solution of 2.71 (2.49 g, 8.07 mmol, 1.0 equiv.) in THF (60 mL) was added 
a solution of LiHMDS (1.0 M in THF, 10.5 mL, 10.5 mmol, 1.3 equiv.) dropwise via syringe. 
The resulting solution was stirred for 30 min at –78°C, before TMSCl (1.34 mL, 10.5 mmol, 
1.3 equiv.) was added dropwise. The mixture was stirred for 1 h at –78°C, and was then 
quenched by addition of sat. aq. NaHCO3 solution and diluted with Et2O. The layers were 
separated and the aqueous layer was extracted with Et2O (2 x). The combined organic layers 
were washed with H2O, dried over Na2SO4, filtered and concentrated to a colorless oil. 
The crude residue was dissolved in CH2Cl2 (80 mL) and cooled to 0°C. KHCO3 (4.04 g, 
40.4 mmol, 5.0 equiv.) and m-CPBA (77 %, 2.35 mg, 10.5 mmol, 1.3 equiv.) were added 
sequentially and the mixture was stirred at 0°C for 2.5 h. Sat. aq. Na2S2O3 solution was added 
and the mixture was extracted with CH2Cl2 (3 x). The combined organic layers were washed 
with H2O (2 x), dried over Na2SO4, filtered and conentrated. 
The crude residue was dissolved in MeOH (70 mL) and citric acid monohydrate (8.48 g, 
40.4 mmol, 5.0 equiv.) was added. The mixture was stirred o.n., before most of the solvent was 
evaporated. The residue was partitioned between Et2O and H2O and the layers were separated. 
The aqueous layer was extracted with Et2O (2 x) and the combined organic layers were dried 
over Na2SO4, filterd and concentrated. The residue was subjected to flash column 
chromatography (pentane/Et2O 2:1) to give 2.86 (1.80 g, 5.55 mmol, 69 %, dr 3:2) as a 
yellowish solid. For analytical purposes, pure fractions of both diastereoisomers 7S-2.86 and 
7R-2.86 were collected separately after flash column chromatography (pentane/Et2O 2:1) to 
give access to both diastereoisomers with a dr > 20:1. 
O
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2.71
O
OTBS(S)HO
69 %, dr 3:2 (7S/7R)
i) LiHMDS, TMSCl, –78°C
ii) m-CPBA, KHCO3, CH2Cl2, 0°C
iii) citric acid, MeOH, rt
O
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+
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(3S,4aR,5R,6R)-6-((tert-Butyldimethylsilyl)oxy)-3-hydroxy-4a,5-dimethyl-4,4a,5,6,7,8-
hexahydronaphthalen-2(3H)-one (7S-2.86): 
TLC: Rf = 0.61 (SiO2, pentane/Et2O 1:1). Optical rotation: [𝛼𝛼]*%( = –130.1° (c = 0.95, CHCl3). 
FTIR (neat): ν/ = 3484, 2955, 2930, 2885, 2858, 1686, 1622, 1472, 1388, 1361, 1256, 1223, 
1125, 1099, 1072, 1006, 939, 888, 862, 836, 775, 727, 694, 490 cm−1. 1H NMR (400 MHz, 
CDCl3) δ = 5.82 (d, J = 1.3 Hz, 1H), 4.21 (dd, J = 13.8, 5.7 Hz, 1H), 3.66 (ddd, J = 11.0, 9.5, 
5.0 Hz, 1H), 3.46 (s, 1H), 2.53 (dddd, J = 14.2, 12.6, 4.9, 1.5 Hz, 1H), 2.46 (dd, J = 13.7, 5.8 
Hz, 1H), 2.23 (ddd, J = 12.6, 4.6, 2.7 Hz, 1H), 2.16 (dtd, J = 12.7, 4.9, 2.7 Hz, 1H), 1.80 (dq, 
J = 9.5, 6.6 Hz, 1H), 1.49 (t, J = 13.8 Hz, 1H), 1.47 – 1.38 (m, 1H), 1.10 (d, J = 6.7 Hz, 3H), 
1.09 (s, 3H), 0.88 (s, 9H), 0.07 (s, 3H), 0.06 (s, 3H). 13C NMR (101 MHz, CDCl3) δ = 199.8, 
172.8, 119.5, 72.5, 68.7, 45.9, 41.3, 40.0, 38.3, 31.2, 26.0 (3C), 22.7, 18.2, 12.9, -3.8, -4.5. 
HRMS (ESI) Exact mass calculated for C18H33O3Si+ [M+H]+: 325.21935, found: 325.22011; 
for C18H32NaO3Si+ [M+Na]+: 347.20129, found: 347.20205. 
(3R,4aR,5R,6R)-6-((tert-Butyldimethylsilyl)oxy)-3-hydroxy-4a,5-dimethyl-4,4a,5,6,7,8-
hexahydronaphthalen-2(3H)-one (7R-2.86):  
TLC: Rf = 0.49 (SiO2, pentane/Et2O 1:1). Optical rotation: [𝛼𝛼]*%( = +77.0° (c = 0.94, CHCl3). 
FTIR (neat): ν/ = 3432, 2952, 2931, 2859, 1676, 1611, 1462, 1388, 1318, 1258, 1227, 1119, 
1102, 1074, 1007, 890, 872, 837, 772, 730, 696, 673 cm−1. 1H NMR (400 MHz, CDCl3) δ = 
5.81 (d, J = 1.7 Hz, 1H), 4.24 (dd, J = 13.7, 5.7 Hz, 1H), 3.57 (td, J = 10.5, 4.4 Hz, 1H), 3.51 
(s, 1H), 2.46 – 2.37 (m, 2H), 2.34 (ddd, J = 14.8, 4.7, 2.7 Hz, 1H), 2.04 (dtd, J = 12.4, 4.8, 2.8 
Hz, 1H), 1.58 (t, J = 13.2 Hz, 1H), 1.46 (dddd, J = 14.2, 12.5, 10.9, 4.7 Hz, 1H), 1.37 (dq, J = 
10.0, 6.7 Hz, 1H), 1.22 (s, 3H), 0.99 (d, J = 6.8 Hz, 3H), 0.89 (s, 9H), 0.08 (s, 3H), 0.07 (s, 
3H). 13C NMR (101 MHz, CDCl3) δ = 199.7, 171.2, 120.8, 71.3, 69.2, 50.8, 44.4, 41.3, 35.8, 
31.5, 26.0 (3C), 18.2, 18.1, 10.9, -3.9, -4.5. HRMS (ESI) Exact mass calculated for C18H33O3Si+ 
[M+H]+: 325.21935, found: 325.21874; for C18H32NaO3Si+ [M+Na]+: 347.20129, found: 
347.20068. 
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To a stirred solution of a mixture of 7S- and 7R-2.86 (50 mg, 0.154 mmol, 1.0 equiv., dr 3:2) 
and TBAI (28 mg, 77 µmol, 0.5 equiv.) in CH2Cl2 (3.0 mL) was added Ag2O (178 mg, 
0.77 mmol, 5.0 equiv.) and crotyl bromide (93 µL, 0.77 mmol, 5.0 equiv.). The reaction 
mixture was stirred at rt o.n. and then filtered through a short plug of celite. The solvent was 
removed by evaporation and the residue subjected to flash column chromatography 
(pentane/Et2O 5:1) to give 7S-2.79 (28.4 mg, 75 µmol, 49 %) and 7R-2.79 (10.9 mg, 29 µmol, 
19 %) both as colorless oils. 
(3S,4aR,5R,6R)-3-(((E)-But-2-en-1-yl)oxy)-6-((tert-butyldimethylsilyl)oxy)-4a,5-dimethyl-
4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one (7S-2.79): 
TLC: Rf = 0.54 (SiO2, pentane/Et2O 3:1). Optical rotation: [𝛼𝛼]*%0 = –37.6° (c = 1.42, CHCl3). 
FTIR (neat): ν/ = 2929, 2857, 1731, 1674, 1624, 1463, 1387, 1360, 1283, 1256, 1221, 1128, 
1098, 1074, 1040, 1006, 966, 941, 887, 834, 774, 667, 509 cm−1. 1H NMR (400 MHz, CDCl3) 
δ = 5.74 (d, J = 1.4 Hz, 1H), 5.75 – 5.68 (m, 1H), 5.59 – 5.53 (m, 1H), 4.14 (ddt, J = 11.8, 5.8, 
1.3 Hz, 1H), 3.94 (ddp, J = 9.9, 6.4, 1.1 Hz, 1H), 3.82 (t, J = 6.3 Hz, 1H), 3.61 (ddd, J = 11.0, 
9.7, 4.7 Hz, 1H), 2.48 (tdd, J = 14.1, 5.0, 1.6 Hz, 1H), 2.26 – 2.21 (m, 1H), 2.09 (dtd, J = 12.5, 
4.9, 2.6 Hz, 1H), 2.04 – 1.96 (m, 2H), 1.70 (dq, J = 6.4, 1.3 Hz, 3H), 1.50 (dq, J = 9.6, 6.7 Hz, 
1H), 1.42 (dddd, J = 14.3, 12.5, 11.0, 4.6 Hz, 1H), 1.17 (s, 3H), 1.03 (d, J = 6.7 Hz, 3H), 0.89 
(s, 9H), 0.08 (s, 3H), 0.06 (s, 3H). 13C NMR (101 MHz, CDCl3) δ = 197.4, 170.0, 129.7, 127.5, 
121.8, 75.6, 72.1, 71.0, 48.8, 40.5, 40.3, 37.2, 31.4, 26.0 (3C), 21.7, 18.2, 17.9, 11.9, -3.8, -4.5. 
HRMS (ESI) Exact mass calculated for C22H39O3Si+ [M+H]+: 379.2663, found: 379.2665; for 
C22H38NaO3Si+ [M+Na]+: 401.2482, found: 401.2487. 
(3R,4aR,5R,6R)-3-(((E)-But-2-en-1-yl)oxy)-6-((tert-butyldimethylsilyl)oxy)-4a,5-di-
methyl-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one (7R-2.79): 
TLC: Rf = 0.31 (SiO2, pentane/Et2O 3:1). Optical rotation: [𝛼𝛼]*%( = +52.9° (c = 0.54, CHCl3). 
FTIR (neat): ν/ = 2929, 2857, 1693, 1462, 1255, 1128, 1103, 1077, 889, 835, 775 cm−1. 
1H NMR (400 MHz, CDCl3) δ = 5.79 – 5.71 (m, 1H), 5.69 (d, J = 1.8 Hz, 1H), 5.64 (dtq, J = 
15.7, 6.4, 1.6 Hz, 1H), 4.36 (ddt, J = 11.5, 6.1, 1.2 Hz, 1H), 4.04 (ddt, J = 11.5, 6.5, 1.1 Hz, 
1H), 3.99 (dd, J = 13.8, 5.2 Hz, 1H), 3.54 (td, J = 10.4, 4.4 Hz, 1H), 2.41 – 2.26 (m, 2H), 2.24 
(dd, J = 12.7, 5.1 Hz, 1H), 2.05 – 1.98 (m, 1H), 1.72 – 1.67 (m, 4H), 1.44 (dddd, J = 14.2, 12.5, 
11.0, 4.8 Hz, 1H), 1.39 – 1.32 (m, 1H), 1.18 (s, 3H), 0.98 (dd, J = 6.8, 1.2 Hz, 3H), 0.88 (s, 
9H), 0.07 (s, 3H), 0.06 (s, 3H). 13C NMR (101 MHz, CDCl3) δ = 198.8, 168.1, 130.2, 127.6, 
122.8, 75.1, 71.7, 71.5, 50.7, 43.2, 41.4, 35.9, 31.0, 26.0 (3C), 18.2, 18.1, 17.9, 11.0, -3.9, -4.6. 
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HRMS (ESI) Exact mass calculated for C22H39O3Si+ [M+H]+: 379.2663, found: 379.2665; for 
C22H38NaO3Si+ [M+Na]+: 401.2482, found: 401.2487. 
 
To a mixture of 7S- and 7R-2.86 (39.5 mg, 0.122 mmol, 1.0 equiv., dr 3:2) and DIPEA (81 µL, 
0.488 mmol, 4.0 equiv.) in CH2Cl2 (2.0 mL) was added MOMBr (20 µL, 0.244 mmol, 
2.0 equiv.). The mixture was allowed to stir at 40°C o.n., before additional MOMBr (10 µL, 
0.122 mmol, 1.0 equiv.) was added. After stirring for 2 h at 40°C, the mixture was diluted with 
CH2Cl2 and sat. aq. NaHCO3 solution was added. The layers were separated and the aqueous 
layer was extracted with CH2Cl2 (2 x). The combined organics were dried over Na2SO4, filtered 
and concentrated. The residue was subjected to flash column chromatography (pentane/Et2O 
4:1) to give 7S-2.88 (23.0 mg, 62 µmol, 51 %) and 7R-2.88 (17.9 mg, 49 µmol, 40 %) both as 
colorless oils. 
(3S,4aR,5R,6R)-6-((tert-Butyldimethylsilyl)oxy)-3-(methoxymethoxy)-4a,5-dimethyl-
4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one (7S-2.88): 
TLC: Rf = 0.72 (SiO2, pentane/Et2O 1:1). Optical rotation: [𝛼𝛼]*%( = –98.1° (c = 0.63, CHCl3). 
FTIR (neat): ν/ = 2952, 2929, 2886, 2857, 1692, 1625, 1472, 1387, 1361, 1257, 1213, 1130, 
1097, 1076, 1038, 1007, 940, 918, 887, 835, 774, 669 cm−1. 1H NMR (400 MHz, CDCl3) δ = 
5.75 (d, J = 1.4 Hz, 1H), 4.80 (d, J = 6.7 Hz, 1H), 4.71 (d, J = 6.7 Hz, 1H), 4.15 (dd, J = 9.7, 
4.8 Hz, 1H), 3.62 (ddd, J = 10.9, 9.7, 4.8 Hz, 1H), 3.39 (s, 3H), 2.54 – 2.43 (m, 1H), 2.24 (ddd, 
J = 13.4, 4.6, 2.7 Hz, 1H), 2.16 – 2.07 (m, 2H), 1.92 (dd, J = 14.1, 9.7 Hz, 1H), 1.65 – 1.58 (m, 
1H), 1.48 – 1.36 (m, 1H), 1.16 (s, 3H), 1.05 (d, J = 6.7 Hz, 3H), 0.89 (s, 9H), 0.07 (s, 3H), 0.06 
(s, 3H). 13C NMR (101 MHz, CDCl3) δ = 197.1, 170.3, 121.7, 96.0, 73.0, 72.1, 55.8, 48.0, 40.6, 
40.1, 37.5, 31.3, 26.0 (3C), 21.9, 18.2, 12.1, -3.9, -4.6. HRMS (ESI) Exact mass calculated for 
C20H36NaO4Si+ [M+Na]+: 391.22751, found: 391.22805. 
(3R,4aR,5R,6R)-6-((tert-Butyldimethylsilyl)oxy)-3-(methoxymethoxy)-4a,5-dimethyl-
4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one (7R-2.88): 
TLC: Rf = 0.54 (SiO2, pentane/Et2O 1:1). Optical rotation: [𝛼𝛼]*%0 = +96.8° (c = 0.56, CHCl3). 
FTIR (neat): ν/ = 2929, 2857, 1690, 1623, 1472, 1463, 1387, 1361, 1252, 1215, 1143, 1126, 
1100, 1074, 1035, 1005, 888, 833, 773, 725, 693, 667 cm−1. 1H NMR (400 MHz, CDCl3) δ = 
5.71 (d, J = 1.6 Hz, 1H), 4.89 (d, J = 6.8 Hz, 1H), 4.79 (d, J = 6.8 Hz, 1H), 4.28 (dd, J = 13.8, 
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5.3 Hz, 1H), 3.55 (td, J = 10.5, 4.5 Hz, 1H), 3.42 (s, 3H), 2.43 – 2.30 (m, 2H), 2.26 (dd, J = 
12.7, 5.4 Hz, 1H), 2.03 (dtd, J = 12.4, 4.8, 2.7 Hz, 1H), 1.75 (t, J = 13.2 Hz, 1H), 1.50 – 1.41 
(m, 1H), 1.41 – 1.33 (m, 1H), 1.21 (s, 3H), 0.99 (d, J = 6.8 Hz, 3H), 0.88 (s, 9H), 0.07 (s, 3H), 
0.06 (s, 3H). 13C NMR (101 MHz, CDCl3) δ = 197.8, 168.6, 122.7, 96.4, 73.0, 71.5, 55.8, 50.7, 
43.3, 41.3, 35.8, 31.1, 26.0 (3C), 18.2, 18.2, 11.0, -3.9, -4.6. HRMS (ESI) Exact mass 
calculated for C20H37O4Si+ [M+H]+: 369.24556, found: 369.24620; for C20H36NaO4Si+ 
[M+Na]+: 391.22751, found: 391.22802. 
 
 
To a mixture of 7S- and 7R-2.86 (425 mg, 1.31 mmol, 1.0 equiv., dr 3:2) in CH2Cl2 (18.0 mL) 
were added Ag2O (911 mg, 3.93 mmol, 3.0 equiv.) and BnBr (470 µL, 3.93 mmol, 3.0 equiv.). 
The mixture was stirred at rt for 2.5 h, before it was filtered through Celite (eluted with CH2Cl2). 
The solvent was evaporated and the residue was purified by flash column chromatography 
(pentane/Et2O 4:1) to give 7S-2.90 (277 mg, 0.668 mmol, 51 %) as colorless oil and 7R-2.90 
(194 mg, 0.468 mmol, 36 %) as colorless solid. 
(3S,4aR,5R,6R)-3-(Benzyloxy)-6-((tert-butyldimethylsilyl)oxy)-4a,5-dimethyl-4,4a,5,6,7,8-
hexahydronaphthalen-2(3H)-one (7S-2.90): 
TLC: Rf = 0.65 (SiO2, pentane/Et2O 3:1). Optical rotation: [𝛼𝛼]*%+ = –59.7° (c = 0.32, CHCl3). 
FTIR (neat): ν/ = 2928, 2856, 1674, 1624, 1472, 1463, 1251, 1130, 1098, 1075, 888, 834, 774, 
734, 696, 667 cm−1. 1H NMR (400 MHz, CDCl3) δ = 7.37 – 7.27 (m, 5H), 5.77 (s, 1H), 4.78 
(d, J = 12.1 Hz, 1H), 4.54 (d, J = 12.1 Hz, 1H), 3.85 (dd, J = 7.2, 4.4 Hz, 1H), 3.60 (td, J = 
10.4, 4.6 Hz, 1H), 2.48 (tdd, J = 14.2, 4.9, 1.3 Hz, 1H), 2.25 (ddd, J = 13.7, 4.5, 2.7 Hz, 1H), 
2.15 – 2.05 (m, 2H), 1.97 (dd, J = 14.4, 4.5 Hz, 1H), 1.49 – 1.36 (m, 2H), 1.21 (s, 3H), 1.00 (d, 
J = 6.8 Hz, 3H), 0.89 (s, 9H), 0.07 (s, 3H), 0.07 (s, 3H). 13C NMR (101 MHz, CDCl3) δ = 197.2, 
170.3, 138.4, 128.5 (2C), 127.7 (2C), 127.7, 121.8, 76.1, 72.2, 72.0, 49.1, 41.0, 40.2, 37.1, 31.5, 
26.0 (3C), 21.7, 18.2, 11.8, -3.8, -4.5. HRMS (ESI) Exact mass calculated for C25H39O3Si+ 
[M+H]+: 415.26630, found: 415.26630. 
(3R,4aR,5R,6R)-3-(Benzyloxy)-6-((tert-butyldimethylsilyl)oxy)-4a,5-dimethyl-
4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one (7R-2.90): 
O
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M.p. = 51.0 – 56.1°C. TLC: Rf = 0.48 (SiO2, pentane/Et2O 3:1). Optical rotation: [𝛼𝛼]*%+ = 
+91.7° (c = 0.29, CHCl3). FTIR (neat): ν/ = 2928, 2856, 1693, 1623, 1472, 1462, 1253, 1217, 
1128, 1103, 1080, 1062, 889, 834, 774, 696, 679 cm−1. 1H NMR (400 MHz, CDCl3) δ = 7.44 
– 7.39 (m, 2H), 7.39 – 7.32 (m, 2H), 7.31 – 7.27 (m, 1H), 5.71 (d, J = 1.4 Hz, 1H), 5.03 (d, J 
= 11.8 Hz, 1H), 4.66 (d, J = 11.8 Hz, 1H), 4.04 (dd, J = 13.7, 5.2 Hz, 1H), 3.54 (td, J = 10.5, 
4.4 Hz, 1H), 2.43 – 2.27 (m, 2H), 2.24 (dd, J = 12.7, 5.2 Hz, 1H), 2.02 (dtd, J = 12.3, 4.7, 2.8 
Hz, 1H), 1.77 (t, J = 13.2 Hz, 1H), 1.45 (dddd, J = 13.9, 12.5, 11.1, 5.0 Hz, 1H), 1.39 – 1.32 
(m, 1H), 1.13 (s, 3H), 0.97 (d, J = 6.8 Hz, 3H), 0.89 (s, 9H), 0.07 (s, 3H), 0.06 (s, 3H). 13C NMR 
(101 MHz, CDCl3) δ = 198.8, 168.3, 138.4, 128.5 (2C), 128.1 (2C), 127.9, 122.8, 75.4, 72.9, 
71.5, 50.7, 43.2, 41.4, 35.9, 31.0, 26.0 (3C), 18.2, 18.1, 11.0, -3.9, -4.5. HRMS (ESI) Exact 
mass calculated for C25H39O3Si+ [M+H]+: 415.26630, found: 415.26630. 
 
 
(3S,4aR,5R,6R)-3-Allyl-3-(benzyloxy)-6-((tert-butyldimethylsilyl)oxy)-4a,5-dimethyl-
4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one (2.91): To a cooled (–78°C) solution of 2.90 
(1.50 g, 3.62 mmol, 1.0 equiv.) in THF (38 mL) was added dropwise a solution of LiHMDS 
(1.0 M in THF, 8.70 mL, 8.70 mmol, 2.4 equiv.). The mixture was stirred for 60 min, before 
DMPU (1.75 mL, 14.5 mmol, 4.0 equiv.) was added and stirring was continued for further 
30 min at –78°C. Then allyl iodide (2.64 mL, 29.0 mmol, 8.0 equiv.), freshly filtered through a 
plug of K2CO3, was added dropwise. The mixture was immediately warmed up to –40°C and 
stirred for 16 h between –35.5°C and –39.5°C. The mixture was quenched by addition of sat. 
aq. NH4Cl solution and extracted with Et2O (3 x). The combined organic layers were dried over 
Na2SO4, filtered and concentrated. The crude mixture was subjected to flash column 
chromatography (pentane/Et2O 10:1) to give 2.91 (1.24 g, 2.73 mmol, 75 %) as a colorless oil. 
TLC: Rf = 0.87 (SiO2, pentane/Et2O 3:1). Optical rotation: [𝛼𝛼]*%1 = –10.8° (c = 1.06, CHCl3). 
FTIR (neat): ν/ = 2929, 2857, 1671, 1628, 1498, 1462, 1386, 1257, 1074, 888, 835, 774, 733, 
697 cm−1. 1H NMR (500 MHz, CDCl3) δ = 7.32 – 7.25 (m, 2H), 7.26 – 7.19 (m, 3H), 5.80 (d, 
J = 1.4 Hz, 1H), 5.84 – 5.71 (m, 1H), 5.17 – 5.11 (m, 1H), 5.11 (s, 1H), 4.49 (d, J = 11.4 Hz, 
1H), 4.19 (d, J = 11.3 Hz, 1H), 3.56 (td, J = 10.5, 4.5 Hz, 1H), 2.85 (dd, J = 14.7, 7.2 Hz, 1H), 
2.45 (td, J = 14.0, 4.6 Hz, 1H), 2.40 – 2.31 (m, 2H), 2.28 (ddd, J = 14.4, 4.4, 2.6 Hz, 1H), 2.10 
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– 2.01 (m, 1H), 1.60 (d, J = 14.9 Hz, 1H), 1.49 – 1.37 (m, 1H), 1.26 (s, 3H), 1.31 – 1.23 (m, 
1H), 0.98 (d, J = 6.7 Hz, 3H), 0.88 (s, 9H), 0.07 (s, 3H), 0.06 (s, 3H). 13C NMR (126 MHz, 
CDCl3) δ = 196.5, 170.4, 138.7, 133.3, 128.3 (2C), 127.5 (2C), 127.4, 121.9, 118.7, 77.5, 71.6, 
65.7, 51.9, 46.7, 39.7, 36.4, 36.2, 31.7, 26.0 (3C), 21.1, 18.2, 11.2, -3.8, -4.5. HRMS (ESI) 
Exact mass calculated for C28H43O3Si+ [M+H]+: 455.29760, found: 455.29783. 
 
 
2-((2R,7R,8R,8aR)-2-(Benzyloxy)-7-((tert-butyldimethylsilyl)oxy)-8,8a-dimethyl-3-oxo-
1,2,3,5,6,7,8,8a-octahydronaphthalen-2-yl)acetaldehyde (2.92): A solution of 2.91 (430 mg, 
0.946 mmol, 1.0 equiv.), pyridine (305 µL, 3.78 mmol, 4.0 equiv.) and Sudan III (spatula tip) 
in CH2Cl2/MeOH (26 mL, 1:1) was cooled to –78°C and O3 was bubbled through the solution 
until the red color disappeared (7 min). The reaction mixture was sequentially purged with O2 
and N2, before PPh3 (496 mg, 1.89 mmol, 2.0 equiv.) was added and the mixture was allowed 
to warm up to rt. After stirring for 2 h, the solvent was removed by evaporation and the residue 
was subjected to flash column chromatography (pentane/Et2O 3:1) to give 2.92 (376 mg, 
0.946 mmol, 87 %) as a colorless oil. 
TLC: Rf = 0.31 (SiO2, pentane/Et2O 3:1). Optical rotation: [𝛼𝛼]*%2 = –19.0° (c = 0.30, CHCl3). 
FTIR (neat): ν/ = 2951, 2857, 1723, 1673, 1626, 1473, 1387, 1251, 1127, 1100, 1071, 888, 836, 
775, 734, 697. cm−1. 1H NMR (500 MHz, CDCl3) δ = 9.79 (t, J = 2.4 Hz, 1H), 7.34 – 7.19 (m, 
5H), 5.85 (d, J = 1.5 Hz, 1H), 4.50 (d, J = 11.2 Hz, 1H), 4.25 (d, J = 11.2 Hz, 1H), 3.57 (td, J 
= 10.5, 4.5 Hz, 1H), 2.96 (dd, J = 15.8, 2.5 Hz, 1H), 2.86 (dd, J = 15.8, 2.5 Hz, 1H), 2.51 – 
2.43 (m, 1H), 2.43 (d, J = 14.4 Hz, 1H), 2.31 (ddd, J = 14.3, 4.4, 2.5 Hz, 1H), 2.12 – 2.02 (m, 
1H), 1.84 (d, J = 14.8 Hz, 1H), 1.46 (dddd, J = 15.0, 12.4, 10.9, 4.5 Hz, 1H), 1.35 – 1.24 (m, 
1H), 1.28 (s, 3H), 0.97 (d, J = 6.7 Hz, 3H), 0.88 (s, 9H), 0.07 (s, 3H), 0.06 (s, 3H). 13C NMR 
(126 MHz, CDCl3) δ = 200.9, 194.9, 171.2, 137.9, 128.5 (2C), 127.7, 127.6 (2C), 121.2, 77.5, 
71.4, 66.2, 51.8, 47.4, 45.9, 40.0, 36.3, 31.8, 25.9 (3C), 21.2, 18.1, 11.2, -3.9, -4.6. HRMS 
(ESI) Exact mass calculated for C27H41O4Si+ [M+H]+: 457.27686, found: 457.27718. 
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2-((2R,7R,8R,8aR)-2-(Benzyloxy)-7-((tert-butyldimethylsilyl)oxy)-8,8a-dimethyl-3-oxo-
1,2,3,5,6,7,8,8a-octahydronaphthalen-2-yl)acrylaldehyde (2.93): Eschenmoser's salt 
(16.5 mg, 87.5 µmol, 5.0 equiv.) was added to a solution of 2.92 (8.00 mg, 17.5 µmol, 
1.0 equiv.) and Et3N (25 µL, 175 µmol, 10 equiv.) in CH2Cl2 (1.0 mL) at rt. The mixture was 
stirred for 18.5 h and then quenched by addition of sat. aq. NaHCO3 solution. The layers were 
separated and the aqueous layer was extracted with CH2Cl2 (2 x). The combined organic layers 
were dried over Na2SO4, filtered and concentrated. The residue was subjected to flash column 
chromatography (pentane/Et2O 3:1) to give 2.93 (6.4 mg, 13.7 µmol, 78 %) as a colorless solid. 
M.p. = 129.1 – 132.2°C. TLC: Rf = 0.29 (SiO2, pentane/Et2O 3:1), 0.63 (SiO2, pentane/Et2O 
1:1). Optical rotation: [𝛼𝛼]*%2 = –13.5° (c = 0.42, CHCl3). FTIR (neat): ν/ = 2928, 2856, 1700, 
1671, 1627, 1462, 1293, 1251, 1116, 1099, 1069, 888, 834, 774, 733, 699, 683 cm−1. 1H NMR 
(500 MHz, CDCl3) δ = 9.60 (s, 1H), 7.34 – 7.25 (m, 5H), 6.55 (s, 1H), 6.26 (s, 1H), 5.88 (d, J 
= 1.5 Hz, 1H), 4.42 (d, J = 12.0 Hz, 1H), 4.15 (d, J = 12.0 Hz, 1H), 3.56 (td, J = 10.5, 4.4 Hz, 
1H), 2.51 – 2.43 (m, 1H), 2.32 (ddd, J = 14.5, 4.5, 2.7 Hz, 1H), 2.18 (d, J = 14.5 Hz, 1H), 2.08 
(d, J = 14.7 Hz, 1H), 2.06 – 2.02 (m, 1H), 1.56 – 1.47 (m, 1H), 1.38 (dq, J = 9.9, 6.7 Hz, 1H), 
1.33 (s, 3H), 0.92 (d, J = 6.7 Hz, 3H), 0.87 (s, 9H), 0.05 (s, 3H), 0.05 (s, 3H). 13C NMR (126 
MHz, CDCl3) δ = 193.2, 193.1, 170.6, 149.9, 138.1, 135.4, 128.4 (2C), 127.4, 127.0 (2C), 
122.0, 80.2, 71.4, 66.4, 51.2, 48.3, 39.7, 36.0, 31.7, 25.8 (3C), 21.7, 18.0, 11.1, -4.0, -4.7. 
HRMS (ESI) Exact mass calculated for C28H40NaO4Si+ [M+Na]+: 491.25881, found: 
491.25899. 
 
 
2-((2R,7R,8R,8aR)-2-(Benzyloxy)-7-((tert-butyldimethylsilyl)oxy)-8,8a-dimethyl-3-oxo-
1,2,3,5,6,7,8,8a-octahydronaphthalen-2-yl)propanal (6.5): A solution of 2.93 (19.1 mg, 
40.8 µmol, 1.0 equiv.) and Et3SiH (33 µL, 204 µmol, 5.0 equiv.) in THF (0.5 mL) was added 
to a suspension of PdCl2 (0.36 mg, 5 mol%) and PCy3 (1.14 mg, 10 mol%) in H2O (0.5 mL). 
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The mixture was stirred at rt and additional Et3SiH (33 µL, 204 µmol, 5.0 equiv.) was added 
after 1 and 2 h. After in total 3 h at rt, the mixture was filtered through a short pad of Al2O3 
(eluted with Et2O) and the solvent was evaporated. The crude residue was subjected to flash 
column chromatography (pentane/Et2O 5:1) to give 6.5 (14.5 mg, 30.8 µmol, 76 %, dr 7:1). 
TLC: Rf = 0.58 (SiO2, pentane/Et2O 3:1, major diastereoisomer) and 0.65 (SiO2, pentane/Et2O 
3:1, minor diastereoisomer). FTIR (neat): ν/ = 2952, 2929, 2856, 1723, 1669, 1628, 1462, 1250, 
1099, 1072, 888, 835, 774, 733, 697 cm−1. 1H NMR (500 MHz, CDCl3) δ = 9.60 (s, 1H), 7.35 
– 7.19 (m, 5H), 5.90 (d, J = 1.5 Hz, 1H), 4.36 (d, J = 11.2 Hz, 1H), 4.19 (d, J = 11.3 Hz, 1H), 
3.71 (q, J = 7.3 Hz, 1H), 3.56 (td, J = 10.4, 4.5 Hz, 1H), 2.47 (tdd, J = 14.5, 5.1, 1.6 Hz, 1H), 
2.32 (ddd, J = 14.4, 4.6, 2.7 Hz, 1H), 2.26 (d, J = 14.6 Hz, 1H), 2.06 (dtd, J = 12.4, 4.8, 2.6 
Hz, 1H), 1.50 (d, J = 14.6 Hz, 1H), 1.46 (s, 1H), 1.29 (dt, J = 9.9, 6.7 Hz, 1H), 1.25 (s, 3H), 
1.16 (d, J = 7.3 Hz, 3H), 0.97 (t, J = 8.0 Hz, Et3SiOH), 0.95 (d, J = 6.7 Hz, 3H), 0.88 (s, 9H), 
0.60 (q, J = 8.0 Hz, Et3SiOH), 0.06 (s, 6H). 13C NMR (126 MHz, CDCl3) δ = 202.7, 195.3, 
171.1, 138.0, 128.4 (2C), 127.6, 127.5 (2C), 121.9, 78.2, 71.5, 65.5, 51.8, 46.1, 43.0, 39.7, 36.2, 
31.8, 25.9 (3C), 21.6, 18.1, 11.2, 6.8, 6.7 (Et3SiOH), 6.0 (Et3SiOH), -3.8, -4.6. HRMS (ESI) 
Exact mass calculated for C28H42NaO4Si+ [M+Na]+: 493.27446, found: 493.27455. 
 
 
2-((2R,8R,8aR)-2-(Benzyloxy)-8,8a-dimethyl-3,7-dioxo-1,2,3,5,6,7,8,8a-
octahydronaphthalen-2-yl)propanal (2.96): To a solution of 6.5 (16.2 mg, 34.5 µmol, 
1.0 equiv.) in MeCN (1.5 mL) was added a solution of HF (48 % in H2O, 14.5 µL, 345 µmol, 
10 equiv.) and the mixture was allowed to stir for 4 h, before it was quenched by addition of 
sat. aq. NaHCO3 solution. The mixture was extracted with Et2O (3 x) and the combined organic 
layers were washed with H2O, dried over Na2SO4, filtered and concentrated. The residue was 
purified by flash column chromatography (pentane/Et2O 1:2) to give the alcohol 6.6 (11.4 mg, 
32.0 µmol, 93 %, dr 7:1) as a colorless oil.  
NaHCO3 (21.5 mg, 256 µmol, 8.0 equiv.) and DMP (27.1 mg, 64 µmol, 2.0 equiv.) were added 
sequentially to a solution of 6.6 (11.4 mg, 32.0 mmol, 1.0 equiv.) in CH2Cl2 (1.2 mL) at rt and 
the mixture was stirred for 50 min at this temperature. The mixture was diluted with CH2Cl2 
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and sat. aq. Na2S2O3 solution was added. The layers were separated and the aqueous layer was 
extracted with CH2Cl2 (2 x). The combined organic layers were washed with H2O, dried over 
Na2SO4, filtered and concentrated. The residue was purified by flash column chromatography 
(pentane/Et2O 1:1) to give 2.96 (8.8 mg, 24.8 µmol, 72 %, dr 10:1) as a colorless solid. 
TLC: Rf = 0.23 (SiO2, pentane/Et2O 1:1). FTIR (neat): ν/ = 2977, 2943, 1717, 1670, 1498, 1455, 
1387, 1276, 1241, 1179, 1053, 883, 739, 699 cm−1. 1H NMR (500 MHz, CDCl3) δ = 9.66 (s, 
1H), 7.33 – 7.27 (m, 3H), 7.24 – 7.19 (m, 2H), 6.05 (d, J = 1.7 Hz, 1H), 4.38 (d, J = 11.2 Hz, 
1H), 4.17 (d, J = 11.2 Hz, 1H), 3.75 (q, J = 7.4 Hz, 1H), 2.84 (dtd, J = 15.1, 10.6, 10.1, 1.9 Hz, 
1H), 2.74 (dt, J = 15.1, 4.9 Hz, 1H), 2.59 – 2.52 (m, 2H), 2.43 (q, J = 6.7 Hz, 1H), 2.21 (d, J = 
14.5 Hz, 1H), 1.84 (d, J = 14.6 Hz, 1H), 1.21 – 1.19 (m, 6H), 1.03 (d, J = 6.7 Hz, 3H). 13C NMR 
(126 MHz, CDCl3) δ = 209.1, 202.6, 195.0, 166.4, 137.6, 128.5 (2C), 127.8, 127.5 (2C), 123.0, 
78.0, 65.7, 55.3, 45.8, 42.6, 41.9, 40.3, 32.7, 22.3, 7.4, 7.0. HRMS (ESI) Exact mass calculated 
for C22H26NaO4+ [M+Na]+: 377.17233, found: 377.17239. 
 
 
(1R,7R,8aS,9R,10R)-7-(Benzyloxy)-10-hydroxy-1,8a,9-trimethyl-1,7,8,8a-tetrahydro-1,7-
ethanonaphthalene-2,6-dione (2.97): A solution of DBU (2.5 µL, 16.9 µmol, 3.0 equiv.) in 
CH2Cl2 (0.2 mL) was added to 2.96 (2.0 mg, 5.6 µmol, 1.0 equiv.) in CH2Cl2 (0.1 mL) and the 
mixture was stirred under an O2 atmosphere at –4°C for 2 d. Sat. aq. NH4Cl solution 
and CH2Cl2 were added and the layers were separated. The aqueous layer was extracted 
with CH2Cl2 (2 x) and the combined organic layers were dried over Na2SO4, filtered and 
concentrated. The residue was purified by preparative TLC (Et2O) to give 2.97 (0.4 mg, 
1.1 µmol, 20 %, dr > 10:1) as a colorless solid. 
TLC: Rf = 0.58 (SiO2, Et2O). 1H NMR (600 MHz, CDCl3) δ = 7.45 (s, 2H), 7.37 – 7.33 (m, 
2H), 7.29 (s, 2H), 6.10 (d, J = 1.0 Hz, 1H), 6.07 (d, J = 10.1 Hz, 1H), 4.56 (d, J = 10.8 Hz, 
1H), 4.42 (d, J = 10.8 Hz, 1H), 3.54 (dd, J = 10.4, 3.7 Hz, 1H), 2.32 (d, J = 13.5 Hz, 1H), 2.34 
– 2.27 (m, 1H), 2.11 (d, J = 13.4 Hz, 1H), 2.00 (dq, J = 10.3, 6.7 Hz, 1H), 1.29 (s, 3H), 1.29 
(s, 3H), 1.06 (d, J = 6.6 Hz, 3H). 13C NMR (151 MHz, CDCl3) δ = 199.6, 194.9, 158.6, 141.3, 
137.6, 128.6, 127.3 (2C), 126.5, 126.4 (2C), 124.8, 80.3, 72.7, 64.7, 54.4, 43.8, 42.5, 35.9, 23.6, 
DBU, CH2Cl2
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11.2, 6.9. HRMS (ESI) Exact mass calculated for C22H24NaO4+ [M+Na]+: 375.15668, found: 
375.15682. 
 
 
(3S,4aR,5R,6R)-3-Allyl-6-((tert-butyldimethylsilyl)oxy)-3-hydroxy-4a,5-dimethyl-
4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one (2.99): To a stirred solution of 2.91 (50 mg, 
110 µmol, 1.0 equiv.) in CH2Cl2 (2.5 mL) at –78°C was added dropwise a solution of BCl3 
(1.0 M in CH2Cl2, 440 µL, 440 µmol, 4.0 equiv.) and the mixture was stirred for 20 min at this 
temperature, before it was allowed to warm up to –50°C and stirred for an additional 1 h. The 
mixture was quenched by slowly addition (crucial) of an aqueous NaOH solution (1.0 M) and 
then warmed up to rt. The layers were separated and the aqueous layer was extracted with 
CH2Cl2 (2 x). The combined organic layers were dried over Na2SO4, filtered and concentrated. 
The residue was subjected to flash column chromatography (pentane/Et2O 3:1) to give 2.99 
(30.0 mg, 82.3 µmol, 75 %) as a colorless solid. 
M.p. = 132.4 – 133.8°C. TLC: Rf = 0.10 (SiO2, pentane/Et2O 5:1). Optical rotation: [𝛼𝛼]*%( = 
+28.2° (c = 0.80, CHCl3). FTIR (neat): ν/ = 3394, 2953, 2855, 1661, 1619, 1463, 1359, 1250, 
1124, 1101, 1073, 1000, 918, 891, 834, 774, 579 cm−1. 1H NMR (500 MHz, CDCl3) δ = 5.81 
(d, J = 1.8 Hz, 1H), 5.86 – 5.76 (m, 1H), 5.16 (ddd, J = 10.1, 2.0, 1.0 Hz, 1H), 5.11 (dq, J = 
17.0, 1.5 Hz, 1H), 3.59 (ddd, J = 11.0, 9.8, 4.6 Hz, 1H), 2.73 (s, 1H), 2.55 – 2.43 (m, 2H), 2.39 
(ddt, J = 13.9, 7.7, 1.1 Hz, 1H), 2.30 (ddd, J = 14.2, 4.4, 2.8 Hz, 1H), 2.08 (ddd, J = 12.9, 4.9, 
2.9 Hz, 1H), 2.04 (d, J = 14.9 Hz, 1H), 1.88 (d, J = 14.8 Hz, 1H), 1.57 – 1.51 (m, 1H), 1.50 – 
1.40 (m, 1H), 1.18 (s, 3H), 1.04 (d, J = 6.6 Hz, 3H), 0.89 (s, 9H), 0.08 (s, 3H), 0.07 (s, 3H). 
13C NMR (126 MHz, CDCl3) δ = 199.9, 170.8, 132.7, 121.0, 119.7, 73.6, 72.1, 48.9, 44.6, 44.4, 
40.2, 36.5, 31.5, 26.0 (3C), 22.8, 18.2, 12.0, -3.8, -4.5. HRMS (ESI) Exact mass calculated for 
C21H36NaO3Si+ [M+Na]+: 387.23259, found: 387.23238. 
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2-((2R,7R,8R,8aR)-7-((tert-Butyldimethylsilyl)oxy)-2-hydroxy-8,8a-dimethyl-3-oxo-
1,2,3,5,6,7,8,8a-octahydronaphthalen-2-yl)acetaldehyde (2.100): A solution of 2.99 (30 mg, 
82.3 µmol, 1.0 equiv.), pyridine (26.5 µL, 329 µmol, 4.0 equiv.) and Sudan III (spatula tip) in 
CH2Cl2/MeOH (3.0 mL, 1:1) was cooled to –78°C and O3 was bubbled through the solution 
until the red color disappeared (2 min). The reaction mixture was purged with O2 and N2. PPh3 
(43.2 mg, 165 µmol, 2.0 equiv.) was added and the mixture was allowed to warm up to rt. After 
stirring for 90 min, the solvent was removed by evaporation and the residue was purified by 
flash column chromatography (pentane/Et2O 1:1) to give 2.100 (26.6 mg, 72.6 µmol, 88 %) as 
a colorless solid. 
M.p. = 113.3 – 117.6°C. TLC: Rf = 0.27 (SiO2, pentane/Et2O 1:2). Optical rotation: [𝛼𝛼]*%+ = 
+29.8° (c = 1.26, CHCl3). FTIR (neat): ν/ = 3425, 2930, 2857, 1719, 1672, 1626, 1463, 1387, 
1250, 1100, 1068, 887, 835, 774 cm−1. 1H NMR (500 MHz, CDCl3) δ = 9.97 (s, 1H), 5.82 (d, 
J = 1.5 Hz, 1H), 3.92 (s, 1H), 3.58 (td, J = 10.4, 4.5 Hz, 1H), 2.79 (dd, J = 15.8, 1.9 Hz, 1H), 
2.53 – 2.46 (m, 1H), 2.47 (d, J = 16.1 Hz, 1H), 2.32 (ddd, J = 14.5, 4.5, 2.7 Hz, 1H), 2.18 (d, 
J = 14.5 Hz, 1H), 2.06 (dtd, J = 12.5, 4.9, 2.7 Hz, 1H), 1.74 (d, J = 14.5 Hz, 1H), 1.44 (dddd, 
J = 14.9, 12.4, 10.9, 4.5 Hz, 1H), 1.36 – 1.30 (m, 1H), 1.29 (s, 3H), 0.99 (d, J = 6.7 Hz, 3H), 
0.88 (s, 9H), 0.07 (s, 3H), 0.06 (s, 3H). 13C NMR (126 MHz, CDCl3) δ = 202.7, 197.0, 171.1, 
120.6, 76.0, 71.5, 50.9, 49.3, 47.7, 40.2, 36.3, 31.7, 26.0 (3C), 21.2, 18.2, 11.3, -3.9, -4.6. 
HRMS (ESI) Exact mass calculated for C20H35O4Si+ [M+H]+: 367.22991, found: 367.23002. 
 
 
(4aR,5R,6R)-6-((tert-Butyldimethylsilyl)oxy)-4a,5-dimethyl-3-((triethylsilyl)oxy)-
4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one (2.103): To a stirred mixture of 7S- and 7R-
2.86 (29.0 mg, 89.4 µmol, 1.0 equiv., dr 5:3) in CH2Cl2 (1.0 mL) at rt were added imidazole 
(18.3 mg, 0.268 mmol, 3.0 equiv.) and TESCl (27 µL, 0.161 mmol, 1.8 equiv.). The mixture 
was stirred for 90 min, before it was quenched by addition of sat. aq. NH4Cl solution. The layers 
were separated and the aqueous layer was extracted with CH2Cl2 (2 x). The combined organic 
layers were dried over Na2SO4, filtered and concentrated. The residue was subjected to flash 
column chromatography (pentane/Et2O 15:1) to give 2.103 (26.6 mg, 60.6 µmol, 68 %, dr 5:3) 
as a colorless oil. 
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TLC: Rf = 0.47 (SiO2, pentane/Et2O 10:1). FTIR (neat): ν/ = 2953, 2929, 2877, 2857, 1698, 
1625, 1462, 1252, 1147, 1099, 1077, 889, 835, 774, 743 cm−1. 1H NMR (500 MHz, CDCl3, 
signals from the major diastereoisomer are marked with a, those from the minor diastereoisomer 
with b) δ = 5.72a (d, J = 1.4 Hz, 1H), 5.69b (d, J = 1.6 Hz, 1H), 4.28b (dd, J = 13.4, 5.3 Hz, 1H), 
4.14a (dd, J = 9.0, 4.6 Hz, 1H), 3.63a (ddd, J = 10.9, 9.7, 4.8 Hz, 1H), 3.55b (td, J = 10.5, 4.4 
Hz, 1H), 2.48a (tdd, J = 14.4, 5.0, 1.6 Hz, 1H), 2.37b (tdd, J = 14.3, 5.0, 1.7 Hz, 1H), 2.29b 
(ddd, J = 14.5, 4.6, 2.1 Hz, 1H), 2.23a (ddd, J = 13.5, 4.6, 2.7 Hz, 1H), 2.16b (dd, J = 12.9, 5.3 
Hz, 1H), 2.11a (dtd, J = 12.5, 4.9, 2.7 Hz, 1H), 2.05 – 1.96a+b (m, 2H), 1.91a (dd, J = 14.2, 9.0 
Hz, 1H), 1.77b (t, J = 13.2 Hz, 1H), 1.54 – 1.33a+b (m, 4H), 1.19b (s, 3H), 1.16a (s, 3H), 1.04a 
(d, J = 6.7 Hz, 3H), 0.99b (d, J = 6.2 Hz, 3H), 0.97a+b (t, J = 4.0 Hz, 18H), 0.90a (s, 9H), 0.89b 
(s, 9H), 0.69 – 0.60a+b (m, 12H), 0.10 – 0.05a+b (m, 12H). 13C NMR (126 MHz, CDCl3, signals 
from the major diastereoisomer are marked with a, those from the minor diastereoisomer with b) 
δ = 198.5b, 197.9a, 169.5a, 167.7b, 122.6b, 121.5a, 72.2a, 71.5b, 70.7a, 70.4b, 50.7b, 48.2a, 46.2b, 
43.0a, 41.3b, 40.5a, 37.4a, 35.9b, 31.3a, 31.1b, 29.9b, 26.0a (3C), 26.0b (3C), 21.9a, 18.2a, 18.1b, 
12.1a, 11.0b, 7.0b (3C), 6.9a (3C), 5.1b (3C), 4.9a (3C), -3.9a+b, -4.5a, -4.5b. HRMS (ESI) Exact 
mass calculated for C24H47O3Si2+ [M+H]+: 439.30582, found: 439.30569. 
 
 
To a mixture of 7S- and 7R-2.86 (291 mg, 0.897 mmol, 1.0 equiv., dr 3:2) and DIPEA (890 µL, 
5.38 mmol, 6.0 equiv.) in CH2Cl2 (14 mL) was added SEMCl (476 µL, 2.69 mmol, 3.0 equiv.). 
The mixture was stirred at rt for 29 h, before it was diluted with CH2Cl2 and sat. aq. NaHCO3 
solution. The layers were separated and the aqueous layer was extracted with CH2Cl2 (2 x). The 
combined organic layers were dried over Na2SO4, filtered and concentrated. The residue was 
subjected to flash column chromatography (pentane/Et2O 3:1) to give 7S-2.105 (227 mg, 
0.499 mmol, 56 %) and 7R-2.105 (113 mg, 0.248 mmol, 28 %) both as colorless oils. 
(3S,4aR,5R,6R)-6-((tert-Butyldimethylsilyl)oxy)-4a,5-dimethyl-3-((2-(trimethylsilyl)-
ethoxy)methoxy)-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one (7S-2.105): 
TLC: Rf = 0.57 (SiO2, pentane/Et2O 3:1). Optical rotation: [𝛼𝛼]*%( = –81.8° (c = 0.34, CHCl3). 
FTIR (neat): ν/ = 2953, 1694, 1472, 1250, 1098, 1076, 1031, 887, 835, 774 cm−1. 1H NMR 
(500 MHz, CDCl3) δ = 5.75 (d, J = 1.3 Hz, 1H), 4.83 (d, J = 6.9 Hz, 1H), 4.79 (d, J = 6.9 Hz, 
O
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1H), 4.18 (dd, J = 10.0, 4.7 Hz, 1H), 3.72 – 3.66 (m, 1H), 3.66 – 3.58 (m, 2H), 2.53 – 2.45 (m, 
1H), 2.23 (ddd, J = 13.4, 4.7, 2.7 Hz, 1H), 2.15 – 2.09 (m, 2H), 1.90 (dd, J = 14.1, 10.0 Hz, 
1H), 1.63 (dq, J = 9.5, 6.7 Hz, 1H), 1.48 – 1.38 (m, 1H), 1.15 (s, 3H), 1.05 (d, J = 6.7 Hz, 3H), 
0.97 – 0.91 (m, 2H), 0.89 (s, 9H), 0.08 (s, 3H), 0.07 (s, 3H), 0.02 (s, 9H). 13C NMR (101 MHz, 
CDCl3) δ = 197.3, 170.2, 121.7, 94.4, 73.0, 72.2, 65.6, 47.8, 40.6, 40.1, 37.6, 31.2, 26.0 (3C), 
22.0, 18.3, 18.2, 12.2, -1.3 (3C), -3.8, -4.6. HRMS (ESI) Exact mass calculated for 
C24H46NaO4Si2+ [M+Na]+: 477.28268, found: 477.28318. 
3R,4aR,5R,6R)-6-((tert-Butyldimethylsilyl)oxy)-4a,5-dimethyl-3-((2-(trimethylsilyl)-
ethoxy)methoxy)-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one (7R-2.105): 
TLC: Rf = 0.38 (SiO2, pentane/Et2O 3:1). Optical rotation: [𝛼𝛼]*%& = +96.0° (c = 0.87, CHCl3). 
FTIR (neat): ν/ = 2952, 2930, 2886, 2858, 1694, 1625, 1463, 1250, 1220, 1189, 1127, 1099, 
1076, 1057, 1040, 889, 862, 834, 774, 693 cm−1. 1H NMR (400 MHz, CDCl3) δ = 5.72 (d, J = 
1.6 Hz, 1H), 4.91 (d, J = 7.0 Hz, 1H), 4.87 (d, J = 7.0 Hz, 1H), 4.30 (dd, J = 13.8, 5.3 Hz, 1H), 
3.70 (dtd, J = 32.2, 9.9, 6.3 Hz, 2H), 3.56 (td, J = 10.5, 4.4 Hz, 1H), 2.44 – 2.30 (m, 2H), 2.27 
(dd, J = 12.8, 5.4 Hz, 1H), 2.07 – 1.99 (m, 1H), 1.74 (t, J = 13.3 Hz, 1H), 1.51 – 1.40 (m, 1H), 
1.40 – 1.33 (m, 1H), 1.21 (s, 3H), 0.99 (d, J = 6.7 Hz, 3H), 0.97 – 0.90 (m, 2H), 0.89 (s, 9H), 
0.08 (s, 3H), 0.07 (s, 3H), 0.03 (s, 9H). 13C NMR (101 MHz, CDCl3) δ = 197.9, 168.4, 122.8, 
94.7, 73.0, 71.5, 65.6, 50.7, 43.4, 41.3, 35.8, 31.1, 26.0 (3C), 18.3, 18.2, 18.2, 11.0, -1.2 
(3C), -3.9, -4.5. HRMS (ESI) Exact mass calculated for C24H46NaO4Si2+ [M+Na]+: 477.28268, 
found: 477.28318. 
 
 
(3S,4aR,5R,6R)-3-Allyl-6-((tert-butyldimethylsilyl)oxy)-4a,5-dimethyl-3-((triethylsilyl)-
oxy)-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one (2.104): To a stirred solution of 2.99 
(24.0 mg, 65.8 µmol, 1.0 equiv.) in CH2Cl2 (1.5 mL) at 0°C were added 2,6-lutidine (23 µL, 
0.197 mmol, 3.0 equiv.) and TESOTf (30 µL, 0.132 mmol, 2.0 equiv.). The mixture was stirred 
for 1 h and then quenched by addition of sat. aq. NH4Cl solution. The layers were separated and 
the aqueous layer was extracted with CH2Cl2 (2 x). The combined organic layers were dried 
over Na2SO4, filtered and concentrated. The residue was subjected to flash column 
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chromatography (pentane/Et2O 10:1) to give 2.104 (26.5 mg, 55.3 µmol, 84 %) as a colorless 
oil. 
TLC: Rf = 0.61 (SiO2, pentane/Et2O 10:1). Optical rotation: [𝛼𝛼]*%1 = +35.1° (c = 0.82, CHCl3). 
FTIR (neat): ν/ = 2953, 2878, 1677, 1628, 1462, 1251, 1127, 1079, 1041, 1007, 914, 890, 836, 
774, 743 cm−1. 1H NMR (500 MHz, CDCl3) δ = 5.76 (d, J = 1.5 Hz, 1H), 5.70 (ddt, J = 20.2, 
9.6, 7.2 Hz, 1H), 5.08 – 5.05 (m, 1H), 5.04 (s, 1H), 3.57 (td, J = 10.4, 4.4 Hz, 1H), 2.55 (dd, J 
= 13.8, 7.0 Hz, 1H), 2.48 – 2.39 (m, 2H), 2.27 (ddd, J = 14.4, 4.5, 2.7 Hz, 1H), 2.08 (d, J = 
14.7 Hz, 1H), 2.06 – 2.01 (m, 1H), 1.58 (d, J = 14.6 Hz, 1H), 1.58 (s, 1H), 1.41 (dddd, J = 15.0, 
12.3, 10.9, 4.5 Hz, 1H), 1.24 (s, 3H), 0.96 (d, J = 6.7 Hz, 3H), 0.93 – 0.82 (m, 18H), 0.56 (q, J 
= 7.6 Hz, 6H), 0.06 (s, 3H), 0.06 (s, 3H). 13C NMR (126 MHz, CDCl3) δ = 197.3, 169.5, 134.1, 
122.4, 118.3, 75.2, 71.6, 51.4, 47.8, 42.6, 39.7, 36.3, 31.6, 26.0 (3C), 20.5, 18.2, 11.3, 7.1 (3C), 
6.3 (3C), -3.8, -4.5. HRMS (ESI) Exact mass calculated for C27H51O3Si2+ [M+H]+: 479.33712, 
found: 479.33737. 
 
 
(3S,4aR,5R,6R)-3-Allyl-6-((tert-butyldimethylsilyl)oxy)-4a,5-dimethyl-3-((2-(trimethyl-
silyl)ethoxy)methoxy)-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one (2.106): To a stirred 
solution of 2.99 (25.0 mg, 68.6 µmol, 1.0 equiv.) in CH2Cl2 (1.5 mL) at rt were added SEMCl 
(49 µL, 0.274 mmol, 4.0 equiv.) and DIPEA (68 µL, 0.412 mmol, 6.0 equiv.). The mixture was 
stirred for 15 h at rt and then quenched by addition of sat. aq. NH4Cl solution. The layers were 
separated and the aqueous layer was extracted with CH2Cl2 (2 x). The combined organic layers 
were dried over Na2SO4, filtered and concentrated. The residue was subjected to flash column 
chromatography (pentane/Et2O 10:1) to give 2.106 (29.3 mg, 59.2 µmol, 86 %) as a colorless 
oil. 
TLC: Rf = 0.57 (SiO2, pentane/Et2O 5:1). Optical rotation: [𝛼𝛼]*%( = +26.8° (c = 1.47, CHCl3). 
FTIR (neat): ν/ = 2952, 2886, 2858, 1675, 1630, 1463, 1438, 1361, 1250, 1197, 1126, 1101, 
1075, 1011, 939, 915, 889, 860, 835, 774, 697, 616 cm−1. 1H NMR (400 MHz, CDCl3) δ = 5.78 
(d, J = 1.4 Hz, 1H), 5.76 – 5.65 (m, 1H), 5.11 (s, 1H), 5.09 – 5.05 (m, 1H), 4.66 (d, J = 6.9 Hz, 
1H), 4.63 (d, J = 6.9 Hz, 1H), 3.58 (dd, J = 10.4, 4.4 Hz, 1H), 3.56 – 3.41 (m, 2H), 2.70 (ddt, 
J = 14.6, 7.2, 1.3 Hz, 1H), 2.44 (tdd, J = 14.4, 5.1, 1.6 Hz, 1H), 2.35 (ddt, J = 14.6, 7.1, 1.3 
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Hz, 1H), 2.30 – 2.23 (m, 1H), 2.26 (d, J = 14.8 Hz, 1H), 2.05 (dtd, J = 12.3, 4.8, 2.6 Hz, 1H), 
1.54 (d, J = 14.9 Hz, 1H), 1.42 (dddd, J = 14.4, 12.5, 10.9, 4.5 Hz, 1H), 1.29 (s, 3H), 1.27 – 
1.20 (m, 1H), 0.97 (d, J = 6.7 Hz, 3H), 0.88 (s, 9H), 0.87 – 0.78 (m, 2H), 0.07 (s, 3H), 0.06 (s, 
3H), -0.02 (s, 9H). 13C NMR (101 MHz, CDCl3) δ = 196.7, 168.6, 133.4, 122.2, 118.7, 89.7, 
76.9, 71.6, 65.9, 51.9, 46.6, 39.5, 37.4, 36.4, 31.6, 26.0 (3C), 20.6, 18.2, 18.0, 11.1, -1.3 
(3C), -3.8, -4.5. HRMS (ESI) Exact mass calculated for C27H50NaO4Si2+ [M+Na]+: 517.31398, 
found: 517.31380. 
 
 
2-((2R,7R,8R,8aR)-7-((tert-Butyldimethylsilyl)oxy)-8,8a-dimethyl-3-oxo-2-((triethylsilyl)-
oxy)-1,2,3,5,6,7,8,8a-octahydronaphthalen-2-yl)acetaldehyde (2.107): A solution of 2.104 
(15.2 mg, 31.7 µmol, 1.0 equiv.), pyridine (10 µL, 0.127 mmol, 4.0 equiv.) and Sudan III 
(spatula tip) in CH2Cl2/MeOH (1.6 mL, 1:1) was cooled to –78°C and O3 was bubbled through 
the solution until the red color disappeared (1 min). The reaction was purged with O2 and N2. 
PPh3 (16.6 mg, 63.4 µmol, 2.0 equiv.) was added and the mixture was allowed to warm up to 
rt. After stirring for 60 min, the solvent was removed by evaporation and the residue was 
subjected to flash column chromatography (pentane/Et2O 7:1) to give 2.107 (12.6 mg, 
26.2 µmol, 83 %) as a colorless oil. 
TLC: Rf = 0.55 (SiO2, pentane/Et2O 5:1). Optical rotation: [𝛼𝛼]*%( = +23.8° (c = 0.63, CHCl3). 
FTIR (neat): ν/ = 2954, 2879, 1725, 1677, 1626, 1462, 1387, 1361, 1251, 1128, 1072, 1007, 
955, 921, 888, 836, 774, 745, 726 cm−1. 1H NMR (400 MHz, CDCl3) δ = 9.72 (t, J = 2.3 Hz, 
1H), 5.82 (d, J = 1.5 Hz, 1H), 3.57 (ddd, J = 10.8, 9.8, 4.5 Hz, 1H), 2.86 (dd, J = 15.7, 2.3 Hz, 
1H), 2.77 (dd, J = 15.7, 2.5 Hz, 1H), 2.47 (tdd, J = 14.4, 5.1, 1.7 Hz, 1H), 2.31 (ddd, J = 14.4, 
4.5, 2.6 Hz, 1H), 2.22 (d, J = 14.5 Hz, 1H), 2.06 (dtd, J = 12.4, 4.9, 2.6 Hz, 1H), 1.74 (d, J = 
14.4 Hz, 1H), 1.51 – 1.39 (m, 1H), 1.32 – 1.23 (m, 1H), 1.27 (s, 3H), 0.96 (d, J = 6.7 Hz, 3H), 
0.91 – 0.86 (m, 18H), 0.60 – 0.53 (m, 6H), 0.06 (s, 3H), 0.06 (s, 3H). 13C NMR (126 MHz, 
CDCl3) δ = 201.1, 195.8, 170.3, 121.7, 74.4, 71.4, 51.5, 51.4, 48.9, 39.9, 36.3, 31.8, 26.0 (3C), 
20.6, 18.2, 11.2, 7.1 (3C), 6.2 (3C), -3.8, -4.5. HRMS (ESI) Exact mass calculated for 
C26H48NaO4Si2+ [M+Na]+: 503.29833, found: 503.29846. 
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2-((2R,7R,8R,8aR)-7-((tert-Butyldimethylsilyl)oxy)-8,8a-dimethyl-3-oxo-2-((2-(trimethyl-
silyl)ethoxy)methoxy)-1,2,3,5,6,7,8,8a-octahydronaphthalen-2-yl)acetaldehyde (2.109): A 
solution of 2.106 (29.3 mg, 59.2 µmol, 1.0 equiv.), pyridine (20 µL, 0.237 mmol, 4 equiv.) and 
Sudan III (traces) in CH2Cl2/MeOH (2.0 mL, 1:1) was cooled to –78°C and O3 was bubbled 
through the solution until the red color disappeared (<1 min). The reaction mixture was purged 
with O2 and N2. PPh3 (31 mg, 0.118 mmol, 2.0 equiv.) was added and the mixture was allowed 
to warm up to rt. After stirring for 60 min, the solvent was removed by evaporation and the 
residue was subjected to flash column chromatography (pentane/Et2O 4:1) to give 2.109 
(24.9 mg, 50.1 µmol, 85 %) as a colorless oil. 
TLC: Rf = 0.19 (SiO2, pentane/Et2O 5:1). Optical rotation: [𝛼𝛼]*%0 = +9.7° (c = 1.24, CHCl3). 
FTIR (neat): ν/ = 2952, 2888, 2857, 1723, 1675, 1628, 1463, 1438, 1386, 1361, 1250, 1196, 
1124, 1100, 1071, 1007, 939, 888, 860, 835, 774, 693 cm−1. 1H NMR (400 MHz, CDCl3) δ = 
9.76 (t, J = 2.3 Hz, 1H), 5.81 (d, J = 1.4 Hz, 1H), 4.68 (s, 2H), 3.62 – 3.49 (m, 3H), 2.93 (dd, 
J = 16.2, 2.3 Hz, 1H), 2.80 (dd, J = 16.2, 2.3 Hz, 1H), 2.45 (tdd, J = 14.4, 5.1, 1.6 Hz, 1H), 
2.38 (d, J = 14.8 Hz, 1H), 2.29 (ddd, J = 14.3, 4.6, 2.7 Hz, 1H), 2.06 (dtd, J = 12.3, 4.9, 2.6 
Hz, 1H), 1.74 (d, J = 14.8 Hz, 1H), 1.44 (dddd, J = 14.4, 12.5, 10.9, 4.5 Hz, 1H), 1.29 (s, 3H), 
1.29 – 1.24 (m, 1H), 0.97 (d, J = 6.7 Hz, 3H), 0.88 (s, 9H), 0.87 – 0.83 (m, 2H), 0.06 (s, 3H), 
0.06 (s, 3H), -0.01 (s, 9H). 13C NMR (101 MHz, CDCl3) δ = 201.0, 195.0, 169.6, 121.4, 90.1, 
76.7, 71.4, 66.2, 51.8, 47.2, 47.1, 39.8, 36.3, 31.7, 25.9 (3C), 20.7, 18.2, 18.0, 11.1, -1.3 
(3C), -3.8, -4.6. HRMS (ESI) Exact mass calculated for C26H48NaO5Si2+ [M+Na]+: 519.29325, 
found: 519.29411. 
 
 
2-((2R,7R,8R,8aR)-7-((tert-Butyldimethylsilyl)oxy)-8,8a-dimethyl-3-oxo-2-((2-(trimethyl-
silyl)ethoxy)methoxy)-1,2,3,5,6,7,8,8a-octahydronaphthalen-2-yl)acrylaldehyde (2.110): 
Eschenmoser's salt (66.3 mg, 0.351 mmol, 3.0 equiv.) was added to a solution of 2.109 
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(58.1 mg, 0.117 mmol, 1.0 equiv.) and DIPEA (116 µL, 0.702 mmol, 6.0 equiv.) in CH2Cl2 
(3.0 mL) at rt. The mixture was stirred for 4.5 h and then quenched by addition of sat. aq. NH4Cl 
solution. The layers were separated and the aqueous layer was extracted with CH2Cl2 (2 x). The 
combined organic layers were dried over Na2SO4, filtered and concentrated. The residue was 
subjected to flash column chromatography (pentane/Et2O 2:1) to give 2.110 (7.7 mg, 
15.1 µmol, 13 %) as a colorless oil. 
TLC: Rf = 0.38 (SiO2, pentane/Et2O 2:1). Optical rotation: [𝛼𝛼]*%( = +33.9° (c = 0.39, CHCl3). 
FTIR (neat): ν/ = 3675, 2954, 2900, 1700, 1676, 1630, 1384, 1292, 1250, 1099, 1074, 1005, 
969, 939, 889, 861, 836, 774, 692 cm−1. 1H NMR (400 MHz, CDCl3) δ = 9.57 (s, 1H), 6.60 (s, 
1H), 6.26 (s, 1H), 5.87 (d, J = 1.6 Hz, 1H), 4.69 (d, J = 6.6 Hz, 1H), 4.58 (d, J = 6.5 Hz, 1H), 
3.63 – 3.48 (m, 3H), 2.47 (tdd, J = 14.4, 5.1, 1.7 Hz, 1H), 2.33 (ddd, J = 14.3, 4.6, 2.6 Hz, 1H), 
2.16 (d, J = 14.7 Hz, 1H), 2.06 (dtd, J = 12.2, 4.8, 2.5 Hz, 1H), 2.01 (d, J = 14.5 Hz, 1H), 1.54 
– 1.47 (m, 1H), 1.40 – 1.35 (m, 1H), 1.34 (s, 3H), 0.93 (d, J = 6.7 Hz, 3H), 0.88 (s, 9H), 0.87 
– 0.78 (m, 2H), 0.07 (s, 3H), 0.06 (s, 3H), -0.01 (s, 9H). 13C NMR (101 MHz, CDCl3) δ = 
193.5, 193.0, 168.6, 150.9, 135.4, 122.6, 90.7, 79.8, 71.6, 66.5, 51.4, 48.1, 39.5, 36.2, 31.7, 
26.0 (3C), 21.2, 18.2, 18.1, 11.2, -1.3 (3C), -3.8, -4.5. HRMS (ESI) Exact mass calculated for 
C27H48NaO5Si2+ [M+Na]+: 531.29325, found: 531.29337. 
 
 
(3R,7R,8R,8aR)-3-((S)-But-3-en-2-yl)-7-((tert-butyldimethylsilyl)oxy)-3-hydroxy-8,8a-di-
methyl-3,5,6,7,8,8a-hexahydronaphthalen-2(1H)-one (11S-2.84): To a solution of 
Rh2(OAc)4 (36.2 mg, 5 mol%) and trans-2-buten-1-ol (2.46 g, 32.8 mmol, 20.0 equiv.) in 
CH2Cl2 (35.0 mL) at rt was added dropwise a solution of 2.82 (550 mg, 1.64 mmol, 1.0 equiv.) 
in CH2Cl2 (10.0 mL) over a period of 15 min and the mixture was stirred for another 1 h at rt. 
The solvent was evaporated and the residue purified by flash column chromatography 
(pentane/Et2O 6:1) to give 11S-2.84 (418 mg, 1.10 mmol, 67 %, dr 2:1) as colorless oil. 
TLC: Rf = 0.67 (SiO2, pentane/Et2O 3:1). FTIR (neat): ν/ = 3488, 2931, 2857, 1718, 1461, 1386, 
1293, 1253, 1145, 1105, 1071, 1006, 890, 837, 775, 675 cm−1. 1H NMR (500 MHz, CDCl3, 
signals from the major diastereoisomer are marked with a, those from the minor diastereoisomer 
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with b) δ = 5.83b (ddd, J = 17.2, 10.3, 8.6 Hz, 1H), 5.71a (ddd, J = 17.1, 10.5, 8.2 Hz, 1H), 5.43a 
(d, J = 1.5 Hz, 1H), 5.35b (d, J = 1.4 Hz, 1H), 5.12b (ddd, J = 10.2, 1.8, 0.6 Hz, 1H), 5.07b 
(ddd, J = 17.2, 1.8, 0.9 Hz, 1H), 5.00a (ddd, J = 10.5, 1.7, 0.8 Hz, 1H), 4.98a (dt, J = 17.2, 1.3 
Hz, 1H), 3.60a+b (s, 2H), 3.49 – 3.41a+b (m, 2H), 2.62b (d, J = 12.3 Hz, 1H), 2.61a (d, J = 12.2 
Hz, 1H), 2.55 – 2.48a (m, 1H), 2.49b (d, J = 12.4 Hz, 1H), 2.48 – 2.41b (m, 1H), 2.44a (d, J = 
12.2 Hz, 1H), 2.27 – 2.16a+b (m, 4H), 2.03 – 1.96a+b (m, 2H), 1.55 – 1.37a+b (m, 4H), 1.15a (d, 
J = 6.8 Hz, 3H), 0.95b (s, 3H), 0.95a (s, 30H), 0.93b (d, J = 6.8 Hz, 3H), 0.92a (d, J = 6.8 Hz, 
3H), 0.91b (d, J = 6.9 Hz, 3H), 0.90a+b (s, 18H), 0.07a+b (s, 12H). 13C NMR (126 MHz, CDCl3, 
signals from the major diastereoisomer are marked with a, those from the minor diastereoisomer 
with b) δ = 212.0b, 211.4a, 144.8a, 144.4b, 138.6a, 138.5b, 124.5b, 123.9a, 116.7b, 115.8a, 78.6a, 
78.3b, 72.1b, 72.1a, 51.1b, 51.0a, 49.7b, 49.6a, 49.0b, 48.7a, 46.8a, 46.7b, 36.8b, 36.7a, 30.2a, 30.1b, 
26.0a+b (6C), 19.8a+b, 18.2b, 18.2a, 15.0b, 13.6a, 11.4a+b, -3.9a+b, -4.6a+b. HRMS (ESI) Exact mass 
calculated for C22H38NaO3Si+ [M+Na]+: 401.2482, found: 401.2486. 
 
 
(3R,4aR,5R,6R)-3-((S)-But-3-en-2-yl)-6-((tert-butyldimethylsilyl)oxy)-3-hydroxy-4a,5-
dimethyl-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one (11S-2.80): A mixture of 11S- and 
11R-2.84 (324 mg, 0.856 mmol, 1.0 equiv., dr 2:1) and Ca(OMe)2 (180 mg, 1.71 mmol, 
2.0 equiv.) in MeOH (20.0 ml) was stirred for 44 h at rt. Sat. aq. NH4Cl solution was added 
slowly and the mixture was diluted with H2O and Et2O. The layers were separated and the 
aqueous layer was extracted with Et2O (2 x). The combined organic layers were dried over 
Na2SO4, filtered and concentrated. The residue was purified by flash column chromatography 
(pentane/Et2O 3:1) to give 11S-2.80 (230 mg, 0.608 mmol, 71 %, dr 2:1) as a colorless solid. 
Purification by additional flash column chromatography (pentane/Et2O 4:1) gave access to 
diastereomerically pure 11S-2.80. 
M.p. = 163.1 – 165.8°C. TLC: Rf = 0.38 (SiO2, pentane/Et2O 3:1). Optical rotation: [𝛼𝛼]*%% = 
–9.0° (c = 0.46, CHCl3). FTIR (neat): ν/ = 3385, 2957, 2855, 1656, 1622, 1461, 1249, 1100, 
1069, 1004, 914, 891, 836, 772, 620. cm−1. 1H NMR (400 MHz, CDCl3) δ = 5.87 – 5.77 (m, 
1H), 5.81 (d, J = 1.9 Hz, 1H), 5.13 (dd, J = 10.4, 1.7 Hz, 1H), 5.06 (dt, J = 17.3, 1.3 Hz, 1H), 
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3.57 (ddd, J = 10.9, 9.7, 4.5 Hz, 1H), 2.98 (s, 1H), 2.62 (p, J = 7.1 Hz, 1H), 2.50 (tdd, J = 14.4, 
4.9, 2.0 Hz, 1H), 2.30 (ddd, J = 14.3, 4.4, 2.9 Hz, 1H), 2.16 (d, J = 14.8 Hz, 1H), 2.06 (dtd, J 
= 12.5, 4.8, 2.8 Hz, 1H), 1.70 (d, J = 14.8 Hz, 1H), 1.67 – 1.59 (m, 1H), 1.52 – 1.40 (m, 1H), 
1.14 (s, 3H), 1.02 (d, J = 6.6 Hz, 3H), 0.95 (d, J = 6.9 Hz, 3H), 0.89 (s, 9H), 0.07 (s, 3H), 0.07 
(s, 3H). 13C NMR (126 MHz, CDCl3) δ = 201.0, 170.6, 139.1, 121.3, 117.2, 75.9, 72.2, 48.4, 
45.4, 42.0, 40.2, 36.3, 31.4, 26.0 (3C), 23.5, 18.2, 14.2, 12.4, -3.8, -4.6. HRMS (ESI) Exact 
mass calculated for C22H39O3Si+ [M+H]+: 379.26630, found: 379.26663; for C22H38NaO3Si+ 
[M+Na]+: 401.24824, found: 401.24859. 
 
 
(3R,7R,8R,8aR)-3-((R)-But-3-en-2-yl)-7-((tert-butyldimethylsilyl)oxy)-3-hydroxy-8,8a-
dimethyl-3,5,6,7,8,8a-hexahydronaphthalen-2(1H)-one (11R-2.84): To a solution of 
Rh2(OAc)4 (13.9 mg, 3.5 mol%) and cis-2-buten-1-ol (1.29 g, 17.9 mmol, 20 equiv.) in toluene 
(4.5 mL) at 65°C was added dropwise a solution of 2.82 (300 mg, 0.897 mmol, 1.0 equiv.) in 
toluene (4.5 mL) over a period of 8 min and the mixture was stirred for additional 40 min at 
this temperature. The solvent was evaporated and the residue purified by flash column 
chromatography (pentane/Et2O 6:1) to give 11R-2.84 (204 mg, 0.539 mmol, 60 %, dr 3:1) as a 
colorless solid. 
M.p. = 84.2 – 86.1°C. TLC: Rf = 0.67 (SiO2, pentane/Et2O 3:1). FTIR (neat): ν/ = 3488, 2931, 
2857, 1718, 1461, 1386, 1293, 1253, 1145, 1105, 1071, 1006, 890, 837, 775, 675 cm−1. 
1H NMR (500 MHz, CDCl3, signals from the major diastereoisomer are marked with a, those 
from the minor diastereoisomer with b) δ = 5.83a (ddd, J = 17.2, 10.3, 8.6 Hz, 1H), 5.71b (ddd, 
J = 17.1, 10.5, 8.2 Hz, 1H), 5.43b (d, J = 1.5 Hz, 1H), 5.35a (d, J = 1.4 Hz, 1H), 5.12a (ddd, J 
= 10.2, 1.8, 0.6 Hz, 1H), 5.07a (ddd, J = 17.2, 1.8, 0.9 Hz, 1H), 5.00b (ddd, J = 10.5, 1.7, 0.8 
Hz, 1H), 4.98b (dt, J = 17.2, 1.3 Hz, 1H), 3.60a+b (s, 2H), 3.49 – 3.41a+b (m, 2H), 2.62a (d, J = 
12.3 Hz, 1H), 2.61b (d, J = 12.2 Hz, 1H), 2.55 – 2.48b (m, 1H), 2.49a (d, J = 12.4 Hz, 1H), 2.48 
– 2.41a (m, 1H), 2.44b (d, J = 12.2 Hz, 1H), 2.27 – 2.16a+b (m, 4H), 2.03 – 1.96a+b (m, 2H), 1.55 
– 1.37a+b (m, 4H), 1.15b (d, J = 6.8 Hz, 3H), 0.95a (s, 3H), 0.95b (s, 30H), 0.93a (d, J = 6.8 Hz, 
3H), 0.92b (d, J = 6.8 Hz, 3H), 0.91a (d, J = 6.9 Hz, 3H), 0.90a+b (s, 18H), 0.07a+b (s, 12H). 
13C NMR (126 MHz, CDCl3, signals from the major diastereoisomer are marked with a, those 
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from the minor diastereoisomer with b) δ = 212.0a, 211.4b, 144.8b, 144.4a, 138.6b, 138.5a, 124.5a, 
123.9b, 116.7a, 115.8b, 78.6b, 78.3a, 72.1a, 72.1b, 51.1a, 51.0b, 49.7a, 49.6b, 49.0a, 48.7b, 46.8b, 
46.7a, 36.8a, 36.7b, 30.2b, 30.1a, 26.0a+b (6C), 19.8a+b, 18.2a, 18.2b, 15.0a, 13.6b, 
11.4a+b, -3.9a+b, -4.6a+b. HRMS (ESI) Exact mass calculated for C22H38NaO3Si+ [M+Na]+: 
401.2482, found: 401.2486. 
 
 
(3R,4aR,5R,6R)-3-((R)-But-3-en-2-yl)-6-((tert-butyldimethylsilyl)oxy)-3-hydroxy-4a,5-
dimethyl-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one (11R-2.80): A mixture of 11R- and 
11S-2.84 (67.3 mg, 0.18 mmol, 1.0 equiv., dr 3:1) and Ca(OMe)2 (37.5 mg, 0.356 mmol, 
2.0 equiv.) in MeOH (6.0 ml) was stirred for 45 h at rt. Sat. aq. NH4Cl solution was added 
slowly and the mixture was diluted with H2O and Et2O. The layers were separated and the 
aqueous layer was extracted with Et2O (2 x). The combined organic layers were dried over 
Na2SO4, filtered and concentrated. The residue was purified by flash column chromatography 
(pentane/Et2O 3:1) to give 11R-2.80 (47.2 mg, 0.13 mmol, 70 %, dr 3:1) as a colorless solid. 
Purification by additional flash column chromatography (pentane/Et2O 4:1) gave access to 
desired 11R-2.80 with a dr 14:1. 
M.p. = 160.4 – 162.2°C. TLC: Rf = 0.33 (SiO2, pentane/Et2O 3:1). Optical rotation: [𝛼𝛼]*%& = 
+20.2° (c = 0.81, CHCl3). FTIR (neat): ν/ = 3388, 2954, 2855, 1655, 1623, 1461, 1360, 1248, 
1131, 1100, 1071, 1007, 916, 890, 835, 772, 703, 595 cm−1. 1H NMR (400 MHz, CDCl3) δ = 
5.87 – 5.73 (m, 2H), 5.14 – 4.99 (m, 2H), 3.59 (td, J = 10.5, 4.4 Hz, 1H), 2.73 (s, 1H), 2.73 – 
2.62 (m, 1H), 2.50 (tdd, J = 14.5, 5.0, 2.0 Hz, 1H), 2.31 (ddd, J = 14.4, 4.4, 2.9 Hz, 1H), 2.11 
(d, J = 14.8 Hz, 1H), 2.10 – 2.02 (m, 1H), 1.72 (d, J = 14.9 Hz, 1H), 1.61 – 1.50 (m, 1H), 1.54 
– 1.39 (m, 1H), 1.16 (s, 3H), 1.07 (d, J = 6.7 Hz, 3H), 1.00 (d, J = 6.8 Hz, 3H), 0.90 (s, 9H), 
0.08 (s, 3H), 0.08 (s, 3H). 13C NMR (101 MHz, CDCl3) δ = 200.4, 170.1, 138.7, 121.6, 116.5, 
76.1, 72.3, 48.6, 44.9, 41.1, 40.1, 36.3, 31.4, 26.0 (3C), 23.3, 18.2, 14.4, 12.3, -3.8, -4.5. HRMS 
(ESI) Exact mass calculated for C22H39O3Si+ [M+H]+: 379.26630, found: 379.26612. 
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Diphenyl ((trifluoromethyl)sulfonyl)phosphoramidate (2.112): Diphenyl chlorophosphate 
(6.6, 1.15 mL, 5.54 mmol, 1.1 equiv.) was added to a mixture of trifluoromethanesulfonamide 
(0.752 g, 5.04 mmol, 1.0 equiv.) and K2CO3 (0.697 g, 5.04 mmol, 1.0 equiv.) in MeCN 
(8.0 mL) at 0°C. The mixture was allowed to warm to rt and stirred at this temperature for 15 h. 
The solution was diluted with H2O and the layers were separated. The aqueous layer was 
extracted with Et2O (3 x) and the combined organics were washed with sat. aq. NaHCO3 and 
aqueous HCl (6 M) solution. After the HCl layer was re-extracted with Et2O, the combined 
organic layers were dried over Na2SO4, filtered and concentrated. The residue was purified by 
flash column chromatography (CH2Cl2/MeOH 10:1) to give 2.112 (1.15 g, 3.02 mmol, 60 %) 
as a colorless solid. 
M.p. = 59.5 – 61.9C. TLC: Rf = 0.68 (SiO2, CH2Cl2/MeOH 10:1). 1H NMR (400 MHz, CDCl3) 
δ = 7.34 – 7.30 (m, 4H), 7.23 – 7.18 (m, 6H), 4.30 (br, s, 1H), 3.45 (s, 1H). 19F NMR (376 
MHz, CDCl3) δ = -77.2. 31P NMR (162 MHz, CDCl3) δ = -16.1. HRMS (ESI) Exact mass 
calculated for C13H12F3NO5PS+ [M+H]+: 382.01204, found: 382.01222. 
 
 
Calcium salt of 2.113: A solution of 2.112 (100 mg, 0.262 mmol, 1.0 equiv.) and Ca(OMe)2 
(13.4 mg, 0.131 mmol, 0.5 equiv.) in CH2Cl2/MeOH (1:1, 10.0 ml) was stirred at rt for 64 h. 
Evaporation of the solvent gave 2.113 as a colorless solid. 
M.p. = 210.5 – 215.7°C. TLC: Rf = 0.68 (SiO2, CH2Cl2/MeOH 10:1). 1H NMR (400 MHz, 
CDCl3) δ = 7.24 – 7.18 (m, 4H), 7.12 – 7.06 (m, 6H), 3.37 (s, 1H), 2.14 (br, s, 1H). 19F NMR 
(376 MHz, CDCl3) δ = -79.4. 31P NMR (162 MHz, CDCl3) δ = -13.3. 
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(3R,4aR,5R,6R)-3-((R)-But-3-en-2-yl)-3,6-dihydroxy-4a,5-dimethyl-4,4a,5,6,7,8-hexa-
hydronaphthalen-2(3H)-one (11R-6.7): To a solution of 11R-2.80 (78.0 mg, 0.206 mmol, 
1.0 equiv.) in MeCN/THF (1:1, 3.0 mL) was added a solution of HF (48 % in H2O, 87 µL, 
2.06 mmol, 10 equiv.). The mixture was stirred for 10 h at rt, before additional HF (21 µL, 
0.50 mmol, 2.4 equiv.) was added and stirring continued for 14 h. The reaction mixture was 
quenched with sat. aq. NaHCO3 solution and extracted with Et2O (3 x). The combined organic 
layers were dried over Na2SO4, filtered and concentrated. Crude 11R-6.7 (54.5 mg, 
0.206 mmol, quant., dr 14:1) was obtained as colorless oil and used without further purification 
in the next step. For analytical purposes, 11R-6.7 was purified by flash column chromatography 
(pentane/Et2O 1:2) and obtained as a colorless oil. 
TLC: Rf = 0.23 (SiO2, pentane/Et2O 1:2). Optical rotation: [𝛼𝛼]*%0 = +30.6° (c = 1.11, CHCl3). 
FTIR (neat): ν/ = 3424, 2972, 2940, 1660, 1455, 1384, 1241, 1128, 1093, 1029, 914, 886, 583 
cm−1. 1H NMR (400 MHz, CDCl3) δ = 5.84 (d, J = 1.9 Hz, 1H), 5.78 (ddd, J = 17.2, 10.3, 8.0 
Hz, 1H), 5.09 – 4.97 (m, 2H), 3.64 (td, J = 10.7, 4.3 Hz, 1H), 2.87 (s, 1H), 2.71 – 2.62 (m, 1H), 
2.54 (tdd, J = 14.3, 5.0, 2.0 Hz, 1H), 2.35 (ddd, J = 14.3, 4.4, 2.8 Hz, 1H), 2.25 – 2.17 (m, 1H), 
2.15 (d, J = 14.9 Hz, 1H), 1.70 (d, J = 14.9 Hz, 1H), 1.63 (s, 1H), 1.59 – 1.52 (m, 1H), 1.51 – 
1.40 (m, 1H), 1.16 (s, 3H), 1.16 (d, J = 6.6 Hz, 3H), 1.01 (d, J = 6.8 Hz, 3H). 13C NMR 
(101 MHz, CDCl3) δ = 200.5, 169.6, 138.6, 121.6, 116.5, 76.2, 71.6, 48.0, 44.9, 40.8, 40.1, 
35.9, 31.3, 23.4, 14.4, 11.8. HRMS (ESI) Exact mass calculated for C16H24O3Na+ [M+Na]+: 
287.16177, found: 287.16170. 
 
 
(1R,7R,8aR)-7-((R)-But-3-en-2-yl)-7-hydroxy-1,8a-dimethyl-1,3,4,7,8,8a-hexahydro-
naphthalene-2,6-dione (11R-2.114): NaHCO3 (138 mg, 1.65 mmol, 8.0 equiv.) and DMP 
(175 mg, 0.412 mmol, 2.0 equiv.) were added sequentially to a solution of crude 11R-6.7 
(54.5 mg, 0.206 mmol, 1.0 equiv.) in CH2Cl2 (4.0 mL) at 0°C and the mixture was stirred for 
2 h 45 min at this temperature. The mixture was diluted with CH2Cl2 and sat. aq. Na2S2O3 
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solution was added. The layers were separated and the aqueous layer was extracted with CH2Cl2 
(2 x). The combined organics were washed with H2O, dried over Na2SO4, filtered and 
concentrated. The residue was purified by flash column chromatography (pentane/Et2O 1:1) to 
give 11R-2.114 (46.4 mg, 0.177 mmol, 86 % over 2 steps, dr 14:1) as a colorless solid. 
M.p. = 103.0 – 106.7°C. TLC: Rf = 0.47 (SiO2, pentane/Et2O 1:2). Optical rotation: [𝛼𝛼]*%0 = 
–0.4° (c = 0.88, CHCl3). FTIR (neat): ν/ = 3469, 2971, 1715, 1672, 1440, 1387, 1238, 1145, 
1094, 1008, 885, 836 cm−1. 1H NMR (400 MHz, CDCl3) δ = 5.99 (d, J = 1.2 Hz, 1H), 5.80 
(ddd, J = 17.2, 10.4, 7.9 Hz, 1H), 5.14 – 5.01 (m, 2H), 2.90 – 2.80 (m, 1H), 2.84 (s, 1H), 2.77 
– 2.63 (m, 3H), 2.62 – 2.49 (m, 2H), 2.19 (d, J = 14.9 Hz, 1H), 1.79 (d, J = 14.9 Hz, 1H), 1.13 
(d, J = 6.7 Hz, 3H), 1.11 (s, 3H), 1.03 (d, J = 6.8 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ = 
209.3, 200.0, 166.1, 138.3, 122.9, 116.9, 76.0, 52.5, 44.8, 42.2, 40.4, 40.1, 31.6, 23.9, 14.4, 8.2. 
HRMS (ESI) Exact mass calculated for C16H23O3+ [M+H]+: 263.16417, found: 263.16421; for 
C16H22NaO3+ [M+Na]+: 285.14612, found: 285.14613. 
 
 
(S)-2-((2R,8R,8aR)-2-Hydroxy-8,8a-dimethyl-3,7-dioxo-1,2,3,5,6,7,8,8a-octahydro-
naphthalen-2-yl)propanal (11S-2.115): A solution of 11R-2.114 (46.4 mg, 0.177 mmol, 
1.0 equiv.), pyridine (57 µL, 0.708 mmol, 4.0 equiv.) and Sudan III (spatula tip) in 
CH2Cl2/MeOH (4.0 mL, 1:1) was cooled to –78°C and O3 was bubbled through the solution 
until the red color disappeared (35 sec). The reaction mixture was sequentially purged with O2 
and N2. PPh3 (92.9 mg, 0.354 mmol, 2.0 equiv.) was added and the mixture was allowed to 
warm to rt. After stirring for 1 h, the solvent was removed by evaporation and the residue was 
purified by flash column chromatography (pentane/Et2O 1:2) to give 11S-2.115 (41.1 mg, 
0.155 mmol, 88 %, dr >10:1) as a colorless oil. 
TLC: Rf = 0.19 (SiO2, pentane/Et2O 1:2). Optical rotation: [𝛼𝛼]*%0 = +13.3° (c = 0.73, CHCl3). 
FTIR (neat): ν/ = 3427, 2977, 1714, 1671, 1441, 1388, 1242, 1151, 1003, 885, 603 cm−1. 
1H NMR (400 MHz, CDCl3) δ = 10.05 (d, J = 1.6 Hz, 1H), 5.99 (d, J = 1.9 Hz, 1H), 3.90 (s, 
1H), 2.93 – 2.80 (m, 1H), 2.80 – 2.70 (m, 2H), 2.64 – 2.50 (m, 2H), 2.43 (q, J = 6.7 Hz, 1H), 
2.14 (d, J = 14.3 Hz, 1H), 1.75 (d, J = 14.4 Hz, 1H), 1.23 (s, 3H), 1.13 (d, J = 7.2 Hz, 3H), 
1.06 (d, J = 6.8 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ = 209.0, 206.3, 197.4, 166.4, 122.4, 
O
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77.6, 54.5, 49.0, 43.5, 42.6, 40.0, 32.3, 21.9, 9.1, 7.5. HRMS (ESI) Exact mass calculated for 
C15H21O4+ [M+H]+: 265.14344, found: 265.14337. 
 
 
(3R,4aR,5R,6R)-3-(But-3-en-2-yl)-6-((tert-butyldimethylsilyl)oxy)-3-((4-methoxybenzyl)-
oxy)-4a,5-dimethyl-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one (2.122): To a mixture of 
11S- and 11R-2.80 (50.0 mg, 0.132 mmol, 1.0 equiv., dr 2:1) and 4 Å MS (50.0 mg) in 
cyclohexane/CH2Cl2 (4.5 mL, 2:1) at rt was added Yb(OTf)3 (4.1 mg, 6.6 µmol, 5 mol%), 
followed by a solution of PMB trichloroacetimidate (0.8 M in CH2Cl2, 0.66 mL, 149 mg, 
0.528 mmol, 4.0 equiv.) over a period of 105 min. The mixture was stirred for additional 15 min 
at rt, before it was partitioned between sat. aq. NaHCO3 solution and Et2O. The layers were 
separated and the aqueous layer was extracted with Et2O (2 x). The combined organic layers 
were dried over Na2SO4, filtered and concentrated. The crude residue was subjected to flash 
column chromatography (pentane/Et2O 6:1) to give 2.122 (57.0 mg, 0.086 mmol, 65 %, dr 2:1, 
75 % purity according to 1H NMR spectrum) as a colorless oil. 
TLC: Rf = 0.85 (SiO2, pentane/Et2O 3:1). FTIR (neat): ν/ = 2952, 2857, 1668, 1629, 1614, 1514, 
1463, 1385, 1302, 1249, 1173, 1129, 1099, 1072, 1038, 1006, 888, 835, 774 cm−1. 1H NMR 
(400 MHz, CDCl3, signals from the major diastereoisomer are marked with a, those from the 
minor diastereoisomer with b) δ = 7.18 – 7.06a+b (m, 4H), 6.85 – 6.78a+b (m, 4H), 6.03 (ddd, J 
= 17.2, 10.8, 6.6, 1H),b 5.82 – 5.78a+b (m, 2H), 5.63a (ddd, J = 17.4, 10.6, 5.6, 1H), 5.19 – 
5.02a+b (m, 4H), 4.45b (d, J = 10.8, 1H), 4.37a (d, J = 11.0, 1H), 4.11a (d, J = 10.9, 1H), 4.08b 
(d, J = 10.7, 1H), 3.79 – 3.76a+b (m, 6H), 3.60 – 3.50a+b (m, 2H), 3.50 – 3.39a+b (m, 2H), 2.50 – 
2.39a+b (m, 2H), 2.31 – 2.23a+b (m, 2H), 2.15b (d, J = 14.6, 1H), 2.14a (d, J = 14.7, 1H), 2.08 – 
2.00a+b (m, 2H), 1.65b (d, J = 14.7, 1H), 1.60a (d, J = 14.7, 1H), 1.50 – 1.37a+b (m, 2H), 1.32 – 
1.22a+b (m, 2H), 1.21a (s, 3H), 1.20b (s, 3H), 1.06a (d, J = 7.0, 3H), 0.97a+b (d, J = 6.7, 6H), 
0.90b (d, J = 6.9, 3H), 0.88b (s, 9H), 0.88a (s, 9H), 0.06a+b (m, 12H). 13C NMR (101 MHz, 
CDCl3) δ = 195.6b, 195.4a, 170.1b, 169.7a, 158.8a+b, 139.3a, 138.5b, 130.8a, 130.7b, 129.1b (2C), 
128.9a (2C), 122.7a, 122.5b, 116.0a, 115.8b, 113.6a (2C), 113.6b (2C), 80.0b, 79.4a, 71.5a, 64.5b, 
64.5a, 64.4b, 55.2a+b, 51.8b, 51.5a, 40.9a+b, 39.2b, 39.1a, 36.2b, 36.1a, 35.1b, 35.0a, 31.5b, 31.5a, 
25.8a+b (6C), 21.3a, 21.1b, 18.0a, 15.0b, 11.1a, 11.1b, 10.9a+b, -4.0a+b, -4.7a+b. HRMS (ESI) Exact 
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mass calculated for C30H47O4Si+ [M+H]+: 499.32381, found: 499.32416; for C30H46NaO4Si+ 
[M+Na]+: 521.30576, found: 521.30599. 
 
 
(3R,4aR,5R,6R)-3-(But-3-en-2-yl)-6-hydroxy-3-((4-methoxybenzyl)oxy)-4a,5-dimethyl-
4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one (6.8): To a solution of 2.122 (75 %, 72.8 mg, 
0.109 mmol, 1.0 equiv., dr 2:1) in MeCN/THF (4.0 mL, 1:1) was added a solution of HF (48 % 
in H2O, 23 µL, 0.545 mmol, 5.0 equiv.). The solution was stirred for 14 h at rt, before sat. aq. 
NaHCO3 solution was added. The mixture was extracted with Et2O (3 x) and the combined 
organic layers were dried over Na2SO4, filtered and concentrated. The residue was subjected to 
flash column chromatography (pentane/Et2O 1:2) to give 6.8 (37.6 mg, 0.098 mmol, 90 %, dr 
2:1) as a colorless oil. 
TLC: Rf = 0.25 (SiO2, pentane/Et2O 1:2). FTIR (neat): ν/ = 3437, 2938, 1663, 1514, 1455, 1382, 
1302, 1248, 1174, 1034, 914, 885, 820, 689, 571 cm−1. 1H NMR (500 MHz, CDCl3, signals 
from the major diastereoisomer are marked with a, those from the minor diastereoisomer with b) 
δ = 7.18 – 7.10a+b (m, 4H), 6.86 – 6.78a+b (m, 4H), 6.03b (ddd, J = 17.2, 10.7, 6.5, 1H), 5.85 – 
5.80a+b (m, 2H), 5.64a (ddd, J = 17.4, 10.6, 5.6, 1H), 5.21 – 5.13b (m, 2H), 5.13 – 5.03a (m, 2H), 
4.45b (d, J = 10.7, 1H), 4.36a (d, J = 10.9, 1H), 4.11a (d, J = 10.9, 1H), 4.07b (d, J = 10.6, 1H), 
3.78a (s, 3H), 3.77b (s, 3H), 3.66 – 3.56a+b (m, 2H), 3.50 – 3.40a+b (m, 2H), 2.54 – 2.45a+b (m, 
2H), 2.37 – 2.29a+b (m, 2H), 2.22 – 2.12a+b (m, 4H), 1.64b (d, J = 14.6, 1H), 1.60a (d, J = 14.8, 
1H), 1.47 – 1.34a+b (m, 4H), 1.23 – 1.20a+b (m, 6H), 1.09 – 1.03a+b (m, 9H), 0.91b (d, J = 6.8, 
3H). 13C NMR (126 MHz, CDCl3, signals from the major diastereoisomer are marked with a, 
those from the minor diastereoisomer with b) δ = 195.7b, 195.5a, 169.6b, 169.2a, 159.0a+b, 139.4a, 
138.5b, 130.8a, 130.8b, 129.3b (2C), 129.1a (2C), 123.1a, 122.9b, 116.2a, 116.0b, 113.8a (2C), 
113.7b (2C), 80.1b, 79.5a, 71.0a, 71.0b, 64.7a, 64.6b, 55.4a+b, 51.7b, 51.4a, 40.9a+b, 39.4b, 39.3a, 
35.8b, 35.7a, 35.1b, 35.1a, 31.6b, 31.5a, 21.3a, 21.2b, 15.1b, 11.0a, 10.7a, 10.7b. HRMS (ESI) Exact 
mass calculated for C24H32NaO4+ [M+Na]+: 407.21928, found: 407.21934. 
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(1R,7R,8aR)-7-(But-3-en-2-yl)-7-((4-methoxybenzyl)oxy)-1,8a-dimethyl-1,3,4,7,8,8a-
hexahydronaphthalene-2,6-dione (6.9): NaHCO3 (65.7 mg, 0.782 mmol, 8.0 equiv.) and 
DMP (83 mg, 0.196 mmol, 2.0 equiv.) were added sequentially to a solution of 6.8 (37.6 mg, 
0.098 mmol, 1.0 equiv.) in CH2Cl2 (2.5 mL) at 0°C and the mixture was stirred for 105 min at 
this temperature. The mixture was diluted with CH2Cl2 and sat. aq. Na2S2O3 solution was added. 
The layers were separated and the aqueous layer was extracted with CH2Cl2 (2 x). The 
combined organic layers were washed with H2O, dried over Na2SO4, filtered and concentrated. 
The residue was purified by flash column chromatography (pentane/Et2O 2:1) to give 6.9 
(31.1 mg, 0.081 mmol, 83 %, dr 2:1) as a colorless oil. 
TLC: Rf = 0.24 and 0.31 (SiO2, pentane/Et2O 2:1). FTIR (neat): ν/ = 2972, 1716, 1670, 1614, 
1514, 1455, 1376, 1302, 1249, 1175, 1034, 884, 821, 569 cm−1. 1H NMR (500 MHz, CDCl3, 
signals from the major diastereoisomer are marked with a, those from the minor diastereoisomer 
with b) δ = 7.16 – 7.09a+b (m, 4H), 6.82a+b (s, 4H), 6.03b (ddd, J = 17.2, 10.7, 6.4, 1H), 5.97 – 
5.94a+b (m, 2H), 5.66a (ddd, J = 16.7, 10.6, 5.7, 1H), 5.22 – 5.06a+b (m, 4H), 4.46b (d, J = 10.6, 
1H), 4.38a (d, J = 10.9, 1H), 4.09a (d, J = 10.9, 1H), 4.06b (d, J = 10.6, 1H), 3.78a (s, 3H), 3.77b 
(s, 3H), 3.51 – 3.43a+b (m, 2H), 2.87 – 2.77a+b (m, 2H), 2.73 – 2.66a+b (m, 2H), 2.58 – 2.49a+b 
(m, 4H), 2.44 – 2.36a+b (m, 2H), 2.14b (d, J = 14.6, 1H), 2.13a (d, J = 14.6, 1H), 1.85b (d, J = 
14.6, 1H), 1.81a (d, J = 14.6, 1H), 1.16a (s, 3H), 1.14b (s, 3H), 1.08a (d, J = 7.0, 3H), 1.03a+b (d, 
J = 6.9, 6H), 0.95b (d, J = 6.8, 3H). 13C NMR (126 MHz, CDCl3, signals from the major 
diastereoisomer are marked with a, those from the minor diastereoisomer with b) δ = 209.5a, 
209.4b, 195.5b, 195.3a, 165.7b, 165.4a, 159.1a+b, 139.2a, 138.2b, 130.5a, 130.5b, 129.3b (2C), 
129.1a (2C), 123.8a, 123.7b, 116.6a, 116.3b, 113.8a (2C), 113.8b (2C), 79.8b, 79.3a, 64.8a, 64.7b, 
55.5b, 55.4a+b, 55.3a, 42.5b, 42.4a, 40.4b (2C), 40.3a (2C), 35.0a+b, 32.5a+b, 22.0a, 21.8b, 15.1b, 
11.0a, 7.4a, 7.4b. 
 
 
OH
6.8, dr 2:1 (11S/11R)
O
*
PMBO
DMP, NaHCO3
CH2Cl2, 0°C O
6.9, 83 %, dr 2:1 (11S/11R)
O
*
PMBO
EXPERIMENTAL PART 197 
 
 
2-((2R,8R,8aR)-2-((4-Methoxybenzyl)oxy)-8,8a-dimethyl-3,7-dioxo-1,2,3,5,6,7,8,8a-
octahydronaphthalen-2-yl)propanal (2.124): A solution of 6.9 (31.1 mg, 81.3 µmol, 
1.0 equiv.), pyridine (26 µL, 0.325 mmol, 4.0 equiv.) and Sudan III (spatula tip) in 
CH2Cl2/MeOH (3.0 mL, 1:1) was cooled to –78°C and O3 was bubbled through the solution 
until the red color disappeared (<1 min). The reaction mixture was sequentially purged with O2 
and N2. PPh3 (42.6 mg, 0.163 mmol, 2.0 equiv.) was added and the mixture was allowed to 
warm up to rt. After stirring for 45 min, the solvent was removed by evaporation and the residue 
was subjected to flash column chromatography (pentane/ Et2O 1:1) to give 2.124 (27.5 mg, 
71.5 µmol, 88 %, dr 5:2) as colorless oil. 
TLC: Rf = 0.17 (SiO2, pentane/Et2O 1:1). FTIR (neat): ν/ = 2942, 1716, 1670, 1614, 1515, 1442, 
1248, 1176, 1033, 884, 822 cm−1. 1H NMR (400 MHz, CDCl3, signals from the major 
diastereoisomer are marked with a, those from the minor diastereoisomer with b) δ = 9.98b (d, J 
= 1.6, 1H), 9.66a (s, 1H), 7.17 – 7.08a+b (m, 4H), 6.87 – 6.76a+b (m, 4H), 6.04a (d, J = 1.7, 1H), 
5.99b (d, J = 1.7, 1H), 4.61b (d, J = 10.7, 1H), 4.29a (d, J = 10.7, 1H), 4.21b (d, J = 10.8, 1H), 
4.10a (d, J = 10.7, 1H), 3.78a+b (s, 6H), 3.73a (q, J = 7.4, 1H), 3.65b (ddd, J = 13.3, 6.5, 1.2, 
1H), 2.89 – 2.79a+b (m, 2H), 2.77 – 2.68a+b (m, 2H), 2.59 – 2.52a+b (m, 4H), 2.42a+b (q, J = 6.7, 
2H), 2.18a (d, J = 14.6, 1H), 2.13b (d, J = 14.6, 1H), 2.02b (d, J = 14.6, 1H), 1.81a (d, J = 14.5, 
1H), 1.19a (d, J = 7.5, 3H), 1.17a+b (s, 6H), 1.04 – 0.99a+b (m, 9H). 13C NMR (126 MHz, CDCl3, 
signals from the major diastereoisomer are marked with a, those from the minor diastereoisomer 
with b) δ = 209.1a, 208.8b, 204.6b, 202.7a, 195.2a, 193.7b, 166.7b, 166.3a, 159.3b, 159.3a, 130.0b, 
129.7a, 129.4b (2C), 129.2a (2C), 123.0a, 122.9b, 113.9b (2C), 113.9a (2C), 80.4b, 77.9a, 65.8b, 
65.4a, 55.4a+b, 55.4b, 55.3a, 45.9a, 44.7b, 42.6a, 42.5b, 41.9a, 41.8b, 40.3a, 40.3b, 32.6a, 32.6b, 
22.2a, 21.9b, 9.9b, 7.4a, 7.0a+b. HRMS (ESI) Exact mass calculated for C23H28NaO5+ [M+Na]+: 
407.18290, found: 407.18279. 
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(1R,7R,8aS,9R,10R)-7,10-Dihydroxy-1,8a,9-trimethyl-1,3,4,7,8,8a-hexahydro-1,7-
ethanonaphthalene-2,6-dione (11R-2.98): To a solution of 11S-2.115 (33.8 mg, 0.128 mmol, 
1.0 equiv.) in toluene (5.0 mL) was added diphenyl phosphate (16.0 mg, 64 µmol, 0.5 equiv.) 
and the mixture was heated at 65°C for 100 min. The yellow solution was partitioned between 
sat. aq. NaHCO3 and EtOAc. The layers were separated and the aqueous layer was extracted 
with EtOAc (2 x). The combined organic layers were dried over Na2SO4, filtered and 
concentrated. The residue was purified by flash column chromatography (pentane/EtOAc 1:1) 
to give 11R-2.98 (23.9 mg, 90 µmol, 71 %, dr >10:1) as a colorless solid. 
M.p. = 149.4 – 154.8°C. TLC: Rf = 0.19 (SiO2, pentane/EtOAc 1:1). Optical rotation: [𝛼𝛼]*%0 = 
–79.8° (c = 0.24, CHCl3). FTIR (neat): ν/ = 3464, 2963, 1704, 1676, 1450, 1388, 1282, 1216, 
1148, 1097, 1059, 1038, 760 cm−1. 1H NMR (500 MHz, CDCl3) δ = 6.15 (d, J = 1.5 Hz, 1H), 
4.05 (s, 1H), 3.84 (dd, J = 10.4, 5.9 Hz, 1H), 2.93 (tdd, J = 12.2, 7.8, 1.6 Hz, 1H), 2.81 (ddd, J 
= 16.5, 11.8, 8.1 Hz, 1H), 2.69 (dd, J = 15.8, 7.2 Hz, 1H), 2.60 (dd, J = 12.5, 8.6 Hz, 1H), 2.08 
(d, J = 13.5 Hz, 1H), 1.90 (d, J = 13.5 Hz, 1H), 1.80 – 1.72 (m, 1H), 1.70 (d, J = 6.4 Hz, 1H), 
1.20 (s, 3H), 1.14 (s, 3H), 0.95 (d, J = 6.7 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ = 210.4, 
199.6, 167.7, 123.8, 76.2, 75.7, 58.6, 43.5, 41.9, 41.4, 38.1, 30.1, 23.3, 11.5, 8.4. HRMS (ESI) 
Exact mass calculated for C15H21O4+ [M+H]+: 265.14344, found: 265.14352. 
 
 
Periconianone A (2.1): To a stirred solution of 11R-2.98 (4.0 mg, 15 µmol, 1.0 equiv.) in THF 
(0.4 mL) at –78°C was added dropwise a solution of LiHMDS (1.0 M in THF, 60 µL, 60 µmol, 
4.0 equiv.). The reaction mixture was stirred at –78°C for 1 h and then PhSeCl (5.8 mg, 
30 µmol, 2.0 equiv.) in THF (0.15 mL) was added dropwise. The mixture was stirred for 
another 2.5 h at –78°C and then quenched by addition of NaIO4 (19.4 mg, 91 µmol, 6.0 equiv.) 
in H2O (0.15 mL). After warming to rt, the mixture was stirred for 1.5 h, before 
additional NaIO4 (19.4 mg, 91 µmol, 6.0 equiv.) in H2O (0.15 mL) was added at rt. To the 
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slurry was added sat. aq. Na2CO3 solution and the mixture was extracted with EtOAc (3 x). The 
combined organic layers were dried over Na2SO4, filtered and concentrated. The residue was 
purified by flash column chromatography (pentane/EtOAc 1:1) to give periconianone A (2.1) 
(1.8 mg, 7 µmol, 45 %, dr 14:1) as colorless crystals. 
M.p. = 169.8 – 172.4°C. TLC: Rf = 0.18 (SiO2, pentane/EtOAc 1:1). Optical rotation: [𝛼𝛼]*%0 = 
+243.0° (c = 0.72, CHCl3). FTIR (neat): ν/ = 3459, 2928, 1668, 1610, 1464, 1386, 1280, 1207, 
1145, 1118, 1063, 1035, 945, 908, 884, 758 cm−1. 1H NMR (500 MHz, CDCl3, 310 K) δ = 7.28 
(d, J = 10.1 Hz, 1H), 6.14 (s, 1H), 6.08 (d, J = 10.1 Hz, 1H), 3.99 (s, 1H), 3.54 (d, J = 10.3 Hz, 
1H), 2.22 (d, J = 14.0 Hz, 1H), 1.94 – 1.87 (m, 1H), 1.87 (d, J = 13.7 Hz, 1H), 1.30 (s, 3H), 
1.26 (s, 3H), 0.94 (d, J = 6.7 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ = 200.7, 199.0, 162.6, 
142.3, 130.1, 122.7, 75.9, 74.0, 55.8, 44.9, 44.8, 40.0, 24.6, 12.0, 8.1. 1H NMR (500 MHz, 
DMSO-d6, 308 K) δ = 7.45 (d, J = 10.2 Hz, 1H), 6.12 (s, 1H), 5.94 (d, J = 10.1 Hz, 1H), 5.07 
(s, 1H), 4.83 (d, J = 7.2 Hz, 1H), 3.38 – 3.31 (m, 1H), 1.96 (d, J = 13.8 Hz, 1H), 1.73 (d, J = 
13.8 Hz, 1H), 1.60 (dq, J = 10.1, 6.7 Hz, 1H), 1.08 (s, 3H), 1.06 (s, 3H), 0.76 (d, J = 6.7 Hz, 
3H). 13C NMR (126 MHz, DMSO-d6) δ = 199.9, 198.7, 161.4, 142.3, 128.8, 123.4, 75.7, 72.8, 
56.0, 44.9, 44.9, 40.2, 23.3, 12.2, 8.0. HRMS (ESI) Exact mass calculated for C15H19O4+ 
[M+H]+: 263.12779, found: 263.12812; for C15H18NaO4+ [M+Na]+: 285.10973, found: 
285.11000. 
6.4 Microsphaeropsisin B and C, Periconianone C218 
 
A solution of 11S-2.80 (24.0 mg, 63.4 µmol, 1.0 equiv., dr 2:1), pyridine (20 µL, 0.254 mmol, 
4.0 equiv.) and Sudan III (spatula tip) in CH2Cl2/MeOH (5.0 mL, 1:1) was cooled to –78°C and 
O3 was bubbled through the solution until the red color disappeared (25 sec). The reaction 
mixture was sequentially purged with O2 and N2. PPh3 (33.3 mg, 0.127 mmol, 2.0 equiv.) was 
added and the mixture was allowed to warm to rt. After stirring for 1 h, the solvent was removed 
by evaporation and the residue was purified by flash column chromatography (pentane/Et2O 
1:1) to give 11R- and 11S-6.10 (20.1 mg, 53 µmol, 83 %, dr 2:1) as a colorless solid. For 
analytical purposes, purification by additional flash column chromatography (pentane/Et2O 
2:1) gave access to diastereomerically pure 11R- and 11S-6.10. 
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(R)-2-((2R,7R,8R,8aR)-7-((tert-Butyldimethylsilyl)oxy)-2-hydroxy-8,8a-dimethyl-3-oxo-
1,2,3,5,6,7,8,8a-octahydronaphthalen-2-yl)propanal (11R-6.10): 
M.p. = 145.5 – 147.8 °C. TLC: Rf = 0.49 (SiO2, pentane/Et2O 1:1). Optical rotation: [𝛼𝛼]*%1 = 
+15.6° (c = 0.66, CHCl3). FTIR (neat): ν/ = 3426, 2951, 2930, 2857, 1719, 1669, 1463, 1387, 
1250, 1099, 1072, 887, 835, 774, 673 cm-1. 1H NMR (400 MHz, CDCl3) δ = 9.79 (d, J = 1.0, 
1H), 5.83 (d, J = 1.6, 1H), 4.06 (d, J = 1.8, 1H), 3.59 (ddd, J = 10.9, 9.8, 4.5, 1H), 2.54 – 2.46 
(m, 2H), 2.32 (ddd, J = 14.5, 4.4, 2.7, 1H), 2.10 – 2.04 (m, 1H), 2.00 (d, J = 14.5, 1H), 1.92 
(dd, J = 14.5, 1.9, 1H), 1.51 – 1.38 (m, 2H), 1.28 (s, 3H), 1.17 (d, J = 7.3, 3H), 1.01 (d, J = 
6.7, 3H), 0.89 (s, 9H), 0.08 (s, 3H), 0.07 (s, 3H). 13C NMR (126 MHz, CDCl3) δ = 206.6, 197.1, 
171.3, 121.3, 79.2, 71.7, 50.7, 50.6, 44.7, 40.3, 36.2, 31.7, 26.0 (3C), 21.7, 18.2, 11.5, 
10.4, -3.9, -4.5. HRMS (ESI) Exact mass calculated for C21H37O4Si+ [M+H]+: 381.24556, 
found: 381.24557. 
(S)-2-((2R,7R,8R,8aR)-7-((tert-Butyldimethylsilyl)oxy)-2-hydroxy-8,8a-dimethyl-3-oxo-
1,2,3,5,6,7,8,8a-octahydronaphthalen-2-yl)propanal (11S-6.10): 
M.p. = 133.9 – 137.9 °C. TLC: Rf = 0.59 (SiO2, pentane/Et2O 1:1). Optical rotation: [𝛼𝛼]*%1 = 
+23.6° (c = 0.15, CHCl3). FTIR (neat): ν/ = 3443, 2952, 2930, 2857, 1722, 1670, 1463, 1251, 
1100, 1073, 887, 835, 774, 673 cm-1. 1H NMR (400 MHz, CDCl3) δ = 10.04 (d, J = 1.9, 1H), 
5.84 (d, J = 1.6, 1H), 3.69 (d, J = 1.8, 1H), 3.59 (ddd, J = 11.0, 9.9, 4.6, 1H), 2.73 (qd, J = 7.1, 
1.9, 1H), 2.50 (tdd, J = 14.6, 5.1, 1.8, 1H), 2.33 (ddd, J = 14.4, 4.5, 2.7, 1H), 2.12 (d, J = 14.5, 
1H), 2.09 – 2.03 (m, 1H), 1.61 (dd, J = 14.6, 1.8, 1H), 1.44 (dddd, J = 14.6, 12.6, 11.0, 4.5, 
1H), 1.36 – 1.27 (m, 1H), 1.28 (s, 3H), 1.11 (d, J = 7.2, 3H), 1.01 (d, J = 6.7, 3H), 0.89 (s, 9H), 
0.08 (s, 3H), 0.07 (s, 3H). 13C NMR (126 MHz, CDCl3) δ = 206.4, 197.8, 170.9, 121.1, 77.9, 
71.6, 50.8, 49.6, 44.1, 40.0, 36.2, 31.7, 26.0 (3C), 21.4, 18.2, 11.5, 9.2, -3.8, -4.5. HRMS (ESI) 
Exact mass calculated for C21H37O4Si+ [M+H]+: 381.24556, found: 381.24559. 
 
 
(3S,3aR,4aR,5R,6R,9aS)-6-((tert-Butyldimethylsilyl)oxy)-3,4a,5-trimethyl-
2,3,4,4a,5,6,7,8-octahydronaphtho[2,3-b]furan-3a,9a-diol (3.8) and (3R,4aR,5R,6R)-6-
((tert-butyldimethylsilyl)oxy)-3-hydroxy-3-((S)-1-hydroxypropan-2-yl)-4a,5-dimethyl-
OH
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4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one (3.8’): DIBAL-H (1.2 M in toluene, 66 µL, 
79 µmol, 2.5 equiv.) was added dropwise to a solution of 11R-6.10 (12 mg, 32 µmol, 1.0 equiv.) 
in CH2Cl2 (0.6 mL) at –78°C and the mixture was stirred for 30 min at this temperature. MeOH 
and sat. aq. Rochelle’s solution were added and the layers were separated after the mixture 
warmed up to rt. The aqueous layer was extracted with CH2Cl2 (3 x), and the combined organic 
layers were dried over Na2SO4, filtered and concentrated. The residue was purified by flash 
column chromatography (pentane/Et2O 2:3) to give 3.8/3.8’ (6.9 mg, 18 µmol, 57 %) as a 
colorless solid. 
M.p. = 107.5 – 109.1°C. TLC: Rf = 0.33 (SiO2, pentane/Et2O 2:3). FTIR (neat): ν/ = 3391, 
2950, 2930, 2883, 2857, 1660, 1462, 1251, 1068, 1006, 890, 835, 773, 677 cm-1. 1H NMR (500 
MHz, CDCl3, signals from the closed form are marked with a, those from the open form with b; 
ratio a/b = 1:2.4) δ = 5.83b (d, J = 1.9, 1H), 5.33a (d, J = 1.9, 1H), 4.07a (t, J = 8.6, 1H), 3.93b 
(dd, J = 11.3, 3.8, 1H), 3.69b (s, 1H), 3.68 – 3.64b (m, 1H), 3.59b (td, J = 11.0, 4.5, 1H), 3.52a 
(td, J = 10.5, 4.6, 1H), 3.33a (dd, J = 10.5, 8.6, 1H), 2.77b (d, J = 8.0, 1H), 2.65a (s, 1H), 2.55 
– 2.44a+b (m, 2H), 2.38b (d, J = 15.0, 1H), 2.33 – 2.25a+b (m, 3H), 2.14 – 2.03a+b (m, 3H), 1.97 
– 1.93a (m, 1H), 1.90a (d, J = 14.2, 1H), 1.72b (d, J = 15.0, 1H), 1.57 – 1.53b (m, 1H), 1.50 – 
1.38a+b (m, 2H), 1.22 – 1.18a (m, 2H), 1.16a+b (s, 6H), 1.08b (d, J = 6.7, 3H), 1.01a (d, J = 6.9, 
3H), 0.97a (d, J = 6.8, 3H), 0.91b (d, J = 7.1, 3H), 0.89b (s, 9H), 0.87a (s, 9H), 0.08b (s, 3H), 
0.07b (s, 3H), 0.05a (s, 3H), 0.04a (s, 3H). 13C NMR (126 MHz, CDCl3, signals from the closed 
form are marked with a, those from the open form with b) δ = 200.9b, 170.5b, 147.4a, 120.7b, 
118.8a, 99.9a, 77.4b, 77.3a, 72.4b, 72.2a, 71.0a, 64.5b, 51.6a, 48.1b, 42.7a, 42.4b, 40.7b, 40.6b, 
39.0a, 38.5a, 36.5a, 36.3b, 31.3b, 30.6a, 26.0a+b (6C), 24.0a, 20.5a, 18.2b, 18.2a, 12.4b, 11.9b, 11.5a, 
9.4a, -3.8a, -3.9b, -4.5b, -4.5a. HRMS (ESI) Exact mass calculated for C21H39O4Si+ [M+H]+: 
383.26121, found: 383.26095. 
 
 
(3R,4aR,5R,6R)-3-((S)-But-3-en-2-yl)-3,6-dihydroxy-4a,5-dimethyl-4,4a,5,6,7,8-hexa-
hydronaphthalen-2(3H)-one (11S-6.7): To a solution of 11S-2.80 (165 mg, 0.436 mmol, 
1.0 equiv.) in MeCN/THF (1:1, 7.0 mL) was added a solution of HF (48 % in H2O, 0.184 mL, 
4.36 mmol, 10 equiv.). The mixture was stirred for 60 h at rt, before it was quenched with sat. 
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aq. NaHCO3 solution and extracted with Et2O (3 x). The combined organic layers were dried 
over Na2SO4, filtered and concentrated. Crude 11S-6.7 (114 mg, 0.431 mmol, 99 %, dr 15:1) 
was obtained as a colorless oil and used without further purification in the next step. For 
analytical purposes, 11S-6.7 was purified by flash column chromatography (pentane/Et2O 1:2). 
TLC: Rf = 0.11 (SiO2, pentane/Et2O 1:1). Optical rotation: [𝛼𝛼]*%& = +6.1° (c = 0.49, CHCl3). 
FTIR (neat): ν/ = 3413, 2971, 2938, 2880, 1656, 1455, 1384, 1242, 1127, 1028, 915, 884, 687, 
580 cm-1. 1H NMR (400 MHz, CDCl3) δ = 5.84 (d, J = 1.9, 1H), 5.88 – 5.79 (m, 1H), 5.15 – 
5.05 (m, 2H), 3.63 (td, J = 10.6, 4.5, 1H), 3.05 (d, J = 0.9, 1H), 2.64 – 2.57 (m, 1H), 2.54 (tdd, 
J = 14.4, 4.6, 2.0, 1H), 2.35 (ddd, J = 14.3, 4.5, 2.8, 1H), 2.22 – 2.16 (m, 1H), 2.18 (d, J = 15.1, 
1H), 1.71 (d, J = 14.8, 1H), 1.64 – 1.57 (m, 2H), 1.52 – 1.40 (m, 1H), 1.14 (s, 3H), 1.11 (d, J 
= 6.7, 3H), 0.95 (d, J = 6.9, 3H). 13C NMR (101 MHz, CDCl3) δ = 200.9, 170.0, 139.1, 121.6, 
117.3, 75.9, 71.6, 48.0, 45.3, 41.8, 40.2, 35.8, 31.3, 23.5, 14.2, 11.8. HRMS (ESI) Exact mass 
calculated for C16H24O3Na+ [M+Na]+: 287.16177, found: 287.16174. 
 
 
(1R,7R,8aR)-7-((S)-But-3-en-2-yl)-7-hydroxy-1,8a-dimethyl-1,3,4,7,8,8a-hexahydro-
naphthalene-2,6-dione (11S-2.114): NaHCO3 (290 mg, 3.46 mmol, 8.0 equiv.) and DMP 
(458 mg, 1.08 mmol, 2.5 equiv.) were added sequentially to a solution of crude 11S-6.7 
(114 mg, 0.431 mmol, 1.0 equiv.) in CH2Cl2 (6.0 mL) at 0°C and the mixture was stirred for 
2 h 30 min at this temperature, before it was diluted with CH2Cl2 and sat. aq. Na2S2O3 solution 
was added. The layers were separated and the aqueous layer was extracted with CH2Cl2 (2 x). 
The combined organic layers were washed with H2O, dried over Na2SO4, filtered and 
concentrated. The residue was purified by flash column chromatography (pentane/Et2O 1:1) to 
give 11S-2.114 (103 mg, 0.393 mmol, 89 % over 2 steps) as a colorless solid. 
M.p. = 71.1 – 72.0°C. TLC: Rf = 0.31 (SiO2, pentane/Et2O 1:1). Optical rotation: [𝛼𝛼]*%& =  
–4.0° (c = 0.33, CHCl3). FTIR (neat): ν/ = 3470, 2972, 1714, 1670, 1454, 1375, 1238, 1134, 
1027, 920, 883, 677, 566 cm-1. 1H NMR (400 MHz, CDCl3) δ = 5.99 (d, J = 1.2, 1H), 5.87 
(ddd, J = 17.3, 10.4, 8.3, 1H), 5.15 (ddd, J = 10.5, 1.7, 0.8, 1H), 5.05 (ddd, J = 17.3, 1.7, 1.0, 
1H), 3.11 (d, J = 0.8, 1H), 2.89 – 2.81 (m, 1H), 2.76 – 2.53 (m, 5H), 2.27 (d, J = 14.0, 1H), 
1.77 (d, J = 14.8, 1H), 1.10 (d, J = 6.6, 3H), 1.08 (s, 3H), 0.98 (d, J = 6.9, 3H). 13C NMR (101 
OH
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MHz, CDCl3) δ = 209.5, 200.7, 166.3, 138.9, 122.6, 117.5, 75.9, 52.3, 45.5, 42.4, 41.3, 40.1, 
31.5, 24.4, 14.5, 8.4. HRMS (ESI) Exact mass calculated for C16H23O3+ [M+Na]+: 285.14612, 
found: 285.14605. 
 
 
(1R,7R,8aR)-7-((S)-But-3-en-2-yl)-7-hydroxy-1,8a-dimethyl-1,7,8,8a-tetrahydro-
naphthalene-2,6-dione (3.9): DBU (17 µL, 0.12 mmol, 3.0 equiv.) was added to a solution of 
11S-2.114 (10 mg, 38 µmol, 1.0 equiv.) in CH2Cl2 (0.5 mL) at rt and the mixture was stirred 
under an O2 atmosphere for 17 h. The reaction mixture was then diluted with sat. aq. NH4Cl 
solution and the layers were separated. The aqueous layer was extracted with CH2Cl2 (3 x) and 
the combined organic layers were dried over Na2SO4, filtered and concentrated. The residue 
was purified by flash column chromatography (pentane/Et2O 1:1) to give 3.9 (5.0 mg, 
89 % purity according to 1H NMR spectrum, 17 µmol, 45 %) as a yellowish oil. 
TLC: Rf = 0.43 (SiO2, pentane/Et2O 1:1). Optical rotation: [𝛼𝛼]*%& = +62.8° (c = 0.25, CHCl3). 
FTIR (neat): ν/ = 3470, 2977, 2934, 1714, 1665, 1454, 1389, 1235, 1127, 1078, 919, 890, 
834 cm-1. 1H NMR (400 MHz, CDCl3) δ = 7.01 (dd, J = 10.0, 0.7, 1H), 6.23 (d, J = 9.8, 1H), 
6.12 (s, 1H), 5.67 (ddd, J = 17.1, 10.5, 7.5, 1H), 5.13 – 5.05 (m, 2H), 2.75 – 2.55 (m, 2H), 2.45 
(d, J = 1.9, 1H), 2.07 (d, J = 14.5, 1H), 2.00 (dd, J = 14.5, 1.3, 1H), 1.24 (s, 3H), 1.18 (d, J = 
6.8, 3H), 1.09 (d, J = 6.9, 3H). 13C NMR (126 MHz, CDCl3) δ = 201.1, 199.8, 160.3, 141.8, 
138.2, 132.5, 128.1, 118.0, 75.7, 52.1, 47.2, 40.5, 40.1, 23.1, 13.0, 7.5. HRMS (EI) Exact mass 
calculated for C16H20O3 [M]+: 260.14070, found: 260.14107.  
 
 
(R)-2-((2R,8R,8aR)-2-Hydroxy-8,8a-dimethyl-3,7-dioxo-1,2,3,5,6,7,8,8a-octahydro-
naphthalen-2-yl)propanal (11R-2.115): A solution of 11S-2.114 (48.0 mg, 0.183 mmol, 
1.0 equiv.), pyridine (59 µL, 0.73 mmol, 4.0 equiv.) and Sudan III (spatula tip) in 
O
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CH2Cl2/MeOH (5.0 mL, 1:1) was cooled to –78°C and O3 was bubbled through the solution 
until the red color disappeared (40 sec). The reaction mixture was sequentially purged with O2 
and N2. PPh3 (96.0 mg, 0.366 mmol, 2.0 equiv.) was added and the mixture was allowed to 
warm to rt. After stirring for 1 h, the solvent was removed by evaporation and the residue was 
purified by flash column chromatography (pentane/Et2O 1:2) to give 11R-2.115 (36.7 mg, 
0.139 mmol, 76 %, dr 6:1) as a colorless solid. 
M.p. = 158.2 – 160.0 °C. TLC: Rf = 0.18 (SiO2, pentane/Et2O 1:2). Optical rotation: [𝛼𝛼]*%1 = 
+29.8° (c = 0.23, CHCl3). FTIR (neat): ν/ = 3424, 2977, 1715, 1671, 1440, 1387, 1242, 1154, 
1030, 886 cm-1. 1H NMR (500 MHz, CDCl3) δ = 9.78 (d, J = 1.3, 1H), 6.00 (d, J = 1.9, 1H), 
4.06 (s, 1H), 2.87 (dddd, J = 14.9, 12.9, 7.0, 1.9, 1H), 2.77 – 2.70 (m, 1H), 2.61 – 2.51 (m, 4H), 
2.10 (d, J = 14.4, 1H), 2.01 (d, J = 14.5, 1H), 1.22 (d, J = 7.3, 3H), 1.22 (s, 3H), 1.08 (d, J = 
6.7, 3H). 13C NMR (126 MHz, CDCl3) δ = 209.0, 206.4, 196.8, 166.7, 122.4, 78.3, 54.1, 50.7, 
43.6, 42.9, 40.2, 32.3, 22.6, 10.2, 7.7. HRMS (ESI) Exact mass calculated for C15H21O4+ 
[M+H]+: 265.14344, found: 265.14360. 
 
 
(3S,3aR,4aR,5R,9aS)-3a,9a-Dihydroxy-3,4a,5-trimethyl-2,3,3a,4a,5,7,8,9a-octahydro-
naphtho[2,3-b]furan-6(4H)-one (3.10) and (1R,7R,8aR)-7-hydroxy-7-((S)-1-hydroxy-
propan-2-yl)-1,8a-dimethyl-1,3,4,7,8,8a-hexahydronaphthalene-2,6-dione (3.10’): 
NaBH(OAc)3 (153 mg, 0.722 mmol, 3.0 equiv.) was added to a solution of 11R-2.115 (63.5 mg, 
0.240 mmol, 1.0 equiv.) in CH2Cl2 (8.0 mL) and the mixture was stirred for 2 h at rt. Sat. aq. 
NH4Cl solution was added and stirring was continued 30 min before the layers were separated 
and the aqueous layer was extracted with CH2Cl2 (3 x). The combined organic layers were dried 
over Na2SO4, filtered and concentrated. The residue was purified by flash column 
chromatography (pentane/Et2O 1:10) to give 3.10/3.10’ (40.0 mg, 0.150 mmol, 63 %) as a 
colorless oil. 
TLC: Rf = 0.40 (SiO2, Et2O). Optical rotation: [𝛼𝛼]*%& = +21.9° (c = 1.4, CHCl3). FTIR (neat): 
ν/ = 3417, 2968, 2942, 2881, 1711, 1670, 1442, 1385, 1291, 1153, 1013, 878, 731, 633 cm-1. 1H 
NMR (500 MHz, CDCl3, signals from the closed form are marked with a, those from the open 
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form with b; ratio a/b = 1.8:1) δ = 6.01b (d, J =1.9, 1H), 5.53a (d, J = 2.0, 1H), 4.14a (t, J = 8.7, 
1H), 3.88b (dd, J = 11.1, 4.3, 1H), 3.76 – 3.70b (m, 1H), 3.68a (s, 1H), 3.40a (dd, J = 10.3, 8.6, 
1H), 2.86b (dddd, J = 14.9, 13.1, 6.4, 2.0, 1H), 2.73 – 2.64b (m, 2H), 2.71b (s, 1H), 2.58b (dd, J 
= 6.5, 2.9, 1H), 2.57 – 2.50a+b (m, 3H), 2.47 – 2.43a+b (m, 4H), 2.40b (s, 1H), 2.36a (s, 1H), 2.33a 
(q, J = 6.9, 1H), 2.17 – 2.13b (m, 1H), 1.89a (d, J = 14.2, 1H), 1.84b (d, J = 14.9, 1H), 1.41a 
(dd, J = 14.2, 2.0, 1H), 1.15b (d, J = 6.7, 3H), 1.13b (s, 3H), 1.12a (s, 3H), 1.03a (d, J = 6.9, 
6H), 0.94b (d, J = 6.9, 3H). 13C NMR (126 MHz, CDCl3, signals from the closed form are 
marked with a, those from the open form with b) δ = 211.1a, 209.1b, 200.4b, 166.1b, 144.3a, 
122.4b, 120.7a, 99.7a, 77.3a (according to HMBC), 76.7b, 71.3a, 64.6b, 55.8a, 52.6b, 42.7b, 42.4a, 
42.1a, 41.7b, 41.1a, 40.8b, 40.3b, 38.4a, 31.9a, 31.7b, 24.4b, 21.1a, 11.9b, 9.5a, 8.3b, 7.6a. HRMS 
(ESI) Exact mass calculated for C15H23O4+ [M+H]+: 267.15909, found: 267.15906. 
or 
 
Stock solution: DIBAL-H (1.2 M in toluene, 0.28 mL, 0.34 mmol) was added to CH2Cl2 
(2.0 mL) and the mixture was stirred for 5 min at rt. The prepared stock solution (0.23 mL, 
34 µmol, 1.5 equiv.) was added slowly along the wall of the reaction vessel to a mixture of 11R-
2.115 (6.0 mg, 23 µmol, 1.0 equiv.) in CH2Cl2 (0.6 mL) at –88°C and stirred at –88 - –78°C for 
50 min. MeOH and sat. aq. Rochelle’s solution were added and the layers were separated after 
the mixture warmed up to rt. The aqueous layer was extracted with CH2Cl2 (3 x), and the 
combined organic layers were dried over Na2SO4, filtered and concentrated. The residue was 
purified by flash column chromatography (pentane/Et2O 1:10) to give 3.10/3.10’ (1.7 mg, 
6.4 µmol, 28 %) as a colorless oil, SM (1.0 mg, 68 % pure, 2.6 µmol, 11 %) as a slightly yellow 
solid as well as 6.11/6.11’ (0.9 mg, 83 % pure, 2.8 µmol, 12 %) as a colorless solid. 
(3S,3aR,4aR,5R,9aS)-3,4a,5-Trimethyl-2,3,4,4a,5,6,7,8-octahydronaphtho[2,3-b]furan-
3a,6,9a-triol (6.11) and (3R,4aR,5R)-3,6-dihydroxy-3-((S)-1-hydroxypropan-2-yl)-4a,5-
dimethyl-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one (6.11’): M.p. = 130.9 – 131.7°C. 
TLC: Rf = 0.30 (SiO2, Et2O). FTIR (neat): ν/ = 3413, 2963, 2937, 2880, 1654, 1457, 1373, 
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1244, 1032, 1007, 945, 731, 646 cm-1. 1H NMR (500 MHz, CDCl3, signals from the closed 
form are marked with a, those from the open form with b; ratio a/b = 1:2.9) δ = 5.88b (d, J = 1.8, 
1H), 5.40a (d, J = 1.8, 1H), 4.08a (t, J = 8.6, 1H), 3.94b (s, 1H), 3.92b (dd, J = 11.1, 4.1, 1H), 
3.86a (s, 1H), 3.69a (s, 1H), 3.66 – 3.61b (m, 1H), 3.66b (s, 1H), 3.32a (dd, J = 10.5, 8.5, 1H), 
2.96 – 2.88b (m, 1H), 2.79a (s, 1H), 2.74 – 2.64a (m, 1H), 2.73b (s, 1H), 2.47 – 2.43a (m, 1H), 
2.35b (d, J = 15.0, 1H), 2.18b (dt, J = 13.4, 3.5, 1H), 2.12 – 2.06b (m, 1H), 2.01 – 1.95a+b (m, 
3H), 1.90a (d, J = 14.2, 1H), 1.77 – 1.71b (m, 2H), 1.70 – 1.68a (m, 1H), 1.68b (d, J = 15.0, 1H), 
1.58b (s, 1H), 1.45a (s, 1H), 1.41a (s, 3H), 1.38b (s, 3H), 1.34 – 1.31a (m, 1H), 1.19b (d, J = 7.1, 
3H), 1.13a (d, J = 14.2, 1H), 1.10a (d, J = 7.2, 3H), 1.01a (d, J = 7.0, 3H), 0.90b (d, J = 7.0, 
3H). 13C NMR (126 MHz, CDCl3, signals from the closed form are marked with a, those from 
the open form with b) δ = 201.0b, 172.7b, 148.7a, 120.3b, 118.7a, 99.9a, 77.5b (according to 
HMBC), 77.2a (according to HMBC), 72.3a, 71.0b, 70.9a, 64.3b, 47.6a, 44.1b, 42.9a, 42.6b, 41.0b, 
40.7b, 39.0a, 38.5a, 35.0b, 34.6a, 27.9b, 26.9a, 26.1b, 22.3a, 12.5b, 12.3a, 11.8b, 9.4a. HRMS (ESI) 
Exact mass calculated for C15H24O4Na+ [M+Na]+: 291.15668, found: 291.15657. 
 
 
Microsphaeropsisin C (3.3/3.3’) and microsphaeropsisin B (3.2/3.2’): To a solution of 
3.10/3.10’ (19.0 mg, 71.3 µmol, 1.0 equiv.) in THF (2.0 ml, distilled prior to use) was added 
TBD (29.9 mg, 0.214 mmol, 3.0 equiv.) and the mixture was stirred under an O2 atmosphere at 
rt for 5 h. Sat. aq. NH4Cl solution was added and the layers were separated. The aqueous layer 
was extracted with Et2O (3 x), dried over Na2SO4, filtered and concentrated. The residue was 
dissolved in MeCN/H2O (1:3, 1.0 mL) and subjected to preparative HPLC separation using the 
conditions given below. Microsphaerospsisin B eluted at 39.6 min, microsphaeropsisin C at 
52.4 min. Concentration of the fractions by rotary evaporator and lyophilizer gave 
microsphaeropsisin B (3.6 mg, 80 % pure, 10.9 µmol) as a slightly yellow solid and pure 
microsphaeropsisin C (6.6 mg, 25.0 µmol, 35%) as a colorless solid. Microsphaeropsisin B 
(3.6 mg, 80% pure, 10.9 µmol) was dissolved in MeCN/H2O (2:3, 0.50 ml) and subjected to the 
HO O
OH O O
O
OH
HO
O
O
OH
OH
O
O
OH
+
Microsphaeropsisin B (3.2/3.2’)
10 % (after HPLC)
Microsphaeropsisin C (3.3/3.3’)
35 % (after HPLC)
TBD, O2
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3.103.10’
HO O
OH O
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same preparative HPLC conditions. Microsphaerospsisin B eluted at 39.4 min and 
concentration of the collected fractions by rotary evaporator and lyophilizer gave pure 
microsphaeropsisin B (1.9 mg, 7.2 µmol, 10%) as a colorless solid. 
Column: Synergi Hydro-RP 10 µm 80 Å, 250 x 21.2 mm; solvent A: H2O; solvent B: MeCN; 
flow = 20.0 mL/min; T = rt; UV detection at 254 nm and 225 nm; solvent system: isocratic, [B] 
= 10 %. 
Microsphaeropsisin C (3.3/3.3’): M.p. = 57.1 – 58.2°C. TLC: Rf = 0.45 (SiO2, Et2O). Optical 
rotation: [𝛼𝛼]*%( = +67.0° (c = 0.48, MeOH). FTIR (neat): ν/ = 3412, 2968, 1669, 1455, 1393, 
1224, 1096, 1077, 1014, 982, 863 cm-1. UV/Vis (MeOH): lmax 282 (3.94). CD (MeOH): 278 
(28.6), 336 (–8.7). 1H NMR (500 MHz, MeOD-d4, signals from the closed form are marked 
with a, those from the open form with b; ratio a/b = 4:1): H NMR (500 MHz, Methanol-d4) δ = 
7.19b (d, J = 9.8, 1H), 7.05a (d, J = 9.8, 1H), 6.20b (d, J = 10.0, 1H), 6.18b (s, 1H), 5.97a (s, 
1H), 5.96a (d, J = 9.4, 1H), 4.07a (t, J = 8.5, 1H), 3.47 – 3.38b (m, 2H), 3.34a (dd, J = 10.6, 8.5, 
1H), 2.69b (q, J = 6.8, 1H), 2.61 – 2.53a (m, 1H), 2.44a (q, J = 6.8, 1H), 2.44 – 2.40b (m, 1H), 
2.09b (d, J = 14.4, 1H), 1.97b (d, J = 14.3, 1H), 1.91a (d, J = 13.9, 1H), 1.51a (d, J = 14.0, 1H), 
1.28b (s, 3H), 1.19a (s, 3H), 1.14b (d, J = 6.8, 3H), 1.10a (d, J = 6.8, 3H), 1.03a+b (d, J = 7.0, 
6H). 1H NMR (500 MHz, DMSO-d6, signals from the closed form are marked with a, those 
from the open form with b; ratio a/b = 1.9:1)) δ = 7.27b (d, J = 10.0, 1H), 7.08a (d, J = 9.8, 1H), 
6.37a (s, 1H), 6.20b (d, J = 9.7, 1H), 6.20b (s, 1H), 5.95a (s, 1H), 5.91a (d, J = 9.8, 1H), 5.11b 
(d, J = 1.7, 1H), 4.46b (t, J = 5.1, 1H), 4.10a (s, 1H), 3.91a (t, J = 8.4, 1H), 3.23 – 3.20a+b (m, 
2H), 3.17 – 3.11b (m, 1H), 2.66b (q, J = 6.7, 1H), 2.48 – 2.41a (m, 1H), 2.35a (q, J = 6.9, 1H), 
2.34 – 2.29b (m, 1H), 1.91b (d, J = 14.2, 1H), 1.81b (d, J = 14.3, 1H), 1.71a (d, J = 13.9, 1H), 
1.40a (d, J = 13.8, 1H), 1.16b (s, 3H), 1.07a (s, 3H), 1.01b (d, J = 6.7, 3H), 0.98a (d, J = 6.8, 
3H), 0.92a (d, J = 6.9, 3H), 0.91b (d, J = 6.9, 3H). 13C NMR (126 MHz, MeOD-d4, signals from 
the closed form are marked with a, those from the open form with b) δ = 203.4a, 202.2b, 200.9b, 
160.8b, 146.1a, 143.8b, 142.4a, 132.8b, 132.2a, 129.4b, 128.4a, 100.3a, 77.6a, 75.4b, 71.6a, 64.9b, 
54.4a, 53.7b, 43.9a, 43.9b, 41.5b, 41.2b, 40.4a, 38.9a, 22.7b, 20.9a, 11.0b, 9.2a, 7.5b, 7.5a. HRMS 
(ESI) Exact mass calculated for C15H20O4Na+ [M+Na]+: 287.12538, found: 287.12540. 
Microsphaeropsisin B (3.2/3.2’): M.p. = 165.7 – 168.1°C. TLC: Rf = 0.45 (SiO2, Et2O). 
Optical rotation: [α]$%& = –20.2° (c = 0.60, MeOH). FTIR (neat): ν/ = 3402, 2965, 2934, 1667, 
1584, 1458, 1394, 1254, 1212, 1080, 1009, 865 cm-1. 1H NMR (500 MHz, MeOD-d4, only 
signals from the closed form are shown since ratio closed/open = 7:1) δ = 7.05 (d, J = 9.8, 1H), 
6.11 (s, 1H), 5.85 (d, J = 9.8, 1H), 4.08 (t, J = 8.5, 1H), 3.35 (dd, J = 10.5, 8.5, 4H), 2.60 – 
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2.55 (m, 1H), 2.25 (q, J = 7.2, 1H), 1.80 (d, J = 14.0, 1H), 1.44 (d, J = 14.1, 1H), 1.37 (s, 3H), 
1.02 (d, J = 7.0, 3H), 0.97 (d, J = 7.1, 3H). 1H NMR (500 MHz, DMSO-d6, signals from the 
closed form are marked with a, those from the open form with b; ratio a/b = 2.4:1) δ = 7.28b (d, 
J = 9.8, 1H), 7.07a (d, J = 9.8, 1H), 6.39a (s, 1H), 6.30b (s, 1H), 6.09b (d, J = 10.0, 1H), 6.09a 
(s, 1H), 5.79a (d, J = 9.7, 1H), 5.15b (s, 1H), 4.49b (s, 1H), 4.14a (s, 1H), 3.92a (t, J = 8.4, 1H), 
3.25 – 3.21b (m, 1H), 3.23a (dd, J = 10.4, 8.4, 1H), 3.18 – 3.15b (m, 1H), 2.56 – 2.43a+b (m, 2H), 
2.38 – 2.32b (m, 1H), 2.15a (q, J = 7.2, 1H), 2.06b (d, J = 14.4, 1H), 1.63a (d, J = 13.9, 1H), 
1.52b (d, J = 14.3, 1H), 1.35b (s, 3H), 1.28a (d, J = 13.9, 1H), 1.26a (s, 3H), 0.93b (d, J = 7.2, 
3H), 0.92b (d, J = 7.1, 3H), 0.91a (d, J = 6.9, 3H), 0.84a (d, J = 7.1, 3H). 1H NMR (500 MHz, 
CDCl3, only signals from the closed form are shown) δ = 6.89 (d, J=9.8, 1H), 6.00 (s, 1H), 5.90 
(d, J=9.8, 1H), 4.15 (t, J=8.6, 1H), 3.40 (dd, J=10.8, 8.7, 1H), 2.75 (s, 1H), 2.56 – 2.49 (m, 1H), 
2.47 (d, J=2.0, 1H), 2.32 (q, J=7.3, 1H), 1.76 (dd, J=14.2, 1.7, 1H), 1.49 (d, J=14.2, 1H), 1.41 
(s, 3H), 1.05 (d, J=7.0, 3H), 0.99 (d, J=7.2, 3H). 13C NMR (126 MHz, MeOD-d4, only signals 
from the closed form are shown) δ = 206.8, 146.6, 139.4, 135.3, 126.3, 100.5, 77.8, 71.8, 55.0, 
43.8, 39.9, 34.6, 28.0, 14.8, 9.2. 13C NMR (126 MHz, CDCl3, only signals from the closed 
form are shown) δ = 203.9, 143.6, 139.2, 131.7, 126.3, 99.3, 77.1, 71.3, 53.6, 43.3, 38.8, 33.0, 
27.7, 14.4, 8.9. HRMS (ESI) Exact mass calculated for C15H20O4Na+ [M+Na]+: 287.12538, 
found: 287.12538. 
 
 
4-epi-Periconianone C (3.11/3.11’): A solution of 3.3/3.3’ (8.2 mg, 31.0 µmol, 1.0 equiv.) and 
Ca(OMe)2 (6.5 mg, 62.0 µmol, 2.0 equiv.) in MeOH (3.5 mL) was stirred at 60°C for 14 h. Sat. 
aq. NH4Cl solution was added slowly and the mixture was diluted with H2O and Et2O. The 
layers were separated and the aqueous layer was extracted with Et2O (3 x). The combined 
organic layers were dried over Na2SO4, filtered and concentrated. The residue was purified by 
flash column chromatography (pentane/Et2O 1:5) to give 3.11/3.11’ (3.1 mg, 11.7 µmol, 38 %) 
and recovered starting material 3.3/3.3’ (3.0 mg, 11.3 µmol, 37 %) both as colorless solids. 
M.p. = 144.2 – 144.9°C. TLC: Rf = 0.58 (SiO2, Et2O). Optical rotation: [α]$%& = +79.4° (c = 
0.52, MeOH). FTIR (neat): ν/ = 3402, 2969, 1674, 1455, 1389, 1217, 1110, 1025, 983, 935, 
905, 862, 715 cm-1. 1H NMR (500 MHz, DMSO-d6, only signals from the closed form are 
O
O
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OH
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Ca(OMe)2
MeOH
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38 % (75 % brsm)
EXPERIMENTAL PART 209 
 
shown since ratio closed/open = 10:1) δ = 7.07 (d, J = 9.8, 1H), 5.99 (s, 1H), 5.89 (d, J = 9.7, 
1H), 5.54 (s, 1H), 5.18 (s, 1H), 3.70 (t, J = 7.4, 1H), 3.53 (dd, J = 11.2, 7.4, 1H), 2.44 (q, J = 
6.7, 1H), 2.28 – 2.20 (m, 1H), 2.05 (d, J = 13.7, 1H), 1.78 (d, J = 13.7, 1H), 0.99 (s, 3H), 0.94 
(d, J = 6.6, 3H), 0.92 (d, J = 6.8, 3H). 13C NMR (126 MHz, DMSO-d6, only signals from the 
closed form are shown since ratio closed/open = 10:1) δ = 200.2, 144.5, 139.8, 133.7, 126.3, 
102.9, 75.7, 70.1, 51.7, 45.6, 44.3, 39.9 (according to HMBC), 19.2, 9.0, 7.0. HRMS (ESI) 
Exact mass calculated for C15H20O4Na+ [M+Na]+: 287.12538, found: 287.12529. 
 
 
Periconianone C (3.1/3.1’): A solution of 3.2/3.2’ (1.4 mg, 5.3 µmol, 1.0 equiv.) and 
Ca(OMe)2 (1.1 mg, 10.6 µmol, 2.0 equiv.) in MeOH (0.6 mL) was stirred at 60°C for 14 h. Sat. 
aq. NH4Cl solution was added slowly and the mixture was diluted with H2O and Et2O. The 
layers were separated and the aqueous layer was extracted with Et2O (3 x). The combined 
organic layers were dried over Na2SO4, filtered and concentrated. The residue was dissolved in 
MeOH/H2O (2:1, 0.2 mL), separated in portions (5 x 40 µL) and subjected to semi-preparative 
HPLC separation using the conditions given below. Periconianone C eluted at 5.21 min, 4-epi-
periconianone C at 6.57 min, microsphaeropsisin C at 4.39 min and microsphaeropsisin B at 
3.59 min. Concentration of all fractions by rotary evaporator and lyophilizer gave 
periconianone C (0.31 mg, 1.2 µmol, 22 %), 4-epi-periconianone C (0.10 mg, 0.38 µmol, 7 %), 
microsphaeropsisin C (0.12 mg, 0.45 µmol, 8 %) and microsphaeropsisin B (0.61 mg, 
2.3 µmol, 43 %) all as colorless solids. 
Column: Synergi Hydro-RP 10 µm 80 Å, 150 x 10.0 mm; solvent A: H2O; solvent B: MeCN; 
flow = 7.0 mL/min; T = rt; UV detection at 254 nm and 225 nm; solvent system: isocratic, [B] 
= 20 %. 
TLC: Rf = 0.45 (SiO2, Et2O). Optical rotation: [α]$%% = –53.8° (c = 0.19, MeOH). FTIR (neat): 
ν/ = 3401, 2966, 2932, 2875, 1669, 1634, 1453, 1394, 1253, 1139, 1108, 1075, 1022, 986, 934, 
905, 866, 719 cm-1. 1H NMR (500 MHz, DMSO-d6, only signals from the closed form are 
shown since ratio closed/open = 5:1) δ = 7.06 (d, J = 9.7, 1H), 6.13 (s, 1H), 5.77 (d, J = 9.7, 
1H), 5.61 (s, 1H), 5.23 (s, 1H), 3.73 (t, J = 7.4, 1H), 3.53 (dd, J = 11.1, 7.4, 1H), 2.22 – 2.12 
O
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(m, 1H), 2.07 (q, J = 7.2, 1H), 1.95 (d, J = 13.9, 1H), 1.65 (d, J = 13.8, 1H), 1.18 (s, 3H), 0.95 
(d, J = 6.6, 3H), 0.87 (d, J = 7.1, 3H). 13C NMR (126 MHz, DMSO-d6, only signals from the 
closed form are shown since ratio closed/open = 5:1): δ = 203.0, 144.6, 136.8, 136.7, 124.2, 
103.0, 76.1, 70.0, 52.5, 44.6, 41.7, 39.7 (according to HMBC), 26.1, 14.2, 9.1. HRMS (ESI) 
Exact mass calculated for C15H20O4Na+ [M+Na]+: 287.12538, found: 287.12527. 
6.5 Guignarderemophilane C and D229 
 
To a solution of enone 2.34 (53.5 mg, 0.16 mmol, 1.0 eq.) in H2O2 (30 % in H2O, 1.55 mL, 
16.5 mmol, 100 eq.) and THF (3.0 mL) at 0°C was added Triton B (40 % in MeOH, 90 µL, 
0.19 mmol, 1.2 eq). The reaction mixture was stirred for 5 h 45 min at that temperature and 
then quenched by addition of sat. aq. NH4Cl solution. The aqueous mixture was extracted with 
Et2O (3 x) and the combined organic layers were dried over Na2SO4, filtered and concentrated 
under reduced pressure. The residue was subjected to flash column chromatography 
(pentane/Et2O 5:1) to give the a,b-epoxy ketones 1S,2R-4.4 (26 mg, 76 µmol, 46 %) and 1R,2S-
4.4 (8.3 mg, 0.024 mmol, 15 %) both as colorless oils. 
(1S,3R,4R,5S,6R)-5-((tert-Butyldimethylsilyl)oxy)-3,4-dimethyl-3-(3-oxobutyl)-7-oxabi-
cyclo[4.1.0]heptan-2-one (1S,2R-4.4): 
TLC: Rf = 0.34 (SiO2, pentane/Et2O 5:1). Optical rotation: [𝛼𝛼]*%1 = –112.9° (c = 0.40, CHCl3). 
FTIR (neat): ν/ = 2956, 2931, 2857, 1714, 1472, 1362, 1256, 1083, 860, 838, 776 cm−1. 
1H NMR (500 MHz, CDCl3) δ = 3.90 (dd, J = 10.1, 1.0 Hz, 1H), 3.50 (d, J = 4.0 Hz, 1H), 3.31 
(d, J = 4.0 Hz, 1H), 2.34 (ddd, J = 16.8, 11.5, 4.8 Hz, 1H), 2.21 (ddd, J = 17.4, 11.4, 4.7 Hz, 
1H), 2.14 – 2.08 (m, 1H), 2.11 (s, 3H), 2.00 (ddd, J = 14.3, 11.5, 4.7 Hz, 1H), 1.65 (ddd, J = 
14.3, 11.4, 4.9 Hz, 1H), 0.94 (s, 9H), 0.92 (s, 3H), 0.91 (d, J = 7.0 Hz, 3H), 0.16 (s, 3H), 0.13 
(s, 3H). 13C NMR (151 MHz, CDCl3) δ = 208.1, 208.1, 70.6, 57.7, 55.5, 49.0, 38.6, 32.9, 30.1, 
29.9, 25.9 (3C), 20.2, 18.2, 10.9, -3.9, -4.5. HRMS (ESI) Exact mass calculated for C18H33O4Si+ 
[M+H]+: 341.21426, found: 341.21431. 
(1R,3R,4R,5S,6S)-5-((tert-Butyldimethylsilyl)oxy)-3,4-dimethyl-3-(3-oxobutyl)-7-oxabi-
cyclo[4.1.0]heptan-2-one (1R,2S-4.4): 
O
OTBS
O
O
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(40 % in MeOH)
H2O2, THF, 0°C
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TLC: Rf = 0.40 (SiO2, pentane/Et2O 5:1). Optical rotation: [𝛼𝛼]*%& = +14.6° (c = 0.26, CHCl3). 
FTIR (neat): ν/	 = 2955, 2930, 2894, 2858, 1712, 1258, 1084, 876, 837, 777 cm−1. 1H NMR 
(400 MHz, CDCl3) δ = 4.01 (d, J = 7.2 Hz, 1H), 3.44 (dd, J = 3.5, 0.7 Hz, 1H), 3.25 (dd, J = 
3.6, 0.9 Hz, 1H), 2.38 (ddd, J = 16.3, 11.1, 4.8 Hz, 1H), 2.25 (ddd, J = 16.8, 11.0, 4.9 Hz, 1H), 
2.13 (s, 3H), 1.99 (ddd, J = 14.3, 11.0, 4.9 Hz, 2H), 1.85 (p, J = 7.1 Hz, 1H), 1.66 (ddd, J = 
14.3, 11.1, 4.9 Hz, 1H), 1.08 (s, 3H), 0.97 (d, J = 7.0 Hz, 3H), 0.94 (s, 9H), 0.18 (s, 3H), 0.14 
(s, 3H). 13C NMR (151 MHz, CDCl3) δ = 208.4 (2C), 70.4, 61.5, 54.1, 47.6, 44.0, 38.5, 30.5, 
30.1, 25.9 (3C), 19.4, 18.2, 13.7, -4.3, -4.7. HRMS (ESI) Exact mass calculated for C18H33O4Si+ 
[M+H]+: 341.21426 found: 341.21428. 
 
 
(1aR,2S,3R,3aR,7bR)-2-((tert-Butyldimethylsilyl)oxy)-3,3a-dimethyl-1a,3,3a,4,5,7b-hexa-
hydronaphtho[1,2-b]oxiren-6(2H)-one (1R,2R-4.3): A mixture of a,b-epoxy ketone 1S,2R-
4.4 (8.5 mg, 25 µmol, 1.0 eq.), pyrrolidine (4 µL, 50 µmol, 2.0 eq.) and AcOH (3 µL, 50 µmol, 
2.0 eq.) in CH2Cl2 (0.5 mL) was stirred for 2 h 20 min at rt, before it was quenched by addition 
of 0.1 M aq. HCl and diluted with CH2Cl2. The layers were separated and the aqueous layer was 
extracted with Et2O (3 x). The combined organic layers were dried over Na2SO4, filtered and 
the solvent was removed under reduced pressure. The crude material was subjected to flash 
column chromatography (pentane/Et2O 3:1) to give the epoxy octalone 1R,2R-4.3 (5.9 mg, 
18 µmol, 73 %) as a colorless solid. 
M.p. = 76.2 – 77.5°C. TLC: Rf = 0.34 (SiO2, pentane/Et2O 1:1). Optical rotation: [𝛼𝛼]*%& = 
+30.7° (c = 0.36, CHCl3). FTIR (neat): ν/ = 2954, 2928, 2856, 1682, 1472, 1258, 1084, 855, 
836, 775 cm−1. 1H NMR (500 MHz, CDCl3) δ = 6.14 (s, 1H), 3.89 (dd, J = 10.0, 1.8 Hz, 1H), 
3.56 (d, J = 3.7 Hz, 1H), 3.46 (dd, J = 3.7, 1.8 Hz, 1H), 2.52 (ddd, J = 18.1, 14.1, 5.5 Hz, 1H), 
2.47 – 2.40 (m, 1H), 1.97 (ddd, J = 13.4, 5.4, 2.3 Hz, 1H), 1.75 (td, J = 13.8, 5.5 Hz, 1H), 1.66 
(dq, J = 10.0, 6.9 Hz, 1H), 1.04 (s, 3H), 0.96 (d, J = 7.0 Hz, 3H), 0.94 (s, 9H), 0.17 (s, 3H), 0.14 
(s, 3H). 13C NMR (126 MHz, CDCl3) δ = 198.4, 161.2, 131.1, 71.4, 56.1, 54.7, 38.2, 37.7, 34.1, 
33.5, 26.0 (3C), 18.3, 17.1, 9.7, -3.8, -4.4. HRMS (ESI) Exact mass calculated for C18H31O3Si+ 
[M+H]+: 323.20370, found: 323.20360. 
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(1aS,2S,3R,3aR,7bS)-2-((tert-Butyldimethylsilyl)oxy)-3,3a-dimethyl-1a,3,3a,4,5,7b-hexa-
hydronaphtho[1,2-b]oxiren-6(2H)-one (1S,2S-4.3): To a solution of TBS-protected enone 
2.34 (21.0 mg, 65 µmol, 1.0 eq.) in THF (1.0 mL) at –10°C were added TBHP (5.5 M in decane, 
59 µL, 0.32 mmol, 5.0 eq.) and Triton B (40 % in MeOH, 35 µL, 78 µmol, 1.2 eq.). The 
reaction mixture was stirred for 5 h 15 min at –10°C and then quenched by addition of sat. aq. 
NH4Cl solution. The aqueous mixture was extracted with Et2O (3 x) and the combined organic 
layers were dried over Na2SO4, filtered and concentrated. The crude material was purified twice 
by flash column chromatography (pentane/Et2O 5:1) to give epoxy octalone 1S,2S-4.3 (8.2 mg, 
25 µmol, 39 %) as a colorless solid.  
M.p. = 107.4 – 110.1°C. TLC: Rf = 0.48 (SiO2, pentane/Et2O 5:1). Optical rotation: [𝛼𝛼]*%1 = 
–39° (c = 0.36, CHCl3). FTIR (neat): ν/ = 2954, 2930, 2885, 2858, 1686, 1472, 1258, 1086, 
1065, 865, 837, 776 cm−1. 1H NMR (500 MHz, CDCl3) δ = 6.16 (s, 1H), 3.76 (d, J = 9.9 Hz, 
1H), 3.48 (d, J = 3.6 Hz, 1H), 3.44 (d, J = 3.6 Hz, 1H), 2.57 (ddd, J = 17.6, 14.9, 5.0 Hz, 1H), 
2.41 (d, J = 17.4 Hz, 1H), 1.99 – 1.95 (m, 1H), 1.68 (td, J = 14.1, 4.5 Hz, 1H), 1.44 (dd, J = 
9.8, 6.7 Hz, 1H), 1.15 (s, 3H), 0.97 (d, J = 6.7 Hz, 3H), 0.94 (s, 9H), 0.19 (s, 3H), 0.14 (s, 3H). 
13C NMR (126 MHz, CDCl3) δ = 198.3, 161.8, 129.6, 70.1, 61.9, 56.5, 47.7, 36.7, 35.8, 33.9, 
25.9 (3C), 18.1, 17.2, 11.7, -4.1, -4.7. HRMS (ESI) Exact mass calculated for C18H31O3Si+ 
[M+H]+: 323.20370, found: 323.20356. 
 
 
(2R,3R,4S,5R)-4-((tert-Butyldimethylsilyl)oxy)-5-hydroxy-2,3-dimethyl-2-(3-oxobutyl)-
cyclohexan-1-one (4.6): Stock solution: To a solution of diphenyl diselenide (89.5 mg, 
287 mmol) in EtOH (1.0 mL) were added NaBH4 (16.7 mg, 573 mmol) and AcOH (4.0 µL), 
and the mixture was stirred at rt for 20 min to form a yellow solution. 
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a,b-Epoxy ketone 1S,2R-4.4 (13.0 mg, 38.0 µmol, 1.0 eq.) was dissolved in CH2Cl2 (0.2 mL) 
and the prepared stock solution (0.2 mL, 57 µmol, 1.5 eq) was added over a period of 5 min at 
rt. The reaction mixture turned yellow and was stirred for 1 h 10 min, before it was diluted with 
CH2Cl2 and brine. The layers were separated and the aqueous layer was extracted with CH2Cl2 
(3 x). The combined organic layers were dried over Na2SO4, filtered and concentrated under 
reduced pressure. The residue was subjected to flash column chromatography (pentane/Et2O 
1:1) to give the b-hydroxy ketone 4.6 (5.6 mg, 16 µmol, 43 %) as a colorless oil. 
TLC: Rf = 0.50 (SiO2, pentane/Et2O 1:3). Optical rotation: [𝛼𝛼]*%1 = +21.8° (c = 0.28, CHCl3). 
FTIR (neat): ν/ = 3493, 2955, 2929, 2857, 1711, 1463, 1254, 1067, 837, 776 cm−1. 1H NMR 
(500 MHz, CDCl3) δ = 4.08 (q, J = 3.4 Hz, 1H), 3.82 (dd, J = 10.0, 2.7 Hz, 1H), 2.69 (ddd, J = 
15.3, 3.4, 2.2 Hz, 1H), 2.57 (dd, J = 15.4, 3.6 Hz, 1H), 2.50 (ddd, J = 17.3, 11.2, 4.5 Hz, 1H), 
2.40 (dd, J = 2.2, 1.0 Hz, 1H), 2.28 (ddd, J = 16.9, 11.1, 4.9 Hz, 1H), 2.17 – 2.08 (m, 1H), 2.14 
(s, 3H), 1.97 (ddd, J = 14.3, 11.2, 4.5 Hz, 1H), 1.04 (s, 3H), 1.61 (ddd, J = 14.2, 11.1, 4.9 Hz, 
1H), 0.96 (d, J = 6.9 Hz, 3H), 0.93 (s, 9H), 0.14 (s, 3H), 0.13 (s, 3H). 13C NMR (126 MHz, 
CDCl3) δ = 212.0, 209.0, 74.2, 71.5, 50.2, 42.5, 38.8, 36.4, 30.2, 28.7, 26.0 (3C), 20.6, 18.2, 
11.7, -4.1, -4.4. HRMS (ESI) Exact mass calculated for C18H35O4Si+ [M+H]+: 343.22991, 
found: 343.22956. 
 
 
(1S,3R,4R,5S,6S)-5-Hydroxy-3,4-dimethyl-3-(3-oxobutyl)-7-oxabi-cyclo[4.1.0]heptan-2-
one (4.7): To a solution of a,b-epoxy ketone 1S,2R-4.4 (9.0 mg, 26 µmol, 1.0 eq.) in MeCN 
(0.5 mL) was added HF (48 % in H2O, 5 µL, 0.26 mmol, 10 eq.). The mixture was stirred for 
3 h 15 min at rt before it was quenched by addition of sat. aq. NaHCO3. The mixture was 
extracted with Et2O (3 x) and the combined organic layers were washed with H2O, dried over 
Na2SO4, filtered and concentrated. The residue was purified by flash column chromatography 
(pentane/Et2O 1:3 to 1:5 to 1:7) to afford the epoxy alcohol 4.7 (3.9 mg, 17 µmol, 65 %) as a 
colorless oil. 
TLC: Rf = 0.50 (SiO2, Et2O). 1H NMR (400 MHz, CDCl3) δ = 3.89 (ddd, J = 10.0, 8.6, 1.2 Hz, 
1H), 3.67 (dd, J = 4.0, 1.1 Hz, 1H), 3.39 (d, J = 4.0 Hz, 1H), 2.40 – 2.18 (m, 2H), 2.12 (s, 3H), 
2.09 – 1.94 (m, 2H), 1.78 (d, J = 8.6 Hz, 1H), 1.66 (ddd, J = 14.3, 10.5, 5.6 Hz, 1H), 1.02 (d, J 
O
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= 6.8 Hz, 3H), 0.94 (s, 3H). 13C NMR (126 MHz, CDCl3) δ = 207.9, 207.2, 70.2, 57.3, 55.6, 
49.1, 38.6, 33.3, 30.1, 29.4, 20.0, 10.4. HRMS (ESI) Exact mass calculated for C12H18O4Na+ 
[M+Na]+: 249.10973, found: 249.10979. 
 
 
(4R,5R,6R)-4-Hydroxy-5,6-dimethyl-6-(3-oxobutyl)cyclohex-2-en-1-one (4.9): To a 
solution of TBS protected alcohol 2.34 (792 mg, 2.44 mmol, 1.0 eq.) in MeCN (36 mL) was 
added HF (48 % in H2O, 1.0 mL, 24.4 mmol, 10 eq.). The mixture was stirred for 38 h at rt, 
before it was quenched by addition of sat. aq. NaHCO3. The solution was extracted with Et2O 
(3 x) and the combined organic layers were washed with H2O, dried over Na2SO4, filtered and 
concentrated. The crude material was subjected to flash column chromatography (Et2O) to yield 
the allylic alcohol 4.9 (471 mg, 2.24 mmol, 92 %) as a colorless solid.  
M.p. = 78.8 – 83.5°C. TLC: Rf = 0.38 (SiO2, Et2O). Optical rotation: [𝛼𝛼]*%1 = –63.6° (c = 0.48, 
CHCl3). FTIR (neat): ν/ = 3472, 2971, 2020, 1713, 1672, 1377, 1041 cm−1. 1H NMR (400 MHz, 
CDCl3) δ = 6.82 (dd, J = 10.3, 2.0 Hz, 1H), 5.92 (dd, J = 10.2, 2.2 Hz, 1H), 4.22 (ddt, J = 9.4, 
7.2, 2.1 Hz, 1H), 2.33 (ddd, J = 15.1, 11.3, 4.2 Hz, 1H), 2.27 – 2.19 (m, 1H), 2.19 – 2.09 (m, 
1H), 2.14 (s, 3H), 1.96 (dq, J = 9.5, 6.7 Hz, 1H), 1.84 (d, J = 7.2 Hz, 1H), 1.62 (ddd, J = 14.0, 
11.3, 4.1 Hz, 1H), 1.11 (d, J = 6.8 Hz, 3H), 1.02 (s, 3H). 13C NMR (126 MHz, CDCl3) δ = 
208.8, 203.2, 150.7, 127.9, 70.6, 48.5, 42.8, 38.5, 30.0, 28.4, 19.3, 10.8. HRMS (ESI) Exact 
mass calculated for C12H19O3+ [M+H]+: 211.13287, found: 211.13286. 
 
 
(1S,5R,6R)-5,6-Dimethyl-4-oxo-5-(3-oxobutyl)cyclohex-2-en-1-yl 4-nitrobenzoate (4.10): 
Triphenylphosphine (517 mg, 1.95 mmol, 2.0 eq.) and DIAD (0.383 mL, 1.95 mmol, 2.0 eq.) 
were dissolved in THF (4.5 mL) at 0°C. After 5 min allylic alcohol 4.9 (205 mg, 0.98 mmol, 
1.0 eq.) in THF (7.5 mL) and 4-nitrobenzoic acid (329 mg, 1.95 mmol, 2.0 eq.) were added to 
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the reaction mixture. After stirring was continued for 5 min at 0°C, the reaction mixture was 
allowed to warm up to rt and was stirred for 35 min, before it was heated to 60°C for 1 h in the 
microwave. After evaporation of the solvent, the crude material was subjected to flash column 
chromatography (pentane/Et2O 1:1) to give the ester 4.10 (345 mg, 0.98 mmol, quant.) as a 
colorless solid. 
M.p. = 72.6 – 74.6°C. TLC: Rf = 0.25 (SiO2, pentane/Et2O 1:1). Optical rotation: [𝛼𝛼]*%1 = 
+159.2° (c = 0.47, CHCl3). FTIR (neat): ν/ = 2982, 1723, 1682, 1528, 1348, 1270, 1102, 1066 
cm−1. 1H NMR (500 MHz, CDCl3) δ = 8.34 – 8.29 (m, 2H), 8.24 – 8.20 (m, 2H), 6.74 (ddd, J 
= 10.2, 2.9, 1.5 Hz, 1H), 6.09 (dt, J = 5.1, 2.6 Hz, 1H), 6.06 (dd, J = 10.2, 2.1 Hz, 1H), 2.59 – 
2.52 (m, 2H), 2.37 (ddd, J = 17.5, 10.5, 5.2 Hz, 1H), 2.17 (s, 3H), 2.02 (ddd, J = 14.4, 10.5, 5.3 
Hz, 1H), 1.93 (ddd, J = 14.4, 10.6, 5.2 Hz, 1H), 1.16 (s, 3H), 1.03 (d, J = 6.9 Hz, 3H). 13C NMR 
(126 MHz, CDCl3) δ = 207.7, 202.3, 164.0, 150.9, 142.6, 135.0, 130.9 (2C), 130.0, 123.9 (2C), 
71.7, 49.2, 40.8, 38.4, 30.2, 29.6, 19.9, 10.1. HRMS (ESI) Exact mass calculated for 
C19H21NO6Na+ [M+Na]+: 382.12611, found: 382.12626. 
 
 
(1R,2S,8aR)-1,8a-Dimethyl-6-oxo-1,2,6,7,8,8a-hexahydro-naphthalen-2-yl 4-nitrobenzo-
ate (4.11): A mixture of ester 4.10 (14.1 mg, 39 µmol, 1.0 eq.), pyrrolidine (6 µL, 78 µmol, 
2.0 eq.) and AcOH (4.5 µL, 78 µmol, 2.0 eq.) in CH2Cl2 (0.4 mL) was stirred for 3 h 10 min at 
rt, before additional pyrrolidine (2.0 eq.) and AcOH (2.0 eq.) were added. After in total 9 h at 
rt the mixture was quenched by addition of 0.1 M aq. HCl and diluted with CH2Cl2. The layers 
were separated and the aqueous layer was extracted with CH2Cl2 (3 x). The combined organic 
layers were dried over Na2SO4, filtered and concentrated. Since the residue still contained 
enone 4.10 (monitored by 1H NMR), a mixture of crude material, pyrrolidine (2.0 eq.) and 
AcOH (2.0 eq.) in CH2Cl2 (0.5 mL) was stirred for additional 14 h at rt. The same work-up 
procedure was carried out as described before and the obtained residue was subjected to flash 
column chromatography (pentane/Et2O 1:1) to give the dienone 4.11 (8.1 mg, 24 µmol, 61 %) 
as a colorless solid. 
M.p. = 162.3 – 163.6°C. TLC: Rf = 0.54 (SiO2, pentane/Et2O 1:2). Optical rotation: [𝛼𝛼]*%1 = 
+699° (c = 0.41, CHCl3). FTIR (neat): ν/ = 3111, 2971, 2944, 1721, 1663, 1527, 1268, 1093, 
O
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719 cm−1. 1H NMR (500 MHz, CDCl3) δ = 8.31 (d, J = 8.7 Hz, 2H), 8.18 (d, J = 8.6 Hz, 2H), 
6.41 (d, J = 9.7 Hz, 1H), 6.33 (dd, J = 9.7, 5.2 Hz, 1H), 5.85 (s, 1H), 5.64 (t, J = 4.9 Hz, 1H), 
2.61 (ddd, J = 18.0, 14.2, 5.4 Hz, 1H), 2.52 (ddd, J = 18.0, 5.3, 2.1 Hz, 1H), 2.14 (ddd, J = 13.4, 
5.4, 2.2 Hz, 1H), 2.08 (dd, J = 7.2, 4.7 Hz, 1H), 1.81 (td, J = 13.8, 5.2 Hz, 1H), 1.41 (s, 3H), 
1.12 (d, J = 7.1 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ = 199.2, 164.5, 160.7, 150.8, 135.5, 
132.4, 131.4, 130.8 (2C), 126.6, 123.9 (2C), 71.5, 41.1, 35.8, 34.3, 34.1, 18.4, 10.5. HRMS 
(ESI) Exact mass calculated for C19H20NO5+ [M+H]+: 342.13360, found: 342.13368. 
 
 
Ester 4.10 (25.6 mg, 71 µmol, 1.0 eq.) was dissolved in THF (1.5 mL) and cooled to 0°C. H2O2 
(30 % in H2O, 675 µL, 7.12 mmol, 100 eq.) and Triton B (40 % in MeOH, 32 µL, 71 µmol, 
1.0 eq.) were added and the reaction mixture was stirred for 2 h 40 min at 0°C, before it was 
quenched by addition of sat. aq. Na2CO3 and diluted with Et2O. The layers were separated and 
the aqueous layer was extracted with Et2O (3 x). The combined organic layers were dried over 
Na2SO4, filtered and the solvent was removed under reduced pressure. The crude residue was 
subjected to flash column chromatography (Et2O/pentane 2:1) to give the epoxy ester 4.8 
(5.80 mg, 15 µmol, 22 %) as a colorless solid and epoxy alcohol 4.14 (9.0 mg, 40 µmol, 56 %) 
as a colorless oil.  
(1S,2R,3R,4R,6S)-3,4-Dimethyl-5-oxo-4-(3-oxobutyl)-7-oxabi-cyclo[4.1.0]heptan-2-yl 4-
nitrobenzoate (4.8): 
M.p. = 112.2 – 113.9°C. TLC: Rf = 0.43 (SiO2, pentane/Et2O 1:1). Optical rotation: 
[𝛼𝛼]*
%( = +27.9° (c = 0.29, CHCl3). FTIR (neat): ν/ = 2919, 1714, 1528, 1348, 1266, 1099, 718 
cm−1. 1H NMR (500 MHz, CDCl3) δ = 8.31 (d, J = 8.8 Hz, 2H), 8.15 – 8.12 (m, 2H), 5.74 (t, J 
= 3.0 Hz, 1H), 3.85 (t, J = 3.6 Hz, 1H), 3.45 (d, J = 4.0 Hz, 1H), 2.56 (qd, J = 7.3, 2.9 Hz, 1H), 
2.48 – 2.32 (m, 2H), 2.15 (s, 3H), 1.95 (ddd, J = 15.4, 9.9, 5.6 Hz, 1H), 1.86 (ddd, J = 14.7, 9.9, 
5.8 Hz, 1H), 1.19 (s, 3H), 1.04 (d, J = 7.3 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ = 208.8, 
207.7, 164.5, 151.0, 134.6, 131.0 (2C), 124.0 (2C), 74.2, 55.1, 54.4, 48.1, 38.4, 33.5, 31.8, 30.3, 
21.2, 11.8. HRMS (ESI) Exact mass calculated for C19H21O7NNa+ [M+Na]+: 398.12102, 
found: 398.12103. 
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(1S,3R,4R,5R,6S)-5-Hydroxy-3,4-dimethyl-3-(3-oxobutyl)-7-oxabi-cyclo[4.1.0]heptan-2-
one (4.14): 
TLC: Rf = 0.27 (SiO2, pentane/Et2O 1:1). Optical rotation: [𝛼𝛼]*%& = –65.5° (c = 0.20, CHCl3). 
FTIR (neat): ν/ = 3481, 2917, 2849, 1700, 1369, 1259, 1167 cm−1. 1H NMR (500 MHz, CDCl3) 
δ = 4.34 (d, J = 3.9 Hz, 1H), 3.64 (t, J = 3.6 Hz, 1H), 3.36 (d, J = 3.9 Hz, 1H), 2.38 (ddd, J = 
16.4, 10.5, 5.4 Hz, 1H), 2.33 – 2.25 (m, 1H), 2.17 (qd, J = 7.4, 2.7 Hz, 1H), 2.12 (s, 3H), 2.04 
(d, J = 4.6 Hz, 1H), 1.85 (ddd, J = 13.9, 10.5, 5.3 Hz, 1H), 1.74 (ddd, J = 14.0, 10.4, 5.4 Hz, 
1H), 1.09 (s, 3H), 1.03 (dd, J = 7.3, 1.1 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ = 209.9, 208.4, 
70.6, 57.0, 54.9, 48.0, 38.7, 33.8, 31.7, 30.2, 21.8, 11.5. HRMS (ESI) Exact mass calculated 
for C12H19O4+ [M+H]+: 227.12779, found: 227.12784. 
 
 
(1S,2R,3R,4R,6S)-3,4-Dimethyl-5-oxo-4-(3-oxobutyl)-7-oxabi-cyclo[4.1.0]heptan-2-yl 
acetate (4.15): To a solution of epoxy alcohol 4.14 (102 mg, 0.45 mmol, 1.0 eq.) in CH2Cl2 
(4.0 mL) was added Et3N (127 µL, 0.90 mmol, 2.0 eq.), Ac2O (0.17 mL, 1.8 mmol, 4.0 eq.) and 
DMAP (5.5 mg, 45 µmol, 0.1 eq.). The resulting mixture was stirred at rt for 1 h, then quenched 
by addition of 0.1 M HCl and diluted with CH2Cl2. After the layers were separated, the aqueous 
layer was extracted with CH2Cl2 (3 x). The combined organic layers were dried over Na2SO4, 
filtered and the solvent was removed under reduced pressure. The crude material was subjected 
to flash column chromatography (pentane/Et2O 1:1) to afford acetate 4.15 (107 mg, 0.40 mmol, 
88 %) as a colorless solid.  
M.p. = 71.8 – 73.9°C. TLC: Rf = 0.45 (SiO2, pentane/Et2O 1:1). Optical rotation: [𝛼𝛼]*%& =  
–14.5° (c = 0.23, CHCl3). FTIR (neat): ν/ = 2918, 2849, 1745, 1700, 1462, 1369, 1227, 1016, 
977 cm−1. 1H NMR (400 MHz, CDCl3) δ = 5.43 (t, J = 3.1 Hz, 1H), 3.72 – 3.68 (m, 1H), 3.36 
(d, J = 3.9 Hz, 1H), 2.46 – 2.26 (m, 3H), 2.13 (s, 3H), 2.10 (s, 3H), 1.88 (ddd, J = 14.3, 10.1, 
5.5 Hz, 1H), 1.77 (ddd, J = 14.3, 10.2, 5.7 Hz, 1H), 1.08 (s, 3H), 0.95 (d, J = 7.3 Hz, 3H). 
13C NMR (126 MHz, CDCl3) δ = (126 MHz, CDCl3) δ = 209.3, 207.9, 170.6, 72.3, 55.0, 54.5, 
48.1, 38.5, 32.7, 31.8, 30.2, 21.2, 20.9, 11.5. HRMS (ESI) Exact mass calculated for 
C14H20O5Na+ [M+Na]+: 291.12029, found: 291.12025. 
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(1aS,2R,3R,3aR,7bR)-3,3a-Dimethyl-6-oxo-1a,2,3,3a,4,5,6,7b-octahydronaphtho[1,2-b]-
oxiren-2-yl acetate (4.12): A mixture of a,b-epoxy ketone 4.15 (19.3 mg, 72 µmol, 1.0 eq), 
pyrrolidine (12 µL, 0.14 mmol, 2.0 eq.) and AcOH (8.2 µL, 0.14 mmol, 2.0 eq) in CH2Cl2 
(0.6 mL) was stirred at rt o.n. The mixture was quenched by addition of 0.1 M aq. HCl and 
diluted with CH2Cl2. The layers were separated and the aqueous layer was extracted 
with CH2Cl2 (3 x). The combined organic layers were dried over Na2SO4, filtered and 
concentrated. The crude residue was subjected to flash column chromatography (pentane/Et2O 
1:1) to yield epoxy octalone 4.12 (14.2 mg, 57 µmol, 79 %) as a colorless solid. 
M.p. = 81.8 – 85.8°C. TLC: Rf = 0.44 (SiO2, pentane/Et2O 1:1). Optical rotation: [𝑎𝑎]*%0 = 
+212.6° (c = 0.62, CHCl3). FTIR (neat): ν/ = 2923, 2853, 1744, 1681, 1374, 1230, 1026 cm−1. 
1H NMR (500 MHz, CDCl3) δ = 6.17 (s, 1H), 5.42 – 5.39 (m, 1H), 3.56 (d, J = 3.3 Hz, 1H), 
3.50 (dd, J = 3.3, 2.1 Hz, 1H), 2.60 (ddd, J = 18.3, 14.1, 5.6 Hz, 1H), 2.52 – 2.42 (m, 1H), 2.15 
(s, 3H), 1.99 (ddd, J = 13.3, 5.4, 2.2 Hz, 1H), 1.87 (qd, J = 7.3, 3.9 Hz, 1H), 1.71 (td, J = 13.7, 
5.4 Hz, 1H), 1.21 (s, 3H), 0.94 (d, J = 7.2 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ = 198.1, 
170.4, 160.6, 131.7, 70.8, 53.0, 53.0, 35.6, 34.7, 34.1, 34.0, 21.1, 18.8, 9.8. HRMS (ESI) Exact 
mass calculated for C14H19O4+ [M+H]+: 251.12779, found: 251.12786. 
 
 
(1R,2R,3R,5S,6S)-5,6-Dihydroxy-2,3-dimethyl-4-oxo-3-(3-oxo-butyl)cyclohexyl acetate 
(4.16): A solution of epoxy ketone 4.15 (108 mg, 0.40 mmol, 1.0 eq.) in toluene (4.5 mL) was 
cooled to 0°C and BF3·Et2O (56.2 µL, 0.44 mmol, 1.1 eq.) was added. The resulting yellow 
solution was stirred for 7 h and then quenched by addition of sat. aq. NaHCO3. The mixture 
was extracted with EtOAc (3 x) and the combined organic layers were dried over Na2SO4, 
O O
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filtered and concentrated. The crude material was subjected to flash column chromatography 
(EtOAc) to give the 1,2-diol 4.16 (50.4 mg, 0.18 mmol, 44 %) as a colorless oil. 
TLC: Rf = 0.25 (SiO2, EtOAc). Optical rotation: [𝛼𝛼]*%( = –1.5° (c = 0.21, CHCl3). FTIR 
(neat): ν/ = 3453, 2918, 2848, 1743, 1713, 1375, 1238, 1103, 1005 cm−1. 1H NMR (500 MHz, 
CDCl3) δ = 5.50 (t, J = 3.3 Hz, 1H), 4.60 (d, J = 10.8 Hz, 1H), 3.59 (dd, J = 10.8, 3.4 Hz, 1H), 
3.52 (brs, 1H), 2.58 (brs, 1H), 2.47 – 2.28 (m, 2H), 2.19 (s, 3H), 2.16 (s, 3H), 2.01 (ddd, J = 
15.2, 10.3, 5.3 Hz, 1H), 1.88 (qd, J = 7.0, 3.1 Hz, 1H), 1.65 (ddd, J = 14.5, 10.4, 5.3 Hz, 1H), 
1.26 (s, 3H), 1.04 (d, J = 7.0 Hz, 3H). 13C NMR (126 MHz, CDCl3) δ = 211.9, 208.1, 170.8, 
75.5, 73.9, 73.9, 49.5, 38.9, 36.2, 30.2, 29.2, 21.3, 21.1, 10.9. HRMS (ESI) Exact mass 
calculated for C14H22O6Na+ [M+Na]+: 309.13086, found: 309.13086. 
 
 
(1S,2R,3R,4R,5R)-4,5-Dimethyl-6-oxo-5-(3-oxobutyl)cyclohexane-1,2,3-triyl triacetate 
(4.17): To a solution of 1,2-diol 4.16 (3.9 mg, 14 µmol, 1.0 eq.) in CH2Cl2 (0.3 mL) was added 
Et3N (6 µL, 41 µmol, 3.0 eq.), Ac2O (9 µL, 95 µmol, 7.0 eq.) and DMAP (0.3 mg, 2.7 µmol, 
0.2 eq.) at rt. The resulting mixture was stirred at rt for 1 h, then quenched by addition of a 
0.1 M aq. HCl solution and diluted with CH2Cl2. The layers were separated and the aqueous 
layer was extracted with CH2Cl2 (3 x). The combined organic layers were dried over Na2SO4, 
filtered and the solvent was removed under reduced pressure. The crude material was subjected 
to flash column chromatography (pentane/Et2O 1:2) to afford the tri-acetylated compound 4.17 
(2.2 mg, 6.0 µmol, 44 %) as a colorless oil. 
TLC: Rf = 0.39 (SiO2, pentane/Et2O 1:2). 1H NMR (400 MHz, CDCl3) δ = 5.72 (d, J = 12.0 
Hz, 1H), 5.55 (t, J = 3.2 Hz, 1H), 5.08 (dd, J = 12.0, 3.4 Hz, 1H), 2.42 (ddd, J = 16.3, 10.7, 5.1 
Hz, 1H), 2.36 – 2.26 (m, 1H), 2.19 (s, 3H), 2.17 (s, 3H), 2.15 (s, 3H), 2.02 (s, 3H), 2.00 – 1.91 
(m, 2H), 1.62 (ddd, J = 14.5, 10.6, 5.2 Hz, 1H), 1.30 (s, 3H), 1.03 (d, J = 7.0 Hz, 3H). 13C NMR 
(101 MHz, CDCl3) δ = 208.0, 204.3, 170.3, 170.2, 169.8, 72.9, 72.5, 71.2, 50.6, 38.8, 35.3, 
30.1, 29.3, 21.0, 21.0, 20.8, 20.7, 10.8. HRMS (ESI) Exact mass calculated for C18H26O8Na+ 
[M+Na]+: 393.15199, found: 393.15203. 
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(1R,2S,4R,5R,6R)-6-Acetoxy-4,5-dimethyl-3-oxo-4-(3-oxobutyl)-cyclohexane-1,2-diyl di-
benzoate (4.19): To a solution of 1,2-diol 4.16 (3.7 mg, 13 µmol, 1.0 eq.) in CH2Cl2 (0.3 mL) 
was added Et3N (3.7 µL, 26 µmol, 2.0 eq.), BzCl (6.0 µL, 52 µmol, 4.0 eq.) and DMAP 
(0.15 mg, 1.3 µmol, 0.1 eq.) at 0°C. The reaction mixture was allowed to warm up to rt and 
stirred for 2 h 15 min, before additional BzCl (20 µL, 0.17 mmol, 13 eq.) was added. After 
stirring for 19 h at rt, additional Et3N (7 µL, 52 µmol, 4.0 eq.) was added to the mixture and the 
solvent was evaporated after the mixture was stirred for in total 23 h 15 min. The residue was 
subjected to flash column chromatography (SiO2, pentane/Et2O 1:1) to afford the dibenzylated 
product 4.19 (1.4 mg, 3 µmol, 22 %) as a colorless solid. 
M.p. = 131.3 – 134.4°C. TLC: Rf = 0.34 (SiO2, pentane/Et2O, 1:1). Optical rotation: [𝛼𝛼]*%( =  
–39.0° (c = 1.10, CHCl3). FTIR (neat): ν/ = 2926, 1720, 1452, 1267, 1224, 1094, 710 cm−1. 
1H NMR (500 MHz, Chloroform-d) δ = 8.04 – 7.99 (m, 2H), 7.93 – 7.88 (m, 2H), 7.56 – 7.51 
(m, 2H), 7.43 – 7.36 (m, 4H), 6.17 (d, J = 11.9, 1H), 5.78 (t, J = 3.3, 1H), 5.56 (dd, J = 11.9, 
3.5, 1H), 2.49 (ddd, J = 16.1, 10.8, 4.9, 1H), 2.38 (ddd, J = 16.8, 10.6, 5.0, 1H), 2.22 (s, 3H), 
2.15 (s, 3H), 2.10 (qd, J = 7.2, 3.3, 1H), 2.04 (td, J = 10.3, 5.3, 1H), 1.68 (ddd, J = 14.4, 10.7, 
5.0, 1H), 1.42 (s, 3H), 1.10 (d, J = 6.9, 3H). 13C NMR (126 MHz, CDCl3) δ = 208.2, 204.1, 
170.0, 165.9, 165.4, 133.6 (2C), 130.0 (2C), 129.8 (2C), 129.2, 129.1, 128.6 (2C), 128.6 (2C), 
73.7, 72.6, 71.8, 50.7, 38.9, 35.7, 30.2, 29.4, 21.0 (2C), 10.9. HRMS (ESI) Exact mass 
calculated for C28H30O8Na+ [M+H]+: 517.18328, found: 517.18333. 
 
 
To a solution of 1,2-diol 4.16 (22.3 mg, 78 µmol, 1.0 eq), imidazole (13.3 mg, 0.20 mmol, 
2.5 eq) and DMAP (4.8 mg, 39 µmol 0.5 eq.) in CH2Cl2 (0.9 mL) was added TBSCl (47.5 mg, 
0.31 µmol, 4.0 eq) and the mixture was stirred at rt for 15 h. The reaction mixture was quenched 
by addition of sat. aq. NH4Cl solution, and extracted with CH2Cl2 (3 x). The combined organic 
layers were washed with H2O and brine, dried over Na2SO4 and concentrated. The crude 
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material was subjected to flash column chromatography (pentane/Et2O, 1:2) to afford the silyl 
ether 4.24 (20.8 mg, 51.9 µmol, 67 %) as a colorless oil and impure 4.25. After a second flash 
column chromatography (pentane/Et2O 4:1 to 2:1 to 1:1) silyl ether 4.25 (7.5 mg, 18.7 µmol, 
24 %) was obtained as a colorless solid. 
(1R,2R,3R,5S,6R)-5-((tert-Butyldimethylsilyl)oxy)-6-hydroxy-2,3-dimethyl-4-oxo-3-(3-
oxobutyl)cyclohexyl acetate (4.24): 
TLC: Rf = 0.21 (SiO2, pentane/Et2O 1:2). Optical rotation: [𝛼𝛼]*%0 = –31.7° (c = 0.99, CHCl3). 
FTIR (neat): ν/ = 3483, 2930, 2857, 1747, 1711, 1234, 1126, 1007, 839, 781 cm−1. 1H NMR 
(500 MHz, CDCl3) δ = 5.55 (t, J = 3.3, 1H), 4.66 (d, J = 10.7, 1H), 3.67 (ddd, J = 10.7, 3.3, 
1.3, 1H), 2.46 (ddd, J = 17.0, 11.0, 4.7, 1H), 2.39 (s, 1H), 2.26 (ddd, J = 16.9, 11.0, 5.0, 1H), 
2.17 (s, 3H), 2.14 (s, 3H), 1.95 (ddd, J = 14.4, 11.0, 4.7, 1H), 1.85 (qd, J = 7.0, 3.2, 1H), 1.57 
(ddd, J = 14.4, 11.0, 5.0, 1H), 1.21 (s, 3H), 1.00 (d, J = 7.1, 3H), 0.93 (s, 9H), 0.18 (s, 3H), 
0.03 (s, 3H). 13C NMR (126 MHz, CDCl3) δ = 210.0, 208.4, 170.6, 75.9, 74.2, 73.9, 50.5, 38.9, 
35.5, 30.1, 29.3, 26.0 (3C), 21.8, 21.1, 18.8, 10.8, -4.3, -5.5. HRMS (ESI) Exact mass calculated 
for C20H37O6Si+ [M+H]+: 401.23539, found: 401.23538 and for C20H36O6SiNa+ [M+Na]+: 
423.21734, found: 423.21699. 
(1R,2R,3R,5S,6S)-6-((tert-Butyldimethylsilyl)oxy)-5-hydroxy-2,3-dimethyl-4-oxo-3-(3-
oxobutyl)cyclohexyl acetate (4.25): 
M.p. = 97.1 – 99.3°C. TLC: Rf = 0.65 (SiO2, pentane/Et2O 1:2). Optical rotation: [𝛼𝛼]*%( =  
–7.1° (c = 0.31, CHCl3). FTIR (neat): ν/ = 3492, 2930, 2857, 1746, 1720, 1372, 1237, 1165, 
1010, 838, 781 cm−1. 1H NMR (500 MHz, CDCl3) δ = 5.37 (t, J = 3.3, 1H), 4.56 (dd, J = 10.4, 
3.9, 1H), 3.50 (dd, J = 10.4, 3.6, 1H), 3.43 (d, J = 4.0, 1H), 2.42 (ddd, J = 16.1, 10.7, 5.1, 1H), 
2.34 (ddd, J = 16.9, 10.6, 5.2, 1H), 2.16 (s, 3H), 2.14 (s, 3H), 1.99 (ddd, J = 14.4, 10.5, 5.0, 
1H), 1.81 (qd, J = 7.0, 3.1, 1H), 1.63 (ddd, J = 14.4, 10.7, 5.2, 1H), 1.23 (s, 3H), 1.01 (d, J = 
7.0, 3H), 0.87 (s, 9H), 0.12 (s, 3H), 0.07 (s, 3H). 13C NMR (126 MHz, CDCl3) δ = 212.8, 208.2, 
170.3, 76.3, 75.2, 74.5, 49.3, 38.9, 35.8, 30.2, 29.3, 25.7 (3C), 21.1 (2C), 18.3, 10.8, -4.5, -5.0. 
HRMS (ESI) Exact mass calculated for C20H36O6SiNa+ [M+Na]+: 423.21734, found: 
423.21744. 
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(5aR,6R,7R,8R,9aS)-2,2,4,4-Tetraisopropyl-7,8-dimethyl-9-oxo-8-(3-oxobutyl)-
hexahydrobenzo[f][1,3,5,2,4]trioxadisilepin-6-yl acetate (4.27): 1,2-Diol 4.16 (50.4 mg, 
0.18 mmol, 1.0 eq.) was dissolved in CH2Cl2 (1.0 mL), before imidazole (48.0 mg, 0.70 mmol, 
4.0 eq.) and TIPDSCl2 (67 µL, 0.21 mmol, 1.2 eq.) were added. The turbid mixture was stirred 
for 9 h 15 min, before it was diluted by addition of sat. aq. NH4Cl solution and CH2Cl2. The 
layers were separated and the aqueous layer was extracted with CH2Cl2 (2 x). The combined 
organic layers were washed with H2O and brine, dried over Na2SO4, filtered and concentrated. 
The residue was subjected to flash column chromatography (pentane/Et2O 2:1) to afford fully 
protected triol 4.27 (64.1 mg, 0.12 mmol, 69 %) as a colorless oil. 
TLC: Rf = 0.67 (SiO2, pentane/Et2O 1:1). Optical rotation: [𝛼𝛼]*%% = +10.2° (c = 0.57, CHCl3). 
FTIR (neat): ν/ = 3514, 2945, 2867, 1755, 1727, 1464, 1367, 1234, 1165, 1054, 985 cm−1. 
1H NMR (500 MHz, CDCl3) δ = 5.50 (t, J = 3.5 Hz, 1H), 4.79 (d, J = 10.1 Hz, 1H), 3.82 (dd, 
J = 10.2, 3.7 Hz, 1H), 2.47 (ddd, J = 16.1, 11.1, 4.6 Hz, 1H), 2.31 (ddd, J = 16.6, 11.1, 4.9 Hz, 
1H), 2.14 (s, 3H), 2.13 (s, 3H), 1.97 (ddd, J = 15.3, 11.1, 4.5 Hz, 1H), 1.83 (qd, J = 7.0, 3.0 Hz, 
1H), 1.56 (ddd, J = 14.4, 11.1, 4.9 Hz, 1H), 1.21 (s, 3H), 1.11-0.96 (m, 31H). 13C NMR (126 
MHz, CDCl3) δ = 208.6, 208.4, 170.2, 76.7, 76.6, 74.8, 50.0, 39.0, 35.3, 30.1, 29.6, 21.4, 21.1, 
17.6 – 17.1 (8C), 13.0, 12.9, 12.8, 12.1, 10.9. HRMS (ESI) Exact mass calculated for 
C26H49O7Si2+ [M+H]+: 529.30113, found: 529.30172 and for C26H48O7Si2Na+ [M+Na]+: 
551.28308, found: 551.28343. 
 
 
(5aR,6R,7R,7aR,11bR)-2,2,4,4-Tetraisopropyl-7,7a-dimethyl-10-oxo-5a,6,7,7a,8,9,10,11b-
octahydronaphtho[1,2-f][1,3,5,2,4]tri-oxadisilepin-6-yl acetate (4.28): A mixture of fully 
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protected triol 4.27 (64 mg, 0.12 mmol, 1.0 eq.), pyrrolidine (20 µL, 0.24 mmol, 2.0 eq.) and 
AcOH (14 µL, 0.24 mmol, 2.0 eq.) in toluene (3.5 mL) was stirred at rt for 18 h. The reaction 
mixture was quenched by addition of a 0.1 M aq. HCl solution. The layers were separated and 
the aqueous layer was extracted with CH2Cl2 (3 x). The combined organic layers were dried 
over Na2SO4, filtered and concentrated. The residue was subjected to flash column 
chromatography (pentane/Et2O 2:1) to afford the octalone 4.28 (42 mg, 82 µmol, 68 %) as a 
colorless solid.  
M.p. = 132.3 – 134.5°C. TLC: Rf = 0.41 (SiO2, pentane/Et2O 2:1). Optical rotation: 
[𝛼𝛼]*
%& = +31.7° (c = 0.31, CHCl3). FTIR (neat): ν/ = 2946, 2925, 1751, 1681, 1469, 1228, 1147, 
980 cm−1. 1H NMR (400 MHz, CDCl3) δ = 6.37 (dd, J = 2.1, 0.9 Hz, 1H), 5.40 (t, J = 3.3 Hz, 
1H), 4.63 (dd, J = 9.6, 2.0 Hz, 1H), 3.75 (dd, J = 9.6, 3.7 Hz, 1H), 2.48 (ddd, J = 17.0, 14.6, 5.0 
Hz, 1H), 2.35 (dddd, J = 17.0, 4.4, 3.1, 1.0 Hz, 1H), 2.11 (s, 3H), 2.06 (ddd, J = 13.4, 5.1, 3.1 
Hz, 1H), 1.78 – 1.62 (m, 2H), 1.29 (s, 3H), 1.11 – 0.96 (m, 31H). 13C NMR (126 MHz, CDCl3) 
δ = 199.4, 170.3, 166.9, 123.0, 77.3, 75.2, 72.3, 42.8, 38.7, 37.0, 33.4, 21.2, 19.1, 17.6 – 17.2 
(8C), 13.0, 12.9, 12.4, 12.0, 11.0. HRMS (ESI) Exact mass calculated for C26H47O6Si2+ 
[M+H]+: 511.29057, found: 511.29098 and for C26H46O6Si2Na+ [M+Na]+: 533.27251, found: 
533.27276. 
 
 
(5aR,6R,7R,7aR,9S,11bR)-9-(2-Hydroxypropan-2-yl)-2,2,4,4-tetraisopropyl-7,7a-di-
methyl-10-oxo-5a,6,7,7a,8,9,10,11b-octa-hydronaphtho[1,2-f][1,3,5,2,4]trioxadisilepin-6-
yl acetate (4.30): To a solution of octalone 4.28 (5.5 mg, 10.8 µmol, 1.0 eq.) in THF (0.3 mL) 
at –78°C was added a solution of LiHMDS (1 M in THF, 54 µL, 54 µmol, 5.0 eq.). After 1 h a 
solution of ZnCl2 (1 M in THF, 22 µL, 22 µmol, 2.0 eq.) was added and the reaction mixture 
was allowed to warm up to –40°C and stirred for 15 min at this temperature. Freshly distilled 
acetone (8 µL, 0.11 mmol, 10 eq.) was added and after stirring for 25 min, the reaction mixture 
was quenched by addition of an aq. tartaric acid solution (5 %). The mixture was extracted with 
Et2O (3 x) and the combined organic layers were washed with brine, dried over Na2SO4, filtered 
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and concentrated. The residue was subjected to flash column chromatography (pentane/Et2O 
2:1) to give the tertiary alcohol 4.30 (4.1 mg, 7.2 µmol, 67 %) as a colorless oil. 
TLC: Rf = 0.41 (SiO2, pentane/Et2O 3:1). Optical rotation: [𝛼𝛼]*%% = +40.5° (c = 0.21, CHCl3). 
FTIR (neat): ν/ = 2945, 2868, 1751, 1653, 1464, 1377, 1226, 1125, 887 cm−1. 1H NMR (500 
MHz, CDCl3) δ = 6.33 (d, J = 2.0 Hz, 1H), 5.41 (t, J = 3.3 Hz, 1H), 4.97 (brs, 1H), 4.62 (dd, J 
= 9.7, 2.0 Hz, 1H), 3.77 – 3.66 (m, 1H), 2.55 (dd, J = 14.6, 4.3 Hz, 1H), 2.12 (s, 3H), 2.03 (dd, 
J = 12.9, 4.4 Hz, 1H), 1.66 (dq, J = 7.1, 4.1 Hz, 1H), 1.48 (t, J = 13.8, 1H), 1.32 (s, 3H), 1.22 
(s, 3H), 1.21 (s, 3H), 1.11 – 0.96 (m, 31H). 13C NMR (126 MHz, CDCl3) δ = 203.2, 170.2, 
167.6, 123.6, 77.0, 75.1, 72.5, 72.2, 50.7, 43.1, 40.0, 39.4, 28.4, 24.9, 21.2, 19.0, 17.6 – 17.2 
(8C), 13.0, 12.9, 12.4, 12.0, 11.0. HRMS (ESI) Exact mass calculated for C29H53O7Si2+ 
[M+H]+: 569.33243, found: 569.33286. Exact mass calculated for C29H52O7Si2Na+ [M+Na]+: 
591.31428, found: 591.31437. 
 
 
(5aR,6R,7R,7aR,9S,11bR)-2,2,4,4-Tetraisopropyl-7,7a-dimethyl-10-oxo-9-(prop-1-en-2-
yl)-5a,6,7,7a,8,9,10,11b-octahydro-naphtho[1,2-f][1,3,5,2,4]trioxadisilepin-6-yl acetate 
(4.31): Tertiary alcohol 4.30 (18.7 mg, 33 µmol, 1.0 eq.) was dissolved in toluene (0.7 mL) and 
Burgess reagent (49 mg, 0.20 mmol, 6.1 eq.) was added. The reaction mixture was stirred at rt 
for 26 h, before it was diluted with H2O and extracted with Et2O (3 x). The combined organic 
layers were dried over Na2SO4, filtered and concentrated. The residue was subjected to flash 
column chromatography (pentane/Et2O 7:1) to afford the isopropenylated compound 4.31 
(9.7 mg, 17.6 µmol, 54 %) as a colorless solid.  
M.p. = 108.5 – 112.2°C. TLC: Rf = 0.76 (SiO2, pentane/Et2O 3:1). Optical rotation: 
[𝛼𝛼]*
%& = +86.2° (c = 0.49, CHCl3). FTIR (neat): ν/ = 2945, 2868, 1751, 1679, 1464, 1229, 1150, 
980, 887 cm−1. 1H NMR (500 MHz, CDCl3) δ = 6.36 (d, J = 2.0 Hz, 1H), 5.41 (t, J = 3.3 Hz, 
1H), 4.99 (t, J = 1.6 Hz, 1H), 4.82 (d, J = 1.7 Hz, 1H), 4.63 (dd, J = 9.6, 2.0 Hz, 1H), 3.76 (dd, 
J = 9.6, 3.8 Hz, 1H), 3.17 (dd, J = 14.4, 4.5 Hz, 1H), 2.12 (s, 3H), 2.00 (dd, J = 13.0, 4.6 Hz, 
1H), 1.86 (t, J = 13.7 Hz, 1H), 1.74 (s, 3H), 1.69 (qd, J = 7.0, 3.0 Hz, 1H), 1.35 (s, 3H), 1.12 – 
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0.95 (m, 31H). 13C NMR (126 MHz, CDCl3) δ = 198.7, 170.2, 165.8, 143.4, 123.1, 114.5, 77.1, 
75.3, 72.2, 50.2, 43.2, 42.9, 39.3, 21.2, 20.3, 19.1, 17.6 – 17.2 (8C), 13.0, 12.9, 12.3, 12.0, 11.0. 
HRMS (ESI) Exact mass calculated for C29H51O6Si2+ [M+H]+: 551.32187, found: 551.32224. 
 
 
Guignarderemophilane C (4.1): The fully protected triol 4.31 (10 mg, 18 µmol, 1.0 eq.) was 
dissolved in THF (0.35 mL) and cooled to 0°C. A solution of TBAF (1 M in THF, 73 µL, 
73 µmol, 4.0 eq.) was added and the reaction mixture was stirred at 0°C for 50 min, before it 
was treated with sat. aq. NH4Cl solution. The layers were separated and the aqueous layer was 
extracted with EtOAc (3 x). The combined organic layers were dried over Na2SO4, filtered and 
concentrated. The crude material was dissolved in a solution of NH3 (7 M in MeOH, 0.35 mL) 
and stirred at rt for 2 h. The solvent was evaporated (at 30°C bath temperature) and the residue 
was purified by flash column chromatography (CH2Cl2/MeOH 12:1) to afford a 4.6:1 mixture 
of guignarderemophilane C and D (3.5 mg, 13.1 µmol, 72 % over two steps). For analytical 
purposes, the mixture of 4.1 and 4.2 was purified by semi-preparative HPLC using the 
conditions given below. The residue was dissolved in a mixture of H2O/MeCN/MeOH (10:4:1, 
0.8 mL) and in total eight runs had to be carried out with injection of 100 µL of the sample per 
run. Two fractions were collected from 18.00 to 19.20 min (fraction 1), and from 19.20 to 21.00 
min (fraction 2), respectively. The first fraction gave pure guignarderemophilane C (2.2 mg, 
63 %) and the second fraction gave a 1:1 mixture of guignarderemophilanes C and D (1.1 mg, 
31 %) after concentration by rotary evaporator and lyophilizer. 
Column: Synergi Hydro-RP 10 µm 80 Å, 150 mm x 10.0 mm; solvent A: H2O; solvent B: 
MeCN; flow = 4.6 mL/min; T = rt; UV detection at 222 nm; solvent system: isocratic, [B] = 
18 %.  
TLC: Rf = 0.43 (SiO2, CH2Cl2/MeOH 12:1) Optical rotation: [𝛼𝛼]*%+ = +35.0° (c = 0.88, 
MeOH). FTIR (neat): ν/ = 3401, 2968, 2940, 2881, 1662, 1443, 1327, 1132, 1101, 1079, 889 
cm−1. 1H NMR (500 MHz, MeOD) δ = 6.20 (d, J = 2.0 Hz, 1H), 4.93 (t, J = 1.7 Hz, 1H), 4.82 
4.31, 54 %
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– 4.80 (m, 1H), 4.48 (dd, J = 10.4, 2.0 Hz, 1H), 3.86 (t, J = 3.0 Hz, 1H), 3.38 (dd, J = 10.4, 3.3 
Hz, 1H), 3.24 (dd, J = 14.4, 4.6 Hz, 1H), 1.99 (dd, J = 13.0, 4.6 Hz, 1H), 1.88 (t, J = 13.7 Hz, 
1H), 1.70 (t, J = 1.0 Hz, 3H), 1.51 (qd, J = 7.1, 2.8 Hz, 1H), 1.41 (s, 3H), 1.14 (d, J = 7.1 Hz, 
3H). 13C NMR (126 MHz, MeOD) δ = 201.7, 172.6, 144.9, 122.0, 114.7, 77.4, 75.6, 70.1, 51.3, 
45.9, 44.4, 40.8, 20.2, 19.8, 11.8. HRMS (ESI) Exact mass calculated for C15H22O4Na+ 
[M+Na]+: 289.14103, found: 289.14085. 
 
 
Guignarderemophilane D (4.2): A solution of 4.1 (2.0 mg, 7.5 µmol, 1.0 equiv.) in NaOMe 
(0.5 M in MeOH, 1.0 mL) was stirred for 6 h at 0°C. The reaction was quenched by addition of 
sat. aq. NH4Cl solution and the resulting turbid mixture was extracted with EtOAc (3 x). The 
combined organic layers were dried over Na2SO4, filtered and concentrated. The crude residue 
was subjected to flash column chromatography (CH2Cl2/MeOH 14:1) to give 
guignarderemophilane D (1.4 mg, 5.3 µmol, 70 %) as a colorless solid. 
TLC: Rf = 0.23 (SiO2, CH2Cl2/MeOH 14:1) Optical rotation: [𝛼𝛼]*%& = +38.2° (c = 0.70, 
MeOH). FTIR (neat): ν/ = 3401, 2965, 2882, 1652, 1626, 1370, 1297, 1072, 1017 cm−1. 
1H NMR (500 MHz, MeOD) δ = 6.20 (d, J = 2.2 Hz, 1H), 4.44 (dd, J = 10.4, 2.2 Hz, 1H), 3.86 
(t, J = 2.9 Hz, 1H), 3.39 (dd, J = 10.3, 3.2 Hz, 1H), 2.98 (d, J = 13.6 Hz, 1H), 2.12 (d, J = 14.3 
Hz, 1H), 2.08 (d, J = 2.1 Hz, 3H), 1.89 (d, J = 1.4 Hz, 3H), 1.56 (qd, J = 7.1, 2.7 Hz, 1H), 1.18 
(d, J = 1.4 Hz, 3H), 1.17 (s, 3H). 13C NMR (126 MHz, MeOD) δ = (126 MHz, MeOD) δ = 
194.2, 171.3, 145.6, 128.6, 124.2, 77.5, 75.6, 70.1, 44.7, 43.6, 43.1, 22.8, 22.4, 20.1, 12.1. 
HRMS (ESI) Exact mass calculated for C15H23O4+ [M+H]+: 267.15909, found: 267.15899 and 
C15H22O4Na+ [M+Na]+: 289.14075, found: 289.14084. 
 
  
4.1
OH
O
H
OH
OH
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OH
O
OH
OHNaOMe
MeOH, 0°C
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7 APPENDICES 
7.1 Crystal Structures 
X-Ray Crystallographic Data for 2.42 
 
Empirical formula  C21H36O2Si 
Formula weight [g mol-1]  348.60 
Crystal color, habit  colorless, needle 
Crystal dimensions [mm]  0.02 x 0.09 x 0.33 
Temperature [K]  100 
Radiation, l [Å]  Cu Ka, 1.54178 
Crystal system  monoclinic 
Space group  P21 
Z  2 
Reflections for cell determination 9949 
2Q range for cell determination [°] 6 – 136 
Unit cell parameters a [Å] 10.8142(2) 
 b [Å] 6.39970(10) 
 c [Å] 15.9412(3) 
 a [°] 90 
 b [°] 105.1560(10) 
 g [°] 90 
 V [Å3] 1064.88(2) 
F(000)  384 
Dx [g cm-3]  1.087  
µ(Cu Ka) [mm-1]  1.031  
2Q(max) [°]  136.0  
Total reflections measured  21476 
Symmetry independent reflections 3788 
Rint  0.039 
Reflections with I > 2s (I)  3610 
Reflections used in refinement 3545 
Parameters refined; restraints  246; 464 
Final R(F) [I > 2s (I) reflections] 0.0291 
 wR(F2) (all data)  0.0322 
Goodness of fit  1.0961 
Final Dmax/s  0.002 
Dr (max; min) [e Å-3]  0.24; -0.19 
s(d(C-C)) [Å]  0.003 – 0.17 
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X-Ray Crystallographic Data for 11R-2.70
 
 
Empirical formula  C15H20O3 
Formula weight [g mol-1]  248.32 
Crystal color, habit  colorless, plate 
Crystal dimensions [mm] 0.02 x 0.11 x 0.20
Temperature [K]  123 
Radiation, l [Å]  Cu Ka, 1.54178 
Crystal system  monoclinic 
Space group  P21 
Z  4 
Reflections for cell determination 6584 
2Q range for cell determination [°] 6 – 136 
Unit cell parameters a [Å] 7.9901(5) 
 b [Å] 11.0438(7) 
 c [Å] 14.7165(9) 
 a [°] 90 
 b [°] 99.899(4) 
 g [°] 90 
 V [Å3] 1279.27(8) 
F(000)  536 
Dx [g cm-3]  1.289  
µ(Cu Ka) [mm-1]  0.711  
2Q(max) [°]  136.0  
Total reflections measured  17596 
Symmetry independent reflections 4636 
Rint  0.034 
Reflections with I > 2s (I)  4047 
Reflections used in refinement 3785 
Parameters refined; restraints  332; 3 
Final R(F) [I > 2s (I) reflections] 0.0615 
 wR(F2) (all data)  0.0454 
Goodness of fit  0.898 
Final Dmax/s  0.000 
Dr (max; min) [e Å-3]  0.30; -0.19 
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X-Ray Crystallographic Data for 11S-2.70
 
 
Empirical formula  C15H20O3 
Formula weight [g mol-1]  248.32 
Crystal color, habit  colorless, plate 
Crystal dimensions [mm] 0.02 x 0.11 x 0.21
Temperature [K]  123 
Radiation, l [Å]  Cu Ka, 1.54178 
Crystal system  orthorhombic 
Space group  P212121 
Z  8 
Reflections for cell determination 8502 
2Q range for cell determination [°] 10 – 138 
Unit cell parameters a [Å] 8.4759(3) 
 b [Å] 11.9984(5) 
 c [Å] 25.2108(10) 
 a [°] 90 
 b [°] 90 
 g [°] 90 
 V [Å3] 2563.87(10) 
F(000)  1072 
Dx [g cm-3]  1.287 
µ(Cu Ka) [mm-1]  0.709 
2Q(max) [°]  138.0  
Total reflections measured  19355 
Symmetry independent reflections 4556 
Rint  0.030 
Reflections with I > 2s (I)  4328 
Reflections used in refinement 4244 
Parameters refined; restraints  332; 2 
Final R(F) [I > 2s (I) reflections] 0.0324 
 wR(F2) (all data)  0.0288 
Goodness of fit  0.9542 
Final Dmax/s  0.001 
Dr (max; min) [e Å-3]  0.36; -0.19 
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X-Ray Crystallographic Data for 11S-2.80
 
Crystallized from hexane / Et2O
Empirical formula  C22H38O3Si 
Formula weight [g mol-1]  378.61 
Crystal color, habit  colorless, needle 
Crystal dimensions [mm]  0.02 x 0.07 x 0.28 
Temperature [K]  160(1) 
Radiation, l [Å]  Cu Ka, 1.54184 
Crystal system  monoclinic  
Space group  C2 
Z  4 
Reflections for cell determination 6505 
2Q range for cell determination [°] 6 – 146 
Unit cell parameters a [Å] 26.0154(6) 
 b [Å] 7.2638(2) 
 c [Å] 12.3046(3) 
 a [°] 90 
 b [°] 94.652(2) 
 g [°] 90 
 V [Å3] 2317.55(10) 
F(000)  832 
Dx [g cm-3]  1.085  
µ(Cu Ka) [mm-1]  1.016  
Scan type  w 
2Q(max) [°]  146.0  
Transmission factors (min; max) 0.719; 1.000  
Total reflections measured  11650 
Symmetry independent reflections 4492 
Rint  0.034 
Reflections with I > 2s (I)  4050 
Reflections used in refinement 4487 
Parameters refined; restraints  287; 50 
Final R(F) [I > 2s (I) reflections] 0.0398 
 wR(F2) (all data)  0.1105 
Goodness of fit  1.069 
Final Dmax/s  0.000 
Dr (max; min) [e Å-3]  0.18; -0.19 
s(d(C-C)) [Å]  0.003 – 0.011  
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X-Ray Crystallographic Data for 11R-2.80
 
Crystallized from  hexane / Et2O 
Empirical formula  C22H38O3Si 
Formula weight [g mol-1]  378.61 
Crystal color, habit  colorless, needle 
Crystal dimensions [mm]  0.02 x 0.07 x 0.26 
Temperature [K]  160(1) 
Radiation, l [Å]  Cu Ka, 1.54184 
Crystal system  monoclinic 
Space group  C2 
Z  4 
Reflections for cell determination 5160 
2Q range for cell determination [°] 7 – 147 
Unit cell parameters a [Å] 25.2644(6) 
 b [Å] 7.33538(18) 
 c [Å] 12.3638(3) 
 a [°] 90 
 b [°] 94.354(2) 
 g [°] 90 
 V [Å3] 2284 
F(000)  832 
Dx [g cm-3]  1.101  
µ(Cu Ka) [mm-1]  1.030  
Scan type  w 
2Q(max) [°]  148.2  
Transmission factors (min; max) 0.732; 1.000  
Total reflections measured  11790  
Symmetry independent reflections 4406  
Rint  0.031  
Reflections with I > 2s (I)  4108  
Reflections used in refinement 4406  
Parameters refined; restraints  287; 50 
Final R(F) [I > 2s (I) reflections] 0.0440 
 wR(F2) (all data)  0.1229 
Goodness of fit  1.029 
Final Dmax/s  0.000 
Dr (max; min) [e Å-3]  0.64; -0.21 
s(d(C-C)) [Å]  0.004 – 0.012  
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X-ray Crystallographic Data for 3.11
 
Crystallized from  CH2Cl2 / pentane 
Empirical formula  C15H20O4 
Formula weight [g mol-1]  264.31 
Crystal color, habit  colorless, plate 
Crystal dimensions [mm]  0.01 x 0.25 x 0.28 
Temperature [K]  160(1)  
Radiation, l [Å]  Cu Ka, 1.54184 
Crystal system  orthorhombic 
Space group  P212121  (#19) 
Z  8 
Reflections for cell determination 27539 
2Q range for cell determination [°] 7 – 149 
Unit cell parameters a [Å] 7.26111(5) 
 b [Å] 12.04626(11) 
 c [Å] 31.0465(3) 
 a [°] 90 
 b [°] 90 
 g [°] 90 
 V [Å3] 2715.61(4) 
F(000)  1136 
Dx [g cm-3]  1.293  
µ(Cu Ka) [mm-1]  0.759  
Scan type  w 
2Q(max) [°]  148.4  
Transmission factors (min; max) 0.656; 1.000  
Total reflections measured  51176 
Symmetry independent reflections 5446 
Rint  0.036 
Reflections with I > 2s (I)  5305 
Reflections used in refinement 5445 
Parameters refined; restraints  365 
Final R(F) [I > 2s (I) reflections] 0.0286 
 wR(F2) (all data)  0.0724 
Goodness of fit  1.060 
Final Dmax/s  0.001 
Dr (max; min) [e Å-3]  0.22; -0.16 
s(d(C-C)) [Å]  0.002 – 0.003 
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7.2 1H and 13C NMR Spectra 
1H and 13C NMR spectra for all the characterized compounds are given at the end of this thesis. 
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